,symbol,name,description__profile,ceo__profile,industry__profile,price__profile,currency__profile,mktCap__profile,image__profile,volAvg__profile,pe__quote,change__quote,volume__quote,ebitda__income_statement,netIncome__income_statement,annual_earnings,quaterly_earnings,eps__income_statement,epsdiluted__income_statement,totalAssets__balance_sheet_statement,totalCurrentAssets__balance_sheet_statement,cashAndShortTermInvestments__balance_sheet_statement,totalLiabilities__balance_sheet_statement,netReceivables__balance_sheet_statement,longTermInvestments__balance_sheet_statement,totalCurrentLiabilities__balance_sheet_statement,cashAndCashEquivalents__balance_sheet_statement,freeCashFlow__cash_flow_statement,growthEBITDA__income_statement_growth,growthNetIncome__income_statement_growth,growthEPS__income_statement_growth,dividend__historical-price-full/stock_dividend,date__historical-price-full/stock_dividend,derived__netIncomeMargin,derived__debtRatio
0,ON,ON Semiconductor Corporation Common Stock,"ON Semiconductor Corporation provides intelligent sensing and power solutions worldwide. Its intelligent power technologies enable the electrification of the automotive industry that allows for lighter and longer-range electric vehicles, empowers fast-charging systems, and propels sustainable energy for the solar strings, industrial power, and storage systems. The company operates through three segments the Power Solutions Group, the Advanced Solutions Group, and the Intelligent Sensing Group segments. It offers analog, discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching and conversion, signal conditioning, circuit protection, signal amplification, and voltage regulation functions. The company also designs and develops analog, mixed-signal, advanced logic, application specific standard product and ASICs, radio frequency, and integrated power solutions for end-users in end-markets, as well as provides foundry and design services for government customers. In addition, it develops complementary metal oxide semiconductor image sensors, image signal processors, and single photon detectors, including silicon photomultipliers and single photon avalanche diode arrays, as well as actuator drivers for autofocus and image stabilization for a broad base of end-users in various end-markets. ON Semiconductor Corporation was incorporated in 1992 and is headquartered in Phoenix, Arizona.",Mr. Hassane S. El-Khoury,Semiconductors,39.2,USD,16519703200,https://images.financialmodelingprep.com/symbol/ON.png,9871557,10.8,7.25,28282498,1767700000,1572800000,"[{'period': '2024', 'revenue': 7.08, 'unit': 'B', 'net_profit': 1.57}, {'period': '2023', 'revenue': 8.25, 'unit': 'B', 'net_profit': 2.18}, {'period': '2022', 'revenue': 8.33, 'unit': 'B', 'net_profit': 1.9}, {'period': '2021', 'revenue': 6.74, 'unit': 'B', 'net_profit': 1.01}]","[{'period': ""Q4 '24"", 'revenue': 1720.0, 'unit': 'M', 'net_profit': 379.9}, {'period': ""Q3 '24"", 'revenue': 1760.0, 'unit': 'M', 'net_profit': 401.7}, {'period': ""Q2 '24"", 'revenue': 1740.0, 'unit': 'M', 'net_profit': 338.2}, {'period': ""Q1 '24"", 'revenue': 1860.0, 'unit': 'M', 'net_profit': 453.0}, {'period': ""Q4 '23"", 'revenue': 2020.0, 'unit': 'M', 'net_profit': 562.7}, {'period': ""Q3 '23"", 'revenue': 2180.0, 'unit': 'M', 'net_profit': 582.7}]",3.68,3.63,14089800000,6752000000,2991300000,5275300000,1160100000,0,1334800000,2691300000,1212400000,-0.4510418931089097,-0.2797545450382379,-0.27416173570019725,__nan__,__nan__,__nan__,0.37440559837613024
1,ONB,Old National Bancorp Common Stock,"Old National Bancorp operates as the bank holding company for Old National Bank that provides various financial services to individual and commercial customers in the United States. It accepts deposit accounts, including noninterest-bearing demand, interest-bearing checking, negotiable order of withdrawal, savings and money market, and time deposits; and offers loans, such as home equity lines of credit, residential real estate loans, consumer loans, commercial loans, commercial real estate loans, letters of credit, and lease financing. The company also provides debit and automated teller machine cards, telephone access, online banking, and other electronic and mobile banking services; cash management, private banking, brokerage, trust, investment advisory, and other traditional banking services; wealth management, investment, and foreign currency services; and treasury management, merchant, health savings, and capital markets services, as well as community development lending and equity investment solutions. As of December 31, 2021, it operated a total of 162 banking centers located primarily in the states of Indiana, Kentucky, Michigan, Minnesota, and Wisconsin. Old National Bancorp was founded in 1834 and is headquartered in Evansville, Indiana.",Mr. James C. Ryan III,Banks - Regional,19.7,USD,6290446400,https://images.financialmodelingprep.com/symbol/ONB.png,3054077,11.73,1.75,5250837,0,539188000,"[{'period': '2024', 'revenue': 1890.0, 'unit': 'M', 'net_profit': 539.19}, {'period': '2023', 'revenue': 1840.0, 'unit': 'M', 'net_profit': 581.99}, {'period': '2022', 'revenue': 1730.0, 'unit': 'M', 'net_profit': 428.29}, {'period': '2021', 'revenue': 810.62, 'unit': 'M', 'net_profit': 277.54}]","[{'period': ""Q4 '24"", 'revenue': 489.95, 'unit': 'M', 'net_profit': 153.87}, {'period': ""Q3 '24"", 'revenue': 485.86, 'unit': 'M', 'net_profit': 143.8}, {'period': ""Q2 '24"", 'revenue': 436.73, 'unit': 'M', 'net_profit': 121.23}, {'period': ""Q1 '24"", 'revenue': 433.98, 'unit': 'M', 'net_profit': 120.28}, {'period': ""Q4 '23"", 'revenue': 464.5, 'unit': 'M', 'net_profit': 132.48}, {'period': ""Q3 '23"", 'revenue': 456.02, 'unit': 'M', 'net_profit': 147.88}]",1.79,1.79,53552272000,7852909000,7852909000,47211922000,0,0,0,1227968000,622284000,-1.0,-0.07354740271343936,-0.08205128205128201,"[0.14, 3.0921]","['2025-03-05', '1985-02-26']",__nan__,0.8816044630188613
2,ONCR,Oncorus Inc. Common Stock,"Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. Oncorus, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.",Mr. Craig R. Jalbert CIRA,Biotechnology,0.126,USD,0,https://images.financialmodelingprep.com/symbol/ONCR.png,108675,-0.03620689655172414,-0.004,135947,-75416000,-78307000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -78.31}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -64.7}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -46.78}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.2}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.29}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.49}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.94}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.54}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.74}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.84}]",-3.02,-3.02,145586000,64618000,25709000,85061000,0,36487000,37207000,25709000,-81621000,-0.19955463655161446,-0.2103652410467255,-0.17968749999999997,"[0.13933, 0.13933]","['2023-12-26', '2023-12-26']",__nan__,0.5842663442913467
3,ONCS,OncoSec Medical Incorporated Common Stock,"OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey.",Dr. Robert H. Arch Ph.D.,Biotechnology,0.2772,USD,1652822,https://images.financialmodelingprep.com/symbol/ONCS.png,2131119,-0.013648449039881832,0.067,51295233,-35916889,-34179634,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.18}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.17}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.25}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.28}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.86}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.82}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.22}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.25}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.91}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.69}]",-19.13,-19.13,21878368,15232471,12299740,15759964,0,0,6633328,12299740,-32383196,0.24069945924112965,0.2432731677400399,0.3665562913907285,__nan__,__nan__,__nan__,0.7203445887737148
4,ONCT,Oncternal Therapeutics Inc. Common Stock,"Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.","Dr. James B. Breitmeyer M.D., Ph.D.",Biotechnology,0.5266,USD,1558546,https://images.financialmodelingprep.com/symbol/ONCT.png,62268,-0.04504704875962361,-0.1674,644135,2235000,-39479000,"[{'period': '2023', 'revenue': 0.785, 'unit': 'M', 'net_profit': -39.48}, {'period': '2022', 'revenue': 1.49, 'unit': 'M', 'net_profit': -43.39}, {'period': '2021', 'revenue': 4.32, 'unit': 'M', 'net_profit': -31.3}, {'period': '2020', 'revenue': 3.38, 'unit': 'M', 'net_profit': -17.21}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.46}, {'period': ""Q2 '24"", 'revenue': 0.801, 'unit': 'M', 'net_profit': -8.56}, {'period': ""Q1 '24"", 'revenue': 0.5690000000000001, 'unit': 'M', 'net_profit': -8.39}, {'period': ""Q4 '23"", 'revenue': 0.297, 'unit': 'M', 'net_profit': -9.16}, {'period': ""Q3 '23"", 'revenue': 0.179, 'unit': 'M', 'net_profit': -9.86}, {'period': ""Q2 '23"", 'revenue': 0.106, 'unit': 'M', 'net_profit': -8.97}]",-13.43,-13.43,36729000,36059000,34255000,6677000,632000,0,5198000,6697000,-32164000,1.0497252319398402,0.09019888000368723,0.18606060606060607,__nan__,__nan__,__nan__,0.18179095537586104
5,ONCY,Oncolytics Biotech Inc. Common Shares,"Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.",Mr. Wayne F. Pisano M.B.A.,Biotechnology,0.5197,USD,44913306,https://images.financialmodelingprep.com/symbol/ONCY.png,1064154,-1.79,0.024,214008,-33710000,-27752000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.75}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.84}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.3}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.55}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.02}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.54}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.26}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.89}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.95}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.93}]",-0.41,-0.41,20187000,18875000,15942000,14204000,68000,0,6687000,15942000,-27205000,-0.25638254258134247,-0.11745520434870144,0.046511627906976785,__nan__,__nan__,__nan__,0.7036211423193144
6,ONDS,Ondas Holdings Inc. Common Stock,"Ondas Holdings Inc., through its subsidiaries, provides private wireless, drone, and automated data solutions. The company operates in two segments, Ondas Networks and American Robotics. The company designs, develops, manufactures, sells, and supports FullMAX, a software defined radio (SDR) platform for wide-area broadband networks. Its FullMAX SDR platform enables secure and reliable industrial-grade connectivity for truly mission-critical applications. The company also offers Scout Drone, an AI-powered drone with imaging payloads; the ScoutBase, a ruggedized base station for housing, charging, data processing, and cloud transfer; and ScoutView, an American robotics analytics and user interface software package. It serves users in rail, energy, mining, agriculture, and critical infrastructure markets in the United States and internationally. The company is headquartered in Waltham, Massachusetts.",Mr. Eric Ashley Brock CPA,Communication Equipment,0.8301,USD,87767303,https://images.financialmodelingprep.com/symbol/ONDS.png,7251475,-1.36,0.0801,12885123,-28722864,-42419462,"[{'period': '2024', 'revenue': 7.19, 'unit': 'M', 'net_profit': -42.42}, {'period': '2023', 'revenue': 15.69, 'unit': 'M', 'net_profit': -44.84}, {'period': '2022', 'revenue': 2.13, 'unit': 'M', 'net_profit': -92.66}, {'period': '2021', 'revenue': 2.91, 'unit': 'M', 'net_profit': -15.02}]","[{'period': ""Q4 '24"", 'revenue': 4.13, 'unit': 'M', 'net_profit': -10.34}, {'period': ""Q3 '24"", 'revenue': 1.48, 'unit': 'M', 'net_profit': -9.53}, {'period': ""Q2 '24"", 'revenue': 0.9578500000000001, 'unit': 'M', 'net_profit': -8.27}, {'period': ""Q1 '24"", 'revenue': 0.62501, 'unit': 'M', 'net_profit': -9.88}, {'period': ""Q4 '23"", 'revenue': 4.96, 'unit': 'M', 'net_profit': -14.14}, {'period': ""Q3 '23"", 'revenue': 2.67, 'unit': 'M', 'net_profit': -7.29}]",-0.61,-0.61,109622288,47520551,29958106,73677776,5223182,0,50576622,29958106,-33469623,0.17076518125736245,0.054084444705294284,0.3068181818181818,__nan__,__nan__,__nan__,0.6721058038854288
7,ONEM,1Life Healthcare Inc. Common Stock,"1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.",Mr. Amir Dan Rubin MBA,Medical - Healthcare Information Services,16.47,USD,3401697462,https://images.financialmodelingprep.com/symbol/ONEM.png,2425987,-7.768867924528302,0.0,15268322,-326495000,-397847000,"[{'period': '2022', 'revenue': 1050.0, 'unit': 'M', 'net_profit': -397.85}, {'period': '2021', 'revenue': 621.55, 'unit': 'M', 'net_profit': -254.64}, {'period': '2020', 'revenue': 380.22, 'unit': 'M', 'net_profit': -88.72}, {'period': '2019', 'revenue': 276.26, 'unit': 'M', 'net_profit': -52.55}]","[{'period': ""Q4 '22"", 'revenue': 274.24, 'unit': 'M', 'net_profit': -101.14}, {'period': ""Q3 '22"", 'revenue': 261.37, 'unit': 'M', 'net_profit': -112.04}, {'period': ""Q2 '22"", 'revenue': 255.84, 'unit': 'M', 'net_profit': -93.81}, {'period': ""Q1 '22"", 'revenue': 254.1, 'unit': 'M', 'net_profit': -90.86}, {'period': ""Q4 '21"", 'revenue': 228.45, 'unit': 'M', 'net_profit': -95.43}, {'period': ""Q3 '21"", 'revenue': 151.33, 'unit': 'M', 'net_profit': -78.6}]",-2.02,-2.02,2432734000,450939000,262427000,888748000,137359000,0,204675000,215447000,-285522000,-0.6641775829552984,-0.5623839051841613,-0.21686746987951813,__nan__,__nan__,__nan__,0.3653288851144433
8,ONEW,OneWater Marine Inc. Class A Common Stock,"OneWater Marine Inc. operates as a recreational boat retailer in the United States. The company offers new and pre-owned recreational boats and yachts, as well as related marine products, such as parts and accessories. It also provides boat repair and maintenance services. In addition, the company arranges boat financing and insurance; and other ancillary services, including indoor and outdoor storage, and marina, as well as rental of boats and personal watercraft. As of September 30, 2021, it operated 70 stores in 11 states, including Texas, Florida, Alabama, North Carolina, South Carolina, Georgia, Ohio and New Jersey. OneWater Marine Inc. was founded in 2014 and is headquartered in Buford, Georgia.",Mr. Philip Austin Singleton Jr.,Auto - Recreational Vehicles,14.45,USD,231607476,https://images.financialmodelingprep.com/symbol/ONEW.png,159550,-20.35,1.55,166941,86991000,-5705000,"[{'period': '2024', 'revenue': 1770.0, 'unit': 'M', 'net_profit': -5.71}, {'period': '2023', 'revenue': 1940.0, 'unit': 'M', 'net_profit': -38.59}, {'period': '2022', 'revenue': 1740.0, 'unit': 'M', 'net_profit': 130.94}, {'period': '2021', 'revenue': 1230.0, 'unit': 'M', 'net_profit': 116.41}]","[{'period': ""Q1 '25"", 'revenue': 375.81, 'unit': 'M', 'net_profit': -11.97}, {'period': ""Q4 '24"", 'revenue': 377.86, 'unit': 'M', 'net_profit': -9.25}, {'period': ""Q3 '24"", 'revenue': 542.44, 'unit': 'M', 'net_profit': 14.68}, {'period': ""Q2 '24"", 'revenue': 488.32, 'unit': 'M', 'net_profit': -3.97}, {'period': ""Q1 '24"", 'revenue': 364.01, 'unit': 'M', 'net_profit': -7.17}, {'period': ""Q4 '23"", 'revenue': 450.98, 'unit': 'M', 'net_profit': -98.87}]",-0.39,-0.39,1589989000,777366000,16849000,1199236000,75847000,0,607719000,16849000,8921000,0.9814363483133272,0.8521714344941956,0.8550185873605948,"[1.8, 1.8]","['2021-06-25', '2021-06-25']",__nan__,0.7542416960117334
9,ONTX,Onconova Therapeutics Inc. Common Stock,"Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent or in combination with other anti-cancer therapies; and oral rigosertib alone or in combination with PD-1 inhibitor, which is in Phase I/IIa for the treatment of progressive K-Ras mutated non-small cell lung cancer. The company develops a Phase Ib/II ISS with rigosertib monotherapy in patients with advanced squamous cell carcinoma associated with recessive dystrophic epidermolysis bullosa; and has a preclinical program comprising IV/oral rigosertib for COVID-19. It has a license agreement with SymBio Pharmaceuticals Limited; license, development, and commercialization agreement with Pint International SA.; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc. for the development, registration, and commercialization of narazaciclib. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.",Dr. Steven M. Fruchtman M.D.,Biotechnology,0.9953,USD,20904684,https://images.financialmodelingprep.com/symbol/ONTX.png,126338,-1.0367708333333332,-0.0047,1254618,-20282000,-18948000,"[{'period': '2023', 'revenue': 0.226, 'unit': 'M', 'net_profit': -18.95}, {'period': '2022', 'revenue': 0.226, 'unit': 'M', 'net_profit': -18.3}, {'period': '2021', 'revenue': 0.226, 'unit': 'M', 'net_profit': -15.83}, {'period': '2020', 'revenue': 0.231, 'unit': 'M', 'net_profit': -25.16}]","[{'period': ""Q1 '24"", 'revenue': 0.056, 'unit': 'M', 'net_profit': -4.98}, {'period': ""Q4 '23"", 'revenue': 0.056, 'unit': 'M', 'net_profit': -4.18}, {'period': ""Q3 '23"", 'revenue': 0.057, 'unit': 'M', 'net_profit': -4.74}, {'period': ""Q2 '23"", 'revenue': 0.057, 'unit': 'M', 'net_profit': -4.25}, {'period': ""Q1 '23"", 'revenue': 0.056, 'unit': 'M', 'net_profit': -5.41}, {'period': ""Q4 '22"", 'revenue': 0.056, 'unit': 'M', 'net_profit': -5.0}]",-0.9,-0.9,22683000,22660000,20821000,12011000,18000,0,9220000,20821000,-17946000,-0.03337239516991899,-0.03535325938473308,-0.02272727272727275,__nan__,__nan__,__nan__,0.5295154961865715
10,ONTXW,Onconova Therapeutics Inc. Warrants,,None,,0.0671,USD,0,https://images.financialmodelingprep.com/symbol/ONTXW.png,0,0.0,-0.0229,415931,-25140000,-25157000,"[{'period': '2020', 'revenue': 0.231, 'unit': 'M', 'net_profit': -25.16}, {'period': '2019', 'revenue': 2.18, 'unit': 'M', 'net_profit': -21.5}, {'period': '2018', 'revenue': 1.23, 'unit': 'M', 'net_profit': -20.57}, {'period': '2017', 'revenue': 0.787, 'unit': 'M', 'net_profit': -24.09}]","[{'period': ""Q2 '21"", 'revenue': 0.057, 'unit': 'M', 'net_profit': -4.23}, {'period': ""Q4 '20"", 'revenue': 0.231, 'unit': 'M', 'net_profit': -25.16}, {'period': ""Q2 '20"", 'revenue': 0.056, 'unit': 'M', 'net_profit': -7.39}, {'period': ""Q4 '19"", 'revenue': 0.03, 'unit': 'M', 'net_profit': -5.75}, {'period': ""Q2 '19"", 'revenue': 2.02, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q4 '18"", 'revenue': 0.059000000000000004, 'unit': 'M', 'net_profit': -5.65}]",-0.14,-0.14,19784000,19784000,19025000,13811000,37000,0,10021000,19025000,-23090000,-0.17044555146887658,-0.16992977724038505,0.0,__nan__,__nan__,__nan__,0.6980893651435504
11,ONVO,Organovo Holdings Inc. Common Stock,"Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.",Mr. Keith E. Murphy,Biotechnology,2.12,USD,3607816,https://images.financialmodelingprep.com/symbol/ONVO.png,672611,-0.21,0.18,50528,-14806000,-14671000,"[{'period': '2023', 'revenue': 0.109, 'unit': 'M', 'net_profit': -14.67}, {'period': '2022', 'revenue': 0.37, 'unit': 'M', 'net_profit': -17.26}, {'period': '2021', 'revenue': 1.5, 'unit': 'M', 'net_profit': -11.45}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.83}]","[{'period': ""Q3 '24"", 'revenue': 0.024, 'unit': 'M', 'net_profit': -3.45}, {'period': ""Q2 '24"", 'revenue': 0.03, 'unit': 'M', 'net_profit': -2.55}, {'period': ""Q1 '24"", 'revenue': 0.039, 'unit': 'M', 'net_profit': -3.34}, {'period': ""Q4 '23"", 'revenue': 0.029, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q3 '23"", 'revenue': 0.005, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.99}]",-1.6,-1.6,6349000,3936000,2901000,2748000,33000,0,1860000,2901000,-14695000,0.15093474022250258,0.14995075033315952,0.19191919191919188,__nan__,__nan__,__nan__,0.43282406678217045
12,OPBK,OP Bancorp Common Stock,"OP Bancorp operates as the bank holding company for Open Bank that provides banking products and services in California. It offers demand, checking, savings, money market, and time deposit accounts, as well as certificates of deposit. The company also provides commercial real estate, small business administration, commercial and industrial business, single-family residential, term, consumer, and home mortgage loans; trade financing products; and letters of credit, and SWIFT and export advice. In addition, it offers debit and credit card, online transfer and bill payment, electronic delivery of customer statements, and mobile banking solutions for iPhone and Android phones, including remote check deposit with mobile bill pay; direct deposits, cashier's checks, person to person payments, wire transfers, and automated clearing house (ACH) services; and cash management services, including balance reporting, transfers between accounts, wire transfer initiation, ACH origination, and stop payment services, as well as remote deposit capture, positive pay, zero balance accounts, and sweep accounts. As of January 27, 2022, the company operated nine full branch offices in Downtown Los Angeles, Los Angeles Fashion District, Los Angeles Koreatown, Gardena, Buena Park, and Santa Clara in California; and Carrollton, Texas. It also had four loan production offices in Atlanta, Georgia; Aurora, Colorado; and Lynnwood and Seattle in Washington. The company was founded in 2005 and is headquartered in Los Angeles, California.",Ms. Min Jung Kim,Banks - Regional,11.45,USD,170768735,https://images.financialmodelingprep.com/symbol/OPBK.png,35590,8.24,0.6,61914,0,21069000,"[{'period': '2024', 'revenue': 79.28, 'unit': 'M', 'net_profit': 21.07}, {'period': '2023', 'revenue': 81.22, 'unit': 'M', 'net_profit': 23.92}, {'period': '2022', 'revenue': 94.53, 'unit': 'M', 'net_profit': 33.31}, {'period': '2021', 'revenue': 77.04, 'unit': 'M', 'net_profit': 28.84}]","[{'period': ""Q4 '24"", 'revenue': 19.8, 'unit': 'M', 'net_profit': 4.97}, {'period': ""Q3 '24"", 'revenue': 20.75, 'unit': 'M', 'net_profit': 5.44}, {'period': ""Q2 '24"", 'revenue': 38.55, 'unit': 'M', 'net_profit': 5.44}, {'period': ""Q1 '24"", 'revenue': 36.5, 'unit': 'M', 'net_profit': 5.23}, {'period': ""Q4 '23"", 'revenue': 35.46, 'unit': 'M', 'net_profit': 5.17}, {'period': ""Q3 '23"", 'revenue': 19.91, 'unit': 'M', 'net_profit': 5.12}]",1.39,1.42,2366013000,134943000,134943000,2161020000,9188000,0,16067000,134943000,29782000,-1.0,-0.11911531064470274,-0.10322580645161299,"[0.12, 0.05]","['2025-02-06', '2019-02-06']",__nan__,0.913359309521968
13,OPCH,Option Care Health Inc. Common Stock,"Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.",Mr. John C. Rademacher,Medical - Care Facilities,33.56,USD,5512028640,https://images.financialmodelingprep.com/symbol/OPCH.png,1892952,27.28,0.77,4014686,396126000,211823000,"[{'period': '2024', 'revenue': 5000.0, 'unit': 'M', 'net_profit': 211.82}, {'period': '2023', 'revenue': 4300.0, 'unit': 'M', 'net_profit': 267.09}, {'period': '2022', 'revenue': 3940.0, 'unit': 'M', 'net_profit': 150.56}, {'period': '2021', 'revenue': 3440.0, 'unit': 'M', 'net_profit': 139.9}]","[{'period': ""Q4 '24"", 'revenue': 1350.0, 'unit': 'M', 'net_profit': 60.13}, {'period': ""Q3 '24"", 'revenue': 1280.0, 'unit': 'M', 'net_profit': 53.86}, {'period': ""Q2 '24"", 'revenue': 1230.0, 'unit': 'M', 'net_profit': 53.04}, {'period': ""Q1 '24"", 'revenue': 1150.0, 'unit': 'M', 'net_profit': 44.79}, {'period': ""Q4 '23"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 57.18}, {'period': ""Q3 '23"", 'revenue': 1090.0, 'unit': 'M', 'net_profit': 56.3}]",1.23,1.23,3421743000,1322627000,412565000,2017505000,409733000,0,780146000,412565000,323392000,-0.18014173241383877,-0.20692276011831218,-0.174496644295302,__nan__,__nan__,__nan__,0.5896132468160233
14,OPEN,Opendoor Technologies Inc Common Stock,"Opendoor Technologies Inc. operates a digital platform for residential real estate in the United States. The company's platform enables consumers to buy and sell a home online. It also provides title insurance and escrow services. Opendoor Technologies Inc. was incorporated in 2013 and is based in Tempe, Arizona.",Ms. Carrie A. Wheeler,Real Estate - Services,1.09,USD,788634620,https://images.financialmodelingprep.com/symbol/OPEN.png,43150939,-1.95,0.1214,40457423,-205000000,-392000000,"[{'period': '2024', 'revenue': 5150.0, 'unit': 'M', 'net_profit': -392.0}, {'period': '2023', 'revenue': 6950.0, 'unit': 'M', 'net_profit': -275.0}, {'period': '2022', 'revenue': 15.57, 'unit': 'B', 'net_profit': -1.35}, {'period': '2021', 'revenue': 8020.0, 'unit': 'M', 'net_profit': -662.0}]","[{'period': ""Q4 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': -113.0}, {'period': ""Q3 '24"", 'revenue': 1380.0, 'unit': 'M', 'net_profit': -78.0}, {'period': ""Q2 '24"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': -92.0}, {'period': ""Q1 '24"", 'revenue': 1180.0, 'unit': 'M', 'net_profit': -109.0}, {'period': ""Q4 '23"", 'revenue': 870.0, 'unit': 'M', 'net_profit': -91.0}, {'period': ""Q3 '23"", 'revenue': 980.0, 'unit': 'M', 'net_profit': -106.0}]",-0.56,-0.56,3126000000,2997000000,679000000,2413000000,0,0,529000000,671000000,-620000000,0.29310344827586204,-0.4254545454545455,-0.33333333333333354,__nan__,__nan__,__nan__,0.77191298784389
15,OPENW,Opendoor Technologies Inc Warrants expiring 12/18/2025,,,,,,,,,,,,-180413000,-286760000,"[{'period': '2020', 'revenue': 2580.0, 'unit': 'M', 'net_profit': -286.76}, {'period': '2019', 'revenue': 4740.0, 'unit': 'M', 'net_profit': -341.02}, {'period': '2018', 'revenue': 1840.0, 'unit': 'M', 'net_profit': -241.29}]","[{'period': ""Q2 '21"", 'revenue': 1190.0, 'unit': 'M', 'net_profit': -143.81}, {'period': ""Q4 '20"", 'revenue': 2580.0, 'unit': 'M', 'net_profit': -286.76}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.04}, {'period': ""Q2 '20"", 'revenue': 739.83, 'unit': 'M', 'net_profit': -55.92}]",0.0,0.0,2169605000,2053111000,1460302000,575575000,0,47637000,393389000,1412665000,664570000,0.0590011735558743,0.15910350510385113,0.0,__nan__,__nan__,__nan__,0.2652902256401511
16,OPGN,OpGen Inc. Common Stock,"OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.",Mr. Honjian  Tan,Medical - Diagnostics & Research,3.75,USD,37755375,https://images.financialmodelingprep.com/symbol/OPGN.png,7434,-0.24,0.3,7143,-29511000,-32668530,"[{'period': '2023', 'revenue': 3.42, 'unit': 'M', 'net_profit': -32.67}, {'period': '2022', 'revenue': 2.61, 'unit': 'M', 'net_profit': -36.74}, {'period': '2021', 'revenue': 4.31, 'unit': 'M', 'net_profit': -34.81}, {'period': '2020', 'revenue': 4.21, 'unit': 'M', 'net_profit': -26.21}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.93}, {'period': ""Q2 '24"", 'revenue': 0.028, 'unit': 'M', 'net_profit': -1.58}, {'period': ""Q1 '24"", 'revenue': 168.15, 'unit': 'K', 'net_profit': 386.03}, {'period': ""Q4 '23"", 'revenue': 1.07, 'unit': 'M', 'net_profit': -17.04}, {'period': ""Q3 '23"", 'revenue': 0.69902, 'unit': 'M', 'net_profit': -4.06}, {'period': ""Q2 '23"", 'revenue': 0.73614, 'unit': 'M', 'net_profit': -5.83}]",-41.47,-41.47,1882274,1579874,1151823,13443858,103316,302262,11422242,1151823,-15119954,0.08871783207296977,0.11088001963064942,0.7244335171772212,__nan__,__nan__,__nan__,7.142349094765161
17,OPHC,OptimumBank Holdings Inc. Common Stock,"OptimumBank Holdings, Inc. operates as the bank holding company for OptimumBank that provides various consumer and commercial banking services to individuals and businesses. It accepts demand interest-bearing and noninterest-bearing, savings, money market, NOW, and time deposit accounts, as well as certificates of deposit; and offers residential and commercial real estate, multi-family real estate, commercial, land and construction, and consumer loans, as well as lending lines for working capital needs. The company also provides debit and ATM cards; investment, cash management, notary, and night depository services; and direct deposits, money orders, cashier's checks, domestic collections, and banking by mail, as well as internet banking services. It operates through two banking offices located in Broward County, Florida. The company was founded in 2000 and is based in Fort Lauderdale, Florida.",Mr. Timothy L. Terry,Banks - Regional,3.89,USD,45711779,https://images.financialmodelingprep.com/symbol/OPHC.png,36888,2.92,0.12,15203,0,13124000,"[{'period': '2024', 'revenue': 59.63, 'unit': 'M', 'net_profit': 13.12}, {'period': '2023', 'revenue': 35.78, 'unit': 'M', 'net_profit': 6.28}, {'period': '2022', 'revenue': 18.8, 'unit': 'M', 'net_profit': 4.02}, {'period': '2021', 'revenue': 11.18, 'unit': 'M', 'net_profit': 6.3}]","[{'period': ""Q4 '24"", 'revenue': 10.3, 'unit': 'M', 'net_profit': 3.95}, {'period': ""Q3 '24"", 'revenue': 10.08, 'unit': 'M', 'net_profit': 3.3}, {'period': ""Q2 '24"", 'revenue': 16.39, 'unit': 'M', 'net_profit': 3.5}, {'period': ""Q1 '24"", 'revenue': 14.7, 'unit': 'M', 'net_profit': 2.38}, {'period': ""Q4 '23"", 'revenue': 12.22, 'unit': 'M', 'net_profit': 2.55}, {'period': ""Q3 '23"", 'revenue': 8.9, 'unit': 'M', 'net_profit': 1.27}]",1.27,1.29,932933000,40103000,36755000,829749000,3348000,0,0,13982000,15605000,-1.0,1.0888110775107434,0.4597701149425288,__nan__,__nan__,__nan__,0.8893982740454031
18,OPI,Office Properties Income Trust Common Shares of Beneficial Interest,"OPI is a REIT focused on owning, operating and leasing properties primarily leased to single tenants and those with high credit quality characteristics such as government entities. OPI is managed by the operating subsidiary of The RMR Group Inc. (Nasdaq: RMR), an alternative asset management company that is headquartered in Newton, Massachusetts.",Ms. Jennifer Babbin Clark,REIT - Office,0.39,USD,27231633,https://images.financialmodelingprep.com/symbol/OPI.png,704942,-0.15,0.0225,458486,223336000,-136107000,"[{'period': '2024', 'revenue': 501.98, 'unit': 'M', 'net_profit': -136.11}, {'period': '2023', 'revenue': 533.55, 'unit': 'M', 'net_profit': -69.43}, {'period': '2022', 'revenue': 554.27, 'unit': 'M', 'net_profit': -2.6}, {'period': '2021', 'revenue': 576.48, 'unit': 'M', 'net_profit': -5.68}]","[{'period': ""Q4 '24"", 'revenue': 118.24, 'unit': 'M', 'net_profit': -148.68}, {'period': ""Q3 '24"", 'revenue': 120.62, 'unit': 'M', 'net_profit': -58.41}, {'period': ""Q2 '24"", 'revenue': 123.69, 'unit': 'M', 'net_profit': 76.17}, {'period': ""Q1 '24"", 'revenue': 139.44, 'unit': 'M', 'net_profit': -5.19}, {'period': ""Q4 '23"", 'revenue': 133.77, 'unit': 'M', 'net_profit': -37.15}, {'period': ""Q3 '23"", 'revenue': 133.36, 'unit': 'M', 'net_profit': -19.59}]",-2.63,-2.63,3822286000,416986000,261318000,2669482000,155668000,17370000,450323000,261318000,67167000,-0.2613109039131312,-0.960292084341514,-0.8263888888888888,"[0.01, 0.4]","['2025-01-27', '2009-10-21']",__nan__,0.6983993348483081
19,OPINI,Office Properties Income Trust 5.875% Senior Notes due 2046,,,,,,,,,,,,366170000,6678000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.68}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -66.7}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.68}]",0.14,0.14,3946436000,42045000,42045000,2337044000,0,0,169729000,42045000,,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.5921910300838529
20,OPINL,Office Properties Income Trust 6.375% Senior Notes due 2050,"Office Properties Income Trust is a real estate investment trust. It owns, operates, and leases office buildings to single tenants and multi-tenant buildings. The company was founded on February 17, 2009 and is headquartered in Newton, MA.",Ms. Jennifer Babbin Clark,REIT - Office,7.65,USD,25966074,https://images.financialmodelingprep.com/symbol/OPINL.png,23629,,0.02,15974,223336000,-136107000,"[{'period': '2024', 'revenue': 501.98, 'unit': 'M', 'net_profit': -136.11}, {'period': '2023', 'revenue': 533.55, 'unit': 'M', 'net_profit': -69.43}, {'period': '2022', 'revenue': 554.27, 'unit': 'M', 'net_profit': -2.6}, {'period': '2021', 'revenue': 576.48, 'unit': 'M', 'net_profit': -5.68}]","[{'period': ""Q4 '24"", 'revenue': 118.24, 'unit': 'M', 'net_profit': -148.68}, {'period': ""Q3 '24"", 'revenue': 120.62, 'unit': 'M', 'net_profit': -58.41}, {'period': ""Q2 '24"", 'revenue': 123.69, 'unit': 'M', 'net_profit': 76.17}, {'period': ""Q1 '24"", 'revenue': 139.44, 'unit': 'M', 'net_profit': -5.19}, {'period': ""Q4 '23"", 'revenue': 133.77, 'unit': 'M', 'net_profit': -37.15}, {'period': ""Q3 '23"", 'revenue': 133.36, 'unit': 'M', 'net_profit': -19.59}]",-2.63,-2.63,3822286000,416986000,261318000,2669482000,155668000,17370000,450323000,261318000,67167000,-0.2613109039131312,-0.960292084341514,-0.8263888888888888,"[0.39844, 0.398]","['2025-02-14', '2020-11-12']",__nan__,0.6983993348483081
21,OPK,OPKO Health Inc. Common Stock,"OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.",Dr. Phillip  Frost Ph.D.,Medical - Diagnostics & Research,1.49,USD,1000609500,https://images.financialmodelingprep.com/symbol/OPK.png,5006314,-18.62,0.03,5677593,135279000,-53224000,"[{'period': '2024', 'revenue': 713.14, 'unit': 'M', 'net_profit': -53.22}, {'period': '2023', 'revenue': 863.5, 'unit': 'M', 'net_profit': -188.86}, {'period': '2022', 'revenue': 1000.0, 'unit': 'M', 'net_profit': -328.0}, {'period': '2021', 'revenue': 1770.0, 'unit': 'M', 'net_profit': -29.5}]","[{'period': ""Q4 '24"", 'revenue': 183.64, 'unit': 'M', 'net_profit': 14.03}, {'period': ""Q3 '24"", 'revenue': 173.63, 'unit': 'M', 'net_profit': 24.89}, {'period': ""Q2 '24"", 'revenue': 182.19, 'unit': 'M', 'net_profit': -10.3}, {'period': ""Q1 '24"", 'revenue': 173.69, 'unit': 'M', 'net_profit': -81.84}, {'period': ""Q4 '23"", 'revenue': 181.9, 'unit': 'M', 'net_profit': -66.51}, {'period': ""Q3 '23"", 'revenue': 178.6, 'unit': 'M', 'net_profit': -84.5}]",-0.0767,-0.0767,2200212000,662089000,431936000,834764000,118017000,54584000,193096000,431936000,-208499000,3.064823859820502,0.7181872574299889,0.6932,__nan__,__nan__,__nan__,0.37940162129831123
22,OPNT,Opiant Pharmaceuticals Inc. Common Stock,"Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.",Dr. Roger  Crystal M.D.,Biotechnology,20.65,USD,108798242,https://images.financialmodelingprep.com/symbol/OPNT.png,72355,-3.1623277182235836,0,562778,5829247,3008790,"[{'period': '2021', 'revenue': 40.73, 'unit': 'M', 'net_profit': 3.01}, {'period': '2020', 'revenue': 27.4, 'unit': 'M', 'net_profit': -1.86}, {'period': '2019', 'revenue': 38.24, 'unit': 'M', 'net_profit': 11.59}, {'period': '2018', 'revenue': 13.51, 'unit': 'M', 'net_profit': -21.2}]","[{'period': ""Q3 '22"", 'revenue': 173.87, 'unit': 'M', 'net_profit': -9.92}, {'period': ""Q2 '22"", 'revenue': 2.33, 'unit': 'M', 'net_profit': -11.74}, {'period': ""Q1 '22"", 'revenue': 2.19, 'unit': 'M', 'net_profit': -12.59}, {'period': ""Q4 '21"", 'revenue': 13040.0, 'unit': 'K', 'net_profit': 752.33}, {'period': ""Q3 '21"", 'revenue': 14.04, 'unit': 'M', 'net_profit': 3.42}, {'period': ""Q2 '21"", 'revenue': 9.31, 'unit': 'M', 'net_profit': 1.68}]",0.68,0.51,70427798,69158964,52868697,23587990,13327364,0,6845558,37853947,1926489,4.788504595211309,2.616369828021074,2.545454545454546,__nan__,__nan__,__nan__,0.3349244285615745
23,OPOF,Old Point Financial Corporation Common Stock,"Old Point Financial Corporation operates as the bank holding company for The Old Point National Bank of Phoebus that provides consumer, mortgage, and business banking services for individual and commercial customers in Virginia. The company offers deposit products, including interest-bearing transaction accounts, money market deposit accounts, savings accounts, time deposits, and demand deposits. It also provides real estate construction, commercial, and mortgage loans, such as residential 1-4 family mortgages, multi-family and second mortgages, and equity lines of credit; and other loans, as well as cash management services. In addition, the company offers retirement planning, estate planning, financial planning, estate and trust administration, retirement plan administration, tax, and investment management services; and insurance products and wealth management services. It operates 14 branches in the Hampton Roads localities of Hampton, Newport News, Norfolk, Virginia Beach, Chesapeake, Williamsburg/James City County, York County, and Isle of Wight County; a loan production office in Richmond, Virginia; and a mortgage loan origination office in Charlotte, North Carolina. The company was founded in 1922 and is headquartered in Hampton, Virginia.",Mr. Robert F. Shuford Jr.,Banks - Regional,37.68,USD,192357530,https://images.financialmodelingprep.com/symbol/OPOF.png,15909,20.04,1.68,26265,508000,9508000,"[{'period': '2024', 'revenue': 60.91, 'unit': 'M', 'net_profit': 9.51}, {'period': '2023', 'revenue': 59.47, 'unit': 'M', 'net_profit': 7.73}, {'period': '2022', 'revenue': 55.72, 'unit': 'M', 'net_profit': 9.11}, {'period': '2021', 'revenue': 53.68, 'unit': 'M', 'net_profit': 8.44}]","[{'period': ""Q4 '24"", 'revenue': 15.41, 'unit': 'M', 'net_profit': 2.88}, {'period': ""Q3 '24"", 'revenue': 18.52, 'unit': 'M', 'net_profit': 2.38}, {'period': ""Q2 '24"", 'revenue': 21.59, 'unit': 'M', 'net_profit': 2.53}, {'period': ""Q1 '24"", 'revenue': 20.61, 'unit': 'M', 'net_profit': 1.72}, {'period': ""Q4 '23"", 'revenue': 21.41, 'unit': 'M', 'net_profit': 1.48}, {'period': ""Q3 '23"", 'revenue': 14.91, 'unit': 'M', 'net_profit': 1.36}]",1.88,1.88,1450570000,140044000,140044000,1336600000,0,0,7920000,139336000,13233000,0.0,0.230012936610608,0.2207792207792207,"[0.14, 0.14]","['2025-03-05', '2000-05-25']",__nan__,0.921430885789724
24,OPRA,Opera Limited American Depositary Shares,"Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. It operates in two segments, Browser and News, and Other. The company offers mobile browser products, such as Opera Mini, Opera for Android and iOS, Opera GX Mobile, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; and Opera News, an AI-powered personalized news discovery and aggregation service. It also provides browser-based cashback rewards under the Dify brand name; owns GameMaker Studio, a 2D gaming development platform; and GXC, a gaming portal. In addition, the company operates online marketing platforms, including Opera Ads, an online advertising platform; and Opera Ads Manager, designs to create, manage, and report on digital advertising campaigns in one place allowing advertisers to reach customers. It operates in Ireland, Singapore, Russia, and internationally. The company was founded in 1995 and is headquartered in Oslo, Norway. Opera Limited is a subsidiary of Kunlun Tech Limited.",Mr. Yahui  Zhou,Internet Content & Information,15.61,USD,690587961,https://images.financialmodelingprep.com/symbol/OPRA.png,484603,17.34,1.73,588019,107957000,80771000,"[{'period': '2024', 'revenue': 480.65, 'unit': 'M', 'net_profit': 80.77}, {'period': '2023', 'revenue': 396.75, 'unit': 'M', 'net_profit': 153.3}, {'period': '2022', 'revenue': 331.04, 'unit': 'M', 'net_profit': 15.04}, {'period': '2021', 'revenue': 250.99, 'unit': 'M', 'net_profit': -14.97}]","[{'period': ""Q4 '24"", 'revenue': 145.83, 'unit': 'M', 'net_profit': 28.69}, {'period': ""Q3 '24"", 'revenue': 123.21, 'unit': 'M', 'net_profit': 17.94}, {'period': ""Q2 '24"", 'revenue': 109.95, 'unit': 'M', 'net_profit': 19.3}, {'period': ""Q1 '24"", 'revenue': 100.8, 'unit': 'M', 'net_profit': 14.84}, {'period': ""Q4 '23"", 'revenue': 114.58, 'unit': 'M', 'net_profit': 107.45}, {'period': ""Q3 '23"", 'revenue': 102.64, 'unit': 'M', 'net_profit': 16.84}]",0.9,0.9,1055585000,231904000,126797000,115485000,92823000,261308000,101093000,126797000,81633000,-0.3795031528277234,-0.47312150605671194,0.046511627906976785,"[0.39, 0.75]","['2025-01-06', '2023-01-27']",__nan__,0.10940379031532278
25,OPRT,Oportun Financial Corporation Common Stock,"Oportun Financial Corporation provides financial services. It offers personal loans, auto loans, and credit cards. The company serves customers online and over-the-phone, as well as through retail locations. It operates in 24 states in the United States, which include Arkansas, Delaware, Indiana, Kentucky, Mississippi, Montana, North Dakota, New Hampshire, Oregon, South Carolina, South Dakota, and Virginia. Oportun Financial Corporation was founded in 2005 and is headquartered in San Carlos, California.",Mr. Raul  Vazquez,Financial - Credit Services,4.58,USD,165495094,https://images.financialmodelingprep.com/symbol/OPRT.png,589904,-2.35,0.23,731184,0,-78682000,"[{'period': '2024', 'revenue': 1000.0, 'unit': 'M', 'net_profit': -78.68}, {'period': '2023', 'revenue': 1060.0, 'unit': 'M', 'net_profit': -179.95}, {'period': '2022', 'revenue': 640.7, 'unit': 'M', 'net_profit': -77.8}, {'period': '2021', 'revenue': 530.4, 'unit': 'M', 'net_profit': 47.41}]","[{'period': ""Q4 '24"", 'revenue': 250.9, 'unit': 'M', 'net_profit': 8.7}, {'period': ""Q3 '24"", 'revenue': 249.95, 'unit': 'M', 'net_profit': -29.96}, {'period': ""Q2 '24"", 'revenue': 250.4, 'unit': 'M', 'net_profit': -31.02}, {'period': ""Q1 '24"", 'revenue': 250.48, 'unit': 'M', 'net_profit': -26.44}, {'period': ""Q4 '23"", 'revenue': 262.7, 'unit': 'M', 'net_profit': -41.8}, {'period': ""Q3 '23"", 'revenue': 268.2, 'unit': 'M', 'net_profit': -21.1}]",-1.95,-1.95,3227103000,59968000,59968000,2873294000,0,0,22511000,59968000,374335000,1.0,0.562758750993326,0.6004098360655737,__nan__,__nan__,__nan__,0.8903632762883614
26,OPRX,OptimizeRx Corporation Common Stock,"OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.",Mr. Stephen L. Silvestro,Medical - Healthcare Information Services,8.29,USD,153285416,https://images.financialmodelingprep.com/symbol/OPRX.png,520121,-7.54,0.85,351702,-8896000,-20110000,"[{'period': '2024', 'revenue': 92.13, 'unit': 'M', 'net_profit': -20.11}, {'period': '2023', 'revenue': 71.52, 'unit': 'M', 'net_profit': -17.57}, {'period': '2022', 'revenue': 62.45, 'unit': 'M', 'net_profit': -10.59}, {'period': '2021', 'revenue': 61290.0, 'unit': 'K', 'net_profit': 273.93}]","[{'period': ""Q4 '24"", 'revenue': 32320.0, 'unit': 'K', 'net_profit': -78.0}, {'period': ""Q3 '24"", 'revenue': 21.31, 'unit': 'M', 'net_profit': -9.12}, {'period': ""Q2 '24"", 'revenue': 18.81, 'unit': 'M', 'net_profit': -4.01}, {'period': ""Q1 '24"", 'revenue': 19.69, 'unit': 'M', 'net_profit': -6.9}, {'period': ""Q4 '23"", 'revenue': 28.37, 'unit': 'M', 'net_profit': -4.14}, {'period': ""Q3 '23"", 'revenue': 16.33, 'unit': 'M', 'net_profit': -2.87}]",-1.1,-1.1,171168000,53971000,13380000,54170000,38212000,0,18654000,13380000,4777000,0.5825120217859644,-0.1448339637795256,-0.06796116504854374,__nan__,__nan__,__nan__,0.31647270517853804
27,OPT,Opthea Limited American Depositary Shares,"Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.","Dr. Frederic  Guerard M.S., Pharm.D.",Biotechnology,3.41,USD,65604669,https://images.financialmodelingprep.com/symbol/OPT.png,32316,-1.52,0.05,3025,-200018770,-220242105,"[{'period': '2024', 'revenue': 0.12467, 'unit': 'M', 'net_profit': -220.24}, {'period': '2023', 'revenue': 0.16116, 'unit': 'M', 'net_profit': -211.88}, {'period': '2022', 'revenue': 0.12505, 'unit': 'M', 'net_profit': -127.99}, {'period': '2021', 'revenue': 0.09198, 'unit': 'M', 'net_profit': -60.79}]","[{'period': ""Q4 '24"", 'revenue': 0.08939, 'unit': 'M', 'net_profit': -185.99}, {'period': ""Q2 '24"", 'revenue': 0.09318000000000001, 'unit': 'M', 'net_profit': -147.42}, {'period': ""Q4 '23"", 'revenue': 0.08334000000000001, 'unit': 'M', 'net_profit': -96.84}, {'period': ""Q2 '23"", 'revenue': 0.07779000000000001, 'unit': 'M', 'net_profit': -115.11}, {'period': ""Q4 '22"", 'revenue': 0.06609999999999999, 'unit': 'M', 'net_profit': -79.81}, {'period': ""Q2 '22"", 'revenue': 0.12469, 'unit': 'M', 'net_profit': -51.55}]",-2.77,-2.77,188791216,188192564,172471346,264601293,11824439,0,64055658,172471346,-161048843,0.10425494058923836,-0.03946289487083013,-5.155555555555555,__nan__,__nan__,__nan__,1.4015551073096537
28,OPTN,OptiNose Inc. Common Stock,"OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.","Dr. Ramy A. Mahmoud M.D., M.P.H.",Drug Manufacturers - Specialty & Generic,9,USD,91146600,https://images.financialmodelingprep.com/symbol/OPTN.png,96755,-4.25,-0.05,498631,-1198000,-21541000,"[{'period': '2024', 'revenue': 78.23, 'unit': 'M', 'net_profit': -21.54}, {'period': '2023', 'revenue': 70.99, 'unit': 'M', 'net_profit': -35.48}, {'period': '2022', 'revenue': 76.28, 'unit': 'M', 'net_profit': -76.39}, {'period': '2021', 'revenue': 74.65, 'unit': 'M', 'net_profit': -81.65}]","[{'period': ""Q4 '24"", 'revenue': 22420.0, 'unit': 'K', 'net_profit': -360.0}, {'period': ""Q3 '24"", 'revenue': 20440.0, 'unit': 'K', 'net_profit': 467.0}, {'period': ""Q2 '24"", 'revenue': 20.49, 'unit': 'M', 'net_profit': -7.58}, {'period': ""Q1 '24"", 'revenue': 14.88, 'unit': 'M', 'net_profit': -14.07}, {'period': ""Q4 '23"", 'revenue': 19.86, 'unit': 'M', 'net_profit': -9.97}, {'period': ""Q3 '23"", 'revenue': 19.82, 'unit': 'M', 'net_profit': -9.29}]",-0.0021,-0.0021,128785000,125843000,84485000,169145000,26392000,0,162813000,84485000,-44752000,0.9229730598598341,0.3929205535044951,0.9934375000000001,__nan__,__nan__,__nan__,1.31339053461195
29,OPTT,Ocean Power Technologies Inc. Common Stock,"Ocean Power Technologies, Inc. develops and commercializes proprietary systems that generate electricity by harnessing the renewable energy of ocean waves in North America, South America, Europe, and Asia. It offers PB3 PowerBuoy system that generates power for use independent of the power grid in offshore locations. The company also provides hybrid PowerBuoy products; subsea battery systems; and software, controls, sensors, integration services, and marine installation services. In addition, it offers distributed offshore power and communications for remote surface and subsea applications in markets, such as defense and security, offshore oil and gas, science and research, and offshore wind. Further, the company provides Wave Adaptive Modular Vessel (WAM-V) technology, which enables roaming capabilities for uncrewed maritime systems in waters; leases WAM-V robotics and access information; maritime domain awareness solutions; and strategic consulting services. Additionally, it offers offshore data collection, integration, analytics, and real time communication for various applications. The company serves public and private entities, and agencies that require remote offshore power. Ocean Power Technologies, Inc. was incorporated in 1984 and is headquartered in Monroe Township, New Jersey.",Dr. Philipp  Stratmann,Electrical Equipment & Parts,0.3913,USD,67323556,https://images.financialmodelingprep.com/symbol/OPTT.png,9747583,-1.57,0.0551,3995756,-28242000,-27483000,"[{'period': '2024', 'revenue': 5.53, 'unit': 'M', 'net_profit': -27.48}, {'period': '2023', 'revenue': 2.73, 'unit': 'M', 'net_profit': -26.33}, {'period': '2022', 'revenue': 1.76, 'unit': 'M', 'net_profit': -18.87}, {'period': '2021', 'revenue': 1.21, 'unit': 'M', 'net_profit': -15.85}]","[{'period': ""Q3 '25"", 'revenue': 0.8250000000000001, 'unit': 'M', 'net_profit': -6.72}, {'period': ""Q2 '25"", 'revenue': 2.42, 'unit': 'M', 'net_profit': -3.91}, {'period': ""Q1 '25"", 'revenue': 1.3, 'unit': 'M', 'net_profit': -4.45}, {'period': ""Q4 '24"", 'revenue': 1.57, 'unit': 'M', 'net_profit': -6.72}, {'period': ""Q3 '24"", 'revenue': 1.79, 'unit': 'M', 'net_profit': -6.51}, {'period': ""Q2 '24"", 'revenue': 0.889, 'unit': 'M', 'net_profit': -7.21}]",-0.47,-0.47,28704000,10543000,3151000,9360000,814000,0,7359000,3151000,-32348000,-0.017253178691063645,-0.0439489478082504,0.0,__nan__,__nan__,__nan__,0.32608695652173914
30,ORBC,ORBCOMM Inc. Common Stock,"ORBCOMM Inc. provides Internet of Things solutions in the United States, South America, Japan, Europe, and internationally. The company offers network connectivity, devices, device management, and web reporting applications that are designed to track, monitor, control, and enhance security for various assets, such as trailers, trucks, rail cars, sea containers, power generators, fluid tanks, marine vessels, diesel or electric powered generators, oil and gas wells, pipeline monitoring equipment, irrigation control systems, and utility meters in transportation and supply chain, heavy equipment, fixed asset monitoring, and maritime industries, as well as for governments. It also provides satellite automatic identification service data services for vessel navigation and to enhance maritime safety for government and commercial customers; and vehicle fleet management, as well as in-cab and fleet vehicle solutions using various network platforms, including its own constellation of low-Earth orbit satellites and accompanying ground infrastructure, as well as terrestrial-based cellular communication services through reseller agreements with various cellular wireless providers. In addition, the company offers customer solutions utilizing additional satellite network service options through service agreements with third party mobile satellite providers; and resells service using the two-way Inmarsat plc satellite network to provide higher bandwidth. It markets and sells its products and services directly to original equipment manufacturers, government customers, and end-users, as well as indirectly through market channel partners and affiliates. ORBCOMM Inc. was founded in 2001 and is headquartered in Rochelle Park, New Jersey.",Mr. Marc Eisenberg,Communication Equipment,11.49,USD,0,https://images.financialmodelingprep.com/symbol/ORBC.png,632978,0,0,1556128,38409000,-33940000,"[{'period': '2020', 'revenue': 248.47, 'unit': 'M', 'net_profit': -33.94}, {'period': '2019', 'revenue': 272.01, 'unit': 'M', 'net_profit': -18.42}, {'period': '2018', 'revenue': 276.14, 'unit': 'M', 'net_profit': -26.24}, {'period': '2017', 'revenue': 254.22, 'unit': 'M', 'net_profit': -61.28}]","[{'period': ""Q2 '21"", 'revenue': 65.93, 'unit': 'M', 'net_profit': -7.64}, {'period': ""Q1 '21"", 'revenue': 63.7, 'unit': 'M', 'net_profit': -10.56}, {'period': ""Q4 '20"", 'revenue': 63.81, 'unit': 'M', 'net_profit': -14.77}, {'period': ""Q3 '20"", 'revenue': 61.74, 'unit': 'M', 'net_profit': -5.53}, {'period': ""Q2 '20"", 'revenue': 56.73, 'unit': 'M', 'net_profit': -6.67}, {'period': ""Q1 '20"", 'revenue': 66.18, 'unit': 'M', 'net_profit': -6.97}]",-0.43,-0.43,510845000,136162000,40384000,301430000,51199000,0,61468000,40384000,28878000,-0.3356108699036516,-0.8422623894045487,-0.8695652173913042,__nan__,__nan__,__nan__,0.590061564662471
31,ORGO,Organogenesis Holdings Inc. Class A Common Stock,"Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.",Mr. Gary S. Gillheeney Sr.,Drug Manufacturers - Specialty & Generic,4.08,USD,517458240,https://images.financialmodelingprep.com/symbol/ORGO.png,1872495,-408,0.38,1208793,-1283000,861000,"[{'period': '2024', 'revenue': 482040.0, 'unit': 'K', 'net_profit': 861.0}, {'period': '2023', 'revenue': 433.14, 'unit': 'M', 'net_profit': 4.95}, {'period': '2022', 'revenue': 450.89, 'unit': 'M', 'net_profit': 15.53}, {'period': '2021', 'revenue': 468.06, 'unit': 'M', 'net_profit': 94.2}]","[{'period': ""Q4 '24"", 'revenue': 126.66, 'unit': 'M', 'net_profit': 7.67}, {'period': ""Q3 '24"", 'revenue': 115.18, 'unit': 'M', 'net_profit': 12.33}, {'period': ""Q2 '24"", 'revenue': 130.23, 'unit': 'M', 'net_profit': -17.04}, {'period': ""Q1 '24"", 'revenue': 109.98, 'unit': 'M', 'net_profit': -2.1}, {'period': ""Q4 '23"", 'revenue': 99650.0, 'unit': 'K', 'net_profit': -568.0}, {'period': ""Q3 '23"", 'revenue': 108.53, 'unit': 'M', 'net_profit': 12.11}]",-0.01,-0.01,497886000,285941000,135571000,112570000,109861000,0,77477000,135571000,4176000,-1.0356082262496185,-0.8258847320525784,-1.2652519893899206,__nan__,__nan__,__nan__,0.22609593360729163
32,ORGS,Orgenesis Inc. Common Stock,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",Ms. Vered  Caplan M.Sc.,Biotechnology,1.96,USD,10135768,https://images.financialmodelingprep.com/symbol/ORGS.png,12272,-0.08,0.03,6467,-60718000,-55361000,"[{'period': '2023', 'revenue': 0.53, 'unit': 'M', 'net_profit': -55.36}, {'period': '2022', 'revenue': 36.02, 'unit': 'M', 'net_profit': -12.17}, {'period': '2021', 'revenue': 35.5, 'unit': 'M', 'net_profit': -18.06}, {'period': '2020', 'revenue': 7.65, 'unit': 'M', 'net_profit': -95.13}]","[{'period': ""Q3 '24"", 'revenue': 0.34700000000000003, 'unit': 'M', 'net_profit': 9.12}, {'period': ""Q2 '24"", 'revenue': 0.246, 'unit': 'M', 'net_profit': -8.9}, {'period': ""Q1 '24"", 'revenue': 0.14100000000000001, 'unit': 'M', 'net_profit': -9.77}, {'period': ""Q4 '23"", 'revenue': -13.6, 'unit': 'M', 'net_profit': -34.39}, {'period': ""Q3 '23"", 'revenue': 0.11, 'unit': 'M', 'net_profit': 12.65}, {'period': ""Q2 '23"", 'revenue': 6.97, 'unit': 'M', 'net_profit': -4.13}]",-1.91,-1.91,14552000,4076000,837000,35535000,88000,8000,16407000,837000,-16933000,-6.312778513790196,-3.5493467006327553,-2.9791666666666665,__nan__,__nan__,__nan__,2.441932380428807
33,ORIAU,Orion Biotech Opportunities Corp. Units,"Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.",Mr. Zuie-Chin  Huang M.B.A.,Shell Companies,9,USD,0,https://images.financialmodelingprep.com/symbol/ORIAU.png,201,55.55555555555556,0,5,-10555645,18412268,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.41}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -820.79}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.82}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.05}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.06}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 4.9}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.26}]",0.92,0.92,203332786,439320,265717,8331760,0,202893,67593,265717,-376757,-13.569598535813764,23.43234635857362,29.04878048780488,__nan__,__nan__,__nan__,0.040975979151734045
34,ORIC,Oric Pharmaceuticals Inc. Common Stock,"ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.","Dr. Jacob M. Chacko M.B.A., M.D.",Biotechnology,4.69,USD,333115692,https://images.financialmodelingprep.com/symbol/ORIC.png,1082598,-2.56,0.435,983960,-142895000,-127847000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -127.85}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -100.7}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -91.48}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -77.68}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.31}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.57}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.96}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.01}, {'period': ""Q4 '23"", 'revenue': 1.54, 'unit': 'M', 'net_profit': -28.33}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.48}]",-1.83,-1.83,274142000,262250000,255960000,31020000,0,0,24846000,59406000,-112662000,-0.30202828297554396,-0.26962074341837394,0.06632653061224485,__nan__,__nan__,__nan__,0.11315303747692801
35,ORLY,O'Reilly Automotive Inc. Common Stock,"O'Reilly Automotive, Inc., together with its subsidiaries, operates as a retailer and supplier of automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States. The company provides new and remanufactured automotive hard parts and maintenance items, such as alternators, batteries, brake system components, belts, chassis parts, driveline parts, engine parts, fuel pumps, hoses, starters, temperature control, water pumps, antifreeze, appearance products, engine additives, filters, fluids, lighting products, and oil and wiper blades; and accessories, including floor mats, seat covers, and truck accessories. Its stores offer auto body paint and related materials, automotive tools, and professional service provider service equipment. The company's stores also provide enhanced services and programs comprising used oil, oil filter, and battery recycling; battery, wiper, and bulb replacement; battery diagnostic testing; electrical and module testing; check engine light code extraction; loaner tool program; drum and rotor resurfacing; custom hydraulic hoses; and professional paint shop mixing and related materials. Its stores offer do-it-yourself and professional service provider customers a selection of products for domestic and imported automobiles, vans, and trucks. As of December 31, 2021, the company owned and operated 5,759 stores in the United States, and 25 stores in Mexico. O'Reilly Automotive, Inc. was founded in 1957 and is headquartered in Springfield, Missouri.",Mr. Brad W. Beckham,Specialty Retail,1348.45,USD,77185952225,https://images.financialmodelingprep.com/symbol/ORLY.png,393118,33.18,33.25,918983,3251157000,2386680000,"[{'period': '2024', 'revenue': 16.71, 'unit': 'B', 'net_profit': 2.39}, {'period': '2023', 'revenue': 15.81, 'unit': 'B', 'net_profit': 2.35}, {'period': '2022', 'revenue': 14.41, 'unit': 'B', 'net_profit': 2.17}, {'period': '2021', 'revenue': 13.33, 'unit': 'B', 'net_profit': 2.16}]","[{'period': ""Q4 '24"", 'revenue': 4100.0, 'unit': 'M', 'net_profit': 551.13}, {'period': ""Q3 '24"", 'revenue': 4360.0, 'unit': 'M', 'net_profit': 665.46}, {'period': ""Q2 '24"", 'revenue': 4270.0, 'unit': 'M', 'net_profit': 622.85}, {'period': ""Q1 '24"", 'revenue': 3980.0, 'unit': 'M', 'net_profit': 547.24}, {'period': ""Q4 '23"", 'revenue': 3830.0, 'unit': 'M', 'net_profit': 552.5}, {'period': ""Q3 '23"", 'revenue': 4200.0, 'unit': 'M', 'net_profit': 649.83}]",40.91,40.66,14893741000,5839895000,130245000,16264702000,495930000,0,8283505000,130245000,2026189000,-0.09630765972220098,0.01708826586425101,0.05438144329896906,__nan__,__nan__,__nan__,1.0920494723253211
36,ORMP,Oramed Pharmaceuticals Inc. Common Stock,"Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.",Mr. Nadav  Kidron Esq.,Biotechnology,2.12,USD,86603060,https://images.financialmodelingprep.com/symbol/ORMP.png,252918,-4.42,0.09,258415,-15573000,5525000,"[{'period': '2023', 'revenue': 1.34, 'unit': 'M', 'net_profit': 5.53}, {'period': '2022', 'revenue': 2.7, 'unit': 'M', 'net_profit': -37.76}, {'period': '2021', 'revenue': 2.7, 'unit': 'M', 'net_profit': -22.24}, {'period': '2020', 'revenue': 2.71, 'unit': 'M', 'net_profit': -11.51}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.62}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.21}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.54}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.34}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.22}, {'period': ""Q2 '23"", 'revenue': 0.674, 'unit': 'M', 'net_profit': -1.19}]",0.14,0.14,220551000,162584000,162047000,57658000,0,56366000,53214000,9055000,-10549000,0.5788349199480745,1.1463033576951593,1.1443298969072164,__nan__,__nan__,__nan__,0.2614270622214363
37,ORPH,Orphazyme A/S American Depositary Shares,"Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.",Ms. Kim  Stratton,Biotechnology,0.87,USD,0,https://images.financialmodelingprep.com/symbol/ORPH.png,1378810,-0.2269170579029734,0,941412,-615847000,-633246000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -633.25}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -337.5}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -229.6}, {'period': '2017', 'revenue': 0.0, 'unit': 'M', 'net_profit': -126.2}]","[{'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -190.92}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -125.71}, {'period': ""Q2 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.37}, {'period': ""Q1 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.37}, {'period': ""Q2 '18"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.4}, {'period': ""Q1 '18"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.4}]",-22.32,-22.32,822493000,783664000,726929000,201968000,18454000,0,166627000,726929000,-544177000,-0.8416972944846004,-0.8763011226766461,-0.32305868405453464,__nan__,__nan__,__nan__,0.2455558892294524
38,ORRF,Orrstown Financial Services Inc Common Stock,"Orrstown Financial Services, Inc. operates as the holding company for Orrstown Bank that provides commercial banking and trust services in the United States. The company accepts various deposits, including checking, savings, time, demand, and money market deposits. It also offers commercial loans, such as commercial real estate, equipment, construction, working capital, and other commercial purpose loans, as well as industrial loans; consumer loans comprising home equity and other consumer loans, as well as home equity lines of credit; residential mortgage loans; acquisition and development loans; municipal loans; and installment and other loans. In addition, the company provides renders services as trustee, executor, administrator, guardian, managing agent, custodian, and investment advisor, as well as provides other fiduciary services under the Orrstown Financial Advisors name; and offers retail brokerage services through a third-party broker/dealer arrangement. Further, it offers investment advisory, insurance, and brokerage services. The company operates through offices in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry, and York counties, Pennsylvania; and Anne Arundel, Baltimore, Howard, and Washington counties, Maryland, as well as Baltimore City, Maryland. Orrstown Financial Services, Inc. was founded in 1919 and is based in Shippensburg, Pennsylvania.",Mr. Thomas Rodney Quinn Jr.,Banks - Regional,27.31,USD,529431660,https://images.financialmodelingprep.com/symbol/ORRF.png,143898,18.45,0.84,184343,0,22050000,"[{'period': '2024', 'revenue': 176.14, 'unit': 'M', 'net_profit': 22.05}, {'period': '2023', 'revenue': 149.9, 'unit': 'M', 'net_profit': 35.66}, {'period': '2022', 'revenue': 1.29, 'unit': 'M', 'net_profit': 22.04}, {'period': '2021', 'revenue': 116.13, 'unit': 'M', 'net_profit': 32.88}]","[{'period': ""Q4 '24"", 'revenue': 60.06, 'unit': 'M', 'net_profit': 13.68}, {'period': ""Q3 '24"", 'revenue': 50.4, 'unit': 'M', 'net_profit': -7.9}, {'period': ""Q2 '24"", 'revenue': 50.43, 'unit': 'M', 'net_profit': 7.74}, {'period': ""Q1 '24"", 'revenue': 49.28, 'unit': 'M', 'net_profit': 8.53}, {'period': ""Q4 '23"", 'revenue': 46.52, 'unit': 'M', 'net_profit': 7.64}, {'period': ""Q3 '23"", 'revenue': 32.14, 'unit': 'M', 'net_profit': 9.03}]",1.48,1.48,5441589000,259366000,238308000,4924907000,21058000,0,0,238308000,33377000,0.0,-0.3817121386310742,-0.5710144927536233,"[0.26, 0.3397]","['2025-02-14', '1999-06-29']",__nan__,0.9050494258202889
39,ORTX,Orchard Therapeutics plc American Depositary Shares,"Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. It has a strategic collaboration agreement with Pharming Group N.V. for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom.","Dr. Hubert Baburaj Gaspar M.D., Ph.D.",Biotechnology,16.7,USD,380108700,https://images.financialmodelingprep.com/symbol/ORTX.png,105224,-4.073170731707317,0.05,372349,-8079000,-7883000,"[{'period': '2022', 'revenue': 6.99, 'unit': 'M', 'net_profit': -7.88}, {'period': '2021', 'revenue': 0.483, 'unit': 'M', 'net_profit': -36.35}, {'period': '2020', 'revenue': 2.6, 'unit': 'M', 'net_profit': -151.98}, {'period': '2019', 'revenue': 2.51, 'unit': 'M', 'net_profit': -163.42}]","[{'period': ""Q3 '23"", 'revenue': 6.3, 'unit': 'M', 'net_profit': -35.32}, {'period': ""Q2 '23"", 'revenue': 7.31, 'unit': 'M', 'net_profit': -12.31}, {'period': ""Q1 '23"", 'revenue': 1.24, 'unit': 'M', 'net_profit': -17.41}, {'period': ""Q4 '22"", 'revenue': 6.99, 'unit': 'M', 'net_profit': 134.89}, {'period': ""Q3 '22"", 'revenue': 5.78, 'unit': 'M', 'net_profit': -47.56}, {'period': ""Q2 '22"", 'revenue': 4.37, 'unit': 'M', 'net_profit': -50.92}]",-0.61,-0.61,218907000,168145000,143750000,120643000,14409000,0,60567000,68424000,-82501000,0.7726850679496919,0.7831302099094886,0.7918088737201365,__nan__,__nan__,__nan__,0.5511153138090604
40,OSBC,Old Second Bancorp Inc. Common Stock,"Old Second Bancorp, Inc. operates as the bank holding company for Old Second National Bank that provides community banking services. It provides demand, NOW, money market, savings, time deposit, individual retirement, and checking accounts, as well as certificate of deposit accounts. The company also offers commercial loans; lease financing receivables; commercial real estate loans; construction loans; residential real estate loans, such as residential first mortgage and second mortgage loans; home equity line of credit; consumer loans, including motor vehicle, home improvement, and signature loans; installment and agricultural loans; residential mortgages; and overdraft checking. Further, it provides safe deposit services; trust and wealth management services; and money orders, cashier's checks, foreign currency, direct deposits, discount brokerage, debit and credit cards, and other services, as well as acquires the U.S. treasury notes and bonds. In addition, the company offers online and mobile banking; corporate cash management products, including remote and mobile deposits capture, investment sweep accounts, zero balance accounts, automated tax payments, automatic teller machines access, telephone banking, lockbox accounts, automated clearing house transactions, account reconciliation, controlled disbursement, detail and general information reporting, foreign and domestic wire transfers, and vault services for currency and coin; and investment, agency, and custodial services for individual, corporate, and not-for-profit clients. It operates through 63 banking centers in Cook, DeKalb, DuPage, Kane, Kendall, LaSalle, and Will counties in Illinois. Old Second Bancorp, Inc. was incorporated in 1981 and is headquartered in Aurora, Illinois.",Mr. James L. Eccher,Banks - Regional,15.42,USD,694627824,https://images.financialmodelingprep.com/symbol/OSBC.png,238265,8.25,0.71,386891,0,85264000,"[{'period': '2024', 'revenue': 279.9, 'unit': 'M', 'net_profit': 85.26}, {'period': '2023', 'revenue': 291.97, 'unit': 'M', 'net_profit': 91.73}, {'period': '2022', 'revenue': 244.92, 'unit': 'M', 'net_profit': 67.41}, {'period': '2021', 'revenue': 133.46, 'unit': 'M', 'net_profit': 20.04}]","[{'period': ""Q4 '24"", 'revenue': 71.7, 'unit': 'M', 'net_profit': 19.11}, {'period': ""Q3 '24"", 'revenue': 76.07, 'unit': 'M', 'net_profit': 22.95}, {'period': ""Q2 '24"", 'revenue': 84.61, 'unit': 'M', 'net_profit': 21.89}, {'period': ""Q1 '24"", 'revenue': 83.78, 'unit': 'M', 'net_profit': 21.31}, {'period': ""Q4 '23"", 'revenue': 82.21, 'unit': 'M', 'net_profit': 18.23}, {'period': ""Q3 '23"", 'revenue': 71.56, 'unit': 'M', 'net_profit': 32.48}]",1.9,1.87,5649377000,1213876000,1213876000,4978343000,489612000,0,20000000,52175000,131533000,-1.0,-0.07047934677146812,-0.07317073170731704,"[0.06, 0.2]","['2025-01-31', '1993-12-22']",__nan__,0.881219822999952
41,OSIS,OSI Systems Inc. Common Stock (DE),"OSI Systems, Inc. designs and manufactures electronic systems and components worldwide. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems, AS&E, and Gatekeeper names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.",Mr. Ajay  Mehra,"Hardware, Equipment & Parts",191.16,USD,3211354188,https://images.financialmodelingprep.com/symbol/OSIS.png,267859,24.57,16.94,452756,230716000,128154000,"[{'period': '2024', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 128.15}, {'period': '2023', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 91.78}, {'period': '2022', 'revenue': 1180.0, 'unit': 'M', 'net_profit': 115.35}, {'period': '2021', 'revenue': 1150.0, 'unit': 'M', 'net_profit': 74.05}]","[{'period': ""Q2 '25"", 'revenue': 419.82, 'unit': 'M', 'net_profit': 37.82}, {'period': ""Q1 '25"", 'revenue': 344.01, 'unit': 'M', 'net_profit': 17.94}, {'period': ""Q4 '24"", 'revenue': 480.91, 'unit': 'M', 'net_profit': 44.68}, {'period': ""Q3 '24"", 'revenue': 405.41, 'unit': 'M', 'net_profit': 34.04}, {'period': ""Q2 '24"", 'revenue': 373.24, 'unit': 'M', 'net_profit': 36.55}, {'period': ""Q1 '24"", 'revenue': 279.21, 'unit': 'M', 'net_profit': 12.88}]",7.55,7.38,1936008000,1215524000,95353000,1072525000,648155000,0,814637000,95353000,-126933000,0.3275409685140858,0.39634770860118984,0.3853211009174311,__nan__,__nan__,__nan__,0.5539878967442283
42,OSMT,Osmotica Pharmaceuticals plc Ordinary Shares,"Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.",Mr. Brian Markison,Biotechnology,1.11,USD,110176380,https://images.financialmodelingprep.com/symbol/OSMT.png,594359,-0.6941838649155723,-0.01999998,296322,-36186000,-51692000,"[{'period': '2022', 'revenue': 49.72, 'unit': 'M', 'net_profit': -51.69}, {'period': '2021', 'revenue': 17.5, 'unit': 'M', 'net_profit': -82.85}, {'period': '2020', 'revenue': 27.76, 'unit': 'M', 'net_profit': -89.01}, {'period': '2019', 'revenue': 240.03, 'unit': 'M', 'net_profit': -270.9}]","[{'period': ""Q2 '23"", 'revenue': 8.26, 'unit': 'M', 'net_profit': -23.89}, {'period': ""Q1 '23"", 'revenue': 8.83, 'unit': 'M', 'net_profit': -11.61}, {'period': ""Q4 '22"", 'revenue': 9.81, 'unit': 'M', 'net_profit': -18.32}, {'period': ""Q3 '22"", 'revenue': 10.02, 'unit': 'M', 'net_profit': -14.45}, {'period': ""Q2 '22"", 'revenue': 8.45, 'unit': 'M', 'net_profit': -12.11}, {'period': ""Q1 '22"", 'revenue': 21.44, 'unit': 'M', 'net_profit': -6.82}]",-0.58,-0.58,128510000,56975000,44543000,77417000,3031000,0,19723000,44543000,-38562000,0.5087962208828799,0.37606971719634513,0.5284552845528455,__nan__,__nan__,__nan__,0.6024200451326746
43,OSN,Ossen Innovation Co. Ltd. American Depositary Shares,"Ossen Innovation Co., Ltd. manufactures coated steel materials. The company is headquartered in Shanghai, Shanghai and currently employs 209 full-time employees. The firm manufactures and sells an array of plain surface prestressed steel materials, and rare earth coated and zinc coated prestressed steel materials. The firm's materials are used in the construction of bridges, highways and other infrastructure projects in the People's Republic of China and internationally. Its facilities are located in Maanshan City, Anhui Province and in Jiujiang City, Jiangxi Province, in the People's Republic of China. Its pre-stressed steel materials are categorized as plain surface products and coated products. Its products are marketed under the Ossen brand name both domestically and internationally. The firm's plain surface products include its uncoated plain surfaced and stabilized products. Its coated pre-stressed products included zinc coated PC products and rare earth coated PC products.",Mr. Wei Hua,Steel,5.0499,USD,0,https://images.financialmodelingprep.com/symbol/OSN.png,65955,3.0076831447290053,-0.00010014,0,15999377,12028634,"[{'period': '2020', 'revenue': 138.58, 'unit': 'M', 'net_profit': 12.03}, {'period': '2019', 'revenue': 138.9, 'unit': 'M', 'net_profit': 12.23}, {'period': '2018', 'revenue': 136.1, 'unit': 'M', 'net_profit': 11.38}, {'period': '2017', 'revenue': 132.38, 'unit': 'M', 'net_profit': 5.9}]","[{'period': ""Q2 '20"", 'revenue': 54.85, 'unit': 'M', 'net_profit': 5.85}, {'period': ""Q4 '19"", 'revenue': 73.82, 'unit': 'M', 'net_profit': 6.05}, {'period': ""Q2 '19"", 'revenue': 65.08, 'unit': 'M', 'net_profit': 6.18}, {'period': ""Q4 '18"", 'revenue': 66.08, 'unit': 'M', 'net_profit': 6.21}, {'period': ""Q2 '18"", 'revenue': 70.02, 'unit': 'M', 'net_profit': 5.17}, {'period': ""Q4 '17"", 'revenue': 42.82, 'unit': 'M', 'net_profit': 2.78}]",1.82,1.82,203305181,195225155,1229400,52193902,52027214,0,37870011,1229400,-10804447,0.024851240252804774,-0.016214109206255527,-0.01621621621621623,__nan__,__nan__,__nan__,0.25672686619825985
44,OSPN,OneSpan Inc. Common Stock,"OneSpan Inc., together with its subsidiaries, designs, develops, and markets digital solutions for identity, security, and business productivity worldwide. The company offers OneSpan Sign, a range of e-signature requirements for occasional agreement to processing tens of thousands of transactions; OneSpan Cloud Authentication, a cloud-based multifactor authentication solution that supports a range of authentication options, including biometrics, push notification, and visual cryptograms for transaction data signing, SMS, and hardware authenticators; and OneSpan Identity Verification, which enables banks and financial institutions identity verification services. It also provides Mobile Security Suite, a software development kit; Mobile Authenticator Studio, a mobile authenticator that operates as a discrete mobile application; and authentication servers, which enables customers to administer a high level of access control. In addition, it offers Trusted Identity Platform, a cloud platform that simplify and secure user journeys; Intelligent Adaptive Authentication; and Risk Analytics, a comprehensive anti-fraud solution. It sells its solutions through its direct sales force, as well as through distributors, resellers, systems integrators, and original equipment manufacturers. The company was formerly known as VASCO Data Security International, Inc. and changed its name to OneSpan Inc. in May 2018. OneSpan Inc. was founded in 1991 and is headquartered in Chicago, Illinois. OneSpan Inc. was a former subsidiary of Guidewire Software, Inc.",Mr. Victor T. Limongelli Esq.,Software - Infrastructure,14.91,USD,569201178,https://images.financialmodelingprep.com/symbol/OSPN.png,424398,10.21,1.34,470381,57613000,57082000,"[{'period': '2024', 'revenue': 243.18, 'unit': 'M', 'net_profit': 57.08}, {'period': '2023', 'revenue': 235.11, 'unit': 'M', 'net_profit': -29.8}, {'period': '2022', 'revenue': 219.01, 'unit': 'M', 'net_profit': -14.43}, {'period': '2021', 'revenue': 214.48, 'unit': 'M', 'net_profit': -30.58}]","[{'period': ""Q4 '24"", 'revenue': 61.17, 'unit': 'M', 'net_profit': 28.79}, {'period': ""Q3 '24"", 'revenue': 56.24, 'unit': 'M', 'net_profit': 8.27}, {'period': ""Q2 '24"", 'revenue': 60.92, 'unit': 'M', 'net_profit': 6.55}, {'period': ""Q1 '24"", 'revenue': 64.84, 'unit': 'M', 'net_profit': 13.47}, {'period': ""Q4 '23"", 'revenue': 62930.0, 'unit': 'K', 'net_profit': 441.0}, {'period': ""Q3 '23"", 'revenue': 58.84, 'unit': 'M', 'net_profit': -4.13}]",1.49,1.46,338734000,175065000,83160000,126204000,64916000,0,110275000,83160000,46422000,12.338909663452077,2.915567636497869,3.0135135135135136,"[0.12, 0.12]","['2025-01-31', '2025-01-31']",__nan__,0.37257553124280407
45,OSS,One Stop Systems Inc. Common Stock,"One Stop Systems, Inc. designs, manufactures, and markets high-performance computing modules and systems for edge deployments in the United States and internationally. Its systems are built using the graphical processing unit and solid-state flash technologies. The company provides custom servers, data acquisition platforms, compute accelerators, solid-state storage arrays, PCIe expansion products, and system I/O expansion systems, as well as edge optimized industrial and panel PCs. It also offers ruggedized mobile tablets and handhelds that meet the specialized requirement for devices deployed at the edge in a diverse set of environmental conditions. The company sells its products to multinational companies, governmental agencies, military contractors, and technology providers through its website, web store, direct sales team, and original equipment manufacturer focused sales, as well as through a network of resellers and distributors. One Stop Systems, Inc. was founded in 1998 and is headquartered in Escondido, California.",Mr. Michael  Knowles,Computer Hardware,2.12,USD,43085396,https://images.financialmodelingprep.com/symbol/OSS.png,241940,-3.26,0.19,108171,-11414672,-13634333,"[{'period': '2024', 'revenue': 7.72, 'unit': 'M', 'net_profit': -13.63}, {'period': '2023', 'revenue': 60.9, 'unit': 'M', 'net_profit': -6.72}, {'period': '2022', 'revenue': 72.42, 'unit': 'M', 'net_profit': -2.23}, {'period': '2021', 'revenue': 61.98, 'unit': 'M', 'net_profit': 2.33}]","[{'period': ""Q4 '24"", 'revenue': 2.38, 'unit': 'M', 'net_profit': -3.13}, {'period': ""Q3 '24"", 'revenue': 13.7, 'unit': 'M', 'net_profit': -6.82}, {'period': ""Q2 '24"", 'revenue': 13.2, 'unit': 'M', 'net_profit': -2.34}, {'period': ""Q1 '24"", 'revenue': 12.65, 'unit': 'M', 'net_profit': -1.34}, {'period': ""Q4 '23"", 'revenue': 13160.0, 'unit': 'K', 'net_profit': -277.56}, {'period': ""Q3 '23"", 'revenue': 13.75, 'unit': 'M', 'net_profit': -3.64}]",-0.65,-0.65,36933982,32201048,10011158,9761937,8177371,0,8195679,6794093,-470846,-1.4848216896010435,-1.030073809858467,-1.03125,__nan__,__nan__,__nan__,0.26430773156276516
46,OSTK,Overstock.com Inc. Common Stock,"Overstock.com, Inc. operates as an online retailer in the United States. The company offers furniture, décor, area rug, bedding and bath, home improvement, outdoor, and kitchen and dining items. It provides its products and services through its internet websites comprising overstock.com, o.co, overstock.ca, and overstockgovernment.com. The company also offers businesses advertising products or services on its website; Market Partner, a service that allows its partners to sell their products through third party sites; products to international customers using third party logistics providers; and Supplier Oasis, a single integration point through its partners can manage their products, inventory, and sales channels, as well as obtain multi-channel fulfillment services through its distribution network. The company was formerly known as D2-Discounts Direct and changed its name to Overstock.com, Inc. in October 1999. Overstock.com, Inc. was founded in 1997 and is headquartered in Midvale, Utah.",Mr. Jonathan E. Johnson III,Specialty Retail,16.78,USD,768037380,https://images.financialmodelingprep.com/symbol/OSTK.png,3269789,-4.6353591160221,0,3736902,-190969000,-258795000,"[{'period': '2024', 'revenue': 1390.0, 'unit': 'M', 'net_profit': -258.8}, {'period': '2023', 'revenue': 1560.0, 'unit': 'M', 'net_profit': -307.84}, {'period': '2022', 'revenue': 1930.0, 'unit': 'M', 'net_profit': -35.24}, {'period': '2021', 'revenue': 2760.0, 'unit': 'M', 'net_profit': 171.79}]","[{'period': ""Q4 '24"", 'revenue': 303.15, 'unit': 'M', 'net_profit': -81.26}, {'period': ""Q3 '24"", 'revenue': 311.43, 'unit': 'M', 'net_profit': -61.03}, {'period': ""Q2 '24"", 'revenue': 398.1, 'unit': 'M', 'net_profit': -42.58}, {'period': ""Q1 '24"", 'revenue': 382.28, 'unit': 'M', 'net_profit': -73.93}, {'period': ""Q4 '23"", 'revenue': 384.46, 'unit': 'M', 'net_profit': -160.99}, {'period': ""Q3 '23"", 'revenue': 373.31, 'unit': 'M', 'net_profit': -63.05}]",-5.56,-5.56,401954000,227507000,159169000,239222000,15847000,78186000,224861000,159169000,-174304000,-0.6169425511197663,0.15932523827158088,0.18355359765051396,"[0.16, 0.16]","['2020-11-27', '2020-11-27']",__nan__,0.595147703468556
47,OSTR,Oyster Enterprises Acquisition Corp. Class A Common Stock,"Oyster Enterprises Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the media, technology, consumer products, industrials, real estate services, financial services, hospitality, and entertainment sectors. The company was incorporated in 2020 and is based in West Palm Beach, Florida.",,Shell Companies,10.07,USD,0,https://images.financialmodelingprep.com/symbol/OSTR.png,134320,62.9375,0.01,730,7959366,16702307,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.7}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 783.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.84}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.33}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.32}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.74}]",0.58,0.58,230687,673.94,673.211,17082,0,230013,729.067,673.211,-1249201,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.07404838590817861
48,OSTRU,Oyster Enterprises Acquisition Corp. Unit,"Oyster Enterprises Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the media, technology, consumer products, industrials, real estate services, financial services, hospitality, and entertainment sectors. The company was incorporated in 2020 and is based in West Palm Beach, Florida.",,Shell Companies,9.94,USD,0,https://images.financialmodelingprep.com/symbol/OSTRU.png,4024,78.88888888888889,-0.11,5300,7959366,16702307,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.7}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 783.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.84}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.33}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.32}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.74}]",0.58,0.58,230687,673.94,673.211,17082,0,230013,729.067,673.211,-1249201,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.07404838590817861
49,OSTRW,Oyster Enterprises Acquisition Corp. Warrant,"Oyster Enterprises Acquisition Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Stamford, Connecticut.",,Shell Companies,0.0005,USD,0,https://images.financialmodelingprep.com/symbol/OSTRW.png,99135,0,0,141303,7959366,16702307,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.7}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 783.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.84}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.33}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.32}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.74}]",0.58,0.58,230687,673.94,673.211,17082,0,230013,729.067,673.211,-1249201,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.07404838590817861
50,OSUR,OraSure Technologies Inc. Common Stock,"OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.",Ms. Carrie  Eglinton Manner,Medical - Instruments & Supplies,3.16,USD,236368316,https://images.financialmodelingprep.com/symbol/OSUR.png,880352,-12.15,0.23,1067500,-13550000,-19500,"[{'period': '2024', 'revenue': 185830.0, 'unit': 'K', 'net_profit': -19.5}, {'period': '2023', 'revenue': 405.47, 'unit': 'M', 'net_profit': 53.66}, {'period': '2022', 'revenue': 387.48, 'unit': 'M', 'net_profit': -17.93}, {'period': '2021', 'revenue': 233.67, 'unit': 'M', 'net_profit': -23.0}]","[{'period': ""Q4 '24"", 'revenue': 37.45, 'unit': 'K', 'net_profit': -10.79}, {'period': ""Q3 '24"", 'revenue': 0.264, 'unit': 'M', 'net_profit': -4.51}, {'period': ""Q2 '24"", 'revenue': 54340.0, 'unit': 'K', 'net_profit': -615.0}, {'period': ""Q1 '24"", 'revenue': 54.13, 'unit': 'M', 'net_profit': -3.58}, {'period': ""Q4 '23"", 'revenue': 75.88, 'unit': 'M', 'net_profit': 20.07}, {'period': ""Q3 '23"", 'revenue': 89.19, 'unit': 'M', 'net_profit': 11.16}]",-0.26,-0.26,479659000,333220000,267763000,69321000,23816000,28300000,33483000,267763000,23577000,-1.2105573943716688,-1.0003634330444506,-1.356164383561644,"[1.6, 1.6]","['1998-01-08', '1998-01-08']",__nan__,0.1445214204257608
51,OSW,OneSpaWorld Holdings Limited Common Shares,"OneSpaWorld Holdings Limited operates health and wellness centers onboard cruise ships and at destination resorts worldwide. Its health and wellness centers offer services, such as traditional body, salon, and skin care services and products; self-service fitness facilities, specialized fitness classes, and personal fitness training; pain management, detoxifying programs, and body composition analyses; weight management programs and products; and medi-spa services. The company also provides its guests access to beauty and wellness brands, including ELEMIS, Kérastase, and Dysport, with various brands offered exclusively in the cruise market. As of December 31, 2021, it offered health, wellness, fitness, beauty services, treatments, and products onboard 170 cruise ships and at 52 destination resorts. The company is based in Nassau, Bahamas.",Mr. Leonard I. Fluxman,Leisure,17.64,USD,1846325880,https://images.financialmodelingprep.com/symbol/OSW.png,1126191,25.57,2.64,2215037,111180000,72864000,"[{'period': '2024', 'revenue': 895.02, 'unit': 'M', 'net_profit': 72.86}, {'period': '2023', 'revenue': 794.04, 'unit': 'M', 'net_profit': -2.97}, {'period': '2022', 'revenue': 546.26, 'unit': 'M', 'net_profit': 53.16}, {'period': '2021', 'revenue': 144.03, 'unit': 'M', 'net_profit': -68.52}]","[{'period': ""Q4 '24"", 'revenue': 217.21, 'unit': 'M', 'net_profit': 14.39}, {'period': ""Q3 '24"", 'revenue': 241.7, 'unit': 'M', 'net_profit': 21.55}, {'period': ""Q2 '24"", 'revenue': 224.89, 'unit': 'M', 'net_profit': 15.76}, {'period': ""Q1 '24"", 'revenue': 211.23, 'unit': 'M', 'net_profit': 21.17}, {'period': ""Q4 '23"", 'revenue': 194.81, 'unit': 'M', 'net_profit': -7.3}, {'period': ""Q3 '23"", 'revenue': 216.27, 'unit': 'M', 'net_profit': 23.41}]",0.7,0.69,746423000,161505000,57439000,191926000,46264000,0,79405000,57439000,72055000,1.6207481790538152,25.500336247478145,24.02631578947368,"[0.04, 0.04]","['2025-03-12', '2020-01-09']",__nan__,0.25712766085718153
52,OTEX,Open Text Corporation Common Shares,"Open Text Corporation engages in the designs, develops, markets, and sells information management software and solutions. It offers content services; business network that manages data within the organization and outside the firewall; security and protection solutions for defending against cyber threats, and preparing for business continuity and response in the event of a breach; digital investigation and forensic security solutions; OpenText security solutions to address information cyber resilience needs; Carbonite and Webroot products; and OpenText Information Management software platform. The company also provides eDiscovery platform that provides forensics and unstructured data analytics; OpenText Developer Cloud; key developer API services; AI and analytics that leverages structured or unstructured data; digital process automation solutions, which enables organizations to transform into digital data-driven businesses; and OpenText Digital Experience platform. In addition, it offers customer support programs, including access to software upgrades, a knowledge base, discussions, product information, and an online mechanism to post and review trouble tickets; and consulting and learning services relating to the implementation, training, and integration of its licensed product offerings, as well as cloud services. The company serves organizations, enterprise and mid-market companies, public sector agencies, small and medium-sized businesses, and direct consumers in Canada, the United States, the United Kingdom, Germany, rest of Europe, the Middle East, Africa, and internationally. It has strategic partnerships with SAP SE, Google Cloud, Amazon AWS, Microsoft Corporation, Oracle Corporation, Salesforce.com Corporation, Accenture plc, ATOS, Capgemini Technology Services SAS, Cognizant Technology Solutions U.S. Corp., Deloitte Consulting LLP, and Tata Consultancy Services. Open Text Corporation was incorporated in 1991 and is headquartered in Waterloo, Canada.",Mr. Mark J. Barrenechea,Software - Application,25.29,USD,6676560000,https://images.financialmodelingprep.com/symbol/OTEX.png,1188903,10.32,2.09,1692272,2091105700,465090000,"[{'period': '2024', 'revenue': 5770.0, 'unit': 'M', 'net_profit': 465.09}, {'period': '2023', 'revenue': 4480.0, 'unit': 'M', 'net_profit': 150.38}, {'period': '2022', 'revenue': 3490.0, 'unit': 'M', 'net_profit': 397.09}, {'period': '2021', 'revenue': 3390.0, 'unit': 'M', 'net_profit': 310.67}]","[{'period': ""Q2 '25"", 'revenue': 1330.0, 'unit': 'M', 'net_profit': 229.86}, {'period': ""Q1 '25"", 'revenue': 1270.0, 'unit': 'M', 'net_profit': 84.37}, {'period': ""Q4 '24"", 'revenue': 1360.0, 'unit': 'M', 'net_profit': 248.23}, {'period': ""Q3 '24"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 98.28}, {'period': ""Q2 '24"", 'revenue': 1530.0, 'unit': 'M', 'net_profit': 37.67}, {'period': ""Q1 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 80.9}]",1.71,1.71,14205707000,2277325000,1280662000,10006026001,757671867,164709000,2800494000,1280662000,808396000,0.6575055604083075,2.092785561813817,2.0535714285714284,"[0.2625, 0.3]","['2025-03-07', '2013-05-29']",__nan__,0.704366632438639
53,OTIC,Otonomy Inc. Common Stock,"Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.",Mr. David M. Maggio,Biotechnology,0.0085,USD,0,https://images.financialmodelingprep.com/symbol/OTIC.png,876957,-0.14166666666666666,-0.107,1943400,-49625000,-50325000,"[{'period': '2021', 'revenue': 0.125, 'unit': 'M', 'net_profit': -50.33}, {'period': '2020', 'revenue': 0.273, 'unit': 'M', 'net_profit': -43.67}, {'period': '2019', 'revenue': 0.6, 'unit': 'M', 'net_profit': -43.53}, {'period': '2018', 'revenue': 0.745, 'unit': 'M', 'net_profit': -49.18}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.26}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.41}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.95}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.37}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.29}, {'period': ""Q2 '21"", 'revenue': 0.035, 'unit': 'M', 'net_profit': -12.51}]",-0.79,-0.79,95637000,80468000,77412000,40730000,0,0,12333000,77412000,-42713000,-0.1411456297284246,-0.15241933637133895,0.26168224299065423,"[0.11, 0.11]","['2023-04-11', '2023-04-11']",__nan__,0.4258811966080074
54,OTLK,Outlook Therapeutics Inc. Common Stock,"Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.",Mr. Lawrence A. Kenyon CPA,Biotechnology,1.2,USD,39144239,https://images.financialmodelingprep.com/symbol/OTLK.png,579840,-0.48,0.04,625672,-71589376,-75366714,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -75.37}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.98}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -66.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -53.16}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.38}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.69}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 44.41}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -114.29}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.18}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.99}]",-9.84,-9.76,28823154000000,27416036000000,14927538000000,101899664000000,0,0,42553729000000,14927538,-68793858000000,-0.25928572564408653,-0.2777772955268826,-1.0847457627118644,__nan__,__nan__,__nan__,3.5353405113125373
55,OTLKW,Outlook Therapeutics Inc. Series A Warrant Expiring 02/18/2022,,None,,0.03,USD,0,https://images.financialmodelingprep.com/symbol/OTLKW.png,0,0,-0.0006,162240,-57375932,-58982668,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.98}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -66.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -53.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.24}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 44.41}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -114.29}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.18}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.99}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.68}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.65}]",-4.72,-4.72,32300601,30979198,23391982,46738378,0,793932,46732159,23391982,-42973400,0.0873305419065636,0.10703033585646662,0.2423756019261638,__nan__,__nan__,__nan__,1.4469816830962372
56,OTLY,Oatly Group AB American Depositary Shares,"Oatly Group AB, an oatmilk company, provides a range of plant-based dairy products made from oats in Sweden. It offers Barista edition oatmilk, oatgurts, frozen desserts, ice-creams, and yogurts; ready-to-go drinks, such as cold brew latte, mocha latte, matcha latte, and mini oat drink in original and chocolate flavors; and cooking products, including Cooking Cream, in regular and organic, Crème Fraiche, Whipping Cream, Vanilla Custard and Spreads in a variety of flavors. The company was formerly known as Havre Global AB and changed its name to Oatly Group AB in March 2021. The company was founded in 1994 and is headquartered in Malmö, Sweden.",Mr. Jean-Christophe  Flatin,Beverages - Non-Alcoholic,9.27,USD,277432486,https://images.financialmodelingprep.com/symbol/OTLY.png,236910,-1.36,0.29,95029,-86128000,-201949000,"[{'period': '2024', 'revenue': 823.67, 'unit': 'M', 'net_profit': -201.95}, {'period': '2023', 'revenue': 783.35, 'unit': 'M', 'net_profit': -416.87}, {'period': '2022', 'revenue': 722.24, 'unit': 'M', 'net_profit': -392.57}, {'period': '2021', 'revenue': 643.19, 'unit': 'M', 'net_profit': -212.39}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '24"", 'revenue': 208.0, 'unit': 'M', 'net_profit': -34.56}, {'period': ""Q2 '24"", 'revenue': 202.19, 'unit': 'M', 'net_profit': -30.38}, {'period': ""Q1 '24"", 'revenue': 198.03, 'unit': 'M', 'net_profit': -45.54}, {'period': ""Q4 '23"", 'revenue': 206.26, 'unit': 'M', 'net_profit': -301.79}, {'period': ""Q3 '23"", 'revenue': 187.59, 'unit': 'M', 'net_profit': 44.09}]",-6.75,-6.75,803980000,299126000,98923000,697857000,124041000,0,535060000,98923000,-155623000,0.7007228193005678,0.5155634556244812,0.5195729537366548,__nan__,__nan__,__nan__,0.8680029353964029
57,OTRA,OTR Acquisition Corp. Class A Common Stock,"As of May 19, 2022, OTR Acquisition Corp. was acquired by Comera Life Sciences Holdings, Inc., in a reverse merger transaction. OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.",,Shell Companies,9.91,USD,0,https://images.financialmodelingprep.com/symbol/OTRA.png,217943,0,-1.3199997,838214,4687173,10428519,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.43}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -199.53}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 309.43}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.23}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -199.53}]",0.79,0.79,107424290,337777,261696,9092992,0,0,176887,261696,-775683,24.490598093557992,53.264370984393636,53.317880794701985,__nan__,__nan__,__nan__,0.08464558620773756
58,OTRAU,OTR Acquisition Corp. Unit,"As of May 19, 2022, OTR Acquisition Corp. was acquired by Comera Life Sciences Holdings, Inc., in a reverse merger transaction. OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.",,Shell Companies,9.55,USD,0,https://images.financialmodelingprep.com/symbol/OTRAU.png,1757,0,-1.9899998,279,4687173,10428519,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.43}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -199.53}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 309.43}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.23}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -199.53}]",0.79,0.79,107424290,337777,261696,9092992,0,0,176887,261696,-775683,24.490598093557992,53.264370984393636,53.317880794701985,__nan__,__nan__,__nan__,0.08464558620773756
59,OTRAW,OTR Acquisition Corp. Warrant,,,,,,,,,,,,4687173,10428519,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.43}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -199.53}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 309.43}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.23}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.25}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -199.53}]",1.0,1.0,107424290,337777,261696,9092992,0,0,176887,261696,-775683,24.490598093557992,53.264370984393636,53.35602094240838,__nan__,__nan__,__nan__,0.08464558620773756
60,OTRK,Ontrak Inc. Common Stock,"Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.",Mr. Brandon H. LaVerne CPA,Medical - Healthcare Information Services,1.507,USD,6356300,https://images.financialmodelingprep.com/symbol/OTRK.png,20072,0.05,-0.033,7756,-14416000,-27920000,"[{'period': '2023', 'revenue': 12.74, 'unit': 'M', 'net_profit': -27.92}, {'period': '2022', 'revenue': 14.51, 'unit': 'M', 'net_profit': -51.57}, {'period': '2021', 'revenue': 84.13, 'unit': 'M', 'net_profit': -37.14}, {'period': '2020', 'revenue': 82.84, 'unit': 'M', 'net_profit': -22.71}]","[{'period': ""Q3 '24"", 'revenue': 2.57, 'unit': 'M', 'net_profit': -5.58}, {'period': ""Q2 '24"", 'revenue': 2.45, 'unit': 'M', 'net_profit': -10.29}, {'period': ""Q1 '24"", 'revenue': 2.68, 'unit': 'M', 'net_profit': -4.46}, {'period': ""Q4 '23"", 'revenue': 3.54, 'unit': 'M', 'net_profit': -6.4}, {'period': ""Q3 '23"", 'revenue': 3.71, 'unit': 'M', 'net_profit': -6.42}, {'period': ""Q2 '23"", 'revenue': 2.96, 'unit': 'M', 'net_profit': -6.76}]",-49.5,-49.5,19846000,12651000,9701000,5575000,607000,0,3942000,9701000,-15783000,0.6598234933220067,0.4586314544432164,-2.7218045112781954,__nan__,__nan__,__nan__,0.28091303033356846
61,OTRKP,Ontrak Inc. 9.50% Series A Cumulative Perpetual Preferred Stock,"Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.",Mr. Brandon H. LaVerne CPA,Medical - Healthcare Information Services,0.2251,USD,893902,https://images.financialmodelingprep.com/symbol/OTRKP.png,2983,-0.08,0,200,-14416000,-27920000,"[{'period': '2023', 'revenue': 12.74, 'unit': 'M', 'net_profit': -27.92}, {'period': '2022', 'revenue': 14.51, 'unit': 'M', 'net_profit': -51.57}, {'period': '2021', 'revenue': 84.13, 'unit': 'M', 'net_profit': -37.14}, {'period': '2020', 'revenue': 82.84, 'unit': 'M', 'net_profit': -22.71}]","[{'period': ""Q3 '24"", 'revenue': 2.57, 'unit': 'M', 'net_profit': -5.58}, {'period': ""Q2 '24"", 'revenue': 2.45, 'unit': 'M', 'net_profit': -10.29}, {'period': ""Q1 '24"", 'revenue': 2.68, 'unit': 'M', 'net_profit': -4.46}, {'period': ""Q4 '23"", 'revenue': 3.54, 'unit': 'M', 'net_profit': -6.4}, {'period': ""Q3 '23"", 'revenue': 3.71, 'unit': 'M', 'net_profit': -6.42}, {'period': ""Q2 '23"", 'revenue': 2.96, 'unit': 'M', 'net_profit': -6.76}]",-49.5,-49.5,19846000,12651000,9701000,5575000,607000,0,3942000,9701000,-15783000,0.6598234933220067,0.4586314544432164,-2.7218045112781954,"[0.594, 0.633]","['2022-02-14', '2020-11-12']",__nan__,0.28091303033356846
62,OTTR,Otter Tail Corporation Common Stock,"Otter Tail Corporation, together with its subsidiaries, engages in electric utility, manufacturing, and plastic pipe businesses in the United States. The company's Electric segment produces, transmits, distributes, and sells electric energy in Minnesota, North Dakota, and South Dakota; and operates as a participant in the Midcontinent Independent System Operator, Inc. markets. This segment generates electricity through coal, wind and hydro, and natural gas. It serves approximately 133,000 residential, industrial, and other commercial customers. Its Manufacturing segment engages in the contract machining, metal parts stamping, fabrication and painting, and production of plastic thermoformed horticultural containers, life science and industrial packaging, and material handling components, and extruded raw material stock for recreational vehicle, agricultural, construction, lawn and garden, and industrial and energy equipment industries. It also manufactures clamshell packing, blister packs, returnable pallets, and handling trays for shipping and storing odd-shaped or difficult-to-handle parts for customers in the horticulture, medical and life sciences, industrial, recreation, and electronics industries. The company's Plastics segment manufactures polyvinyl chloride pipes for municipal water, rural water, wastewater, storm drainage and water reclamation system, and other uses. This segment markets its products to wholesalers and distributors through independent sales representatives, company salespersons, and customer service representatives. The company was formerly known as Otter Tail Power Company and changed its name to Otter Tail Corporation in 2001. Otter Tail Corporation was founded in 1907 and is headquartered in Fergus Falls, Minnesota.",Mr. Charles S. MacFarlane,Diversified Utilities,77.98,USD,3261747440,https://images.financialmodelingprep.com/symbol/OTTR.png,279019,10.88,3.36,639914,515828000,301662000,"[{'period': '2024', 'revenue': 1330.0, 'unit': 'M', 'net_profit': 301.66}, {'period': '2023', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 294.19}, {'period': '2022', 'revenue': 1460.0, 'unit': 'M', 'net_profit': 284.18}, {'period': '2021', 'revenue': 1200.0, 'unit': 'M', 'net_profit': 176.77}]","[{'period': ""Q4 '24"", 'revenue': 303.11, 'unit': 'M', 'net_profit': 54.85}, {'period': ""Q3 '24"", 'revenue': 338.03, 'unit': 'M', 'net_profit': 85.48}, {'period': ""Q2 '24"", 'revenue': 342.34, 'unit': 'M', 'net_profit': 87.0}, {'period': ""Q1 '24"", 'revenue': 347.07, 'unit': 'M', 'net_profit': 74.34}, {'period': ""Q4 '23"", 'revenue': 314.31, 'unit': 'M', 'net_profit': 57.77}, {'period': ""Q3 '23"", 'revenue': 358.06, 'unit': 'M', 'net_profit': 91.97}]",7.22,7.17,3652082000,630041000,294651000,1983583000,145964000,121177000,309790000,294651000,94081000,0.033474915851899344,0.02539506647042228,0.02266288951841362,"[0.525, 0.73]","['2025-02-14', '1987-02-09']",__nan__,0.5431375856292383
63,OVBC,Ohio Valley Banc Corp. Common Stock,"Ohio Valley Banc Corp. operates as the bank holding company for The Ohio Valley Bank Company that provides commercial and consumer banking products and services. The company operates in two segments, Banking and Consumer Finance. It accepts various deposit products, including checking, savings, time, and money market accounts, as well as individual retirement accounts, demand deposits, NOW accounts, and certificates of deposit. The company also provides various residential real estate loans, including one-to four-family residential mortgages; commercial loans for securing equipment, inventory, stock, commercial real estate, and rental property; and consumer loans secured by automobiles, mobile homes, recreational vehicles, and other personal property, as well as personal loans, unsecured credit card receivables, floor plan and student loans, and construction loans. In addition, it offers safe deposit boxes, wire transfers, credit card services, and Internet banking services; and financial management online services, such as cash management and news updates related to repossession auctions, current rates, and general bank news. Further, the company provides automatic teller machine (ATM) services, consumer finance, seasonal tax preparation services, and commercial property and various liability insurance services, as well as trust and online-only consumer direct mortgage services. It operates sixteen offices in Ohio and West Virginia; and six consumer finance offices in Ohio. The company owns and operates thirty- six ATMs, including twenty off-site ATMs. Ohio Valley Banc Corp. was founded in 1872 and is headquartered in Gallipolis, Ohio.",Mr. Larry E. Miller II,Banks - Regional,30.45,USD,143449950,https://images.financialmodelingprep.com/symbol/OVBC.png,12026,13.13,2.99,28527,0,10999000,"[{'period': '2024', 'revenue': 61.98, 'unit': 'M', 'net_profit': 11.0}, {'period': '2023', 'revenue': 56.57, 'unit': 'M', 'net_profit': 12.63}, {'period': '2022', 'revenue': 54.94, 'unit': 'M', 'net_profit': 13.34}, {'period': '2021', 'revenue': 50.88, 'unit': 'M', 'net_profit': 11.73}]","[{'period': ""Q4 '24"", 'revenue': 16.99, 'unit': 'M', 'net_profit': 2.52}, {'period': ""Q3 '24"", 'revenue': 19.0, 'unit': 'M', 'net_profit': 2.72}, {'period': ""Q2 '24"", 'revenue': 21.35, 'unit': 'M', 'net_profit': 2.97}, {'period': ""Q1 '24"", 'revenue': 21.38, 'unit': 'M', 'net_profit': 2.79}, {'period': ""Q4 '23"", 'revenue': 20.7, 'unit': 'M', 'net_profit': 3.22}, {'period': ""Q3 '23"", 'revenue': 13.94, 'unit': 'M', 'net_profit': 2.25}]",2.33,2.33,1503412000,281719000,281719000,1353084000,4805000,275170000,0,83107000,11664000,-1.0,-0.12920592193808883,-0.12075471698113202,"[0.22, 0.38]","['2025-01-24', '1995-01-23']",__nan__,0.9000087800283622
64,OVID,Ovid Therapeutics Inc. Common Stock,"Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.","Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.",Biotechnology,0.2788,USD,19815710,https://images.financialmodelingprep.com/symbol/OVID.png,412140,-0.75,0.0238,299037,-61885000,-26433000,"[{'period': '2024', 'revenue': 0.5660000000000001, 'unit': 'M', 'net_profit': -26.43}, {'period': '2023', 'revenue': 0.39169, 'unit': 'M', 'net_profit': -52.34}, {'period': '2022', 'revenue': 1.5, 'unit': 'M', 'net_profit': -51.41}, {'period': '2021', 'revenue': 208.38, 'unit': 'M', 'net_profit': 122.83}]","[{'period': ""Q4 '24"", 'revenue': 0.076, 'unit': 'M', 'net_profit': -9.25}, {'period': ""Q3 '24"", 'revenue': 0.17300000000000001, 'unit': 'M', 'net_profit': -14.01}, {'period': ""Q2 '24"", 'revenue': 0.169, 'unit': 'M', 'net_profit': 8.52}, {'period': ""Q1 '24"", 'revenue': 0.148, 'unit': 'M', 'net_profit': -11.69}, {'period': ""Q4 '23"", 'revenue': 0.14156, 'unit': 'M', 'net_profit': -15.32}, {'period': ""Q3 '23"", 'revenue': 0.10897, 'unit': 'M', 'net_profit': -11.25}]",-0.37,-0.37,92167000,55940000,53075000,23941000,0,20974000,10522000,26301000,-56027000,-0.07279780362570121,0.4949651176669372,0.5,__nan__,__nan__,__nan__,0.2597567459068864
65,OVLY,Oak Valley Bancorp (CA) Common Stock,"Oak Valley Bancorp operates as the bank holding company for Oak Valley Community Bank that provides a range of commercial banking services to individuals and small to medium-sized businesses in the Central Valley and the Eastern Sierras. The company's deposits products include checking and savings, money market, health savings, and individual retirement accounts, as well as certificates of deposit. It also offers commercial real estate loans, commercial business lending and trade finance, and small business administration lending, as well as consumer loans consisting of automobile loans, home mortgage loans, revolving lines of credit, and other personal loans. In addition, the company provides online banking, remote deposit capture, mobile banking, merchant, night depository, extended hours, wire transfer of funds, and note collection services, as well as automated teller machines. As of December 31, 2021, it operated through seventeen full-service branch offices in Oakdale, Sonora, Bridgeport, Bishop, Mammoth Lakes, Modesto, Manteca, Patterson, Turlock, Tracy, Ripon, Stockton, Escalon, California, and Sacramento. The company was incorporated in 1990 and is headquartered in Oakdale, California.",Mr. Christopher M. Courtney,Banks - Regional,25.425,USD,212482064,https://images.financialmodelingprep.com/symbol/OVLY.png,15565,8.42,1.495,15347,0,24948000,"[{'period': '2024', 'revenue': 78.21, 'unit': 'M', 'net_profit': 24.95}, {'period': '2023', 'revenue': 80.67, 'unit': 'M', 'net_profit': 30.85}, {'period': '2022', 'revenue': 65.65, 'unit': 'M', 'net_profit': 22.9}, {'period': '2021', 'revenue': 54.26, 'unit': 'M', 'net_profit': 16.34}]","[{'period': ""Q4 '24"", 'revenue': 19.28, 'unit': 'M', 'net_profit': 6.01}, {'period': ""Q3 '24"", 'revenue': 19.5, 'unit': 'M', 'net_profit': 7.32}, {'period': ""Q2 '24"", 'revenue': 22.03, 'unit': 'M', 'net_profit': 5.89}, {'period': ""Q1 '24"", 'revenue': 18.76, 'unit': 'M', 'net_profit': 5.73}, {'period': ""Q4 '23"", 'revenue': 19.67, 'unit': 'M', 'net_profit': 5.87}, {'period': ""Q3 '23"", 'revenue': 20.5, 'unit': 'M', 'net_profit': 7.35}]",3.02,3.02,1900604000,75072000,75072000,1717168000,0,0,0,0,23857000,0.0,-0.1912603734439834,-0.19680851063829782,"[0.3, 0.6525]","['2025-02-03', '2004-07-29']",__nan__,0.90348541831965
66,OXBR,Oxbridge Re Holdings Limited Ordinary Shares,"Oxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. It underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. The company distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.",Mr. Sanjay  Madhu,Insurance - Reinsurance,1.52,USD,11313238,https://images.financialmodelingprep.com/symbol/OXBR.png,35285,-3.38,0,13173,0,-1764000,"[{'period': '2024', 'revenue': 0.546, 'unit': 'M', 'net_profit': -1.76}, {'period': '2023', 'revenue': -7.05, 'unit': 'M', 'net_profit': -9.91}, {'period': '2022', 'revenue': 0.85, 'unit': 'M', 'net_profit': -3.54}, {'period': '2021', 'revenue': 10.22, 'unit': 'M', 'net_profit': 8.66}]","[{'period': ""Q4 '24"", 'revenue': 422.0, 'unit': 'K', 'net_profit': -214.0}, {'period': ""Q3 '24"", 'revenue': 205.0, 'unit': 'K', 'net_profit': -293.0}, {'period': ""Q2 '24"", 'revenue': 44.0, 'unit': 'K', 'net_profit': -821.0}, {'period': ""Q1 '24"", 'revenue': -125.0, 'unit': 'K', 'net_profit': -905.0}, {'period': ""Q4 '23"", 'revenue': -1.91, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q3 '23"", 'revenue': -6.38, 'unit': 'M', 'net_profit': -7.07}]",-0.29,-0.29,7465000,5893000,5893000,3355000,0,0,1732000,2135000,-1232000,1.0,0.822087745839637,0.8284023668639053,"[0.12, 0.12]","['2017-09-21', '2014-08-06']",__nan__,0.449430676490288
67,OXBRW,Oxbridge Re Holdings Limited Warrant expiring 3/26/2024,"Oxbridge Re Holdings Limited, together with its subsidiaries, provides specialty property and casualty reinsurance solutions. It underwrites reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. The company distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.",Mr. Sanjay  Madhu,Insurance - Reinsurance,0.31,USD,11313241,https://images.financialmodelingprep.com/symbol/OXBRW.png,10369.30189,0.22,0,101,0,-1764000,"[{'period': '2024', 'revenue': 0.546, 'unit': 'M', 'net_profit': -1.76}, {'period': '2023', 'revenue': -7.05, 'unit': 'M', 'net_profit': -9.91}, {'period': '2022', 'revenue': 0.85, 'unit': 'M', 'net_profit': -3.54}, {'period': '2021', 'revenue': 10.22, 'unit': 'M', 'net_profit': 8.66}]","[{'period': ""Q4 '24"", 'revenue': 422.0, 'unit': 'K', 'net_profit': -214.0}, {'period': ""Q3 '24"", 'revenue': 205.0, 'unit': 'K', 'net_profit': -293.0}, {'period': ""Q2 '24"", 'revenue': 44.0, 'unit': 'K', 'net_profit': -821.0}, {'period': ""Q1 '24"", 'revenue': -125.0, 'unit': 'K', 'net_profit': -905.0}, {'period': ""Q4 '23"", 'revenue': -1.91, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q3 '23"", 'revenue': -6.38, 'unit': 'M', 'net_profit': -7.07}]",-0.29,-0.29,7465000,5893000,5893000,3355000,0,0,1732000,2135000,-1232000,1.0,0.822087745839637,0.8284023668639053,__nan__,__nan__,__nan__,0.449430676490288
68,OXLC,Oxford Lane Capital Corp. Common Stock,"Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities. The fund primarily invests in securitization vehicles which in turn invest in senior secured loans made to companies whose debt is rated below investment grade or is unrated. Oxford Lane Capital Corp was formed on June 9, 2010 and is domiciled in the United States.",Mr. Jonathan H. Cohen,Asset Management,4.69,USD,2050468000,https://images.financialmodelingprep.com/symbol/OXLC.png,7570406,5.79,0.35,12318833,267964996,235105659,"[{'period': '2023', 'revenue': 290.64, 'unit': 'M', 'net_profit': 235.11}, {'period': '2022', 'revenue': 241.84, 'unit': 'M', 'net_profit': -171.29}, {'period': '2021', 'revenue': 200.63, 'unit': 'M', 'net_profit': 125.88}, {'period': '2020', 'revenue': 58.26, 'unit': 'M', 'net_profit': 289.93}]","[{'period': ""Q2 '24"", 'revenue': 204.2, 'unit': 'M', 'net_profit': 65.59}, {'period': ""Q4 '23"", 'revenue': 157.58, 'unit': 'M', 'net_profit': 119.86}, {'period': ""Q2 '23"", 'revenue': 133.07, 'unit': 'M', 'net_profit': 115.25}, {'period': ""Q4 '22"", 'revenue': 127.67, 'unit': 'M', 'net_profit': 14.15}, {'period': ""Q2 '22"", 'revenue': 114.17, 'unit': 'M', 'net_profit': -185.44}, {'period': ""Q4 '21"", 'revenue': 112.18, 'unit': 'M', 'net_profit': -19.69}]",1.12,1.12,1750939125,71435908,42974356,579853135,28461552,1679096080,0,42974356,-123794003,2.921127651942495,2.372569203276383,1.9824561403508771,"[0.09, 0.25]","['2025-09-16', '2011-03-17']",__nan__,0.33116693020381277
69,OXLCL,Oxford Lane Capital Corp. 6.75% Notes due 2031,Oxford Lane Capital is an investment company that invests primarily in debt and equity tranches of CLO vehicles.,Jonathan H. Cohen,Asset Management,23.07,USD,10086204000,https://images.financialmodelingprep.com/symbol/OXLCL.png,3108,,0.25,1414,267964996,235105659,"[{'period': '2023', 'revenue': 290.64, 'unit': 'M', 'net_profit': 235.11}, {'period': '2022', 'revenue': 241.84, 'unit': 'M', 'net_profit': -171.29}, {'period': '2021', 'revenue': 200.63, 'unit': 'M', 'net_profit': 125.88}, {'period': '2020', 'revenue': 58.26, 'unit': 'M', 'net_profit': 289.93}]","[{'period': ""Q2 '24"", 'revenue': 204.2, 'unit': 'M', 'net_profit': 65.59}, {'period': ""Q4 '23"", 'revenue': 157.58, 'unit': 'M', 'net_profit': 119.86}, {'period': ""Q2 '23"", 'revenue': 133.07, 'unit': 'M', 'net_profit': 115.25}, {'period': ""Q4 '22"", 'revenue': 127.67, 'unit': 'M', 'net_profit': 14.15}, {'period': ""Q2 '22"", 'revenue': 114.17, 'unit': 'M', 'net_profit': -185.44}, {'period': ""Q4 '21"", 'revenue': 112.18, 'unit': 'M', 'net_profit': -19.69}]",1.12,1.12,1750939125,71435908,42974356,579853135,28461552,1679096080,0,42974356,-123794003,2.921127651942495,2.372569203276383,1.9824561403508771,"[0.42188, 0.141]","['2025-03-14', '2021-06-14']",__nan__,0.33116693020381277
70,OXLCM,Oxford Lane Capital Corp. 6.75% Series 2024 Term Preferred Stock,"Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities. The fund primarily invests in securitization vehicles which in turn invest in senior secured loans made to companies whose debt is rated below investment grade or is unrated. Oxford Lane Capital Corp was formed on June 9, 2010 and is domiciled in the United States.",Mr. Jonathan H. Cohen,Asset Management,24.9903,USD,466418959,https://images.financialmodelingprep.com/symbol/OXLCM.png,5835,28.69150401836969,0.0103,1309,267964996,235105659,"[{'period': '2023', 'revenue': 290.64, 'unit': 'M', 'net_profit': 235.11}, {'period': '2022', 'revenue': 241.84, 'unit': 'M', 'net_profit': -171.29}, {'period': '2021', 'revenue': 200.63, 'unit': 'M', 'net_profit': 125.88}, {'period': '2020', 'revenue': 58.26, 'unit': 'M', 'net_profit': 289.93}]","[{'period': ""Q2 '24"", 'revenue': 204.2, 'unit': 'M', 'net_profit': 65.59}, {'period': ""Q4 '23"", 'revenue': 157.58, 'unit': 'M', 'net_profit': 119.86}, {'period': ""Q2 '23"", 'revenue': 133.07, 'unit': 'M', 'net_profit': 115.25}, {'period': ""Q4 '22"", 'revenue': 127.67, 'unit': 'M', 'net_profit': 14.15}, {'period': ""Q2 '22"", 'revenue': 114.17, 'unit': 'M', 'net_profit': -185.44}, {'period': ""Q4 '21"", 'revenue': 112.18, 'unit': 'M', 'net_profit': -19.69}]",1.12,1.12,1750939125,71435908,42974356,579853135,28461552,1679096080,0,42974356,-123794003,2.921127651942495,2.372569203276383,1.9824561403508771,"[0.14063, 0.22031]","['2024-06-14', '2017-07-13']",__nan__,0.33116693020381277
71,OXLCP,Oxford Lane Capital Corp. 6.25% Series 2027 Term Preferred Shares,"Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities. The fund primarily invests in securitization vehicles which in turn invest in senior secured loans made to companies whose debt is rated below investment grade or is unrated. Oxford Lane Capital Corp was formed on June 9, 2010 and is domiciled in the United States.",Mr. Jonathan H. Cohen,Asset Management,23.88,USD,10440336000,https://images.financialmodelingprep.com/symbol/OXLCP.png,5134,27.42,-0.22,9465,267964996,235105659,"[{'period': '2023', 'revenue': 290.64, 'unit': 'M', 'net_profit': 235.11}, {'period': '2022', 'revenue': 241.84, 'unit': 'M', 'net_profit': -171.29}, {'period': '2021', 'revenue': 200.63, 'unit': 'M', 'net_profit': 125.88}, {'period': '2020', 'revenue': 58.26, 'unit': 'M', 'net_profit': 289.93}]","[{'period': ""Q2 '24"", 'revenue': 204.2, 'unit': 'M', 'net_profit': 65.59}, {'period': ""Q4 '23"", 'revenue': 157.58, 'unit': 'M', 'net_profit': 119.86}, {'period': ""Q2 '23"", 'revenue': 133.07, 'unit': 'M', 'net_profit': 115.25}, {'period': ""Q4 '22"", 'revenue': 127.67, 'unit': 'M', 'net_profit': 14.15}, {'period': ""Q2 '22"", 'revenue': 114.17, 'unit': 'M', 'net_profit': -185.44}, {'period': ""Q4 '21"", 'revenue': 112.18, 'unit': 'M', 'net_profit': -19.69}]",1.12,1.12,1750939125,71435908,42974356,579853135,28461552,1679096080,0,42974356,-123794003,2.921127651942495,2.372569203276383,1.9824561403508771,"[0.13021, 0.213]","['2025-05-16', '2020-03-16']",__nan__,0.33116693020381277
72,OXSQ,Oxford Square Capital Corp. Common Stock,"Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans. The firm primarily invests in debt and/or equity securities of technology-related companies that operate in the computer software, Internet, information technology infrastructure and services, media, telecommunications and telecommunications equipment, semiconductors, hardware, technology-enabled services, semiconductor capital equipment, medical device technology, diversified technology, and networking systems sectors. It concentrates its investments in companies having annual revenues of less than $200 million and a market capitalization or enterprise value of less than $300 million. The firm invests between $5 million and $30 million per transaction. It seeks to exit its investments within 7 years. It serves as the investment adviser to TICC. Oxford Square Capital Corp., formerly known as TICC Capital Corp., was founded in 2003 and is headquartered in Greenwich, Connecticut.",Mr. Jonathan H. Cohen,Asset Management,2.48,USD,173077960,https://images.financialmodelingprep.com/symbol/OXSQ.png,441729,27.56,0.11,740059,0,5879681,"[{'period': '2024', 'revenue': 9.96, 'unit': 'M', 'net_profit': 5.88}, {'period': '2023', 'revenue': 51.82, 'unit': 'M', 'net_profit': 17.24}, {'period': '2022', 'revenue': 43.12, 'unit': 'M', 'net_profit': -85.55}, {'period': '2021', 'revenue': 37.18, 'unit': 'M', 'net_profit': 39.58}]","[{'period': ""Q4 '24"", 'revenue': 4.31, 'unit': 'M', 'net_profit': 3.26}, {'period': ""Q3 '24"", 'revenue': 10340.0, 'unit': 'K', 'net_profit': -874.54}, {'period': ""Q2 '24"", 'revenue': 11.45, 'unit': 'M', 'net_profit': 5.26}, {'period': ""Q1 '24"", 'revenue': 10.68, 'unit': 'M', 'net_profit': -1.77}, {'period': ""Q4 '23"", 'revenue': 12.32, 'unit': 'M', 'net_profit': -7.31}, {'period': ""Q3 '23"", 'revenue': 13.05, 'unit': 'M', 'net_profit': 6.69}]",0.09,0.09,299730974000000,37650517000000,34926468000000,139065494000000,2724049000000,260852859,123599319000000,34926468000000,25708741,-1.0,-0.6589122027183155,-0.71875,"[0.035, 0.1]","['2025-06-16', '2004-03-11']",__nan__,0.46396771125829656
73,OXSQG,Oxford Square Capital Corp. 5.50% Notes due 2028,Oxford Square Capital is a business development company primarily engaged in providing capital to technology-related companies. TICC concentrates its investments in companies having annual revenues of less than $200 million and/or a market capitalization or enterprise value of less than $300 million.,Jonathan H. Cohen,Asset Management,23.25,USD,165401151,https://images.financialmodelingprep.com/symbol/OXSQG.png,608,,0,38,0,5879681,"[{'period': '2024', 'revenue': 9.96, 'unit': 'M', 'net_profit': 5.88}, {'period': '2023', 'revenue': 51.82, 'unit': 'M', 'net_profit': 17.24}, {'period': '2022', 'revenue': 43.12, 'unit': 'M', 'net_profit': -85.55}, {'period': '2021', 'revenue': 37.18, 'unit': 'M', 'net_profit': 39.58}]","[{'period': ""Q4 '24"", 'revenue': 4.31, 'unit': 'M', 'net_profit': 3.26}, {'period': ""Q3 '24"", 'revenue': 10340.0, 'unit': 'K', 'net_profit': -874.54}, {'period': ""Q2 '24"", 'revenue': 11.45, 'unit': 'M', 'net_profit': 5.26}, {'period': ""Q1 '24"", 'revenue': 10.68, 'unit': 'M', 'net_profit': -1.77}, {'period': ""Q4 '23"", 'revenue': 12.32, 'unit': 'M', 'net_profit': -7.31}, {'period': ""Q3 '23"", 'revenue': 13.05, 'unit': 'M', 'net_profit': 6.69}]",0.09,0.09,299730974000000,37650517000000,34926468000000,139065494000000,2724049000000,260852859,123599319000000,34926468000000,25708741,-1.0,-0.6589122027183155,-0.71875,"[0.34375, 0.271]","['2025-04-15', '2021-07-14']",__nan__,0.46396771125829656
74,OXSQL,Oxford Square Capital Corp. 6.50% Notes due 2024,"Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans. The firm primarily invests in debt and/or equity securities of technology-related companies that operate in the computer software, Internet, information technology infrastructure and services, media, telecommunications and telecommunications equipment, semiconductors, hardware, technology-enabled services, semiconductor capital equipment, medical device technology, diversified technology, and networking systems sectors. It concentrates its investments in companies having annual revenues of less than $200 million and a market capitalization or enterprise value of less than $300 million. The firm invests between $5 million and $30 million per transaction. It seeks to exit its investments within 7 years. It serves as the investment adviser to TICC. Oxford Square Capital Corp., formerly known as TICC Capital Corp., was founded in 2003 and is headquartered in Greenwich, Connecticut.",None,Asset Management,25.32,USD,181945950,https://images.financialmodelingprep.com/symbol/OXSQL.png,1555,30.915750915750916,-0.01,133,0,5879681,"[{'period': '2024', 'revenue': 9.96, 'unit': 'M', 'net_profit': 5.88}, {'period': '2023', 'revenue': 51.82, 'unit': 'M', 'net_profit': 17.24}, {'period': '2022', 'revenue': 43.12, 'unit': 'M', 'net_profit': -85.55}, {'period': '2021', 'revenue': 37.18, 'unit': 'M', 'net_profit': 39.58}]","[{'period': ""Q4 '24"", 'revenue': 4.31, 'unit': 'M', 'net_profit': 3.26}, {'period': ""Q3 '24"", 'revenue': 10340.0, 'unit': 'K', 'net_profit': -874.54}, {'period': ""Q2 '24"", 'revenue': 11.45, 'unit': 'M', 'net_profit': 5.26}, {'period': ""Q1 '24"", 'revenue': 10.68, 'unit': 'M', 'net_profit': -1.77}, {'period': ""Q4 '23"", 'revenue': 12.32, 'unit': 'M', 'net_profit': -7.31}, {'period': ""Q3 '23"", 'revenue': 13.05, 'unit': 'M', 'net_profit': 6.69}]",0.09,0.09,299730974000000,37650517000000,34926468000000,139065494000000,2724049000000,260852859,123599319000000,34926468000000,25708741,-1.0,-0.6589122027183155,-0.71875,"[0.40625, 0.406]","['2023-09-14', '2018-03-15']",__nan__,0.46396771125829656
75,OXSQZ,Oxford Square Capital Corp. 6.25% Notes due 2026,Oxford Square Capital is a business development company primarily engaged in providing capital to technology-related companies. TICC concentrates its investments in companies having annual revenues of less than $200 million and/or a market capitalization or enterprise value of less than $300 million.,None,Asset Management,24.6586,USD,173077998,https://images.financialmodelingprep.com/symbol/OXSQZ.png,2255,,-0.1414,5615,0,5879681,"[{'period': '2024', 'revenue': 9.96, 'unit': 'M', 'net_profit': 5.88}, {'period': '2023', 'revenue': 51.82, 'unit': 'M', 'net_profit': 17.24}, {'period': '2022', 'revenue': 43.12, 'unit': 'M', 'net_profit': -85.55}, {'period': '2021', 'revenue': 37.18, 'unit': 'M', 'net_profit': 39.58}]","[{'period': ""Q4 '24"", 'revenue': 4.31, 'unit': 'M', 'net_profit': 3.26}, {'period': ""Q3 '24"", 'revenue': 10340.0, 'unit': 'K', 'net_profit': -874.54}, {'period': ""Q2 '24"", 'revenue': 11.45, 'unit': 'M', 'net_profit': 5.26}, {'period': ""Q1 '24"", 'revenue': 10.68, 'unit': 'M', 'net_profit': -1.77}, {'period': ""Q4 '23"", 'revenue': 12.32, 'unit': 'M', 'net_profit': -7.31}, {'period': ""Q3 '23"", 'revenue': 13.05, 'unit': 'M', 'net_profit': 6.69}]",0.09,0.09,299730974000000,37650517000000,34926468000000,139065494000000,2724049000000,260852859,123599319000000,34926468000000,25708741,-1.0,-0.6589122027183155,-0.71875,"[0.39063, 0.391]","['2025-04-15', '2019-07-12']",__nan__,0.46396771125829656
76,OYST,Oyster Point Pharma Inc. Common Stock,"As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.",Dr. Jeffrey Nau,Biotechnology,11.17,USD,0,https://images.financialmodelingprep.com/symbol/OYST.png,417562,0,0,2088283,-96784000,-104393000,"[{'period': '2021', 'revenue': 24.54, 'unit': 'M', 'net_profit': -104.39}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -70.52}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.71}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.5}]","[{'period': ""Q3 '22"", 'revenue': 5.59, 'unit': 'M', 'net_profit': -40.24}, {'period': ""Q2 '22"", 'revenue': 4.69, 'unit': 'M', 'net_profit': -53.1}, {'period': ""Q1 '22"", 'revenue': 2.7, 'unit': 'M', 'net_profit': -50.96}, {'period': ""Q4 '21"", 'revenue': 6.6, 'unit': 'M', 'net_profit': -44.67}, {'period': ""Q3 '21"", 'revenue': 17.94, 'unit': 'M', 'net_profit': -17.67}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.02}]",-4.01,-4.01,222617000,215250000,193372000,123080000,6656000,886000,28802000,193372000,-90855000,-0.3814641944646655,-0.4803318207600681,-0.37328767123287665,__nan__,__nan__,__nan__,0.5528778125659766
77,OZK,Bank OZK Common Stock,"Bank OZK provides various retail and commercial banking services. It accepts various deposit products, including non-interest-bearing checking, interest bearing transaction, business sweep, savings, money market, individual retirement, and other accounts, as well as time deposits. The company also offers real estate, consumer and business purpose, indirect recreational vehicle and marine, commercial and industrial, government guaranteed, agricultural, small business, homebuilder, and affordable housing loans; business aviation and subscription financing services; and mortgage and other lending products. In addition, it provides trust and wealth services, such as personal, custodial, investment management, and retirement accounts, as well as corporate trust services comprising trustee, paying and registered transfer agent, and other incidental services. Further, the company offers treasury management services comprising automated clearing house, wire transfer, transaction reporting, wholesale lockbox, remote deposit capture, automated credit line transfer, reconciliation, positive pay, and merchant and commercial card services, as well as zero balance and investment sweep accounts. Additionally, it provides ATMs; telephone, online, and mobile banking services; debit and credit cards; safe deposit boxes; and other products and services, as well as processes merchant debit and credit card transactions. As of December 31, 2021, it operated approximately 240 offices in Arkansas, Georgia, Florida, North Carolina, Texas, Carolina, California, New York, and Mississippi. The company was formerly known as Bank of the Ozarks and changed its name to Bank OZK in July 2018. Bank OZK was founded in 1903 and is headquartered in Little Rock, Arkansas.",Mr. George G. Gleason II,Banks - Regional,40.46,USD,4589458720,https://images.financialmodelingprep.com/symbol/OZK.png,1430762,6.59,2.88,2973837,0,716456000,"[{'period': '2024', 'revenue': 1660.0, 'unit': 'M', 'net_profit': 716.46}, {'period': '2023', 'revenue': 1370.0, 'unit': 'M', 'net_profit': 690.78}, {'period': '2022', 'revenue': 1250.0, 'unit': 'M', 'net_profit': 564.14}, {'period': '2021', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 579.0}]","[{'period': ""Q4 '24"", 'revenue': 412.34, 'unit': 'M', 'net_profit': 182.18}, {'period': ""Q3 '24"", 'revenue': 715.66, 'unit': 'M', 'net_profit': 181.19}, {'period': ""Q2 '24"", 'revenue': 696.62, 'unit': 'M', 'net_profit': 177.54}, {'period': ""Q1 '24"", 'revenue': 666.14, 'unit': 'M', 'net_profit': 175.54}, {'period': ""Q4 '23"", 'revenue': 642.52, 'unit': 'M', 'net_profit': 175.12}, {'period': ""Q3 '23"", 'revenue': 389.85, 'unit': 'M', 'net_profit': 173.79}]",6.16,6.14,38258852000,5791276000,5617251000,32552658000,174025000,2836150000,0,2781101000,738848000,-1.0,0.03716507209934234,0.045840407470288703,"[0.43, 0.8]","['2025-04-14', '1997-10-08']",__nan__,0.8508529738424979
78,OZON,Ozon Holdings PLC American Depositary Shares each ADS representing one ordinary share,"Ozon Holdings PLC, together with its subsidiaries, operates as an internet retailer of multi-category consumer products to the general public primarily in the Russian Federation. The company provides products in various categories that include electronics, home and décor products, children's goods, fast moving consumer goods, fresh food, and car parts. It also manages an online marketplace platform that enables third-party sellers to offer their products to consumers on its mobile apps, as well as ozon.ru and ozon.travel websites. In addition, the company provides advertising and financial services, as well as airline and railway tickets. Ozon Holdings PLC was incorporated in 1999 and is headquartered in Nicosia, Cyprus.",Mr. Stanislav  Kondratyev,Specialty Retail,11.6,USD,2422346997,https://images.financialmodelingprep.com/symbol/OZON.png,0,-2.6126126126126126,0,112254,4208000000,-42665000000,"[{'period': '2023', 'revenue': 424.29, 'unit': 'B', 'net_profit': -42.66}, {'period': '2022', 'revenue': 277.12, 'unit': 'B', 'net_profit': -58.19}, {'period': '2021', 'revenue': 178.22, 'unit': 'B', 'net_profit': -56.78}, {'period': '2020', 'revenue': 104.35, 'unit': 'B', 'net_profit': -22.26}]","[{'period': ""Q3 '24"", 'revenue': 153690.0, 'unit': 'M', 'net_profit': -740.0}, {'period': ""Q2 '24"", 'revenue': 122.53, 'unit': 'B', 'net_profit': -27.97}, {'period': ""Q1 '24"", 'revenue': 122.93, 'unit': 'B', 'net_profit': -13.17}, {'period': ""Q4 '23"", 'revenue': 127.81, 'unit': 'B', 'net_profit': -18.18}, {'period': ""Q3 '23"", 'revenue': 108.96, 'unit': 'B', 'net_profit': -22.03}, {'period': ""Q2 '23"", 'revenue': 94.16, 'unit': 'B', 'net_profit': -13.09}]",-204.27,-204.27,476026000000,276908000000,173680000000,542603000000,57949000000,4277000000,341885000000,169814000000,88714000000,1.3687992988606486,0.26676061663258116,0.26716653512233624,__nan__,__nan__,__nan__,1.1398600076466412
79,PAA,Plains All American Pipeline L.P. Common Units representing Limited Partner Interests,"Plains All American Pipeline, L.P., through its subsidiaries, engages in the pipeline transportation, terminalling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates in two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and at times on barges or railcars. This segment provides terminalling, storage, and other facilities-related services, as well as merchant activities. As of December 31, 2021, this segment owned and leased 18,300 miles of active crude oil transportation pipelines and gathering systems, as well as an additional 110 miles of pipelines that supports crude oil storage and terminalling facilities; 74 million barrels of commercial crude oil storage capacity; 38 million barrels of active, above-ground tank capacity; four marine facilities; a condensate processing facility; seven crude oil rail terminals and 2,100 crude oil railcars; and 640 trucks and 1,275 trailers. The Natural Gas Liquids segment engages in the natural gas processing, NGL fractionation, storage, transportation, and terminalling activities. As of December 31, 2021, this segment owned and operated four natural gas processing plants; nine fractionation plants; 28 million barrels of NGL storage capacity; approximately 1,620 miles of active NGL transportation pipelines, as well as an additional 55 miles of pipeline that supports NGL storage facilities; 16 NGL rail terminals and approximately 3,900 NGL rail cars; and approximately 220 trailers. The company was founded in 1981 and is headquartered in Houston, Texas. Plains All American Pipeline, L.P. operates as a subsidiary of Plains GP Holdings, L.P.",Mr. Wilfred C.W. Chiang,Oil & Gas Midstream,17.16,USD,12076796160,https://images.financialmodelingprep.com/symbol/PAA.png,4127537,23.51,1.13,7523284,2736000000,772000000,"[{'period': '2024', 'revenue': 50070.0, 'unit': 'M', 'net_profit': 772.0}, {'period': '2023', 'revenue': 48.71, 'unit': 'B', 'net_profit': 1.23}, {'period': '2022', 'revenue': 57.34, 'unit': 'B', 'net_profit': 1.04}, {'period': '2021', 'revenue': 42040.0, 'unit': 'M', 'net_profit': 593.0}]","[{'period': ""Q4 '24"", 'revenue': 12400.0, 'unit': 'M', 'net_profit': 36.0}, {'period': ""Q3 '24"", 'revenue': 12740.0, 'unit': 'M', 'net_profit': 220.0}, {'period': ""Q2 '24"", 'revenue': 12980.0, 'unit': 'M', 'net_profit': 250.0}, {'period': ""Q1 '24"", 'revenue': 11990.0, 'unit': 'M', 'net_profit': 266.0}, {'period': ""Q4 '23"", 'revenue': 12710.0, 'unit': 'M', 'net_profit': 312.0}, {'period': ""Q3 '23"", 'revenue': 12070.0, 'unit': 'M', 'net_profit': 203.0}]",1.47,1.47,26562000000,4802000000,348000000,8516000000,3901000000,2811000000,4950000000,348000000,2490000000,-0.10500490677134446,-0.3723577235772358,0.050000000000000044,"[0.38, 0.45]","['2025-05-01', '1999-01-27']",__nan__,0.3206083879225962
80,PAAS,Pan American Silver Corp. Common Stock,"Pan American Silver Corp., together with its subsidiaries, engages in the exploration, mine development, extraction, processing, refining, and reclamation of silver, gold, zinc, lead, and copper mines in Canada, Mexico, Peru, Argentina, and Bolivia. It holds interests in the La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, San Vicente, Joaquin, Cap-Oeste Sur Este, and Navidad mines. The company was formerly known as Pan American Minerals Corp. and changed its name to Pan American Silver Corp. in April 1995. Pan American Silver Corp. was incorporated in 1979 and is headquartered in Vancouver, Canada.",Mr. Christopher  Emerson,Silver,24.41,USD,8839788580,https://images.financialmodelingprep.com/symbol/PAAS.png,3494340,78.74,2.69,6977563,1051000000,111500000,"[{'period': '2024', 'revenue': 2820.0, 'unit': 'M', 'net_profit': 111.5}, {'period': '2023', 'revenue': 2320.0, 'unit': 'M', 'net_profit': -103.7}, {'period': '2022', 'revenue': 1490.0, 'unit': 'M', 'net_profit': -340.06}, {'period': '2021', 'revenue': 1630.0, 'unit': 'M', 'net_profit': 97.43}]","[{'period': ""Q4 '24"", 'revenue': 815.1, 'unit': 'M', 'net_profit': 107.6}, {'period': ""Q3 '24"", 'revenue': 716.1, 'unit': 'M', 'net_profit': 57.16}, {'period': ""Q2 '24"", 'revenue': 686.16, 'unit': 'M', 'net_profit': -21.9}, {'period': ""Q1 '24"", 'revenue': 601.4, 'unit': 'M', 'net_profit': -30.9}, {'period': ""Q4 '23"", 'revenue': 669.6, 'unit': 'M', 'net_profit': -51.5}, {'period': ""Q3 '23"", 'revenue': 616.3, 'unit': 'M', 'net_profit': -21.8}]",0.31,0.31,7202700000,1720400000,887300000,2486100000,195800000,0,687000000,862800000,400800000,1.204278523489933,2.0752169720347156,1.96875,"[0.1, 0.025]","['2025-03-03', '2010-02-24']",__nan__,0.3451622308301054
81,PACB,Pacific Biosciences of California Inc. Common Stock,"Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.",Mr. Mark  Van Oene Ph.D.,Medical - Devices,1.45,USD,431885400,https://images.financialmodelingprep.com/symbol/PACB.png,11549795,-0.91,0.25,28472540,-356381000,-309851000,"[{'period': '2024', 'revenue': 154.01, 'unit': 'M', 'net_profit': -309.85}, {'period': '2023', 'revenue': 200.52, 'unit': 'M', 'net_profit': -306.74}, {'period': '2022', 'revenue': 128.3, 'unit': 'M', 'net_profit': -296.93}, {'period': '2021', 'revenue': 130.51, 'unit': 'M', 'net_profit': -181.22}]","[{'period': ""Q4 '24"", 'revenue': 39.22, 'unit': 'M', 'net_profit': 2.37}, {'period': ""Q3 '24"", 'revenue': 39.97, 'unit': 'M', 'net_profit': -60.73}, {'period': ""Q2 '24"", 'revenue': 36.01, 'unit': 'M', 'net_profit': -173.32}, {'period': ""Q1 '24"", 'revenue': 38.81, 'unit': 'M', 'net_profit': -78.18}, {'period': ""Q4 '23"", 'revenue': 58.36, 'unit': 'M', 'net_profit': -82.02}, {'period': ""Q3 '23"", 'revenue': 55.69, 'unit': 'M', 'net_profit': -66.87}]",-1.13,-1.07,1260447000,495681000,389931000,753853000,27524000,0,66299000,55370000,-212246000,-0.2852655419392532,-0.010158605962801767,0.0661157024793389,__nan__,__nan__,__nan__,0.5980838543786451
82,PACW,PacWest Bancorp Common Stock,"PacWest Bancorp operates as the bank holding company for Pacific Western Bank that provides various banking products and services. The company accepts demand, money market, and time deposits. It also provides real estate loans to professional developers and real estate investors for the acquisition, refinancing, renovation, and construction of commercial real estate properties; small business administration loans; asset-based loans for working capital needs; venture capital loans to support the operations of entrepreneurial and venture-backed companies; and equipment-secured loans and leases. In addition, the company offers consumer loans comprising personal loans, auto loans, home equity lines of credit, revolving lines of credit, and other loans. Further, it provides international banking and multi-state deposit services; money market sweep products; investment advisory and asset management services; treasury and cash management services; telephone banking, remote deposit, and online and mobile banking services; and automated teller machine services. The company offers its products and services to small and mid-sized companies, venture capital and private equity investors, professionals, and other individuals. As of February 1, 2022, it operated through 69 full-service branches located in California; one branch located in Durham, North Carolina; one branch located in Denver, Colorado; and various loan production offices. The company was formerly known as First Community Bancorp and changed its name to PacWest Bancorp in April 2008. PacWest Bancorp was founded in 1999 and is headquartered in Beverly Hills, California.",Mr. Paul W. Taylor,Banks - Regional,7.54,USD,904521020,https://images.financialmodelingprep.com/symbol/PACW.png,4803756,-0.6336134453781512,-0.21,24138031,882529000,423613000,"[{'period': '2022', 'revenue': 1290.0, 'unit': 'M', 'net_profit': 423.61}, {'period': '2021', 'revenue': 1260.0, 'unit': 'M', 'net_profit': 606.96}, {'period': '2020', 'revenue': 1.13, 'unit': 'B', 'net_profit': -1.24}, {'period': '2019', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 468.64}]","[{'period': ""Q3 '23"", 'revenue': 143.32, 'unit': 'M', 'net_profit': -23.34}, {'period': ""Q2 '23"", 'revenue': 25.45, 'unit': 'M', 'net_profit': -197.41}, {'period': ""Q1 '23"", 'revenue': 0.51779, 'unit': 'B', 'net_profit': -1.2}, {'period': ""Q4 '22"", 'revenue': 279.64, 'unit': 'M', 'net_profit': 49.51}, {'period': ""Q3 '22"", 'revenue': 354.9, 'unit': 'M', 'net_profit': 131.62}, {'period': ""Q2 '22"", 'revenue': 339.49, 'unit': 'M', 'net_profit': 122.36}]",3.61,3.61,41228936000,5055760000,7083709000,37278405000,395867000,7112622000,2224984000,2240222000,581110000,0.013442456159288397,-0.30207312190774005,-0.292156862745098,"[0.01, 0.09]","['2023-11-09', '2000-11-14']",__nan__,0.9041806220757188
83,PACX,Pioneer Merger Corp. Class A Ordinary Share,"Pioneer Merger Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology and consumer sectors. The company was incorporated in 2020 and is based in New York, New York.",Mr. Ryan Francis El Khoury,Shell Companies,10.2,USD,513187480,https://images.financialmodelingprep.com/symbol/PACX.png,430564,0,0,3231780,8456053,23172465,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.17}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.81}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.36}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 52.88}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 33.78}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.9}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.88}]",0.46,0.46,403003,464.976,13.726,32544,0,402538,5381.404,13.726,-1812587,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.0807537412872857
84,PACXU,Pioneer Merger Corp. Unit,"Pioneer Merger Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology and consumer sectors. The company was incorporated in 2020 and is based in New York, New York.",Mr. Ryan Francis El Khoury,Shell Companies,10.19,USD,0,https://images.financialmodelingprep.com/symbol/PACXU.png,996,0,0,10,8456053,23172465,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.17}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.81}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.36}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 52.88}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 33.78}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.9}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.88}]",0.46,0.46,403003,464.976,13.726,32544,0,402538,5381.404,13.726,-1812587,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.0807537412872857
85,PACXW,Pioneer Merger Corp. Warrant,"Pioneer Merger Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Ryan  Khoury,Shell Companies,0.0004,USD,0,https://images.financialmodelingprep.com/symbol/PACXW.png,0,0,0,215950,8456053,23172465,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.17}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.81}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.36}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 52.88}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 33.78}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.9}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.88}]",0.46,0.46,403003,464.976,13.726,32544,0,402538,5381.404,13.726,-1812587,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.0807537412872857
86,PAE,PAE Incorporated Class A Common Stock,"PAE Incorporated provides operational solutions and outsourced services for the United States government, other allied governments, international organizations, and companies. The company operates through two segments, Global Mission Services and National Security Solutions. The Global Mission Services segment engages in logistics and stability operations, including lifecycle logistics operations, humanitarian, and stability operations; infrastructure management, such as mission operations support, space development and operations, and test and training ranges; and force readiness comprising the maintenance and repair of military and civilian vehicle fleets and aircraft. The National Security Solutions segment offers counter-threat solutions, such as training support and counter-terrorism solutions; information optimization services, including business process outsourcing services to government agencies, such as citizenship processing and litigation services, and systems support; and intelligence solutions comprising intelligence analysis, mission support, program management, engineering, and training solutions. PAE Incorporated was founded in 1955 and is headquartered in Falls Church, Virginia. As of February 15, 2022, PAE Incorporated operates as a subsidiary of Amentum Government Services Holdings LLC.",Mr. John E. Heller,Specialty Business Services,10.05,USD,0,https://images.financialmodelingprep.com/symbol/PAE.png,779554,19.744597249508843,0,656531,135868000,15290000,"[{'period': '2020', 'revenue': 2710.0, 'unit': 'M', 'net_profit': 15.29}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.46}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.74}, {'period': '2017', 'revenue': 0.0, 'unit': 'K', 'net_profit': -23.68}]","[{'period': ""Q3 '21"", 'revenue': 689.51, 'unit': 'M', 'net_profit': 29.79}, {'period': ""Q2 '21"", 'revenue': 747.2, 'unit': 'M', 'net_profit': 14.35}, {'period': ""Q1 '21"", 'revenue': 748.57, 'unit': 'M', 'net_profit': 13.38}, {'period': ""Q4 '20"", 'revenue': 787.83, 'unit': 'M', 'net_profit': -6.11}, {'period': ""Q3 '20"", 'revenue': 666.24, 'unit': 'M', 'net_profit': 10.32}, {'period': ""Q2 '20"", 'revenue': 643.3, 'unit': 'M', 'net_profit': 16.02}]",0.18,0.18,1829370000,733026000,85908000,1672718000,585511000,18272000,632181000,85908000,97027000,44.13351738680828,9.484264688941671,5.164383561643835,__nan__,__nan__,__nan__,0.9143683344539377
87,PAEWW,PAE Incorporated Warrants,,None,Specialty Business Services,2.05,USD,0,https://images.financialmodelingprep.com/symbol/PAEWW.png,0,0,0.00999999,2200,135868000,15290000,"[{'period': '2020', 'revenue': 2710.0, 'unit': 'M', 'net_profit': 15.29}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.46}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.74}, {'period': '2017', 'revenue': 0.0, 'unit': 'K', 'net_profit': -23.68}]","[{'period': ""Q3 '21"", 'revenue': 689.51, 'unit': 'M', 'net_profit': 29.79}, {'period': ""Q2 '21"", 'revenue': 747.2, 'unit': 'M', 'net_profit': 14.35}, {'period': ""Q1 '21"", 'revenue': 748.57, 'unit': 'M', 'net_profit': 13.38}, {'period': ""Q4 '20"", 'revenue': 787.83, 'unit': 'M', 'net_profit': -6.11}, {'period': ""Q3 '20"", 'revenue': 666.24, 'unit': 'M', 'net_profit': 10.32}, {'period': ""Q2 '20"", 'revenue': 643.3, 'unit': 'M', 'net_profit': 16.02}]",0.18,0.18,1829370000,733026000,85908000,1672718000,585511000,18272000,632181000,85908000,97027000,44.13351738680828,9.484264688941671,5.164383561643835,__nan__,__nan__,__nan__,0.9143683344539377
88,PAGP,Plains GP Holdings L.P. Class A Units representing Limited Partner Interests,"Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream energy infrastructure in the United States and Canada. The company operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the transportation of crude oil and NGLs on pipelines, gathering systems, and trucks. As of December 31, 2021, this segment owned and leased assets comprising 18,300 miles of crude oil and NGL pipelines and gathering systems; 38 million barrels of above-ground tank capacity; and 1,275 trailers. It engages in the provision of storage, terminalling, and throughput services primarily for crude oil, NGLs, and natural gas; NGL fractionation and isomerization services; and natural gas and condensate processing services. As of December 31, 2021, this segment owned and operated approximately 74 million barrels of crude oil storage capacity; 28 million barrels of NGL storage capacity; four natural gas processing plants; a condensate processing facility; nine fractionation plants; 16 NGL rail terminals; four marine facilities; and 110 miles of pipelines. As of December 31, 2021, this segment owned 15 million barrels of crude oil and 2 NGL linefill; 3 million barrels of crude oil and 1 NGL linefill in pipelines owned by third parties and other inventory; 640 trucks and 1,275 trailers; and 3,900 NGL railcars. The company offers logistics services to producers, refiners, and other customers. PAA GP Holdings LLC operates as a general partner of the company. Plains GP Holdings, L.P. was incorporated in 2013 and is headquartered in Houston, Texas.",Mr. Wilfred C.W. Chiang,Oil & Gas Midstream,18.29,USD,3616737760,https://images.financialmodelingprep.com/symbol/PAGP.png,1805409,35.17,1.04,3137494,2682000000,103000000,"[{'period': '2024', 'revenue': 50070.0, 'unit': 'M', 'net_profit': 103.0}, {'period': '2023', 'revenue': 48710.0, 'unit': 'M', 'net_profit': 198.0}, {'period': '2022', 'revenue': 57.34, 'unit': 'B', 'net_profit': 1.16}, {'period': '2021', 'revenue': 42040.0, 'unit': 'M', 'net_profit': 600.0}]","[{'period': ""Q4 '24"", 'revenue': 12400.0, 'unit': 'M', 'net_profit': -11.0}, {'period': ""Q3 '24"", 'revenue': 12740.0, 'unit': 'M', 'net_profit': 376.0}, {'period': ""Q2 '24"", 'revenue': 12980.0, 'unit': 'M', 'net_profit': 39.0}, {'period': ""Q1 '24"", 'revenue': 12170.0, 'unit': 'M', 'net_profit': 42.0}, {'period': ""Q4 '23"", 'revenue': 12660.0, 'unit': 'M', 'net_profit': 52.0}, {'period': ""Q3 '23"", 'revenue': 12070.0, 'unit': 'M', 'net_profit': 203.0}]",0.52,0.52,27756000000,4776000000,349000000,13440000000,3901000000,2811000000,4924000000,349000000,1844000000,-0.12094395280235988,-0.4797979797979798,1.0,"[0.38, 0.12505]","['2025-05-01', '2014-01-29']",__nan__,0.4842196281884998
89,PAHC,Phibro Animal Health Corporation Class A Common Stock,"Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.",Mr. Jack Clifford Bendheim,Drug Manufacturers - Specialty & Generic,19.06,USD,771998730,https://images.financialmodelingprep.com/symbol/PAHC.png,257486,39.71,1.18,299551,84607000,2416000,"[{'period': '2024', 'revenue': 1020.0, 'unit': 'M', 'net_profit': 2.42}, {'period': '2023', 'revenue': 977.89, 'unit': 'M', 'net_profit': 32.61}, {'period': '2022', 'revenue': 942.3, 'unit': 'M', 'net_profit': 49.17}, {'period': '2021', 'revenue': 833.4, 'unit': 'M', 'net_profit': 54.38}]","[{'period': ""Q2 '25"", 'revenue': 309.26, 'unit': 'M', 'net_profit': 3.19}, {'period': ""Q1 '25"", 'revenue': 260.43, 'unit': 'M', 'net_profit': 6.97}, {'period': ""Q4 '24"", 'revenue': 273160.0, 'unit': 'K', 'net_profit': 752.0}, {'period': ""Q3 '24"", 'revenue': 263.22, 'unit': 'M', 'net_profit': 8.4}, {'period': ""Q2 '24"", 'revenue': 249.94, 'unit': 'M', 'net_profit': 1.27}, {'period': ""Q1 '24"", 'revenue': 231.3, 'unit': 'M', 'net_profit': -8.0}]",0.0596,0.0596,982184000,600997000,114613000,725543000,169452000,11488000,204148000,70613000,46356000,-0.2745629303175025,-0.9259032079985279,-0.9264197530864198,"[0.12, 0.1]","['2025-03-05', '2014-08-29']",__nan__,0.7387037459376247
90,PAIC,Petra Acquisition Inc. Common Stock,"Petra Acquisition, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2019 and is based in New York, New York.",Mr. Andreas A. Typaldos,Shell Companies,8.32,USD,29714714,https://images.financialmodelingprep.com/symbol/PAIC.png,43347,-29.928057553956833,-0.63,55409,-136408,-136408,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -136.41}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -757.64}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.33}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.18}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.86}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -868.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -521.0}]",-0.0312,-0.0312,74162206,651291,537021,2945032,0,0,33772,11734,-218713,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.039710684981512014
91,PAICU,Petra Acquisition Inc. Units,"Petra Acquisition, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2019 and is based in New York, New York.",Mr. Andreas A. Typaldos,Shell Companies,10.75,USD,0,https://images.financialmodelingprep.com/symbol/PAICU.png,149,-38.669064748201436,-0.41,363,-136408,-136408,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -136.41}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -757.64}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.33}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.18}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.86}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -868.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -521.0}]",-0.0312,-0.0312,74162206,651291,537021,2945032,0,0,33772,11734,-218713,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.039710684981512014
92,PAICW,Petra Acquisition Inc. Warrant,,,,,,,,,,,,-136408,-136408,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -136.41}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -757.64}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.33}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.18}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.86}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -868.0}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': -521.0}]",-0.03,-0.03,74162206,651291,537021,2945032,0,0,33772,11734,-218713,0.0,0.0,0.0,__nan__,__nan__,__nan__,0.039710684981512014
93,PALI,Palisade Bio Inc. Common Stock,"Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.",Mr. J. D. Finley,Biotechnology,0.705,USD,1950016,https://images.financialmodelingprep.com/symbol/PALI.png,541872,-0.07,0.035,46793,-14859000,-14438000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.44}, {'period': '2023', 'revenue': 0.25, 'unit': 'M', 'net_profit': -12.3}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.8}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.27}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.34}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.49}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.08}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.53}, {'period': ""Q4 '23"", 'revenue': -0.25, 'unit': 'M', 'net_profit': -2.97}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.6}]",-10.19,-10.19,10880000,10494000,9821000,3388000,24000,0,3236000,9821000,-12193000,-0.20991775914013516,-0.17382113821138212,0.6227323213624584,__nan__,__nan__,__nan__,0.3113970588235294
94,PANA,Panacea Acquisition Corp. II Class A Ordinary Shares,"Panacea Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.",Mr. Oleg  Nodelman,Shell Companies,10.24,USD,241100800,https://images.financialmodelingprep.com/symbol/PANA.png,69482,170.66666666666666,-0.01,114315,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
95,PANL,Pangaea Logistics Solutions Ltd. Common Shares,"Pangaea Logistics Solutions, Ltd., together with its subsidiaries, provides seaborne dry bulk logistics and transportation services to industrial customers worldwide. The company offers various dry bulk cargoes, such as grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. Its ocean logistics services comprise cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. As of March 16, 2022, the company owned and operated a fleet of 25 vessels. Pangaea Logistics Solutions, Ltd. was founded in 1996 and is based in Newport, Rhode Island.",Mr. Mark L. Filanowski,Marine Shipping,4.4,USD,288764960,https://images.financialmodelingprep.com/symbol/PANL.png,241965,6.98,0.41,465251,82321416,28903383,"[{'period': '2024', 'revenue': 536.54, 'unit': 'M', 'net_profit': 28.9}, {'period': '2023', 'revenue': 499.27, 'unit': 'M', 'net_profit': 26.32}, {'period': '2022', 'revenue': 699.71, 'unit': 'M', 'net_profit': 79.49}, {'period': '2021', 'revenue': 718.1, 'unit': 'M', 'net_profit': 67.23}]","[{'period': ""Q4 '24"", 'revenue': 147.17, 'unit': 'M', 'net_profit': 8.44}, {'period': ""Q3 '24"", 'revenue': 153.12, 'unit': 'M', 'net_profit': 5.11}, {'period': ""Q2 '24"", 'revenue': 131.5, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q1 '24"", 'revenue': 104.75, 'unit': 'M', 'net_profit': 11.67}, {'period': ""Q4 '23"", 'revenue': 131.88, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q3 '23"", 'revenue': 135.62, 'unit': 'M', 'net_profit': 18.87}]",0.64,0.63,936457081000000,191993893000000,86805470000000,508635462000000,42370830000000,3751860,109108111000000,86805470000000,65691393,0.08181196286831043,0.09801518046749458,0.08474576271186449,"[0.1, 0.035]","['2025-02-28', '2019-05-31']",__nan__,0.5431487169244866
96,PAQC,Provident Acquisition Corp. Class A Ordinary Shares,"As of October 28, 2022, Provident Acquisition Corp. was acquired by Perfect Corp., in a reverse merger transaction. Provident Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is headquartered in New Taipei City, Taiwan.",Mr. Winato  Kartono,Shell Companies,11,USD,0,https://images.financialmodelingprep.com/symbol/PAQC.png,64549,25,0,442615,10600247,23647733,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.65}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.73}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 859.82}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 515.78}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 2.91}]",0.82,0.82,230.845628,0.82352,0.42352,18.872104,0,230.01443700000002,0.485296,0.42352,-1108900,0,0,0,__nan__,__nan__,__nan__,0.08175205293469973
97,PAQCU,Provident Acquisition Corp. Units,"As of October 28, 2022, Provident Acquisition Corp. was acquired by Perfect Corp., in a reverse merger transaction. Provident Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is headquartered in New Taipei City, Taiwan.",,Shell Companies,10.8,USD,0,https://images.financialmodelingprep.com/symbol/PAQCU.png,15772,58.37837837837838,-0.18,15019,10600247,23647733,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.65}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.73}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 859.82}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 515.78}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 2.91}]",0.82,0.82,230.845628,0.82352,0.42352,18.872104,0,230.01443700000002,0.485296,0.42352,-1108900,0,0,0,__nan__,__nan__,__nan__,0.08175205293469973
98,PAQCW,Provident Acquisition Corp. Warrant,"Provident Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in Central, Hong Kong.",Mr. Winato  Kartono,Shell Companies,0.3627,USD,0,https://images.financialmodelingprep.com/symbol/PAQCW.png,0,0,-0.0322,62916,10600247,23647733,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.65}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.73}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 859.82}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 515.78}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 2.91}]",0.82,0.82,230.845628,0.82352,0.42352,18.872104,0,230.01443700000002,0.485296,0.42352,-1108900,0,0,0,__nan__,__nan__,__nan__,0.08175205293469973
99,PASG,Passage Bio Inc. Common Stock,"Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and PBCM06 for the treatment of Charcot-Marie-Tooth Type 2A. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.",Dr. William  Chou M.D.,Biotechnology,0.409,USD,25418655,https://images.financialmodelingprep.com/symbol/PASG.png,168175,-0.38,0.083,194020,-70400000,-64767000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -64.77}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -102.06}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -136.86}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -191.5}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.72}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.34}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.99}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.71}, {'period': ""Q4 '23"", 'revenue': 5.91, 'unit': 'M', 'net_profit': -16.76}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.11}]",-1.07,-1.07,102412000,78815000,76756000,41151000,0,0,19363000,37573000,-47990000,0.2841236107015385,0.365415139816974,0.42473118279569894,__nan__,__nan__,__nan__,0.4018181463109792
100,PATI,Patriot Transportation Holding Inc. Common Stock,"Patriot Transportation Holding, Inc., through its subsidiary, Florida Rock & Tank Lines, Inc., transports petroleum and other liquids, and dry bulk commodities. The company is involved in hauling petroleum related products, including gas and diesel fuel; and dry bulk commodities, such as cement, lime, and various industrial powder products, as well as liquid chemicals. Its petroleum clients include convenience stores and hypermarket accounts, fuel wholesalers, and oil companies; and dry bulk and chemical customers comprise industrial companies, such as cement and concrete accounts, as well as product distribution companies. As of September 30, 2021, the company operated a fleet of 282 company tractors, 22 owner operators, and 420 trailers from its 18 terminals and 6 satellite locations in Florida, Georgia, Alabama, and Tennessee. Patriot Transportation Holding, Inc. is headquartered in Jacksonville, Florida.",Mr. Robert E. Sandlin,Trucking,16.26,USD,57781048,https://images.financialmodelingprep.com/symbol/PATI.png,21846,21.972972972972972,0.015,19376,2559000,2673000,"[{'period': '2023', 'revenue': 94.78, 'unit': 'M', 'net_profit': 2.67}, {'period': '2022', 'revenue': 87.88, 'unit': 'M', 'net_profit': 7.19}, {'period': '2021', 'revenue': 81270.0, 'unit': 'K', 'net_profit': 625.0}, {'period': '2020', 'revenue': 88710.0, 'unit': 'K', 'net_profit': 257.0}]","[{'period': ""Q4 '23"", 'revenue': 24220.0, 'unit': 'K', 'net_profit': 526.0}, {'period': ""Q3 '23"", 'revenue': 24.25, 'unit': 'M', 'net_profit': 1.19}, {'period': ""Q2 '23"", 'revenue': 23460.0, 'unit': 'K', 'net_profit': 475.0}, {'period': ""Q1 '23"", 'revenue': 22850.0, 'unit': 'K', 'net_profit': 485.0}, {'period': ""Q4 '22"", 'revenue': 22880.0, 'unit': 'K', 'net_profit': 470.0}, {'period': ""Q3 '22"", 'revenue': 23500.0, 'unit': 'K', 'net_profit': 771.0}]",0.76,0.76,52667000,19470000,6429000,18336000,6637000,0,9057000,6429000,0,7.763698630136986,-0.6282336578581363,-0.6346153846153846,"[3.75, 3]","['2021-11-16', '2020-01-14']",__nan__,0.3481496952550933
101,PATK,Patrick Industries Inc. Common Stock,"Patrick Industries, Inc. manufactures and distributes components, building products, and materials for the recreational vehicle, marine, manufactured housing, and industrial markets in the United States, China, and Canada. Its Manufacturing segment manufactures and sells furniture, shelving, wall, countertop, and cabinet product; cabinet door, fiberglass bath fixture, and tile system; hardwood furniture, vinyl printing, amplifiers, tower speakers, soundbars, and subwoofers; solid surface, granite, and quartz countertop fabrication; aluminum product; fiberglass and plastic components; RV painting; decorative vinyl and paper laminated panels; softwoods lumber; custom cabinet; polymer-based flooring product; dash panels; and other products. This segment also provides wrapped vinyl, paper, and hardwood profile moulding; interior passage doors; air handling products; slide-out trim and fascia; treated, untreated, and laminated plywood; fiberglass and plastic helm systems and components; boat covers, tower, top, and frame; adhesives and sealants; thermoformed shower surrounds; specialty bath, and closet building products; wiring and wire harnesses; aluminum and plastic fuel tanks; CNC molds, composite part, marine hardware; slotwall panels, components; and other products. The company's Distribution segment distributes pre-finished wall and ceiling panel, drywall and finishing product, electronic, audio system component, appliance, marine accessories, wiring product, electrical and plumbing product, fiber reinforced polyester product; cement siding product, raw and processed lumber, interior passage, roofing, laminate, and ceramic flooring product, shower door, furniture, fireplace and surround, interior and exterior lighting product, and other products. This segment also offers transportation and logistics service. The company was founded in 1959 and is headquartered in Elkhart, Indiana.",Mr. Andy L. Nemeth,"Furnishings, Fixtures & Appliances",81.55,USD,2736426560,https://images.financialmodelingprep.com/symbol/PATK.png,391495,19.84,7.22,609653,258040000,138401000,"[{'period': '2024', 'revenue': 3720.0, 'unit': 'M', 'net_profit': 138.4}, {'period': '2023', 'revenue': 3470.0, 'unit': 'M', 'net_profit': 142.9}, {'period': '2022', 'revenue': 4880.0, 'unit': 'M', 'net_profit': 328.2}, {'period': '2021', 'revenue': 4080.0, 'unit': 'M', 'net_profit': 224.91}]","[{'period': ""Q4 '24"", 'revenue': 846.12, 'unit': 'M', 'net_profit': 14.56}, {'period': ""Q3 '24"", 'revenue': 919.44, 'unit': 'M', 'net_profit': 40.87}, {'period': ""Q2 '24"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 47.88}, {'period': ""Q1 '24"", 'revenue': 933.49, 'unit': 'M', 'net_profit': 35.09}, {'period': ""Q4 '23"", 'revenue': 781.19, 'unit': 'M', 'net_profit': 30.82}, {'period': ""Q3 '23"", 'revenue': 866.07, 'unit': 'M', 'net_profit': 39.55}]",4.25,4.11,3020954000,822617000,33561000,1892588000,188083000,0,353615000,33561000,251159000,-0.3624596348794173,-0.031463221761128646,-0.3609022556390978,"[0.4, 0.06]","['2025-02-18', '1995-06-13']",__nan__,0.6264868647453752
102,PAVM,PAVmed Inc. Common Stock,"PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.",Dr. Lishan  Aklog M.D.,Medical - Devices,0.693,USD,11633530,https://images.financialmodelingprep.com/symbol/PAVM.png,181378,1.39,0.09,368570,-44487000000,31966000000,"[{'period': '2024', 'revenue': 3.0, 'unit': 'B', 'net_profit': 31.97}, {'period': '2023', 'revenue': 2.45, 'unit': 'M', 'net_profit': -64.17}, {'period': '2022', 'revenue': 0.377, 'unit': 'M', 'net_profit': -101.29}, {'period': '2021', 'revenue': 0.5, 'unit': 'M', 'net_profit': -50.35}]","[{'period': ""Q4 '24"", 'revenue': 0.01, 'unit': 'M', 'net_profit': 1.43}, {'period': ""Q3 '24"", 'revenue': 0.996, 'unit': 'M', 'net_profit': 64.4}, {'period': ""Q2 '24"", 'revenue': 0.979, 'unit': 'M', 'net_profit': -10.83}, {'period': ""Q1 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -15.21}, {'period': ""Q4 '23"", 'revenue': 1.05, 'unit': 'M', 'net_profit': -14.04}, {'period': ""Q3 '23"", 'revenue': 0.791, 'unit': 'M', 'net_profit': -17.75}]",3.3,3.3,30660000000,2164000000,1185000000,37693000000,18000,0,35446000000,1185000,-33554000000,-586.3491589870878,499.10673938449554,1.3601047577477083,__nan__,__nan__,__nan__,1.2293868232224396
103,PAVMW,PAVmed Inc. Warrant,"PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.",Dr. Lishan Aklog M.D.,Medical - Devices,0.029,USD,769747,https://images.financialmodelingprep.com/symbol/PAVMW.png,6563,-0.050347222222222224,0.0149,32626,-44487000000,31966000000,"[{'period': '2024', 'revenue': 3.0, 'unit': 'B', 'net_profit': 31.97}, {'period': '2023', 'revenue': 2.45, 'unit': 'M', 'net_profit': -64.17}, {'period': '2022', 'revenue': 0.377, 'unit': 'M', 'net_profit': -101.29}, {'period': '2021', 'revenue': 0.5, 'unit': 'M', 'net_profit': -50.35}]","[{'period': ""Q4 '24"", 'revenue': 0.01, 'unit': 'M', 'net_profit': 1.43}, {'period': ""Q3 '24"", 'revenue': 0.996, 'unit': 'M', 'net_profit': 64.4}, {'period': ""Q2 '24"", 'revenue': 0.979, 'unit': 'M', 'net_profit': -10.83}, {'period': ""Q1 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -15.21}, {'period': ""Q4 '23"", 'revenue': 1.05, 'unit': 'M', 'net_profit': -14.04}, {'period': ""Q3 '23"", 'revenue': 0.791, 'unit': 'M', 'net_profit': -17.75}]",3.3,3.3,30660000000,2164000000,1185000000,37693000000,18000,0,35446000000,1185000,-33554000000,-586.3491589870878,499.10673938449554,1.3601047577477083,__nan__,__nan__,__nan__,1.2293868232224396
104,PAVMZ,PAVmed Inc. Series Z Warrant,"PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.",Dr. Lishan  Aklog M.D.,Medical - Devices,0.0032,USD,11539983,https://images.financialmodelingprep.com/symbol/PAVMZ.png,14168.68323,,0,15860,-44487000000,31966000000,"[{'period': '2024', 'revenue': 3.0, 'unit': 'B', 'net_profit': 31.97}, {'period': '2023', 'revenue': 2.45, 'unit': 'M', 'net_profit': -64.17}, {'period': '2022', 'revenue': 0.377, 'unit': 'M', 'net_profit': -101.29}, {'period': '2021', 'revenue': 0.5, 'unit': 'M', 'net_profit': -50.35}]","[{'period': ""Q4 '24"", 'revenue': 0.01, 'unit': 'M', 'net_profit': 1.43}, {'period': ""Q3 '24"", 'revenue': 0.996, 'unit': 'M', 'net_profit': 64.4}, {'period': ""Q2 '24"", 'revenue': 0.979, 'unit': 'M', 'net_profit': -10.83}, {'period': ""Q1 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -15.21}, {'period': ""Q4 '23"", 'revenue': 1.05, 'unit': 'M', 'net_profit': -14.04}, {'period': ""Q3 '23"", 'revenue': 0.791, 'unit': 'M', 'net_profit': -17.75}]",3.3,3.3,30660000000,2164000000,1185000000,37693000000,18000,0,35446000000,1185000,-33554000000,-586.3491589870878,499.10673938449554,1.3601047577477083,__nan__,__nan__,__nan__,1.2293868232224396
105,PAX,Patria Investments Limited Class A Common Shares,"Patria Investments Limited operates as a private market investment firm focused on investing in Latin America. The company offers asset management services to investors focusing on private equity funds, infrastructure development funds, co-investments funds, constructivist equity funds, and real estate and credit funds. Patria Investments Limited was founded in 1994 and is headquartered in Grand Cayman, the Cayman Islands.",Mr. Alexandre Teixeira de Assumpcao Saigh,Asset Management,10.45,USD,1618005049,https://images.financialmodelingprep.com/symbol/PAX.png,578273,21.77,0.77,1011941,179911993,73400000,"[{'period': '2024', 'revenue': 374.2, 'unit': 'M', 'net_profit': 73.4}, {'period': '2023', 'revenue': 329.41, 'unit': 'M', 'net_profit': 118.4}, {'period': '2022', 'revenue': 258.88, 'unit': 'M', 'net_profit': 92.96}, {'period': '2021', 'revenue': 235.51, 'unit': 'M', 'net_profit': 122.48}]","[{'period': ""Q4 '24"", 'revenue': 157.3, 'unit': 'M', 'net_profit': 56.8}, {'period': ""Q3 '24"", 'revenue': 78.0, 'unit': 'M', 'net_profit': 1.5}, {'period': ""Q2 '24"", 'revenue': 75000.0, 'unit': 'K', 'net_profit': 800.0}, {'period': ""Q1 '24"", 'revenue': 63.68, 'unit': 'M', 'net_profit': 15.45}, {'period': ""Q4 '23"", 'revenue': 112.07, 'unit': 'M', 'net_profit': 46.99}, {'period': ""Q3 '23"", 'revenue': 63.54, 'unit': 'M', 'net_profit': 18.47}]",0.48,0.48,1215000000,388300000,92400000,723600001,223200000,48900000,403900000,33400000,0,0.22925131355092615,-0.38006756756756754,-0.4000000000000001,"[0.15, 0.106]","['2025-02-28', '2021-06-01']",__nan__,0.5955555563786008
106,PAYA,Paya Holdings Inc. Class A Common Stock,"Paya Holdings Inc., through its subsidiaries, operates as an independent integrated payments platform. It operates through two segments, Integrated Solutions and Payment Services. The company processes payments through credit and debit card, automated clearing house, and check payments. It serves customers through distribution partners with focus on targeted verticals, such as B2B goods and services, healthcare, faith-based and non-profit, government and utilities, and education markets. The company is headquartered in Atlanta, Georgia with additional offices in Reston, Virginia; Fort Walton Beach, Florida; Dayton, Ohio; Mt. Vernon, Ohio; Dallas, Texas; and Tempe, Arizona.",Mr. Jeffrey I. Hack,Software - Infrastructure,9.74,USD,1289819500,https://images.financialmodelingprep.com/symbol/PAYA.png,2574039,139.14285714285714,0,1126108,59665000,8262000,"[{'period': '2022', 'revenue': 282.74, 'unit': 'M', 'net_profit': 8.26}, {'period': '2021', 'revenue': 249360.0, 'unit': 'K', 'net_profit': -811.0}, {'period': '2020', 'revenue': 206050.0, 'unit': 'K', 'net_profit': -524.0}, {'period': '2019', 'revenue': 203.37, 'unit': 'M', 'net_profit': -9.02}]","[{'period': ""Q4 '22"", 'revenue': 72.89, 'unit': 'M', 'net_profit': 3.05}, {'period': ""Q3 '22"", 'revenue': 71.37, 'unit': 'M', 'net_profit': 1.35}, {'period': ""Q2 '22"", 'revenue': 72.49, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q1 '22"", 'revenue': 65.99, 'unit': 'M', 'net_profit': 2.21}, {'period': ""Q4 '21"", 'revenue': 67.06, 'unit': 'M', 'net_profit': 4.26}, {'period': ""Q3 '21"", 'revenue': 63.06, 'unit': 'M', 'net_profit': -2.96}]",0.065,0.065,744260000,380266000,168833000,487366000,25515000,0,222947000,168833000,32243000,0.3371506689675265,11.187422934648582,11.15625,__nan__,__nan__,__nan__,0.6548329884717706
107,PAYAW,Paya Holdings Inc. Warrant,,,,,,,,,,,,24578680,-524,"[{'period': '2020', 'revenue': 206050.0, 'unit': '', 'net_profit': -524.0}, {'period': '2019', 'revenue': 203.37, 'unit': 'M', 'net_profit': -9.02}, {'period': '2018', 'revenue': 185.08, 'unit': 'M', 'net_profit': -3.17}]","[{'period': ""Q2 '21"", 'revenue': 63.98, 'unit': 'M', 'net_profit': -3.15}, {'period': ""Q4 '20"", 'revenue': 206050.0, 'unit': '', 'net_profit': -524.0}, {'period': ""Q2 '20"", 'revenue': 51090.0, 'unit': 'K', 'net_profit': 625.0}]",-0.01,-0.01,396055,44326,23617,359309,17493,0,25008,23617,8148000,-0.2080335105526019,0.9999419326241135,0,__nan__,__nan__,__nan__,0.9072199568241784
108,PAYS,Paysign Inc. Common Stock,"PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. It offers various services, such as transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a proprietary card-processing platform. The company also develops prepaid card programs for corporate incentive and rewards, including consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments, and pharmaceutical payment assistance; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, it offers and Per Diem/Corporate Expense Payments that allows businesses, and nonprofits and government agencies the ability to control employee spending while reducing administration costs by eliminating the need for traditional expense reports. Further, the company provides payment claims processing and other administrative services; pharmacy-based voucher and copay, and medical claims and debit-based affordability programs; PaySign Premier, a demand deposit account debit card; and payment solution for source plasma collection centers, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and Mexico. The company was formerly known as 3PEA International, Inc. and changed its name to PaySign, Inc. in April 2019. PaySign, Inc. was incorporated in 1995 and is based in Henderson, Nevada.",Mr. Mark R. Newcomer,Software - Infrastructure,2.07,USD,111257739,https://images.financialmodelingprep.com/symbol/PAYS.png,279375,29.57,0.13,274005,7016494,3815907,"[{'period': '2024', 'revenue': 58.38, 'unit': 'M', 'net_profit': 3.82}, {'period': '2023', 'revenue': 47.27, 'unit': 'M', 'net_profit': 6.46}, {'period': '2022', 'revenue': 38.03, 'unit': 'M', 'net_profit': 1.03}, {'period': '2021', 'revenue': 29.46, 'unit': 'M', 'net_profit': -2.72}]","[{'period': ""Q4 '24"", 'revenue': 15.61, 'unit': 'M', 'net_profit': 1.37}, {'period': ""Q3 '24"", 'revenue': 15.26, 'unit': 'M', 'net_profit': 1.44}, {'period': ""Q2 '24"", 'revenue': 14330.0, 'unit': 'K', 'net_profit': 697.1}, {'period': ""Q1 '24"", 'revenue': 13190.0, 'unit': 'K', 'net_profit': 309.1}, {'period': ""Q4 '23"", 'revenue': 13.69, 'unit': 'M', 'net_profit': 5.62}, {'period': ""Q3 '23"", 'revenue': 12.4, 'unit': 'M', 'net_profit': 1.1}]",0.0717,0.0686,179028197,158836633,10766982,148586565,34245518,0,146106495,10766982,22512219,0.8180634271865816,-0.4091858968493327,-0.40249999999999997,__nan__,__nan__,__nan__,0.8299618020506568
109,PAYX,Paychex Inc. Common Stock,"Paychex, Inc. provides integrated human capital management solutions for human resources (HR), payroll, benefits, and insurance services for small to medium-sized businesses in the United States, Europe, and India. It offers payroll processing services; payroll tax administration services; employee payment services; and regulatory compliance services, such as new-hire reporting and garnishment processing. The company also provides HR solutions, including payroll, employer compliance, HR and employee benefits administration, risk management outsourcing, and the on-site availability of a professionally trained HR representative; and retirement services administration, including plan implementation, ongoing compliance with government regulations, employee and employer reporting, participant and employer online access, electronic funds transfer, and other administrative services. In addition, it offers cloud-based HR administration software products for employee benefits management and administration, time and attendance, digital communication solutions, recruiting, and onboarding solutions; plan administration outsourcing and state unemployment insurance services; various business services to small to medium-sized businesses comprising payroll funding and outsourcing services, which include payroll processing, invoicing, and tax preparation; and payment processing services, financial fitness programs, and a small-business loan resource center. Further, the company provides insurance services for property and casualty coverage, such as workers' compensation, business-owner policies, cyber security protection, and commercial auto, as well as health and benefits coverage, including health, dental, vision, and life. It markets and sells its services primarily through its direct sales force. The company was founded in 1971 and is headquartered in Rochester, New York.",Mr. John B. Gibson Jr.,Staffing & Employment Services,146.15,USD,52641914650,https://images.financialmodelingprep.com/symbol/PAYX.png,2210511,30.32,9.14,5022387,2350600000,1690400000,"[{'period': '2024', 'revenue': 5.28, 'unit': 'B', 'net_profit': 1.69}, {'period': '2023', 'revenue': 5.01, 'unit': 'B', 'net_profit': 1.56}, {'period': '2022', 'revenue': 4.61, 'unit': 'B', 'net_profit': 1.39}, {'period': '2021', 'revenue': 4.06, 'unit': 'B', 'net_profit': 1.1}]","[{'period': ""Q3 '25"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': 519.3}, {'period': ""Q2 '25"", 'revenue': 1320.0, 'unit': 'M', 'net_profit': 413.4}, {'period': ""Q1 '25"", 'revenue': 1320.0, 'unit': 'M', 'net_profit': 427.4}, {'period': ""Q4 '24"", 'revenue': 1300.0, 'unit': 'M', 'net_profit': 379.9}, {'period': ""Q3 '24"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 498.6}, {'period': ""Q2 '24"", 'revenue': 1260.0, 'unit': 'M', 'net_profit': 392.7}]",4.69,4.67,10383100000,7251500000,1502800000,6582100000,1625300000,3700000,5309100000,1468900000,1736300000,0.06376431189754266,0.0854684389648751,0.08564814814814817,"[0.98, 0.03]","['2025-02-07', '1988-11-04']",__nan__,0.6339243578507382
110,PBCT,People's United Financial Inc. Common Stock,"People's United Financial, Inc. operates as the bank holding company for People's United Bank, National Association that provides commercial banking, retail banking, and wealth management services to individual, corporate, and municipal customers. The company offers commercial deposit products, commercial real estate lending, middle market and business banking, equipment financing, mortgage warehouse and asset-based lending, treasury management services, and capital market capabilities. It also provides consumer lending, including residential mortgage and home equity lending; and consumer deposit gathering services. In addition, the company offers brokerage, financial and investment advisory, investment management, life insurance, financial management and planning, and non-institutional trust services, as well as cash management, municipal banking, online banking, investment trading, and telephone banking services. As of March 04, 2022, it operated approximately 400 retail locations in Connecticut, New York, Massachusetts, Vermont, New Hampshire, and Maine. The company also operates 562 ATMs. People's United Financial, Inc. was founded in 1842 and is headquartered in Bridgeport, Connecticut. As of April 1, 2022, People's United Financial, Inc. operates as a subsidiary of M&T Bank Corporation.",Mr. John Barnes,Banks - Regional,19.41,USD,0,https://images.financialmodelingprep.com/symbol/PBCT.png,7401366,13.964028776978417,0,1,896400000,604900000,"[{'period': '2021', 'revenue': 1890.0, 'unit': 'M', 'net_profit': 604.9}, {'period': '2020', 'revenue': 1990.0, 'unit': 'M', 'net_profit': 219.6}, {'period': '2019', 'revenue': 1840.0, 'unit': 'M', 'net_profit': 520.4}, {'period': '2018', 'revenue': 1600.0, 'unit': 'M', 'net_profit': 468.1}]","[{'period': ""Q4 '21"", 'revenue': 461.6, 'unit': 'M', 'net_profit': 149.9}, {'period': ""Q3 '21"", 'revenue': 470.7, 'unit': 'M', 'net_profit': 139.7}, {'period': ""Q2 '21"", 'revenue': 479.9, 'unit': 'M', 'net_profit': 170.8}, {'period': ""Q1 '21"", 'revenue': 480.5, 'unit': 'M', 'net_profit': 144.5}, {'period': ""Q4 '20"", 'revenue': 485.0, 'unit': 'M', 'net_profit': -145.3}, {'period': ""Q3 '20"", 'revenue': 492.5, 'unit': 'M', 'net_profit': 144.6}]",1.42,1.42,64642400000,40837700000,17233300000,56740600000,0,20754300000,0,320500000,465000000,0.3339285714285714,1.7545537340619308,1.7307692307692306,"[0.1825, 0.176]","['2022-01-31', '1988-10-26']",__nan__,0.8777613454945979
111,PBCTP,People's United Financial Inc. Perpetual Preferred Series A Fixed-to-floating Rate,"People's United Financial, Inc. operates as the bank holding company for People's United Bank, National Association that provides commercial banking, retail banking, and wealth management services to individual, corporate, and municipal customers. The company offers commercial deposit products, commercial real estate lending, middle market and business banking, equipment financing, mortgage warehouse and asset-based lending, treasury management services, and capital market capabilities. It also provides consumer lending, including residential mortgage and home equity lending; and consumer deposit gathering services. In addition, the company offers brokerage, financial and investment advisory, investment management, life insurance, financial management and planning, and non-institutional trust services, as well as cash management, municipal banking, online banking, investment trading, and telephone banking services. As of March 04, 2022, it operated approximately 400 retail locations in Connecticut, New York, Massachusetts, Vermont, New Hampshire, and Maine. The company also operates 562 ATMs. People's United Financial, Inc. was founded in 1842 and is headquartered in Bridgeport, Connecticut. As of April 2, 2022, People's United Financial, Inc. operates as a subsidiary of M&T Bank Corporation.",Mr. John P. Barnes,Banks - Regional,26.07,USD,0,https://images.financialmodelingprep.com/symbol/PBCTP.png,21424,18.755395683453237,0,6452,896400000,604900000,"[{'period': '2021', 'revenue': 1890.0, 'unit': 'M', 'net_profit': 604.9}, {'period': '2020', 'revenue': 1990.0, 'unit': 'M', 'net_profit': 219.6}, {'period': '2019', 'revenue': 1840.0, 'unit': 'M', 'net_profit': 520.4}, {'period': '2018', 'revenue': 1600.0, 'unit': 'M', 'net_profit': 468.1}]","[{'period': ""Q4 '21"", 'revenue': 461.6, 'unit': 'M', 'net_profit': 149.9}, {'period': ""Q3 '21"", 'revenue': 470.7, 'unit': 'M', 'net_profit': 139.7}, {'period': ""Q2 '21"", 'revenue': 479.9, 'unit': 'M', 'net_profit': 170.8}, {'period': ""Q1 '21"", 'revenue': 480.5, 'unit': 'M', 'net_profit': 144.5}, {'period': ""Q4 '20"", 'revenue': 485.0, 'unit': 'M', 'net_profit': -145.3}, {'period': ""Q3 '20"", 'revenue': 492.5, 'unit': 'M', 'net_profit': 144.6}]",1.42,1.42,64642400000,40837700000,17233300000,56740600000,0,20754300000,0,320500000,465000000,0.3339285714285714,1.7545537340619308,1.7307692307692306,"[0.352, 0.17578]","['2022-02-28', '2016-11-29']",__nan__,0.8777613454945979
112,PBFS,Pioneer Bancorp Inc. Common Stock,"Pioneer Bancorp, Inc. operates as a holding company for Pioneer Savings Bank that provides various banking products and services in New York. The company accepts various deposit products, such as demand, savings, and money market accounts, as well as certificates of deposit accounts. Its loan products include commercial real estate, commercial and industrial, commercial construction, one- to four-family residential real estate, home equity, and consumer loans; and home equity lines of credit. The company also invests in the U.S. governmental securities, fixed rate collateralized mortgage obligations, mortgage-backed securities, fixed-rate investment grade bonds, and equity securities. In addition, the company offers personal and commercial insurance products, including homeowners, automobile, and comprehensive business insurance; employee benefit products and services, such as group health, dental, disability, and life insurance products, as well as defined contribution, defined benefit administration, and human resource management services; and wealth management services comprising investment advice, retirement income planning, estate planning, business succession, and employer retirement planning. It operates through a network of 22 retail banking offices in Albany, Greene, Rensselaer, Saratoga, Schenectady, and Warren Counties in New York. The company was founded in 1889 and is based in Albany, New York. Pioneer Bancorp, Inc. operates as a subsidiary of Pioneer Bancorp, MHC.",Mr. Thomas L. Amell,Banks - Regional,11.31,USD,292342011,https://images.financialmodelingprep.com/symbol/PBFS.png,21778,15.71,0.24,23486,0,15260000,"[{'period': '2024', 'revenue': 74.19, 'unit': 'M', 'net_profit': 15.26}, {'period': '2023', 'revenue': 79.69, 'unit': 'M', 'net_profit': 21.95}, {'period': '2022', 'revenue': 56.45, 'unit': 'M', 'net_profit': 10.28}, {'period': '2021', 'revenue': 57.57, 'unit': 'M', 'net_profit': 1.08}]","[{'period': ""Q1 '25"", 'revenue': 22.02, 'unit': 'M', 'net_profit': 6.31}, {'period': ""Q4 '24"", 'revenue': 27.25, 'unit': 'M', 'net_profit': 3.93}, {'period': ""Q3 '24"", 'revenue': 27.35, 'unit': 'M', 'net_profit': 4.72}, {'period': ""Q2 '24"", 'revenue': 20.37, 'unit': 'M', 'net_profit': 3.19}, {'period': ""Q1 '24"", 'revenue': 20.16, 'unit': 'M', 'net_profit': 3.42}, {'period': ""Q4 '23"", 'revenue': 19.36, 'unit': 'M', 'net_profit': 4.51}]",0.61,0.61,1895404000,1645974000,294346000,1598876000,1351628000,0,0,36937000,23009000,-1,-0.3047202478585748,-0.2988505747126437,__nan__,__nan__,__nan__,0.8435541974164875
113,PBHC,Pathfinder Bancorp Inc. Common Stock (MD),"Pathfinder Bancorp, Inc. operates as a holding company for Pathfinder Bank that provides various banking and financial products and services primarily in Oswego and Onondaga Counties, New York. The company accepts various deposits, including checking, savings, and money market deposit accounts, as well as certificates of deposit, and demand and time deposits. Its loan portfolio comprises commercial real estate loans; commercial loans; residential real estate and construction loans; tax-exempt loans; home equity loans and junior liens; municipal loans; and consumer loans comprising automobile, recreational vehicles, and unsecured personal loans, as well as unsecured lines of credit and loans secured by deposit accounts. The company is also involved in the property, casualty, and life insurance brokerage business. It primarily serves individuals, families, small to mid-size businesses, and municipalities. As of February 03, 2022, it operated through ten full-service offices located in Oswego and Onondaga Counties, as well as one limited purpose office located in Oneida County. Pathfinder Bancorp, Inc. was founded in 1859 and is headquartered in Oswego, New York.",Mr. Robert G. Butkowski Jr.,Banks - Regional,16.12,USD,99041119,https://images.financialmodelingprep.com/symbol/PBHC.png,3826,29.85,0.55,1094,0,0,"[{'period': '2024', 'revenue': 47900000.0, 'unit': '', 'net_profit': 0.0}, {'period': '2023', 'revenue': 41.18, 'unit': 'M', 'net_profit': 9.29}, {'period': '2022', 'revenue': 46.41, 'unit': 'M', 'net_profit': 9.72}, {'period': '2021', 'revenue': 43.7, 'unit': 'M', 'net_profit': 12.41}]","[{'period': ""Q4 '24"", 'revenue': 11.63, 'unit': 'M', 'net_profit': 3.91}, {'period': ""Q3 '24"", 'revenue': 4.47, 'unit': 'M', 'net_profit': -4.64}, {'period': ""Q2 '24"", 'revenue': 10.4, 'unit': 'M', 'net_profit': 2.0}, {'period': ""Q1 '24"", 'revenue': 20.08, 'unit': 'M', 'net_profit': 1.61}, {'period': ""Q4 '23"", 'revenue': 19.61, 'unit': 'M', 'net_profit': 1.92}, {'period': ""Q3 '23"", 'revenue': 10.06, 'unit': 'M', 'net_profit': 1.65}]",-0.76,-0.76,1474874000,1191918000,283294000,1353391000,908624000,0,61546000,13963000,2876000,0,-1,-1.6551724137931034,"[0.1, 0.1234]","['2025-04-17', '1996-03-27']",__nan__,0.917631607852603
114,PBIP,Prudential Bancorp Inc. Common Stock,"Prudential Bancorp, Inc. operates as the bank holding company for Prudential Bank that provides various banking products or services. The company accepts interest-bearing and non-interest-bearing checking, money market, savings, and certificates of deposit accounts. Its loan portfolio comprises single-family residential mortgage loans, construction and land development loans, non-residential or commercial real estate mortgage loans, home equity loans and lines of credit, and commercial business loans, as well as consumer loans, such as loans secured by deposit accounts and unsecured personal loans. The company also manages a portfolio of investment and mortgage-backed securities; and provides ATM, and online and mobile banking services. It operates a main office in Philadelphia, Pennsylvania, as well as nine additional full-service branch offices, including seven in Philadelphia, Philadelphia County; one in Drexel Hill, Delaware County; and one in Huntingdon Valley, Montgomery County, Pennsylvania. Prudential Bancorp, Inc. was incorporated in 1886 and is headquartered in Philadelphia, Pennsylvania.",Mr. Dennis Pollack,Banks - Regional,15.13,USD,0,https://images.financialmodelingprep.com/symbol/PBIP.png,0,-265.43859649122805,-0.09999943,40567,24282000,7780000,"[{'period': '2021', 'revenue': 26.88, 'unit': 'M', 'net_profit': 7.78}, {'period': '2020', 'revenue': 30.91, 'unit': 'M', 'net_profit': 9.55}, {'period': '2019', 'revenue': 27.84, 'unit': 'M', 'net_profit': 9.53}, {'period': '2018', 'revenue': 27.21, 'unit': 'M', 'net_profit': 7.06}]","[{'period': ""Q2 '22"", 'revenue': 5.97, 'unit': 'M', 'net_profit': -6.51}, {'period': ""Q1 '22"", 'revenue': 6.3, 'unit': 'M', 'net_profit': 1.84}, {'period': ""Q4 '21"", 'revenue': 7.19, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 7.17, 'unit': 'M', 'net_profit': 2.24}, {'period': ""Q2 '21"", 'revenue': 6.3, 'unit': 'M', 'net_profit': 1.72}, {'period': ""Q1 '21"", 'revenue': 6.22, 'unit': 'M', 'net_profit': 1.84}]",1,1,1100468000,761227000,389751000,970012000,4326000,326043000,11940000,83804000,4894000,-0.21832346124130828,-0.1857666143380429,-0.10714285714285723,"[0.07, 0.04]","['2022-06-06', '2005-07-13']",__nan__,0.8814540722674353
115,PBLA,Panbela Therapeutics Inc. Common Stock,"Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.","Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D.",Biotechnology,0.313,USD,1519562,https://images.financialmodelingprep.com/symbol/PBLA.png,21106,-0.01,0.008,350,-51294000,-25263000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.26}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.93}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.13}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.77}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.17}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.14}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.12}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.47}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.83}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.83}]",-232429.55,-232429.55,11802000,3060000,2578000,16512000,183000,0,12318000,2578000,-25249000,-0.4756192284456719,0.27681561846964187,-4.703992802692217,__nan__,__nan__,__nan__,1.3990849008642603
116,PBPB,Potbelly Corporation Common Stock,"Potbelly Corporation, through its subsidiaries, owns, operates, and franchises Potbelly sandwich shops. As of December 26, 2021, it had 443 shops in 33 states and the District of Columbia, which included 397 shops and 46 franchisees operated shops. The company was formerly known as Potbelly Sandwich Works, Inc. and changed its name to Potbelly Corporation in 2002. Potbelly Corporation was founded in 1977 and is headquartered in Chicago, Illinois.",Mr. Robert D. Wright,Restaurants,8.73,USD,260848035,https://images.financialmodelingprep.com/symbol/PBPB.png,304793,6.66,0.38,483209,21285000,40294000,"[{'period': '2024', 'revenue': 462.6, 'unit': 'M', 'net_profit': 40.29}, {'period': '2023', 'revenue': 491.41, 'unit': 'M', 'net_profit': 5.12}, {'period': '2022', 'revenue': 451.97, 'unit': 'M', 'net_profit': 4.34}, {'period': '2021', 'revenue': 380.05, 'unit': 'M', 'net_profit': -23.62}]","[{'period': ""Q4 '24"", 'revenue': 116.63, 'unit': 'M', 'net_profit': 4.61}, {'period': ""Q3 '24"", 'revenue': 115.12, 'unit': 'M', 'net_profit': 3.73}, {'period': ""Q2 '24"", 'revenue': 119.7, 'unit': 'M', 'net_profit': 34.71}, {'period': ""Q1 '24"", 'revenue': 111.15, 'unit': 'M', 'net_profit': -2.77}, {'period': ""Q4 '23"", 'revenue': 125.75, 'unit': 'M', 'net_profit': 2.74}, {'period': ""Q3 '23"", 'revenue': 120.77, 'unit': 'M', 'net_profit': 1.5}]",1.35,1.31,263146000,33201000,11663000,205198000,9765000,0,65233000,11663000,379000,-0.028259678597516436,6.871459269388552,6.500000000000001,__nan__,__nan__,__nan__,0.7797876464016174
117,PBTS,Powerbridge Technologies Co. Ltd. Ordinary Shares,"Powerbridge Technologies Co., Ltd. provides software application and technology solutions and services primarily in China. It offers Powerbridge System Solutions that include Trade Enterprise and Trade Compliance, as well as Import & Export Loan and Insurance Processing for customers to streamline their trade operations, trade logistics, and regulatory compliance. The company also provides Powerbridge Software-as-a-Service solutions, which comprise Logistics Service Cloud and Trade Zone Operations Cloud, as well as Inward Processed Manufacturing Cloud, Cross-Border eCommerce Cloud, and Import & Export Loan; and Powerbridge Blockchain-as-a-Service solutions that include Compliance Blockchain and Supply Chain Blockchain Services. It serves international trade businesses and manufacturers, government agencies and authorities, and logistics service and other providers. The company sells its solutions and services through its direct sales organization, indirect channel partners, and strategic government partners. Powerbridge Technologies Co., Ltd. was founded in 1997 and is headquartered in Zhuhai, China.",Mr. Shiang  Lor,Software - Application,1.1,USD,284024415,https://images.financialmodelingprep.com/symbol/PBTS.png,207820,-0.02788339670468948,0.075,370755,-17890176,-21548700,"[{'period': '2022', 'revenue': 10.48, 'unit': 'M', 'net_profit': -21.55}, {'period': '2021', 'revenue': 32.09, 'unit': 'M', 'net_profit': -9.48}, {'period': '2020', 'revenue': 26.66, 'unit': 'M', 'net_profit': -18.36}, {'period': '2019', 'revenue': 20.1, 'unit': 'M', 'net_profit': -10.79}]","[{'period': ""Q4 '22"", 'revenue': 1.73, 'unit': 'M', 'net_profit': -6.51}, {'period': ""Q3 '22"", 'revenue': 1.73, 'unit': 'M', 'net_profit': -6.51}, {'period': ""Q4 '21"", 'revenue': 4.77, 'unit': 'M', 'net_profit': 1.39}, {'period': ""Q4 '20"", 'revenue': -0.65634, 'unit': 'M', 'net_profit': -7.49}, {'period': ""Q2 '20"", 'revenue': 7230.0, 'unit': 'K', 'net_profit': -85.54}, {'period': ""Q4 '19"", 'revenue': 7.3, 'unit': 'M', 'net_profit': -7.9}]",-0.2,-0.2,130588110,87408491,9380322,28037968,76580417,30764195,27935976,9380322,-13530280,-1.9350897104871743,-1.2724828019093803,0.9653379549393414,__nan__,__nan__,__nan__,0.21470536636145512
118,PBYI,Puma Biotechnology Inc Common Stock,"Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.",Mr. Alan H. Auerbach,Biotechnology,2.91,USD,144367428,https://images.financialmodelingprep.com/symbol/PBYI.png,427152,4.69,0.02,609641,48076000,30278000,"[{'period': '2024', 'revenue': 230.47, 'unit': 'M', 'net_profit': 30.28}, {'period': '2023', 'revenue': 235.64, 'unit': 'M', 'net_profit': 21.59}, {'period': '2022', 'revenue': 228000.0, 'unit': 'K', 'net_profit': 912.0}, {'period': '2021', 'revenue': 253.2, 'unit': 'M', 'net_profit': -29.1}]","[{'period': ""Q4 '24"", 'revenue': 59.08, 'unit': 'M', 'net_profit': 19.3}, {'period': ""Q3 '24"", 'revenue': 80.54, 'unit': 'M', 'net_profit': 20.32}, {'period': ""Q2 '24"", 'revenue': 47.08, 'unit': 'M', 'net_profit': -4.53}, {'period': ""Q1 '24"", 'revenue': 43.77, 'unit': 'M', 'net_profit': -4.82}, {'period': ""Q4 '23"", 'revenue': 72.18, 'unit': 'M', 'net_profit': 12.27}, {'period': ""Q3 '23"", 'revenue': 56.12, 'unit': 'M', 'net_profit': 5.8}]",0.62,0.62,213333000,147658000,100965000,121208000,32011000,0,96111000,69219000,38862000,0.011636470761525998,0.40234356907970914,0.3478260869565217,__nan__,__nan__,__nan__,0.5681633877552934
119,PCAR,PACCAR Inc. Common Stock,"PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Europe, Mexico, South America, Australia, and internationally. It operates through three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks for the over-the-road and off-highway hauling of commercial and consumer goods. It sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full-service leasing operations under the PacLease trade name, as well as provides finance and leasing products and services to customers and dealers. This segment also offers equipment financing and administrative support services for its franchisees; retail loan and leasing services for small, medium, and large commercial trucking companies, as well as independent owners/operators and other businesses; and truck inventory financing services to independent dealers. In addition, this segment offers loans and leases directly to customers for the acquisition of trucks and related equipment. The company also manufactures and markets industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.",Mr. R. Preston Feight,Agricultural - Machinery,93.93,USD,49307144456,https://images.financialmodelingprep.com/symbol/PCAR.png,2948049,11.89,7.53,6936494,5809300000,4162000000,"[{'period': '2024', 'revenue': 31.56, 'unit': 'B', 'net_profit': 4.16}, {'period': '2023', 'revenue': 35.13, 'unit': 'B', 'net_profit': 4.6}, {'period': '2022', 'revenue': 28.82, 'unit': 'B', 'net_profit': 3.01}, {'period': '2021', 'revenue': 23.52, 'unit': 'B', 'net_profit': 1.87}]","[{'period': ""Q4 '24"", 'revenue': 7360.0, 'unit': 'M', 'net_profit': 872.0}, {'period': ""Q3 '24"", 'revenue': 8240.0, 'unit': 'M', 'net_profit': 972.1}, {'period': ""Q2 '24"", 'revenue': 8.77, 'unit': 'B', 'net_profit': 1.12}, {'period': ""Q1 '24"", 'revenue': 8.74, 'unit': 'B', 'net_profit': 1.2}, {'period': ""Q4 '23"", 'revenue': 9.08, 'unit': 'B', 'net_profit': 1.42}, {'period': ""Q3 '23"", 'revenue': 8.7, 'unit': 'B', 'net_profit': 1.23}]",7.92,7.9,43418900000,13950800000,9649900000,25912000000,1933800000,0,8333200000,7060800000,2895300000,-0.1233759374669906,-0.09537471744044514,-0.09794988610478354,"[0.33, 0.46]","['2025-02-12', '1987-11-12']",__nan__,0.5967907984771609
120,PCB,PCB Bancorp Common Stock,"PCB Bancorp operates as the bank holding company for Pacific City Bank that provides various banking products and services to small to medium-sized businesses, individuals, and professionals in Southern California. The company offers demand, savings, money market, and time deposits, as well as certificates of deposit; and remote deposit capture, courier deposit services, positive pay services, zero balance accounts, and sweep accounts. It also provides real estate loans, including commercial and residential, Small Business Administration (SBA) property, and construction loans; commercial and industrial loans, such as commercial term and lines of credit, SBA commercial term, and SBA Paycheck Protection Program loans; and other consumer loans comprising automobile secured loans and personal loans. In addition, the company offers access to account balances, online transfers, and online bill payment and electronic delivery of customer statements; and mobile banking solutions that include remote check deposit and mobile bill pay. Further, it provides automated teller machines; and banking by telephone, mail, personal appointment, debit cards, direct deposit, and cashier's checks, as well as treasury management, wire transfer, and automated clearing house services. The company operates through a network of 11 full-service branches in Los Angeles and Orange counties, California; and one full-service branch in each of Englewood Cliffs, New Jersey, and Bayside, New York. It also operates 10 loan production offices in Irvine, Artesia, and Los Angeles, California; Annandale, Virginia; Atlanta, Georgia; Chicago, Illinois; Bellevue, Washington; Aurora, Colorado; Carrollton, Texas; and New York, New York. The company was formerly known as Pacific City Financial Corporation and changed its name to PCB Bancorp in July 2019. PCB Bancorp was founded in 2003 and is headquartered in Los Angeles, California.",Mr. Henry  Kim,Banks - Regional,18.01,USD,258996407,https://images.financialmodelingprep.com/symbol/PCB.png,27719,10.35,1.21,46682,0,25810000,"[{'period': '2024', 'revenue': 99.71, 'unit': 'M', 'net_profit': 25.81}, {'period': '2023', 'revenue': 99.32, 'unit': 'M', 'net_profit': 30.7}, {'period': '2022', 'revenue': 104.13, 'unit': 'M', 'net_profit': 34.99}, {'period': '2021', 'revenue': 95.57, 'unit': 'M', 'net_profit': 40.1}]","[{'period': ""Q4 '24"", 'revenue': 26.21, 'unit': 'M', 'net_profit': 7.03}, {'period': ""Q3 '24"", 'revenue': 25.34, 'unit': 'M', 'net_profit': 7.81}, {'period': ""Q2 '24"", 'revenue': 47.43, 'unit': 'M', 'net_profit': 6.28}, {'period': ""Q1 '24"", 'revenue': 46.5, 'unit': 'M', 'net_profit': 4.68}, {'period': ""Q4 '23"", 'revenue': 43.45, 'unit': 'M', 'net_profit': 5.91}, {'period': ""Q3 '23"", 'revenue': 24.95, 'unit': 'M', 'net_profit': 7.02}]",1.87,1.74,3063971000,183915000,173449000,2700157000,10466000,0,15000000,27100000,38985000,0,-0.15942028985507245,-0.12616822429906543,"[0.2, 0.03]","['2025-02-14', '2017-02-24']",__nan__,0.8812606255085312
121,PCH,PotlatchDeltic Corporation Common Stock,"PotlatchDeltic (NASDAQ:PCH) is a leading Real Estate Investment Trust (REIT) that owns 1.8 million acres of timberlands in Alabama, Arkansas, Idaho, Louisiana, Minnesota and Mississippi. Through its taxable REIT subsidiary, the company also operates six sawmills, an industrial-grade plywood mill, a residential and commercial real estate development business and a rural timberland sales program. PotlatchDeltic, a leader in sustainable forest management, is committed to environmental and social responsibility and to responsible governance.",Mr. Eric J. Cremers,REIT - Specialty,40.37,USD,3180671560,https://images.financialmodelingprep.com/symbol/PCH.png,462934,144.18,2.15,658111,33192000,21876000,"[{'period': '2024', 'revenue': 1060.0, 'unit': 'M', 'net_profit': 21.88}, {'period': '2023', 'revenue': 1020.0, 'unit': 'M', 'net_profit': 62.1}, {'period': '2022', 'revenue': 1330.0, 'unit': 'M', 'net_profit': 333.9}, {'period': '2021', 'revenue': 1340.0, 'unit': 'M', 'net_profit': 423.86}]","[{'period': ""Q4 '24"", 'revenue': 258.15, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q3 '24"", 'revenue': 255.13, 'unit': 'M', 'net_profit': 3.31}, {'period': ""Q2 '24"", 'revenue': 320.67, 'unit': 'M', 'net_profit': 13.68}, {'period': ""Q1 '24"", 'revenue': 228130.0, 'unit': 'K', 'net_profit': -305.0}, {'period': ""Q4 '23"", 'revenue': 254500.0, 'unit': 'K', 'net_profit': -140.0}, {'period': ""Q3 '23"", 'revenue': 265.51, 'unit': 'M', 'net_profit': 23.68}]",0.28,0.28,3305443000,299130000,151551000,1267773000,23358000,0,200278000,151551000,67474000,-0.8398510062386313,-0.6477351411410445,-0.641025641025641,"[0.45, 0.39]","['2025-03-07', '1986-02-07']",__nan__,0.3835410261196457
122,PCOM,Points International Ltd. Common Shares,"Points.com Inc. provides technology solutions to loyalty industry in the United States, Europe, and internationally. It offers Currency Retailing for its members to get more of their currency, whenever they need it; Travel Accrual for its members to book any hotel, car, or activity and earn currency; Everyday Accrual for members to earn currency on day-to-day purchases; Travel Rewards for members to redeem their currency for hotel stays and car rentals; Everyday Rewards for members to redeem their currency for more than travel; and Currency Utility for members to do so much more with currency. The company was founded in 2000 and is headquartered in Toronto, Canada. As of June 30, 2022, Points.com Inc. operates as a subsidiary of Plusgrade LP.",Mr. Robert MacLean,Internet Content & Information,24.99,USD,0,https://images.financialmodelingprep.com/symbol/PCOM.png,0,166.6,0.020000458,84418,4538000,-344000,"[{'period': '2021', 'revenue': 370010.0, 'unit': 'K', 'net_profit': -344.0}, {'period': '2020', 'revenue': 217.39, 'unit': 'M', 'net_profit': -5.36}, {'period': '2019', 'revenue': 401.18, 'unit': 'M', 'net_profit': 11.89}, {'period': '2018', 'revenue': 376.25, 'unit': 'M', 'net_profit': 7.79}]","[{'period': ""Q1 '22"", 'revenue': 127.42, 'unit': 'M', 'net_profit': 1.35}, {'period': ""Q4 '21"", 'revenue': 115.11, 'unit': 'M', 'net_profit': 1.53}, {'period': ""Q3 '21"", 'revenue': 86.87, 'unit': 'M', 'net_profit': -1.24}, {'period': ""Q2 '21"", 'revenue': 103010.0, 'unit': 'K', 'net_profit': 452.0}, {'period': ""Q1 '21"", 'revenue': 65.03, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q4 '20"", 'revenue': 56360.0, 'unit': 'K', 'net_profit': -683.0}]",-0.0237,-0.0237,148742000,126486000,99648000,89790000,20840000,0,88744000,99648000,24345000,5.069955156950672,0.935784954265447,0.9421951219512195,__nan__,__nan__,__nan__,0.6036627179949173
123,PCRX,Pacira BioSciences Inc. Common Stock,"Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.",Mr. Frank D. Lee,Drug Manufacturers - Specialty & Generic,25.84,USD,1195777008,https://images.financialmodelingprep.com/symbol/PCRX.png,941426,-12.02,-0.43,2681560,29118000,-99560000,"[{'period': '2024', 'revenue': 700.97, 'unit': 'M', 'net_profit': -99.56}, {'period': '2023', 'revenue': 674.98, 'unit': 'M', 'net_profit': 41.95}, {'period': '2022', 'revenue': 666.82, 'unit': 'M', 'net_profit': 15.91}, {'period': '2021', 'revenue': 541.53, 'unit': 'M', 'net_profit': 41.98}]","[{'period': ""Q4 '24"", 'revenue': 187.25, 'unit': 'M', 'net_profit': 16.04}, {'period': ""Q3 '24"", 'revenue': 168.57, 'unit': 'M', 'net_profit': -143.47}, {'period': ""Q2 '24"", 'revenue': 178.02, 'unit': 'M', 'net_profit': 18.89}, {'period': ""Q1 '24"", 'revenue': 167.12, 'unit': 'M', 'net_profit': 8.98}, {'period': ""Q4 '23"", 'revenue': 181.24, 'unit': 'M', 'net_profit': 24.87}, {'period': ""Q3 '23"", 'revenue': 163.93, 'unit': 'M', 'net_profit': 10.86}]",-2.15,-2.15,1553516000,745130000,276774000,775168000,113304000,35649000,309920000,276774000,178753000,-0.8152188398347516,-3.3730187105231795,-3.3626373626373627,__nan__,__nan__,__nan__,0.49897651520808284
124,PCSA,Processa Pharmaceuticals Inc. Common Stock,"Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase 2A clinical trials for the treatment of gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia; PCS3117, a cytosine analog, which is in Phase 2B clinical trials for the treatment of pancreatic and non-small cell lung cancer; and PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase that is in Phase 1B clinical trials for treating metastatic colorectal and breast cancer. In addition, it develops PCS11T, an analog of SN38 and irinotecan drug for the treatment of various cancers. The company was incorporated in 2011 and is based in Hanover, Maryland.","Mr. George K. Ng Esq., J.D.",Biotechnology,0.265,USD,1396349,https://images.financialmodelingprep.com/symbol/PCSA.png,1228567,-0.07,0.0258,2184564,0,-11850118,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.85}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.12}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -54.85}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.43}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.38}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.01}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.08}]",-3.62,-3.62,3229289,1873619,1191325,1533118,0,0,1532631,1191325,-11248286,1,-0.06551244793877097,0.5731132075471698,__nan__,__nan__,__nan__,0.474754040285648
125,PCSB,PCSB Financial Corporation Common Stock,"PCSB Financial Corporation operates as the bank holding company for PCSB Bank that provides financial services to individuals and businesses in Putnam, Southern Dutchess, Rockland, and Westchester Counties in New York. The company offers deposit products, including interest and non-interest bearing, time, and demand; checking, NOW, money market, savings, certificate of deposit, and individual retirement accounts; and online and mobile deposit services, as well as cash management services comprising escrow, sweep, and lockbox accounts. It also provides commercial real estate, multi-family residential real estate, commercial business, construction, residential mortgage, and consumer and deposit overdraft loans, as well as home equity lines of credit, insurance products, and securities. In addition, the company is involved in investment activities. As of June 30, 2022, PCSB Financial Corporation offered its services from executive offices/headquarters and 14 banking offices. The company was founded in 1871 and is headquartered in Yorktown Heights, New York.",Mr. Joseph D. Roberto,Banks - Regional,19.04,USD,0,https://images.financialmodelingprep.com/symbol/PCSB.png,59256,0,-0.22,124818,28043000,14879000,"[{'period': '2022', 'revenue': 56.26, 'unit': 'M', 'net_profit': 14.88}, {'period': '2021', 'revenue': 49.84, 'unit': 'M', 'net_profit': 12.42}, {'period': '2020', 'revenue': 49.75, 'unit': 'M', 'net_profit': 9.36}, {'period': '2019', 'revenue': 45.81, 'unit': 'M', 'net_profit': 8.32}]","[{'period': ""Q1 '23"", 'revenue': 15.65, 'unit': 'M', 'net_profit': 4.78}, {'period': ""Q4 '22"", 'revenue': 15.02, 'unit': 'M', 'net_profit': 3.5}, {'period': ""Q3 '22"", 'revenue': 13.64, 'unit': 'M', 'net_profit': 3.47}, {'period': ""Q2 '22"", 'revenue': 14.45, 'unit': 'M', 'net_profit': 4.29}, {'period': ""Q1 '22"", 'revenue': 13.15, 'unit': 'M', 'net_profit': 3.61}, {'period': ""Q4 '21"", 'revenue': 13.15, 'unit': 'M', 'net_profit': 3.41}]",1.04,1.04,1989132000,1516509000,151143000,1711970000,6396000,447070000,0,116522000,20811000,-0.021323375444964054,0.1976014166130071,0.2380952380952382,"[0.07, 0.03]","['2022-11-09', '2018-08-16']",__nan__,0.8606618364191014
126,PCT,PureCycle Technologies Inc. Common stock,"PureCycle Technologies, Inc. produces recycled polypropylene (PP). The company holds a license for restoring waste PP into ultra-pure recycled resin. Its recycling process separates color, odor, and other contaminants from plastic waste feedstock to transform it into virgin-like resin. The company was founded in 2015 and is headquartered in Orlando, Florida.",Mr. Thomas  Cripe Ph.D.,Industrial - Pollution & Treatment Controls,6.5,USD,1166178000,https://images.financialmodelingprep.com/symbol/PCT.png,2515857,-3.71,0.75,4713441,0,-289136000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -289.14}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -101.72}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.75}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -77.5}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -64.68}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -90.64}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -48.21}, {'period': ""Q1 '24"", 'revenue': 11.94, 'unit': 'M', 'net_profit': -85.61}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.18}, {'period': ""Q3 '23"", 'revenue': 4.84, 'unit': 'M', 'net_profit': 8.53}]",-1.82,-1.76,798385000,53899000,15683000,617936000,0,0,90877000,15683000,-200410000,1,-1.8426092513395271,-1.9354838709677422,__nan__,__nan__,__nan__,0.7739824771256975
127,PCTI,PCTEL Inc. Common Stock,"PCTEL, Inc., together with its subsidiaries, provides industrial Internet of Thing devices (IoT), antenna systems, and test and measurement solutions worldwide. The company designs and manufactures precision antennas and industrial IoT devices that are deployed in small cells, enterprise Wi-Fi access points, fleet management and transit systems, and in equipment and devices for the industrial IoT. Its antenna portfolio includes Wi-Fi, Bluetooth, land mobile radio, tetra, global navigation satellite systems, cellular, industrial, scientific, medical, long range, and combination antenna solutions for used in public safety and military communications, utilities and energy, precision agriculture, smart traffic management, electric vehicle charging stations, embedded vehicles, forestry machinery, and off-road vehicles, as well as offers engineering design services. The company's industrial IoT devices include access points, radio modules, sensor communication modules, and wireless communication sensors for used in utilities and smart grid, oil and gas, manufacturing, logistics, industrial automation, smart metering, and asset tracking markets. It also offers radio frequency (RF) test and measurement products that enhance the performance of wireless networks with a focus on LTE, public safety, and 5G technologies for cellular testing, public safety and private radio network testing, federal government communications testing, and indoor building network testing applications. In addition, the company provides a cloud-based reporting platform for public safety to manage the data collection process and access final reports through an online map-based interface. It supplies its products to wireless equipment distributors, public and private carriers, wireless infrastructure providers, and value-added resellers, as well as original equipment manufacturers. PCTEL, Inc. was incorporated in 1994 and is headquartered in Bloomingdale, Illinois.",Mr. David A. Neumann,Communication Equipment,6.99,USD,135281664,https://images.financialmodelingprep.com/symbol/PCTI.png,245058,30.391304347826086,-0.01,143862,7829000,2869000,"[{'period': '2022', 'revenue': 99.43, 'unit': 'M', 'net_profit': 2.87}, {'period': '2021', 'revenue': 87810.0, 'unit': 'K', 'net_profit': 153.0}, {'period': '2020', 'revenue': 77.46, 'unit': 'M', 'net_profit': 3.42}, {'period': '2019', 'revenue': 90.62, 'unit': 'M', 'net_profit': 3.75}]","[{'period': ""Q3 '23"", 'revenue': 17390.0, 'unit': 'K', 'net_profit': -110.0}, {'period': ""Q2 '23"", 'revenue': 20580.0, 'unit': 'K', 'net_profit': 999.0}, {'period': ""Q1 '23"", 'revenue': 22.97, 'unit': 'M', 'net_profit': 1.32}, {'period': ""Q4 '22"", 'revenue': 25.92, 'unit': 'M', 'net_profit': 2.05}, {'period': ""Q3 '22"", 'revenue': 25.99, 'unit': 'M', 'net_profit': 1.97}, {'period': ""Q2 '22"", 'revenue': 24980.0, 'unit': 'K', 'net_profit': 411.0}]",0.16,0.15,89875000,69622000,29990000,20877000,18853000,0,17253000,7736000,3339000,0.4391544117647059,17.751633986928105,15,"[0.055, 0.5]","['2023-08-07', '2008-05-13']",__nan__,0.2322892906815021
128,PCTTU,PureCycle Technologies Inc. Unit,"PureCycle Technologies, Inc. produces recycled polypropylene (PP). The company holds a license for restoring waste PP into ultra-pure recycled resin. Its recycling process separates color, odor, and other contaminants from plastic waste feedstock to transform it into virgin-like resin. The company was founded in 2015 and is headquartered in Orlando, Florida.",Mr. Thomas  Cripe Ph.D.,Industrial - Pollution & Treatment Controls,7.4626,USD,1031619973,https://images.financialmodelingprep.com/symbol/PCTTU.png,636,-11.98,-0.7774,63,0,-289136000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -289.14}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -101.72}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.75}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -77.5}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -64.68}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -90.64}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -48.21}, {'period': ""Q1 '24"", 'revenue': 11.94, 'unit': 'M', 'net_profit': -85.61}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.18}, {'period': ""Q3 '23"", 'revenue': 4.84, 'unit': 'M', 'net_profit': 8.53}]",-1.82,-1.76,798385000,53899000,15683000,617936000,0,0,90877000,15683000,-200410000,1,-1.8426092513395271,-1.9354838709677422,__nan__,__nan__,__nan__,0.7739824771256975
129,PCTTW,PureCycle Technologies Inc. Warrant,"PureCycle Technologies LLC produces recycled polypropylene. It uses a recycling process that separates color, odor, and contaminants from plastic waste feedstock into recycled polypropylene. Its recycling service converts waste plastic into virgin-like plastic. The company was founded in 2015 and is based in Orlando, Florida.",Mr. Thomas  Cripe Ph.D.,Industrial - Pollution & Treatment Controls,1.3,USD,233235600,https://images.financialmodelingprep.com/symbol/PCTTW.png,11524.92105,,0.3,13165,0,-289136000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -289.14}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -101.72}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.75}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -77.5}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -64.68}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -90.64}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -48.21}, {'period': ""Q1 '24"", 'revenue': 11.94, 'unit': 'M', 'net_profit': -85.61}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.18}, {'period': ""Q3 '23"", 'revenue': 4.84, 'unit': 'M', 'net_profit': 8.53}]",-1.82,-1.76,798385000,53899000,15683000,617936000,0,0,90877000,15683000,-200410000,1,-1.8426092513395271,-1.9354838709677422,__nan__,__nan__,__nan__,0.7739824771256975
130,PCTY,Paylocity Holding Corporation Common Stock,"Paylocity Holding Corporation provides cloud-based human capital management and payroll software solutions for workforce in the United States. The company offers Payroll and Tax Services solution to simplifies payroll, automates processes, and manages compliance requirements within one system; and expense management, on demand payment, and garnishment solutions. It also provides human capital management and employee self-service solutions, document library, compliance dashboard, and HR edge; time and attendance solution; schedule tracking services; and time collection devices, including kiosks, time clocks, and mobile and web applications. In addition, the company offers talent management solutions comprising recruiting and onboarding, as well as learning, performance, and compensation management; employee benefits management and third-party administrative solutions; employee experiences solutions, including community, premium video, survey, and peer recognition; and insights and recommendations solutions, such as modern workforce index, data insights, and reporting. Further, it provides implementation and training, client, and tax and regulatory services. The company serves for-profit and non-profit organizations across industries, including business services, financial services, healthcare, manufacturing, restaurants, retail, technology, and others. It sells its products through sales representatives. The company was founded in 1997 and is headquartered in Schaumburg, Illinois.",Mr. Toby J. Williams J.D.,Software - Application,187.74,USD,10492262928,https://images.financialmodelingprep.com/symbol/PCTY.png,472481,48.39,15.2,492516,336519000,206766000,"[{'period': '2024', 'revenue': 1400.0, 'unit': 'M', 'net_profit': 206.77}, {'period': '2023', 'revenue': 1170.0, 'unit': 'M', 'net_profit': 140.82}, {'period': '2022', 'revenue': 852.65, 'unit': 'M', 'net_profit': 90.78}, {'period': '2021', 'revenue': 635.63, 'unit': 'M', 'net_profit': 70.82}]","[{'period': ""Q2 '25"", 'revenue': 376.98, 'unit': 'M', 'net_profit': 37.47}, {'period': ""Q1 '25"", 'revenue': 362.96, 'unit': 'M', 'net_profit': 49.57}, {'period': ""Q4 '24"", 'revenue': 357.29, 'unit': 'M', 'net_profit': 48.82}, {'period': ""Q3 '24"", 'revenue': 401.28, 'unit': 'M', 'net_profit': 85.31}, {'period': ""Q2 '24"", 'revenue': 326.36, 'unit': 'M', 'net_profit': 38.12}, {'period': ""Q1 '24"", 'revenue': 317.59, 'unit': 'M', 'net_profit': 34.52}]",3.68,3.63,4245460000,3524492000,401811000,3212396000,32997000,0,3117360000,401811000,305916000,0.5587377021844255,0.46827910411725443,0.4545454545454547,__nan__,__nan__,__nan__,0.7566661798721458
131,PCVX,Vaxcyte Inc. Common Stock,"Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.",Mr. Grant E. Pickering M.B.A.,Biotechnology,30.8,USD,3965869600,https://images.financialmodelingprep.com/symbol/PCVX.png,1885518,-8.11,0.6,5402432,-569546000,-463927000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -463.93}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -402.27}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -239.64}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -100.08}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -137.08}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -103.12}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -128.7}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -95.02}, {'period': ""Q4 '23"", 'revenue': 14.45, 'unit': 'M', 'net_profit': -180.8}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -92.66}]",-3.8,-3.8,3511318000,1787985000,1747208000,205499000,0,1387510000,140180000,387878000,-475054000,-0.2251330974326984,-0.15328414531678045,0.08212560386473428,__nan__,__nan__,__nan__,0.05852474768733564
132,PCYG,Park City Group Inc. Common Stock,"Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah.",Mr. Randall K. Fields,Software - Application,9.8,USD,0,https://images.financialmodelingprep.com/symbol/PCYG.png,20550,36.2962962962963,0.06,25498,6745116,5958290,"[{'period': '2024', 'revenue': 20.45, 'unit': 'M', 'net_profit': 5.96}, {'period': '2023', 'revenue': 19.1, 'unit': 'M', 'net_profit': 5.59}, {'period': '2022', 'revenue': 18.05, 'unit': 'M', 'net_profit': 4.0}, {'period': '2021', 'revenue': 21.01, 'unit': 'M', 'net_profit': 4.12}]","[{'period': ""Q2 '25"", 'revenue': 5.49, 'unit': 'M', 'net_profit': 1.55}, {'period': ""Q1 '25"", 'revenue': 5.44, 'unit': 'M', 'net_profit': 1.67}, {'period': ""Q4 '24"", 'revenue': 5.18, 'unit': 'M', 'net_profit': 1.58}, {'period': ""Q3 '24"", 'revenue': 5.08, 'unit': 'M', 'net_profit': 1.55}, {'period': ""Q2 '24"", 'revenue': 5.13, 'unit': 'M', 'net_profit': 1.45}, {'period': ""Q1 '24"", 'revenue': 5.06, 'unit': 'M', 'net_profit': 1.38}]",0.33,0.31,51596732,29300167,25153862,4742114,3968359,0,4543142,25153862,6891084,0.12701763179989725,0.0658286181626746,0.10000000000000009,"[0.015, 0.015]","['2023-09-28', '2022-10-14']",__nan__,0.09190725490133755
133,PCYO,Pure Cycle Corporation Common Stock,"Pure Cycle Corporation designs, constructs, operates, and maintains water and wastewater systems in the Denver metropolitan area and Colorado Front Range in the United States. It operates in two segments, Wholesale Water and Wastewater Services, and Land Development. The company engages in the wholesale water production, storage, treatment, and distribution systems; wastewater collection and treatment systems; development of master-planned community; and oil and gas leasing business. It serves domestic, commercial, and industrial customers in the Denver metropolitan region. Pure Cycle Corporation was founded in 1976 and is based in Watkins, Colorado.",Mr. Mark W. Harding,Regulated Water,10.78,USD,259548982,https://images.financialmodelingprep.com/symbol/PCYO.png,38939,19.6,0.83,59282,18171000,11613000,"[{'period': '2024', 'revenue': 28.75, 'unit': 'M', 'net_profit': 11.61}, {'period': '2023', 'revenue': 14.59, 'unit': 'M', 'net_profit': 4.7}, {'period': '2022', 'revenue': 23.0, 'unit': 'M', 'net_profit': 9.62}, {'period': '2021', 'revenue': 17.12, 'unit': 'M', 'net_profit': 20.11}]","[{'period': ""Q2 '25"", 'revenue': 4.0, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q1 '25"", 'revenue': 5.75, 'unit': 'M', 'net_profit': 3.94}, {'period': ""Q4 '24"", 'revenue': 12.56, 'unit': 'M', 'net_profit': 6.61}, {'period': ""Q3 '24"", 'revenue': 7.6, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '24"", 'revenue': 3200.0, 'unit': 'K', 'net_profit': 118.0}, {'period': ""Q1 '24"", 'revenue': 5.39, 'unit': 'M', 'net_profit': 2.06}]",0.48,0.48,147354000,37862000,22113000,17652000,1472000,0,9349000,22113000,-461000,1.1173386157072944,1.4713768886997234,1.3999999999999997,__nan__,__nan__,__nan__,0.11979315118693758
134,PDCE,PDC Energy Inc. Common Stock (Delaware),"PDC Energy, Inc., an independent exploration and production company, acquires, explores for, develops, and produces crude oil, natural gas, and natural gas liquids in the United States. The company's operations are primarily located in the Wattenberg Field in Colorado and the Delaware Basin in Texas. As of December 31, 2021, it owned interests in approximately 3,500 productive gross wells. The company was formerly known as Petroleum Development Corporation and changed its name to PDC Energy, Inc. in June 2012. PDC Energy, Inc. was founded in 1969 and is headquartered in Denver, Colorado.",Mr. Barton R. Brookman Jr.,Oil & Gas Exploration & Production,73.85,USD,0,https://images.financialmodelingprep.com/symbol/PDCE.png,15498053,3.1695278969957084,0,15498053,3427240000,1778121000,"[{'period': '2022', 'revenue': 4.3, 'unit': 'B', 'net_profit': 1.78}, {'period': '2021', 'revenue': 2550.0, 'unit': 'M', 'net_profit': 522.31}, {'period': '2020', 'revenue': 1150.0, 'unit': 'M', 'net_profit': -724.32}, {'period': '2019', 'revenue': 1310.0, 'unit': 'M', 'net_profit': -56.67}]","[{'period': ""Q2 '23"", 'revenue': 871.81, 'unit': 'M', 'net_profit': 288.71}, {'period': ""Q1 '23"", 'revenue': 813.28, 'unit': 'M', 'net_profit': 414.13}, {'period': ""Q4 '22"", 'revenue': 976.0, 'unit': 'M', 'net_profit': 349.74}, {'period': ""Q3 '22"", 'revenue': 1200.0, 'unit': 'M', 'net_profit': 797.97}, {'period': ""Q2 '22"", 'revenue': 1240.0, 'unit': 'M', 'net_profit': 662.38}, {'period': ""Q1 '22"", 'revenue': 882.38, 'unit': 'M', 'net_profit': -31.96}]",18.76,18.49,7982765000,593755000,6494000,4000020000,546311000,0,1420192000,6494000,606312000,2.2695995283405868,2.404333816442694,2.539622641509434,"[0.4, 0.12]","['2023-06-07', '2021-06-09']",__nan__,0.5010820185737649
135,PDCO,Patterson Companies Inc. Common Stock,"Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.",Mr. Donald J. Zurbay,Medical - Distribution,31.22,USD,2762152036,https://images.financialmodelingprep.com/symbol/PDCO.png,1367421,20.41,0.16,2453416,374756000,185931000,"[{'period': '2024', 'revenue': 6570.0, 'unit': 'M', 'net_profit': 185.93}, {'period': '2023', 'revenue': 6470.0, 'unit': 'M', 'net_profit': 207.56}, {'period': '2022', 'revenue': 6500.0, 'unit': 'M', 'net_profit': 203.21}, {'period': '2021', 'revenue': 5910.0, 'unit': 'M', 'net_profit': 155.98}]","[{'period': ""Q3 '25"", 'revenue': 1570.0, 'unit': 'M', 'net_profit': 31.25}, {'period': ""Q2 '25"", 'revenue': 1670.0, 'unit': 'M', 'net_profit': 26.77}, {'period': ""Q1 '25"", 'revenue': 1540.0, 'unit': 'M', 'net_profit': 13.71}, {'period': ""Q4 '24"", 'revenue': 1720.0, 'unit': 'M', 'net_profit': 67.04}, {'period': ""Q3 '24"", 'revenue': 1620.0, 'unit': 'M', 'net_profit': 47.7}, {'period': ""Q2 '24"", 'revenue': 1650.0, 'unit': 'M', 'net_profit': 39.96}]",2,1.98,2896732000,1778763000,114462000,1895000000,547287000,166320000,1332550000,114462000,-857004000,-0.02947650839855181,-0.10419306503755595,-0.0654205607476636,"[0.26, 0.1]","['2024-10-18', '2010-03-30']",__nan__,0.6541854752182804
136,PDD,Pinduoduo Inc. American Depositary Shares,"PDD Holdings Inc., a multinational commerce group, owns and operates a portfolio of businesses. It operates Pinduoduo, an e-commerce platform that offers products in various categories, including agricultural produce, apparel, shoes, bags, mother and childcare products, food and beverage, electronic appliances, furniture and household goods, cosmetics and other personal care, sports and fitness items and auto accessories; and Temu, an online marketplace. It focuses on bringing businesses and people into the digital economy. The company was formerly known as Pinduoduo Inc. and changed its name to PDD Holdings Inc. in February 2023. The company was incorporated in 2015 and is based in Dublin, Ireland.",Mr. Lei  Chen,Specialty Retail,94.15,USD,32688188280,https://images.financialmodelingprep.com/symbol/PDD.png,10367804,9.02,0.17,36300978,109209097000,112434512000,"[{'period': '2024', 'revenue': 393.84, 'unit': 'B', 'net_profit': 112.43}, {'period': '2023', 'revenue': 247.64, 'unit': 'B', 'net_profit': 60.03}, {'period': '2022', 'revenue': 130.56, 'unit': 'B', 'net_profit': 31.54}, {'period': '2021', 'revenue': 93.95, 'unit': 'B', 'net_profit': 7.77}]","[{'period': ""Q4 '24"", 'revenue': 110.61, 'unit': 'B', 'net_profit': 27.45}, {'period': ""Q3 '24"", 'revenue': 99.35, 'unit': 'B', 'net_profit': 24.98}, {'period': ""Q2 '24"", 'revenue': 97.06, 'unit': 'B', 'net_profit': 32.01}, {'period': ""Q1 '24"", 'revenue': 86.81, 'unit': 'B', 'net_profit': 28.0}, {'period': ""Q4 '23"", 'revenue': 88.88, 'unit': 'B', 'net_profit': 23.28}, {'period': ""Q3 '23"", 'revenue': 68.84, 'unit': 'B', 'net_profit': 15.54}]",76,76.01,505034316000,415648232000,331559909000,191721192000,11248489000,0,188422853000,57768053000,121929292000,0.8359099354077466,0.8730798827931856,6.38760631834751,__nan__,__nan__,__nan__,0.3796201286250814
137,PDEX,Pro-Dex Inc. Common Stock,"Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.",Mr. Richard Lee Van Kirk Jr.,Medical - Instruments & Supplies,58.63,USD,191194775,https://images.financialmodelingprep.com/symbol/PDEX.png,35244,29.91,3.66,65415,8333000,2127000,"[{'period': '2024', 'revenue': 53.84, 'unit': 'M', 'net_profit': 2.13}, {'period': '2023', 'revenue': 46.09, 'unit': 'M', 'net_profit': 7.07}, {'period': '2022', 'revenue': 42.04, 'unit': 'M', 'net_profit': 4.57}, {'period': '2021', 'revenue': 38.03, 'unit': 'M', 'net_profit': 4.45}]","[{'period': ""Q2 '25"", 'revenue': 16.79, 'unit': 'M', 'net_profit': 2.04}, {'period': ""Q1 '25"", 'revenue': 14.89, 'unit': 'M', 'net_profit': 2.47}, {'period': ""Q4 '24"", 'revenue': 15.03, 'unit': 'M', 'net_profit': 1.59}, {'period': ""Q3 '24"", 'revenue': 14290.0, 'unit': 'K', 'net_profit': 655.0}, {'period': ""Q2 '24"", 'revenue': 12590.0, 'unit': 'K', 'net_profit': 500.0}, {'period': ""Q1 '24"", 'revenue': 11940.0, 'unit': 'K', 'net_profit': -615.0}]",0.61,0.6,52477000,36611000,6848000,21610000,13887000,1563000,12892000,2631000,5216000,0.2589515032482248,-0.6993214588634435,-0.6919191919191919,__nan__,__nan__,__nan__,0.411799454999333
138,PDFS,PDF Solutions Inc. Common Stock,"PDF Solutions, Inc. provides proprietary software and physical intellectual property products for integrated circuit designs, electrical measurement hardware tools, proven methodologies, and professional services in the United States, China, Japan, Taiwan, and internationally. The company offers Exensio software products, such as Manufacturing Analytics that stores collected data in a common environment with a consistent view for enabling product engineers to identify and analyze production yield, performance, reliability, and other issues; Process Control that provides failure detection and classification capabilities for monitoring, alarming, and controlling manufacturing tool sets; Test Operations that offers data collection and analysis capabilities; and Assembly Operations that provides device manufacturers with the capability to link assembly and packaging data, including fabrication and characterization data over the product life cycle. It also provides design-for-inspection (DFI) Systems, such as DFI on-chip instruments; eProbe non-contactless E-beam tool; and Characterization Vehicle (CV) system, which includes CV test chips and pdFasTest electrical testers, as well as Exensio characterization software, designed to analyze the measurements collected from DFI on-chip instruments using the eProbe tool. In addition, the company offers Cimetrix software products that enables equipment manufacturers to provide industry standard interfaces on their products; and software-as-a-service, software related services, and characterization services. It sells its technologies and services through direct sales force, service teams, and strategic alliances to integrated device manufacturers, fabless semiconductor companies, foundries, equipment manufacturers, electronics manufacturing suppliers, original device manufacturers, out-sourced semiconductor assembly and test, and system houses. The company was founded in 1991 and is headquartered in Santa Clara, California.",Dr. John K. Kibarian Ph.D.,Software - Application,18.96,USD,741597648,https://images.financialmodelingprep.com/symbol/PDFS.png,262867,189.6,2.55,498547,7794000,4057000,"[{'period': '2024', 'revenue': 179.47, 'unit': 'M', 'net_profit': 4.06}, {'period': '2023', 'revenue': 165.84, 'unit': 'M', 'net_profit': 3.1}, {'period': '2022', 'revenue': 148.55, 'unit': 'M', 'net_profit': -3.43}, {'period': '2021', 'revenue': 111.06, 'unit': 'M', 'net_profit': -21.49}]","[{'period': ""Q4 '24"", 'revenue': 50090.0, 'unit': 'K', 'net_profit': 539.0}, {'period': ""Q3 '24"", 'revenue': 46.41, 'unit': 'M', 'net_profit': 5.05}, {'period': ""Q2 '24"", 'revenue': 41.66, 'unit': 'M', 'net_profit': 1.71}, {'period': ""Q1 '24"", 'revenue': 41310.0, 'unit': 'K', 'net_profit': -393.0}, {'period': ""Q4 '23"", 'revenue': 41120.0, 'unit': 'K', 'net_profit': 887.0}, {'period': ""Q3 '23"", 'revenue': 42.35, 'unit': 'M', 'net_profit': -4.97}]",0.11,0.1,315289000,205979000,114885000,69252000,73649000,0,60542000,90594000,-7452000,-0.07059373605935322,0.3066022544283414,0.346389228886169,__nan__,__nan__,__nan__,0.21964610246472285
139,PDLB,PDL Community Bancorp Common Stock,"Ponce Financial Group, Inc. operates as the bank holding company for Ponce Bank that provides various banking products and services. It accepts various deposit products, including demand accounts, NOW/IOLA accounts, money market accounts, reciprocal deposits, savings accounts, and certificates of deposit. The company also provides one-to-four family investor-owned and owner-occupied residential, multifamily residential, nonresidential property, construction and land, commercial and industrial, business, and consumer loans; lines of credit; and paycheck protection program. In addition, it invests in securities, which consist of U.S. Government and federal agency securities and securities issued by government-sponsored or government-owned enterprises, as well as mortgage-backed securities, corporate bonds and obligations, and Federal Home Loan Bank stock. It operates 4 banking offices in Bronx, 2 banking offices in Manhattan, 3 banking offices in Queens, and 3 banking offices in Brooklyn, New York; 1 banking office in Union City, New Jersey; and 2 mortgage loan offices in Queens, 1 mortgage loan office in Brooklyn, New York; and 1 mortgage loan office in Englewood Cliffs and 1 mortgage loan office in Bergenfield, New Jersey. Ponce Financial Group, Inc. was founded in 1960 and is headquartered in Bronx, New York.",Mr. Carlos P. Naudon,Banks - Regional,11.66,USD,264264572,https://images.financialmodelingprep.com/symbol/PDLB.png,47313,25.35,0.23,81170,0,10972000,"[{'period': '2024', 'revenue': 162.64, 'unit': 'M', 'net_profit': 10.97}, {'period': '2023', 'revenue': 73.87, 'unit': 'M', 'net_profit': 3.35}, {'period': '2022', 'revenue': 70.97, 'unit': 'M', 'net_profit': -30.0}, {'period': '2021', 'revenue': 69.33, 'unit': 'M', 'net_profit': 25.41}]","[{'period': ""Q4 '24"", 'revenue': 42.89, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q3 '24"", 'revenue': 41.29, 'unit': 'M', 'net_profit': 2.43}, {'period': ""Q2 '24"", 'revenue': 41.12, 'unit': 'M', 'net_profit': 3.19}, {'period': ""Q1 '24"", 'revenue': 41.43, 'unit': 'M', 'net_profit': 2.41}, {'period': ""Q4 '23"", 'revenue': 35950.0, 'unit': 'K', 'net_profit': 518.0}, {'period': ""Q3 '23"", 'revenue': 21.8, 'unit': 'M', 'net_profit': 2.59}]",0.46,0.46,3039938000,2444818000,140448000,2534438000,2304370000,0,3712000,140088000,7212000,-1,2.2732696897374702,2.0666666666666673,__nan__,__nan__,__nan__,0.8337137138981124
140,PDSB,PDS Biotechnology Corporation Common Stock,"PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.",Dr. Frank K. Bedu-Addo Ph.D.,Biotechnology,1,USD,45395900,https://images.financialmodelingprep.com/symbol/PDSB.png,634244,-0.97,0.0649,415219,-36321195000,-39348722000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'B', 'net_profit': -39.35}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.94}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.85}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.92}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.95}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.73}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.33}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.6}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.9}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.85}]",-1079.45,-1079.45,45358657000,45054443000,41689591000,26353809000,0,0,17087201000,41689591000,-35030223000,-905.1051038856984,-915.3183030360951,-775.5827338129496,__nan__,__nan__,__nan__,0.5810094641911466
141,PEBK,Peoples Bancorp of North Carolina Inc. Common Stock,"Peoples Bancorp of North Carolina, Inc. operates as the bank holding company for Peoples Bank that provides various commercial and consumer banking products and services to individuals and small to medium-sized businesses. It offers checking, savings, money market, and time deposits; demand deposits; and certificates of deposit, as well as borrowed funds. The company's loan products comprise commercial real estate, commercial, construction and land development, single-family residential, residential mortgage, and individual taxpayer identification number mortgage loans, as well as agricultural loans. It also provides investment counseling and non-deposit investment products, such as stocks, bonds, mutual funds, tax deferred annuities, and related brokerage services; and real estate appraisal and brokerage services. In addition, the company operates as a clearing-house for the provision of appraisal services for community banks; and acquires, manages, and disposes real property, other collateral, and other assets obtained in the ordinary course of collecting debts, as well as offers insurance agency services. As of December 31, 2021, it operated 17 banking offices located in Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Mooresville, Raleigh, and Cary, North Carolina. The company also operates loan production offices in Charlotte, Denver, Salisbury, and Winston-Salem, North Carolina. Peoples Bancorp of North Carolina, Inc. was founded in 1912 and is headquartered in Newton, North Carolina.",Mr. William D. Cable Sr.,Banks - Regional,27.16,USD,148278390,https://images.financialmodelingprep.com/symbol/PEBK.png,7367,9.11,1.5,4968,0,16353000,"[{'period': '2024', 'revenue': 71.14, 'unit': 'M', 'net_profit': 16.35}, {'period': '2023', 'revenue': 76.07, 'unit': 'M', 'net_profit': 15.55}, {'period': '2022', 'revenue': 67.39, 'unit': 'M', 'net_profit': 16.12}, {'period': '2021', 'revenue': 60.68, 'unit': 'M', 'net_profit': 15.13}]","[{'period': ""Q4 '24"", 'revenue': 18.15, 'unit': 'M', 'net_profit': 3.56}, {'period': ""Q3 '24"", 'revenue': 17.88, 'unit': 'M', 'net_profit': 3.96}, {'period': ""Q2 '24"", 'revenue': 17.99, 'unit': 'M', 'net_profit': 4.89}, {'period': ""Q1 '24"", 'revenue': 17.13, 'unit': 'M', 'net_profit': 3.95}, {'period': ""Q4 '23"", 'revenue': 17.23, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q3 '23"", 'revenue': 17.54, 'unit': 'M', 'net_profit': 4.13}]",3.09,2.98,1651962000,293049000,293049000,1521399000,0,390731000,0,59266000,19971000,0,0.05191045928213045,0.07665505226480827,"[0.2, 0.1597]","['2025-03-03', '1987-02-24']",__nan__,0.920964889022871
142,PEBO,Peoples Bancorp Inc. Common Stock,"Peoples Bancorp Inc. operates as the holding company for Peoples Bank that provides commercial and retail banking products and services. The company accepts various deposit products, including demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and provides commercial and industrial, commercial real estate, construction, finance, residential real estate, and consumer indirect and direct loans, as well as home equity lines of credit and overdrafts. It also offers debit and automated teller machine (ATM) cards; safe deposit rental facilities; money orders and cashier's checks; and telephone, mobile, and Internet-based banking services. In addition, the company provides various life, health, and property and casualty insurance products; third-party insurance administration; insurance premium financing; commercial and technology equipment leasing; fiduciary and trust; underwriting, origination and servicing of equipment leases, and equipment financing agreements; and asset management and administration services, as well as employee benefit, retirement, and health care plan administration services. Further, it offers brokerage services through an unaffiliated registered broker-dealers; insurance premium finance lending and lease financing services; and credit cards to individuals and businesses, as well as provides merchant credit card transaction processing, and person-to-person payment processing services. The company operates through 135 financial service offices and ATMs, including 119 full-service branches in Ohio, West Virginia, Kentucky, Virginia, Washington, D.C., and Maryland. Peoples Bancorp Inc. was founded in 1902 and is based in Marietta, Ohio.",Mr. Tyler J. Wilcox,Banks - Regional,28.15,USD,1004116130,https://images.financialmodelingprep.com/symbol/PEBO.png,147996,8.5,1.04,287284,0,117205000,"[{'period': '2024', 'revenue': 520.78, 'unit': 'M', 'net_profit': 117.2}, {'period': '2023', 'revenue': 411.21, 'unit': 'M', 'net_profit': 113.36}, {'period': '2022', 'revenue': 320.93, 'unit': 'M', 'net_profit': 101.29}, {'period': '2021', 'revenue': 231.9, 'unit': 'M', 'net_profit': 47.55}]","[{'period': ""Q4 '24"", 'revenue': 114.68, 'unit': 'M', 'net_profit': 26.93}, {'period': ""Q3 '24"", 'revenue': 111.48, 'unit': 'M', 'net_profit': 31.68}, {'period': ""Q2 '24"", 'revenue': 154.45, 'unit': 'M', 'net_profit': 29.01}, {'period': ""Q1 '24"", 'revenue': 153.32, 'unit': 'M', 'net_profit': 29.58}, {'period': ""Q4 '23"", 'revenue': 149.38, 'unit': 'M', 'net_profit': 33.83}, {'period': ""Q3 '23"", 'revenue': 114.09, 'unit': 'M', 'net_profit': 31.88}]",3.34,3.31,9254247000,1192276000,1192276000,8142657000,393705000,0,193474000,108721000,136365000,-1,0.03389112849871651,-0.03468208092485552,"[0.4, 0.26]","['2025-02-03', '1993-03-09']",__nan__,0.8798832579247129
143,PEGA,Pegasystems Inc. Common Stock,"Pegasystems Inc. develops, markets, licenses, hosts, and supports enterprise software applications in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific. It provides Pega Platform, an application development product for clients; and Pega Infinity, a software platform that unifies customer engagement and digital process automation. The company also offers customer engagement applications, including Pega Customer Decision Hub that enable enterprises to enhance customer acquisition and experiences across inbound, outbound, and paid media channels; Pega Sales Automation to automate and manage the sales process; and Pega Customer Service to anticipate customer needs, connect customers to people and systems, and automate customer interactions to evolve the customer service experience, as well as to allow enterprises to deliver interactions across channels and enhance employee productivity. In addition, it provides intelligent automation software; Pega Cloud that allows clients to develop, test, and deploy applications and the Pega Platform using an Internet-based infrastructure; Pega Academy, which offers instructor-led and online training to its employees, clients, and partners; and guidance, implementation, and technical support services. The company primarily markets its software and services to financial services, life sciences, healthcare, communications and media, government, insurance, manufacturing and high tech, and consumer services markets through a direct sales force, as well as partnerships with technology providers and application developers. Pegasystems Inc. was incorporated in 1983 and is headquartered in Cambridge, Massachusetts.",Mr. Alan  Trefler,Software - Application,70.69,USD,6072193241,https://images.financialmodelingprep.com/symbol/PEGA.png,989622,63.68,8.26,986466,184898000,99189000,"[{'period': '2024', 'revenue': 1500.0, 'unit': 'M', 'net_profit': 99.19}, {'period': '2023', 'revenue': 1430.0, 'unit': 'M', 'net_profit': 67.81}, {'period': '2022', 'revenue': 1320.0, 'unit': 'M', 'net_profit': -345.58}, {'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': -63.04}]","[{'period': ""Q4 '24"", 'revenue': 490.83, 'unit': 'M', 'net_profit': 119.09}, {'period': ""Q3 '24"", 'revenue': 325.05, 'unit': 'M', 'net_profit': -14.39}, {'period': ""Q2 '24"", 'revenue': 351.15, 'unit': 'M', 'net_profit': 6.61}, {'period': ""Q1 '24"", 'revenue': 330.15, 'unit': 'M', 'net_profit': -12.12}, {'period': ""Q4 '23"", 'revenue': 474.23, 'unit': 'M', 'net_profit': 142.66}, {'period': ""Q3 '23"", 'revenue': 334.64, 'unit': 'M', 'net_profit': -7.28}]",1.16,1.11,1768273000,1333704000,739973000,1182793000,539960000,0,1086058000,337103000,345926000,0.5273000611257042,0.46279200094384143,0.5466666666666665,"[0.03, 1.08]","['2025-04-01', '1996-09-05']",__nan__,0.6688972800014478
144,PENN,Penn National Gaming Inc. Common Stock,"PENN Entertainment, Inc., together with its subsidiaries, provides integrated entertainment, sports content, and casino gaming experiences in North America. The company operates through five segments: Northeast, South, West, Midwest, and Interactive. It operates 44 properties in 20 states; online sports betting in 13 jurisdictions; and iCasino in five under a portfolio of brands, including Hollywood Casino, L'Auberge, Barstool Sportsbook, and theScore Bet. The company was formerly known as Penn National Gaming, Inc. and changed its name to PENN Entertainment, Inc. in August 2022. PENN Entertainment, Inc. was founded in 1972 and is based in Wyomissing, Pennsylvania.",Mr. Jay A. Snowden,"Gambling, Resorts & Casinos",16.28,USD,2489977160,https://images.financialmodelingprep.com/symbol/PENN.png,4571008,-7.94,2.53,6260719,562800000,-311500000,"[{'period': '2024', 'revenue': 6580.0, 'unit': 'M', 'net_profit': -311.5}, {'period': '2023', 'revenue': 6360.0, 'unit': 'M', 'net_profit': -490.0}, {'period': '2022', 'revenue': 6400.0, 'unit': 'M', 'net_profit': 222.1}, {'period': '2021', 'revenue': 5910.0, 'unit': 'M', 'net_profit': 420.8}]","[{'period': ""Q4 '24"", 'revenue': 1670.0, 'unit': 'M', 'net_profit': -133.3}, {'period': ""Q3 '24"", 'revenue': 1640.0, 'unit': 'M', 'net_profit': -36.7}, {'period': ""Q2 '24"", 'revenue': 1660.0, 'unit': 'M', 'net_profit': -26.8}, {'period': ""Q1 '24"", 'revenue': 1610.0, 'unit': 'M', 'net_profit': -114.7}, {'period': ""Q4 '23"", 'revenue': 1400.0, 'unit': 'M', 'net_profit': -358.1}, {'period': ""Q3 '23"", 'revenue': 1620.0, 'unit': 'M', 'net_profit': -724.8}]",-2.05,-2.05,15261700000,1154400000,706600000,12403300000,256800000,86200000,1415100000,706600000,-123400000,0.4062968515742129,0.36428571428571427,0.3633540372670808,"[0.62, 1.5038]","['2017-06-14', '2008-06-26']",__nan__,0.8127076275906354
145,PEP,PepsiCo Inc. Common Stock,"PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.",Mr. Ramon Luis Laguarta,Beverages - Non-Alcoholic,145.59,USD,199649022900,https://images.financialmodelingprep.com/symbol/PEP.png,7580965,20.98,5.29,14043468,16680000000,9578000000,"[{'period': '2024', 'revenue': 91.85, 'unit': 'B', 'net_profit': 9.58}, {'period': '2023', 'revenue': 91.47, 'unit': 'B', 'net_profit': 9.07}, {'period': '2022', 'revenue': 86.39, 'unit': 'B', 'net_profit': 8.91}, {'period': '2021', 'revenue': 79.47, 'unit': 'B', 'net_profit': 7.62}]","[{'period': ""Q4 '24"", 'revenue': 27.78, 'unit': 'B', 'net_profit': 1.52}, {'period': ""Q3 '24"", 'revenue': 23.32, 'unit': 'B', 'net_profit': 2.93}, {'period': ""Q2 '24"", 'revenue': 22.5, 'unit': 'B', 'net_profit': 3.08}, {'period': ""Q1 '24"", 'revenue': 18.25, 'unit': 'B', 'net_profit': 2.04}, {'period': ""Q4 '23"", 'revenue': 27.85, 'unit': 'B', 'net_profit': 1.3}, {'period': ""Q3 '23"", 'revenue': 23.45, 'unit': 'B', 'net_profit': 3.09}]",6.98,6.95,99467000000,25826000000,9266000000,81296000000,10333000000,3331000000,31536000000,8505000000,7189000000,0.05877872286403453,0.055543310557637206,0.05918057663125957,"[1.355, 0.25]","['2025-03-07', '1972-06-05']",__nan__,0.8173162958569173
146,PERI,Perion Network Ltd. Ordinary Shares,"Perion Network Ltd. provides digital advertising solutions to brands, agencies, and publishers in North America, Europe, and internationally. It provides Wildfire, a content monetization platform; search monetization solutions, including website monetization, search mediation, and app monetization; and cross-channel digital advertising software as a service platform. The company also offers supply management platform; demand management platform for campaign planning and design; analytics platform, which provides information and performance insights on the results of campaign investment and other campaign metrics; creative platform to create advertisements; and an AI platform that uses machine learning to bring intelligence to the various phases of campaigns. In addition, it provides an actionable performance monitoring platform to support the various phases of campaign management; an online video player and integrated ad server to upload, manage, and stream video content; content monetization system, which integrates ads within the content layouts at the page level. Further, the company offers a publisher management system that provides analytics and performance optimization tools, as well as reports; search-demand management systems; monetization products that integrate and onboards demand vendors; and AI Systems. Additionally, it provides Intelligent HUB (iHUB), a platform for pulling in signals across various advertising channels and optimizing traffic at scale, and yielding engagement metrics and KPIs; and strategic optimization of relevant traits (SORT), a provisional patent technology that eliminates the need for cookies. The company was formerly known as IncrediMail Ltd. and changed its name to Perion Network Ltd. in November 2011. Perion Network Ltd. was incorporated in 1999 and is headquartered in Holon, Israel.",Mr. Tal  Jacobson,Internet Content & Information,7.91,USD,356244252,https://images.financialmodelingprep.com/symbol/PERI.png,433418,31.64,0.83,505015,21832000,12614000,"[{'period': '2024', 'revenue': 498.29, 'unit': 'M', 'net_profit': 12.61}, {'period': '2023', 'revenue': 743.15, 'unit': 'M', 'net_profit': 117.41}, {'period': '2022', 'revenue': 640.26, 'unit': 'M', 'net_profit': 99.22}, {'period': '2021', 'revenue': 478.5, 'unit': 'M', 'net_profit': 38.71}]","[{'period': ""Q4 '24"", 'revenue': 129.58, 'unit': 'M', 'net_profit': 4.94}, {'period': ""Q3 '24"", 'revenue': 102.2, 'unit': 'M', 'net_profit': 2.11}, {'period': ""Q2 '24"", 'revenue': 108.69, 'unit': 'M', 'net_profit': -6.21}, {'period': ""Q1 '24"", 'revenue': 157.82, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q4 '23"", 'revenue': 234.23, 'unit': 'M', 'net_profit': 39.4}, {'period': ""Q3 '23"", 'revenue': 185.31, 'unit': 'M', 'net_profit': 32.82}]",0.27,0.25,916451000,561226000,373335000,196695000,164119000,0,164795000,156228000,113000,-0.8563684210526316,-0.8925672625688807,-0.891566265060241,"[0.4, 0.5]","['2011-03-23', '2009-07-09']",__nan__,0.21462685948294016
147,PESI,Perma-Fix Environmental Services Inc. Common Stock,"Perma-Fix Environmental Services, Inc., through its subsidiaries, operates as an environmental and technology know-how company in the United States. It operates in three segments: Treatment, Services, and Medical. The Treatment segment offers nuclear, low-level radioactive, mixed waste, hazardous and non-hazardous waste treatment, and processing and disposal services through treatment and storage facilities. This segment is also involved in the research and development activities to identify, develop, and implement waste processing techniques for problematic waste streams. The Services segment provides technical services, including professional radiological measurement and site survey of government and commercial installations; integrated occupational safety and health services; and consulting, engineering, project and waste management, environmental, decontamination and decommissioning (D&D) field, technical, on-site waste management services, and management personnel and services. This segment also offers nuclear services, including technology-based services comprising engineering, D&D, specialty, construction, logistics, transportation, processing, and disposal; offers remediation of nuclear licensed and federal facilities, as well as cleanup of nuclear legacy sites; and owns an equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources health physics, industrial hygiene, and customized nuclear, environmental, and occupational safety and health instrumentation. The Medical segment is involved in the research and development of medical isotope production technology. The company provides its services to research institutions, commercial companies, public utilities, and governmental agencies through direct sales to customers or through intermediaries. Perma-Fix Environmental Services, Inc. was incorporated in 1990 and is based in Atlanta, Georgia.",Mr. Mark J. Duff,Waste Management,7.07,USD,130288788,https://images.financialmodelingprep.com/symbol/PESI.png,154639,-5.44,0.56,137717,-12898000,-19979000,"[{'period': '2024', 'revenue': 59.12, 'unit': 'M', 'net_profit': -19.98}, {'period': '2023', 'revenue': 89730.0, 'unit': 'K', 'net_profit': 485.0}, {'period': '2022', 'revenue': 70.6, 'unit': 'M', 'net_profit': -3.21}, {'period': '2021', 'revenue': 72190.0, 'unit': 'K', 'net_profit': 835.0}]","[{'period': ""Q4 '24"", 'revenue': 14.7, 'unit': 'M', 'net_profit': -3.49}, {'period': ""Q3 '24"", 'revenue': 16.81, 'unit': 'M', 'net_profit': -8.98}, {'period': ""Q2 '24"", 'revenue': 13.99, 'unit': 'M', 'net_profit': -3.95}, {'period': ""Q1 '24"", 'revenue': 13.62, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q4 '23"", 'revenue': 22720.0, 'unit': 'K', 'net_profit': 81.0}, {'period': ""Q3 '23"", 'revenue': 21880.0, 'unit': 'K', 'net_profit': 341.0}]",-1.33,-1.33,97248000,50223000,28975000,34858000,16569000,0,244000,28975000,-18823000,-4.291145700433784,-42.19381443298969,-38.04735376044568,__nan__,__nan__,__nan__,0.3584443896018427
148,PETQ,PetIQ Inc. Class A Common Stock,"PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.",Mr. McCord  Christensen,Drug Manufacturers - Specialty & Generic,30.98,USD,919170404,https://images.financialmodelingprep.com/symbol/PETQ.png,884426,83.72972972972973,-0.01,928270,81486000,2131000,"[{'period': '2023', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 2.13}, {'period': '2022', 'revenue': 921.51, 'unit': 'M', 'net_profit': -48.62}, {'period': '2021', 'revenue': 932.53, 'unit': 'M', 'net_profit': -16.38}, {'period': '2020', 'revenue': 780.05, 'unit': 'M', 'net_profit': -81.02}]","[{'period': ""Q2 '24"", 'revenue': 328.94, 'unit': 'M', 'net_profit': 15.32}, {'period': ""Q1 '24"", 'revenue': 308.44, 'unit': 'M', 'net_profit': 14.91}, {'period': ""Q4 '23"", 'revenue': 219.93, 'unit': 'M', 'net_profit': -17.49}, {'period': ""Q3 '23"", 'revenue': 277020.0, 'unit': 'K', 'net_profit': 451.0}, {'period': ""Q2 '23"", 'revenue': 314.55, 'unit': 'M', 'net_profit': 9.47}, {'period': ""Q1 '23"", 'revenue': 290.47, 'unit': 'M', 'net_profit': 9.7}]",0.0731,0.0722,868226000,430834000,116369000,645228000,142511000,0,189529000,116369000,52742000,5.47330842654182,1.0438296997120526,1.0437724550898204,__nan__,__nan__,__nan__,0.743156735688634
149,PETS,PetMed Express Inc. Common Stock,"PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.",Ms. Sandra Y. Campos,Medical - Pharmaceuticals,3.25,USD,67133625,https://images.financialmodelingprep.com/symbol/PETS.png,256183,325,0.17,416164,-1106000,-7464000,"[{'period': '2024', 'revenue': 281.06, 'unit': 'M', 'net_profit': -7.46}, {'period': '2023', 'revenue': 256860.0, 'unit': 'K', 'net_profit': 233.0}, {'period': '2022', 'revenue': 273.42, 'unit': 'M', 'net_profit': 18.72}, {'period': '2021', 'revenue': 309.21, 'unit': 'M', 'net_profit': 23.92}]","[{'period': ""Q3 '25"", 'revenue': 52980.0, 'unit': 'K', 'net_profit': -707.0}, {'period': ""Q2 '25"", 'revenue': 59.57, 'unit': 'M', 'net_profit': 2.33}, {'period': ""Q1 '25"", 'revenue': 67.95, 'unit': 'M', 'net_profit': 3.75}, {'period': ""Q4 '24"", 'revenue': 66.5, 'unit': 'M', 'net_profit': -5.02}, {'period': ""Q3 '24"", 'revenue': 65.32, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q2 '24"", 'revenue': 71000.0, 'unit': 'K', 'net_profit': -70.0}]",-0.37,-0.37,169884000,93648000,55296000,73153000,3283000,5300000,72158000,55296000,-194000,-1.5226843100189036,-33.0343347639485,-33.173913043478265,"[0.3, 0.1]","['2023-08-11', '2009-08-12']",__nan__,0.4306055896964988
150,PETZ,TDH Holdings Inc. Common Shares,"TDH Holdings, Inc., together with its subsidiaries, develops, manufactures, and sells pet food products for pet owners in the People's Republic of China, Asia, Europe, and North America. It offers approximately 200 products, which include 4 product lines consisting of pet chews, dried pet snacks, wet canned pet food, and dental health snacks, as well as non-food items, such as dog leashes, pet toys, etc. The company sells its products under the Pet Cuisine, Hum & Cheer, and various other brand names. It offers its products to retailers and wholesalers, as well as through e-commerce platform. The company was founded in 2002 and is based in Qingdao, the People's Republic of China.",Ms. Dandan  Liu,Packaged Foods,1.075,USD,11097548,https://images.financialmodelingprep.com/symbol/PETZ.png,10000,-1.58,0.025,4027,-8226829,-23626172,"[{'period': '2023', 'revenue': 3.18, 'unit': 'M', 'net_profit': -23.63}, {'period': '2022', 'revenue': 3100.0, 'unit': 'K', 'net_profit': 803.7}, {'period': '2021', 'revenue': 1.09, 'unit': 'M', 'net_profit': -5.66}, {'period': '2020', 'revenue': 815.23, 'unit': 'K', 'net_profit': -874.67}]","[{'period': ""Q2 '24"", 'revenue': 0.10341, 'unit': 'M', 'net_profit': 1.32}, {'period': ""Q4 '23"", 'revenue': 1.62, 'unit': 'M', 'net_profit': -8.61}, {'period': ""Q2 '23"", 'revenue': 1550.0, 'unit': 'K', 'net_profit': 64.6}, {'period': ""Q4 '22"", 'revenue': 1.65, 'unit': 'M', 'net_profit': 1.7}, {'period': ""Q2 '22"", 'revenue': 1450.0, 'unit': 'K', 'net_profit': -896.0}, {'period': ""Q4 '21"", 'revenue': 0.9575800000000001, 'unit': 'M', 'net_profit': -5.18}]",-0.83,-0.83,28901397,27221277,26979264,3852240,4961,0,3389044,13661382,-2500380,-1.6990767108834075,-30.396755008087595,-9.299999999999999,__nan__,__nan__,__nan__,0.13328905865692237
151,PFBC,Preferred Bank Common Stock,"Preferred Bank provides various commercial banking products and services to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high net worth individuals in the United States. The company accepts checking, savings, and money market deposit accounts; fixed-rate and fixed maturity retail, and non-retail certificates of deposit; and individual retirement accounts. It also provides real estate mortgage loans that are secured by retail, industrial, office, special purpose, and residential single and multi-family properties; real estate construction loans; and commercial loans comprising lines of credit for working capital, term loans for capital expenditures, and commercial and stand-by letters of credit; and SBA loans. In addition, the company offers trade finance services, including commercial and export letters of credit, import lines of credit, documentary collections, international wire transfers, acceptances/trust receipt financing products, export financing, documentary collections, and bills purchase programs. Further, it provides various high-wealth banking services to wealthy individuals residing in the Pacific Rim area; and remote deposit capture, and online and mobile banking services. Additionally, the company offers various banking services to physicians, accountants, attorneys, business managers, and other professionals; and safe deposit boxes, account reconciliation, courier service, and cash management services to the manufacturing, service, and distribution companies. As of December 31, 2021, it had eleven full-service branch offices in Alhambra, Century City, City of Industry, Torrance, Arcadia, Irvine, Diamond Bar, Pico Rivera, Tarzana, and San Francisco; and one branch in Flushing, New York. The company was incorporated in 1991 and is headquartered in Los Angeles, California.",Mr. Li  Yu,Banks - Regional,79.39,USD,1063246453,https://images.financialmodelingprep.com/symbol/PFBC.png,95659,8.24,3.91,175631,0,130662000,"[{'period': '2024', 'revenue': 283.96, 'unit': 'M', 'net_profit': 130.66}, {'period': '2023', 'revenue': 275.59, 'unit': 'M', 'net_profit': 150.04}, {'period': '2022', 'revenue': 254.4, 'unit': 'M', 'net_profit': 128.84}, {'period': '2021', 'revenue': 193.62, 'unit': 'M', 'net_profit': 95.24}]","[{'period': ""Q4 '24"", 'revenue': 70.58, 'unit': 'M', 'net_profit': 30.22}, {'period': ""Q3 '24"", 'revenue': 69.11, 'unit': 'M', 'net_profit': 33.38}, {'period': ""Q2 '24"", 'revenue': 130.67, 'unit': 'M', 'net_profit': 33.59}, {'period': ""Q1 '24"", 'revenue': 129.45, 'unit': 'M', 'net_profit': 33.47}, {'period': ""Q4 '23"", 'revenue': 126.78, 'unit': 'M', 'net_profit': 35.84}, {'period': ""Q3 '23"", 'revenue': 75.93, 'unit': 'M', 'net_profit': 38.19}]",9.8,9.65,6923429000,765515000,765515000,6160277000,35756000,427073000,0,765515000,163605000,-1,-0.1291522260730472,-0.07894736842105261,"[0.75, 0.38]","['2025-04-07', '2001-05-23']",__nan__,0.8897725390120994
152,PFBI,Premier Financial Bancorp Inc. Common Stock,"Premier Financial Bancorp, Inc. is a multi-bank holding company, which engages in the provision of community banking services. The company is headquartered in Huntington, West Virginia and currently employs 363 full-time employees. The firm's banking subsidiaries (the Banks or Affiliate Banks) consist of Citizens Deposit Bank and Trust, Inc., Vanceburg, Kentucky and Premier Bank, Inc., Huntington, West Virginia. Through the Banks, the Company focuses on providing community banking services to individuals and small-to-medium sized businesses. The Banks provide a range of retail and commercial banking services, including commercial, real estate, agricultural and consumer lending; depository and funds transfer services; collections; safe deposit boxes; cash management services; and other services tailored for both individuals and businesses. The firm operates over nine banking offices in Kentucky, approximately five banking offices in Ohio, over 30 banking offices in West Virginia, approximately four banking offices in Washington, DC, over one banking offices in Maryland and approximately four banking offices in Virginia.",Mr. Robert Walker,Banks - Regional,17.79,USD,0,https://images.financialmodelingprep.com/symbol/PFBI.png,29551,11.11875,-0.05999947,524099,33775000,22438000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 22.44}, {'period': '2019', 'revenue': 76.23, 'unit': 'M', 'net_profit': 24.2}, {'period': '2018', 'revenue': 68.85, 'unit': 'M', 'net_profit': 20.17}, {'period': '2016', 'revenue': 61.88, 'unit': 'M', 'net_profit': 12.17}]","[{'period': ""Q2 '21"", 'revenue': 19.07, 'unit': 'M', 'net_profit': 5.17}, {'period': ""Q1 '21"", 'revenue': 19.29, 'unit': 'M', 'net_profit': 6.55}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 22.44}, {'period': ""Q3 '20"", 'revenue': 19.17, 'unit': 'M', 'net_profit': 5.62}, {'period': ""Q2 '20"", 'revenue': 18.7, 'unit': 'M', 'net_profit': 5.51}, {'period': ""Q1 '20"", 'revenue': 18.59, 'unit': 'M', 'net_profit': 5.37}]",1.51,1.51,77025000,24961000,24961000,1685915000,0,421190000,5475000,24961000,27683000,-0.2136387976997043,-0.0726566374607373,-0.07926829268292677,"[0.15, 0.125]","['2021-08-31', '1996-06-20']",__nan__,21.887893541058098
153,PFC,Premier Financial Corp. Common Stock,"Premier Financial Corp., through its subsidiaries, provides various banking services. It offers various demand, checking, money market, and savings accounts, as well as certificates of deposits and certificates of deposit account registry service; and investment products. The company also provides residential and commercial real estate, commercial, construction, home improvement and home equity, and consumer loans. In addition, it invests in the U.S. treasury and federal government agency obligations, obligations of states and political subdivisions, mortgage-backed securities that are issued by federal agencies, collateralized mortgage obligations, and corporate bonds. Further, the company offers property and casualty, life, and group health insurance agency services; mezzanine funding services; and online banking services, which include mobile banking, person-to-person payments, online bill pay, and online account opening, as well as the MoneyPass ATM network. It operates through 75 banking center offices and 12 loan offices in Ohio, Michigan, Indiana, Pennsylvania, and West Virginia. The company was formerly known as First Defiance Financial Corp. and changed its name to Premier Financial Corp. in June 2020. Premier Financial Corp. was founded in 1920 and is headquartered in Defiance, Ohio.",Mr. Gary M. Small,Banks - Regional,28.04,USD,1007339804,https://images.financialmodelingprep.com/symbol/PFC.png,246367,14.16161616161616,0,3065094,0,64042000,"[{'period': '2024', 'revenue': 392.67, 'unit': 'M', 'net_profit': 64.04}, {'period': '2023', 'revenue': 300.56, 'unit': 'M', 'net_profit': 104.55}, {'period': '2022', 'revenue': 305.08, 'unit': 'M', 'net_profit': 92.32}, {'period': '2021', 'revenue': 307.33, 'unit': 'M', 'net_profit': 104.13}]","[{'period': ""Q4 '24"", 'revenue': 63.06, 'unit': 'M', 'net_profit': 19.0}, {'period': ""Q3 '24"", 'revenue': 61.56, 'unit': 'M', 'net_profit': 16.66}, {'period': ""Q2 '24"", 'revenue': 110.62, 'unit': 'M', 'net_profit': 14.13}, {'period': ""Q1 '24"", 'revenue': 103.83, 'unit': 'M', 'net_profit': 15.44}, {'period': ""Q4 '23"", 'revenue': 108.09, 'unit': 'M', 'net_profit': 19.27}, {'period': ""Q3 '23"", 'revenue': 67.52, 'unit': 'M', 'net_profit': 21.41}]",1.81,1.8,8581575000,7676406000,1239953000,7579762000,6436453000,0,0,121489000,89700000,0,-0.38746269798760424,-0.38013698630136983,"[0.31, 0.125]","['2025-01-31', '1993-10-05']",__nan__,0.8832600076326316
154,PFDR,Pathfinder Acquisition Corporation Class A Ordinary Shares,"Pathfinder Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology or technology-enabled sectors. The company was incorporated in 2020 and is based in Palo Alto, California.",Mr. David H. S. Chung,Shell Companies,8.58,USD,436528950,https://images.financialmodelingprep.com/symbol/PFDR.png,166457,0,-1.42,158577,-28271000,-33047000,"[{'period': '2022', 'revenue': 40.47, 'unit': 'M', 'net_profit': -33.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.42}]","[{'period': ""Q2 '23"", 'revenue': 8.36, 'unit': 'M', 'net_profit': -13.86}, {'period': ""Q1 '23"", 'revenue': 9.17, 'unit': 'M', 'net_profit': 15.71}, {'period': ""Q4 '22"", 'revenue': 12.12, 'unit': 'M', 'net_profit': -14.4}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.75}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.11}]",-0.0029,-0.0029,328795516,159128,76535,10779951,0,328636388,8307451,76535,-694682,-1.4576483579934163,-2.8966452044123474,-1.0060416666666667,__nan__,__nan__,__nan__,0.03278618617171166
155,PFDRU,Pathfinder Acquisition Corporation Unit,"Pathfinder Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology or technology-enabled sectors. The company was incorporated in 2020 and is based in Palo Alto, California.",Mr. David H. S. Chung,Shell Companies,7.95,USD,0,https://images.financialmodelingprep.com/symbol/PFDRU.png,2646,0,-2.46,5030,-28271000,-33047000,"[{'period': '2022', 'revenue': 40.47, 'unit': 'M', 'net_profit': -33.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.42}]","[{'period': ""Q2 '23"", 'revenue': 8.36, 'unit': 'M', 'net_profit': -13.86}, {'period': ""Q1 '23"", 'revenue': 9.17, 'unit': 'M', 'net_profit': 15.71}, {'period': ""Q4 '22"", 'revenue': 12.12, 'unit': 'M', 'net_profit': -14.4}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.75}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.11}]",-0.0029,-0.0029,328795516,159128,76535,10779951,0,328636388,8307451,76535,-694682,-1.4576483579934163,-2.8966452044123474,-1.0060416666666667,__nan__,__nan__,__nan__,0.03278618617171166
156,PFDRW,Pathfinder Acquisition Corporation Warrant,,,Shell Companies,0.27,USD,0,https://images.financialmodelingprep.com/symbol/PFDRW.png,0,0,0.07,111161,-28271000,-33047000,"[{'period': '2022', 'revenue': 40.47, 'unit': 'M', 'net_profit': -33.05}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.42}]","[{'period': ""Q2 '23"", 'revenue': 8.36, 'unit': 'M', 'net_profit': -13.86}, {'period': ""Q1 '23"", 'revenue': 9.17, 'unit': 'M', 'net_profit': 15.71}, {'period': ""Q4 '22"", 'revenue': 12.12, 'unit': 'M', 'net_profit': -14.4}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.75}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.11}]",-0.0029,-0.0029,328795516,159128,76535,10779951,0,328636388,8307451,76535,-694682,-1.4576483579934163,-2.8966452044123474,-1.0060416666666667,__nan__,__nan__,__nan__,0.03278618617171166
157,PFG,Principal Financial Group Inc Common Stock,"Principal Financial Group, Inc. provides retirement, asset management, and insurance products and services to businesses, individuals, and institutional clients worldwide. The company operates through Retirement and Income Solutions, Principal Global Investors, Principal International, and U.S. Insurance Solutions segments. The Retirement and Income Solutions segment provides a portfolio of asset accumulation products and services for retirement savings and income. It offers products and services for defined contribution plans, including 401(k) and 403(b) plans, defined benefit pension plans, nonqualified executive benefit plans, employee stock ownership plans, equity compensation, and pension risk transfer services; individual retirement accounts; investment only products; and mutual funds, individual variable annuities, and bank products. The Principal Global Investors segment provides equity, fixed income, real estate, and other alternative investments, as well as asset allocation, stable value management, and other structured investment strategies. The Principal International segment offers pension accumulation products and services, mutual funds, asset management, income annuities, and life insurance accumulation products, as well as voluntary savings plans in Brazil, Chile, Mexico, China, Hong Kong Special Administrative Region, India, and Southeast Asia. The U.S. Insurance Solutions segment provides specialty benefits, such as group dental and vision insurance, group life insurance, and group and individual disability insurance, as well as administers group dental, disability, and vision benefits; and individual life insurance products comprising universal, variable universal, indexed universal, and term life insurance products in the United States. It also offers insurance solutions for small and medium-sized businesses and their owners, as well as executives. Principal Financial Group, Inc. was founded in 1879 and is based in Des Moines, Iowa.",Ms. Deanna Dawnette Strable-Soethout,Insurance - Diversified,77.27,USD,17429871170,https://images.financialmodelingprep.com/symbol/PFG.png,1593704,11.57,7.71,2933058,0,1571000000,"[{'period': '2024', 'revenue': 16.13, 'unit': 'B', 'net_profit': 1.57}, {'period': '2023', 'revenue': 13670.0, 'unit': 'M', 'net_profit': 623.2}, {'period': '2022', 'revenue': 17.49, 'unit': 'B', 'net_profit': 4.76}, {'period': '2021', 'revenue': 14.26, 'unit': 'B', 'net_profit': 1.58}]","[{'period': ""Q4 '24"", 'revenue': 4750.0, 'unit': 'M', 'net_profit': 905.4}, {'period': ""Q3 '24"", 'revenue': 3010.0, 'unit': 'M', 'net_profit': -220.0}, {'period': ""Q2 '24"", 'revenue': 4310.0, 'unit': 'M', 'net_profit': 353.1}, {'period': ""Q1 '24"", 'revenue': 4050.0, 'unit': 'M', 'net_profit': 532.5}, {'period': ""Q4 '23"", 'revenue': 2690.0, 'unit': 'M', 'net_profit': -871.7}, {'period': ""Q3 '23"", 'revenue': 4.6, 'unit': 'B', 'net_profit': 1.25}]",6.77,6.68,313663600000,4211899999,29937100000,302194600000,0,77650600000,18265000000,4211900000,4534100000,0,1.5208600770218228,1.564393939393939,"[0.75, 0.25]","['2025-03-12', '2002-11-06']",__nan__,0.9634353492085151
158,PFHD,Professional Holding Corp. Class A Common stock,"Professional Holding Corp. operates primarily through its subsidiary, Professional Bank, provides banking products and services to small and medium sized businesses, other professionals, and entrepreneurs. Its deposit products include checking, NOW, savings, and money market accounts, as well as IRAs and certificates of deposit. The company's lending products comprise commercial loans, residential mortgage loans, home equity lines of credit, installment loans, and consumer lines of credit. It also offers online/digital and mobile banking services, as well as cash management and treasury management services. The company operates through a network of eleven locations in the regional areas of Miami, Broward, and Palm Beach counties, as well as has a digital innovation center located in Cleveland, Ohio and a loan production office in St. Pete, Florida, Jacksonville, and Bedford, New Hampshire. Professional Holding Corp. was founded in 2008 and is headquartered in Coral Gables, Florida.",Mr. Abel L. Iglesias,Banks - Regional,28.65,USD,0,https://images.financialmodelingprep.com/symbol/PFHD.png,65346,0,-0.15,274894,42343000,22148000,"[{'period': '2022', 'revenue': 93.93, 'unit': 'M', 'net_profit': 22.15}, {'period': '2021', 'revenue': 78.5, 'unit': 'M', 'net_profit': 21.36}, {'period': '2020', 'revenue': 64.36, 'unit': 'M', 'net_profit': 8.3}, {'period': '2019', 'revenue': 30.85, 'unit': 'M', 'net_profit': 2.34}]","[{'period': ""Q4 '22"", 'revenue': 23.9, 'unit': 'M', 'net_profit': 4.26}, {'period': ""Q3 '22"", 'revenue': 26.02, 'unit': 'M', 'net_profit': 8.47}, {'period': ""Q2 '22"", 'revenue': 23.69, 'unit': 'M', 'net_profit': 6.99}, {'period': ""Q1 '22"", 'revenue': 20.32, 'unit': 'M', 'net_profit': 2.42}, {'period': ""Q4 '21"", 'revenue': 19.41, 'unit': 'M', 'net_profit': 3.96}, {'period': ""Q3 '21"", 'revenue': 20.58, 'unit': 'M', 'net_profit': 6.29}]",1.59,1.59,2589313000,321728000,321728000,2343936000,0,172921000,26258000,155109000,16999000,0.5275252525252525,0.03669724770642202,0,__nan__,__nan__,__nan__,0.9052347089749289
159,PFIE,Profire Energy Inc. Common Stock,"Profire Energy, Inc., a technology company, provides burner, and combustion management systems and solutions for natural and forced draft applications in the United States and Canada. It primarily focuses on the upstream, midstream, and downstream transmission segments of the oil and gas industry. It also sells and installs its systems in Europe, South America, Africa, the Middle East, and Asia. The company was founded in 2002 and is based in Lindon, Utah.",Mr. Cameron M. Tidball,Oil & Gas Equipment & Services,2.54,USD,117347238,https://images.financialmodelingprep.com/symbol/PFIE.png,896518,13.368421052631579,0,0,13564823,10776714,"[{'period': '2023', 'revenue': 58.21, 'unit': 'M', 'net_profit': 10.78}, {'period': '2022', 'revenue': 45.94, 'unit': 'M', 'net_profit': 3.95}, {'period': '2021', 'revenue': 26.36, 'unit': 'M', 'net_profit': -1.05}, {'period': '2020', 'revenue': 21.46, 'unit': 'M', 'net_profit': -2.18}]","[{'period': ""Q3 '24"", 'revenue': 17.2, 'unit': 'M', 'net_profit': 2.18}, {'period': ""Q2 '24"", 'revenue': 15.16, 'unit': 'M', 'net_profit': 2.06}, {'period': ""Q1 '24"", 'revenue': 13.64, 'unit': 'M', 'net_profit': 1.43}, {'period': ""Q4 '23"", 'revenue': 14.38, 'unit': 'M', 'net_profit': 3.29}, {'period': ""Q3 '23"", 'revenue': 14.83, 'unit': 'M', 'net_profit': 2.04}, {'period': ""Q2 '23"", 'revenue': 14.44, 'unit': 'M', 'net_profit': 2.86}]",0.23,0.22,66293845,44472716,13567058,9455619,14215383,6425582,9095470,10767519,5835775,1.1546335470893245,1.729830080855979,1.747909199522103,__nan__,__nan__,__nan__,0.1426319291029205
160,PFIN,P & F Industries Inc. Class A Common Stock,"P&F Industries, Inc., through its subsidiaries, designs, imports, manufactures, and sells pneumatic hand tools primarily to the retail, industrial, automotive, and aerospace markets primarily in the United States. The company provides sanders, grinders, drills, saws, and impact wrenches under the Florida Pneumatic, Universal Tool, Jiffy Air Tool, AIRCAT, and NITROCAT names, as well as under private label trade names through in-house sales personnel and manufacturers' representatives to retailers, distributors, manufacturers, and private label customers. It also designs, manufactures, and distributes industrial tools, pneumatic systems, gearing products, accessories, and various replacement parts under the ATP, NUMATX, Thaxton, and Power Transmission Group brands directly to original equipment manufacturers, as well as through a network of specialized industrial distributors serving power generation, petrochemical, aerospace, construction, railroad, mining, ship building, fabricated metals, and other industries. P&F Industries, Inc. was founded in 1959 and is based in Melville, New York.",Mr. Richard A. Horowitz,Manufacturing - Tools & Accessories,12.995,USD,41515127,https://images.financialmodelingprep.com/symbol/PFIN.png,17188,-56.5,-0.005,3979,1090000,-1476000,"[{'period': '2022', 'revenue': 59.04, 'unit': 'M', 'net_profit': -1.48}, {'period': '2021', 'revenue': 53.55, 'unit': 'M', 'net_profit': 2.29}, {'period': '2020', 'revenue': 49.14, 'unit': 'M', 'net_profit': -4.95}, {'period': '2019', 'revenue': 58.67, 'unit': 'M', 'net_profit': 4.91}]","[{'period': ""Q3 '23"", 'revenue': 14400.0, 'unit': 'K', 'net_profit': -721.0}, {'period': ""Q2 '23"", 'revenue': 16160.0, 'unit': 'K', 'net_profit': 237.0}, {'period': ""Q1 '23"", 'revenue': 15740.0, 'unit': 'K', 'net_profit': 337.0}, {'period': ""Q4 '22"", 'revenue': 12690.0, 'unit': 'K', 'net_profit': -600.0}, {'period': ""Q3 '22"", 'revenue': 14520.0, 'unit': 'K', 'net_profit': -237.0}, {'period': ""Q2 '22"", 'revenue': 17810.0, 'unit': 'K', 'net_profit': -21.0}]",-0.46,-0.46,61004000,35281000,667000,19048000,7370000,0,14443000,667000,914000,-0.776134729924009,-1.6445414847161572,-1.6388888888888888,"[0.05, 0.25]","['2023-11-20', '1991-12-19']",__nan__,0.31224182020851093
161,PFIS,Peoples Financial Services Corp. Common Stock,"Peoples Financial Services Corp. operates as the bank holding company for Peoples Security Bank and Trust Company that provides various commercial and retail banking services. The company accepts money market, NOW, savings, individual retirement, demand deposit, and certificates of deposit accounts. It also provides residential real estate, automobile, manufactured housing, personal, and home equity loans; and commercial real estate, working capital, construction, small business administration, and agricultural loans, as well as loans for equipment and other commercial needs, and mineral rights. In addition, the company offers investment management, IRA trustee, estate administration, living and life insurance trust, trustee under will, guardianship, custodial/IRA custodial, and corporate trust services, as well as pension and profit sharing plans. Further, it provides investment portfolio management, estate and business succession planning, annuities, insurance, retirement plan, and tax planning, as well as education funding strategies; and securities and brokerage, and investor services. Additionally, the company offers small business checking and merchant money market accounts, online and telephone banking, business credit cards, merchant line of credit, and financial checkup services; and remote deposit capture, automatic clearing house transaction, cash management, automated teller machine, point of sale transaction, safe deposit box, night depository, direct deposit, and official check services. It serves business, non-profit, governmental, municipal agency, and professional customers, as well as retail customers through 28 full-service community banking offices located in Allegheny, Bucks, Lackawanna, Lebanon, Lehigh, Luzerne, Monroe, Montgomery, Northampton, Susquehanna, and Wyoming Counties of Pennsylvania; Middlesex County of New Jersey; and Broome County of New York. The company was founded in 1905 and is headquartered in Scranton, Pennsylvania.",Mr. Thomas P. Tulaney,Banks - Regional,43.51,USD,434867222,https://images.financialmodelingprep.com/symbol/PFIS.png,26159,43.95,2.73,24275,0,8498000,"[{'period': '2024', 'revenue': 134.32, 'unit': 'M', 'net_profit': 8.5}, {'period': '2023', 'revenue': 163.61, 'unit': 'M', 'net_profit': 27.38}, {'period': '2022', 'revenue': 108.07, 'unit': 'M', 'net_profit': 38.09}, {'period': '2021', 'revenue': 98.12, 'unit': 'M', 'net_profit': 43.52}]","[{'period': ""Q4 '24"", 'revenue': 44.18, 'unit': 'M', 'net_profit': 6.09}, {'period': ""Q3 '24"", 'revenue': 44.97, 'unit': 'M', 'net_profit': -4.34}, {'period': ""Q2 '24"", 'revenue': 41.81, 'unit': 'M', 'net_profit': 3.28}, {'period': ""Q1 '24"", 'revenue': 42.38, 'unit': 'M', 'net_profit': 3.47}, {'period': ""Q4 '23"", 'revenue': 43.41, 'unit': 'M', 'net_profit': 3.63}, {'period': ""Q3 '23"", 'revenue': 24.99, 'unit': 'M', 'net_profit': 6.75}]",1,1,5091657000,2935000,-12697000,4622707000,15632000,629909000,37083000,0,31348000,-1,-0.689627465303141,-0.7402597402597403,"[0.6175, 0.14]","['2025-02-28', '1999-11-04']",__nan__,0.9078983521474443
162,PFLT,PennantPark Floating Rate Capital Ltd. Common Stock,"PennantPark Floating Rate Capital Ltd. is a business development company. It seeks to make secondary direct, debt, equity, and loan investments. The fund seeks to invest through floating rate loans in private or thinly traded or small market-cap, public middle market companies. It primarily invests in the United States and to a limited extent non-U.S. companies. The fund typically invests between $2 million and $20 million. The fund also invests in equity securities, such as preferred stock, common stock, warrants or options received in connection with debt investments or through direct investments. It primarily invests between $10 million and $50 million in investments in senior secured loans and mezzanine debt. It seeks to invest in companies not rated by national rating agencies. The companies if rated would be between BB and CCC under the Standard & Poor's system. The fund invests 30% is invested in non-qualifying assets like investments in public companies whose securities are not thinly traded or do not have a market capitalization of less than $250 million, securities of middle-market companies located outside of the United States, high-yield bonds, distressed debt, private equity, securities of public companies that are not thinly traded, and investment companies as defined in the 1940 Act. Under normal conditions, the fund expects atleast 80 percent of its net assets plus any borrowings for investment purposes to be invested in Floating Rate Loans and investments with similar economic characteristics, including cash equivalents invested in money market funds. It expects to represent 65 percent of its portfolio through senior secured loans. In case of floating rate loans, it holds investments for a period of three to ten years.",Mr. Arthur Howard Penn,Asset Management,9.83,USD,864606497,https://images.financialmodelingprep.com/symbol/PFLT.png,1549721,7.18,0.65,2701482,0,91839000,"[{'period': '2024', 'revenue': 110.28, 'unit': 'M', 'net_profit': 91.84}, {'period': '2023', 'revenue': 139.34, 'unit': 'M', 'net_profit': 39.26}, {'period': '2022', 'revenue': 11.61, 'unit': 'M', 'net_profit': 3.45}, {'period': '2021', 'revenue': 61.91, 'unit': 'M', 'net_profit': 56.52}]","[{'period': ""Q1 '25"", 'revenue': 29.7, 'unit': 'M', 'net_profit': 28.33}, {'period': ""Q4 '24"", 'revenue': 32.39, 'unit': 'M', 'net_profit': 21.34}, {'period': ""Q3 '24"", 'revenue': 48.51, 'unit': 'M', 'net_profit': 16.92}, {'period': ""Q2 '24"", 'revenue': 48.36, 'unit': 'M', 'net_profit': 31.11}, {'period': ""Q1 '24"", 'revenue': 24.24, 'unit': 'M', 'net_profit': 22.47}, {'period': ""Q4 '23"", 'revenue': 29.43, 'unit': 'M', 'net_profit': 28.05}]",1.4,1.4,2108845000,125341000,112050000,1231551000,12802000,1983504000,244472000,112050000,-801378000,1,1.3391915641476275,0.818181818181818,"[0.1025, 0.05]","['2025-04-15', '2011-06-22']",__nan__,0.5839931336821815
163,PFMT,Performant Financial Corporation Common Stock,"Performant Financial Corporation provides technology-enabled audit, recovery, outsource customer, and related analytics services in the United States. The company offers recovery services to the clients in Federal guaranteed student loan program and private institutions; identifies and tracks defaulted borrowers across its clients' portfolios of student loans; rehabilitates and recovers past due student loans; provides tax recovery services to federal, state and municipal agencies; recovers government debt for various federal agencies; and offers audit and recovery services to identify improper healthcare payments for public and private healthcare clients. It also identifies improper payments resulting from incorrect coding, procedures that were not medically necessary, incomplete documentation, and claims submitted based on outdated fee schedules; and provides first party call center and other outsourced services. In addition, the company offers Performant Insight that provides various services, such as post- and pre-payment audit of healthcare claims, detection of fraud, waste and abuse of healthcare claims, coordination of benefits, and pharmacy fraud detection services. The company was formerly known as DCS Holdings, Inc. and changed its name to Performant Financial Corporation in 2005. Performant Financial Corporation was founded in 1976 and is headquartered in Livermore, California.",Mr. Simeon M. Kohl,Specialty Business Services,3.56,USD,278717384,https://images.financialmodelingprep.com/symbol/PFMT.png,139145,-35.6,-0.12,155789,828000,-7519000,"[{'period': '2023', 'revenue': 113.74, 'unit': 'M', 'net_profit': -7.52}, {'period': '2022', 'revenue': 109.18, 'unit': 'M', 'net_profit': -6.54}, {'period': '2021', 'revenue': 124.39, 'unit': 'M', 'net_profit': -10.29}, {'period': '2020', 'revenue': 155.94, 'unit': 'M', 'net_profit': -13.99}]","[{'period': ""Q3 '24"", 'revenue': 31.52, 'unit': 'M', 'net_profit': -2.38}, {'period': ""Q2 '24"", 'revenue': 29.36, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q1 '24"", 'revenue': 27.33, 'unit': 'M', 'net_profit': -4.02}, {'period': ""Q4 '23"", 'revenue': 32.57, 'unit': 'M', 'net_profit': 1.25}, {'period': ""Q3 '23"", 'revenue': 29960.0, 'unit': 'K', 'net_profit': -580.0}, {'period': ""Q2 '23"", 'revenue': 25.48, 'unit': 'M', 'net_profit': -3.97}]",-0.0987,-0.0987,99030000,39782000,7252000,18323000,28798000,0,12380000,7252000,-283000,1.7236842105263157,-0.15022181428789966,-0.10156249999999997,__nan__,__nan__,__nan__,0.1850247399777845
164,PFPT,Proofpoint Inc. Common Stock,"Proofpoint, Inc. operates as a security-as-a-service provider that enables large and mid-sized organizations to defend, protect, archive, and govern their sensitive data worldwide. It offers protection against advanced and targeted threats, including malicious attachments, polymorphic threats, zero-day exploits, user-transparent ?drive-by' downloads, malicious web links, hybrid threats, malware free attacks, and other penetration tactics. The company also provides integrated email security, cloud security, advanced threat, information protection and archiving, and digital risk protection product services. In addition, it offers solutions that enable secure business-to-business and business-to-consumer communications; email encryption services that encrypt sensitive emails and deliver them to PC or mobile device; file-transfer solutions for end-users to share various forms of documents and other content; security optimized cloud architecture solutions; and extensible security-as-a-service platform. The company serves aerospace and defense, education, financial services, government, healthcare, manufacturing, and retail sectors. Proofpoint, Inc. was founded in 2002 and is headquartered in Sunnyvale, California.",Mr. Gary Steele,Software - Infrastructure,175.9,USD,0,https://images.financialmodelingprep.com/symbol/PFPT.png,877117,0,0,4847762,1317000,-163809000,"[{'period': '2020', 'revenue': 1050.0, 'unit': 'M', 'net_profit': -163.81}, {'period': '2019', 'revenue': 888.19, 'unit': 'M', 'net_profit': -130.26}, {'period': '2018', 'revenue': 716.99, 'unit': 'M', 'net_profit': -103.75}, {'period': '2017', 'revenue': 515.29, 'unit': 'M', 'net_profit': -84.34}]","[{'period': ""Q2 '21"", 'revenue': 308.65, 'unit': 'M', 'net_profit': -52.91}, {'period': ""Q1 '21"", 'revenue': 287.83, 'unit': 'M', 'net_profit': -45.32}, {'period': ""Q4 '20"", 'revenue': 275.13, 'unit': 'M', 'net_profit': -35.1}, {'period': ""Q3 '20"", 'revenue': 266.67, 'unit': 'M', 'net_profit': -31.88}, {'period': ""Q2 '20"", 'revenue': 258.44, 'unit': 'M', 'net_profit': -22.59}, {'period': ""Q1 '20"", 'revenue': 249.77, 'unit': 'M', 'net_profit': -74.24}]",-2.86,-2.86,2498710000,1259738000,910279000,2056966000,255390000,0,865228000,910279000,192068000,1.0753001715265866,-0.2575058534525774,-0.2274678111587982,__nan__,__nan__,__nan__,0.8232111769673152
165,PFSW,PFSweb Inc. Common Stock,"PFSweb, Inc., together with its subsidiaries, provides omni-channel commerce solutions in the United States, Belgium, Bulgaria, the United Kingdom, Canada, and India. The company offers order to cash service, which provides distributed order orchestration and payment processing; order fulfillment services; contact center services that are focused on providing essential services, such as order entry, returns authorization, product inquiry, and order tracking, as well as iCA, an application where agents provides customer service functions, such as placing orders, checking order status, facilitating returns, initiating upsell and cross sell, managing escalations, and gathering voice of the customer information. It serves clients in various industries, such as fashion apparel and accessories, fragrance and beauty products, health, luxury goods, cosmetics, footwear, consumer packaged goods, housewares, coins and collectibles, jewelry, computer and office products, and other industries. The company was incorporated in 1999 and is headquartered in Allen, Texas.",Mr. Michael C. Willoughby,Specialty Business Services,7.495,USD,170589948,https://images.financialmodelingprep.com/symbol/PFSW.png,256217,-17.430232558139537,0.005,111793,-20014000,-20205000,"[{'period': '2022', 'revenue': 295.12, 'unit': 'M', 'net_profit': -20.2}, {'period': '2021', 'revenue': 277.3, 'unit': 'M', 'net_profit': -13.64}, {'period': '2020', 'revenue': 342.5, 'unit': 'M', 'net_profit': -5.5}, {'period': '2019', 'revenue': 294.02, 'unit': 'M', 'net_profit': -2.17}]","[{'period': ""Q2 '23"", 'revenue': 67920.0, 'unit': 'K', 'net_profit': -128.0}, {'period': ""Q1 '23"", 'revenue': 69.26, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q4 '22"", 'revenue': 98.52, 'unit': 'M', 'net_profit': -2.15}, {'period': ""Q3 '22"", 'revenue': 65.48, 'unit': 'M', 'net_profit': -6.09}, {'period': ""Q2 '22"", 'revenue': 64.63, 'unit': 'M', 'net_profit': -4.5}, {'period': ""Q1 '22"", 'revenue': 66.49, 'unit': 'M', 'net_profit': -7.47}]",-0.89,-0.89,204662000,129817000,30034000,118438000,92118000,0,87753000,30034000,-17930000,-0.8526335277237804,-0.4815222173339199,-0.390625,"[4.5, 4.5]","['2022-12-16', '2022-11-30']",__nan__,0.5787004915421524
166,PFX,PhenixFIN Corporation Common Stock,"PhenixFIN Corporation is a business development company. The firm seeks to invest in privately negotiated debt and equity securities of small and middle market companies. It primarily invests in the following sectors: business services; buildings and real estate; automobile; oil and gas; aerospace and defense; home and office furnishings, housewares, and durable consumer products; healthcare, education and childcare; personal, food, and miscellaneous services; retail stores, diversified or conglomerate manufacturing; telecommunications; mining, steel, iron, and non-precious metals; leisure, amusement, motion pictures, and entertainment; chemicals, plastics, and rubber; finance; personal and nondurable consumer products (manufacturing only); beverage, food, and tobacco; containers, packaging, and glass; structure finance securities; machinery (non-agriculture, non-construction, non-electric); diversified or conglomerate service; restaurant and franchise; electronics; and cargo transport. The fund seeks to invest in companies located in North America. The fund targets private debt transactions in companies with enterprise values or asset values between $25 million and $250 million. The fund seeks to invest in companies with debt investment values between $10 million and $50 million. It exits its investments between three years and seven years; it holds most of its investments to maturity or repayment, but may realize or sell some investments earlier. The fund may take a board seat on its investee companies and can also offer managerial assistance to certain portfolio companies. It structures its investments as first lien senior secured loans, second lien senior secured loans, senior secured notes, senior subordinated notes, subordinate notes, unitranche loans, and seeks warrants or other equity participation. The fund may co-invest in privately negotiated transactions under certain conditions. PhenixFIN Corporation was founded in 2010 and is headquartered in New York, New York.",Mr. David Aaron Lorber,Asset Management,50.4654,USD,101929006,https://images.financialmodelingprep.com/symbol/PFX.png,2339,6.18,-1.3346,529,4895935000,18619122,"[{'period': '2024', 'revenue': 14300.0, 'unit': 'M', 'net_profit': 18.62}, {'period': '2023', 'revenue': 20.13, 'unit': 'M', 'net_profit': 26.92}, {'period': '2022', 'revenue': 15.54, 'unit': 'M', 'net_profit': -6.11}, {'period': '2021', 'revenue': 32.31, 'unit': 'M', 'net_profit': 1.28}]","[{'period': ""Q1 '25"", 'revenue': 3770.0, 'unit': 'M', 'net_profit': 2.46}, {'period': ""Q4 '24"", 'revenue': 8.53, 'unit': 'M', 'net_profit': 6.1}, {'period': ""Q3 '24"", 'revenue': 14.93, 'unit': 'M', 'net_profit': 2.61}, {'period': ""Q2 '24"", 'revenue': 4.66, 'unit': 'M', 'net_profit': 5.37}, {'period': ""Q1 '24"", 'revenue': 5.72, 'unit': 'M', 'net_profit': 4.53}, {'period': ""Q4 '23"", 'revenue': 5.68, 'unit': 'M', 'net_profit': 7.34}]",9.13,9.13,302751813000,68885157000,67571559000,142444040,1313598000,227915858,6426341,67571559000,16104773,149.87546682724928,-0.3083109136744688,-0.2905982905982905,"[1.43, 0.22]","['2025-02-14', '2017-02-17']",__nan__,0.00047049772745704415
167,PFXNL,PhenixFIN Corporation 6.125% Senior Notes due 2023,"PhenixFIN Corporation is a business development company. The firm seeks to invest in privately negotiated debt and equity securities of small and middle market companies. It primarily invests in the following sectors: business services; buildings and real estate; automobile; oil and gas; aerospace and defense; home and office furnishings, housewares, and durable consumer products; healthcare, education and childcare; personal, food, and miscellaneous services; retail stores, diversified or conglomerate manufacturing; telecommunications; mining, steel, iron, and non-precious metals; leisure, amusement, motion pictures, and entertainment; chemicals, plastics, and rubber; finance; personal and nondurable consumer products (manufacturing only); beverage, food, and tobacco; containers, packaging, and glass; structure finance securities; machinery (non-agriculture, non-construction, non-electric); diversified or conglomerate service; restaurant and franchise; electronics; and cargo transport. The fund seeks to invest in companies located in North America. The fund targets private debt transactions in companies with enterprise values or asset values between $25 million and $250 million. The fund seeks to invest in companies with debt investment values between $10 million and $50 million. It exits its investments between three years and seven years; it holds most of its investments to maturity or repayment, but may realize or sell some investments earlier. The fund may take a board seat on its investee companies and can also offer managerial assistance to certain portfolio companies. It structures its investments as first lien senior secured loans, second lien senior secured loans, senior secured notes, senior subordinated notes, subordinate notes, unitranche loans, and seeks warrants or other equity participation. The fund may co-invest in privately negotiated transactions under certain conditions. PhenixFIN Corporation was founded in 2010 and is headquartered in New York, New York.",Mr. David Aaron Lorber,Asset Management,25.04,USD,0,https://images.financialmodelingprep.com/symbol/PFXNL.png,1389,0,0.01,3140,4895935000,18619122,"[{'period': '2024', 'revenue': 14300.0, 'unit': 'M', 'net_profit': 18.62}, {'period': '2023', 'revenue': 20.13, 'unit': 'M', 'net_profit': 26.92}, {'period': '2022', 'revenue': 15.54, 'unit': 'M', 'net_profit': -6.11}, {'period': '2021', 'revenue': 32.31, 'unit': 'M', 'net_profit': 1.28}]","[{'period': ""Q1 '25"", 'revenue': 3770.0, 'unit': 'M', 'net_profit': 2.46}, {'period': ""Q4 '24"", 'revenue': 8.53, 'unit': 'M', 'net_profit': 6.1}, {'period': ""Q3 '24"", 'revenue': 14.93, 'unit': 'M', 'net_profit': 2.61}, {'period': ""Q2 '24"", 'revenue': 4.66, 'unit': 'M', 'net_profit': 5.37}, {'period': ""Q1 '24"", 'revenue': 5.72, 'unit': 'M', 'net_profit': 4.53}, {'period': ""Q4 '23"", 'revenue': 5.68, 'unit': 'M', 'net_profit': 7.34}]",9.13,9.13,302751813000,68885157000,67571559000,142444040,1313598000,227915858,6426341,67571559000,16104773,149.87546682724928,-0.3083109136744688,-0.2905982905982905,"[0.383, 0.383]","['2022-12-14', '2021-03-12']",__nan__,0.00047049772745704415
168,PGC,Peapack-Gladstone Financial Corporation Common Stock,"Peapack-Gladstone Financial Corporation operates as the bank holding company for Peapack-Gladstone Bank that provides private banking and wealth management services in the United States. The company operates in two segments, Banking and Peapack Private. It offers checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. The company also provides working capital lines of credit, term loans for fixed asset acquisitions, commercial mortgages, multi-family mortgages, and other forms of asset-based financing services; and residential mortgages, home equity lines of credit, and other second mortgage loans. In addition, it offers corporate and industrial (C&I) and equipment finance, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; C&I advisory services; escrow management; deposit generation; asset and investment management services; personal trust services, including services as executor, trustee, administrator, custodian, and guardian; and other financial planning, tax preparation, and advisory services. Further, the company provides telephone and Internet banking, merchant credit card, and customer support sales services. Its private banking clients include businesses, non-profits, and consumers; and wealth management clients comprise individuals, families, foundations, endowments, trusts, and estates. The company operates its private banking locations in Bedminster, Morristown, Princeton, and Teaneck, New Jersey; and wealth management branches in Somerset, Morris, Hunterdon, and Union counties, as well as operates automated teller machines at 20 locations. Peapack-Gladstone Financial Corporation was founded in 1921 and is headquartered in Bedminster, New Jersey.",Mr. Douglas L. Kennedy,Banks - Regional,26.52,USD,466651224,https://images.financialmodelingprep.com/symbol/PGC.png,96165,14.34,1.49,211789,0,32988000,"[{'period': '2024', 'revenue': 224.11, 'unit': 'M', 'net_profit': 32.99}, {'period': '2023', 'revenue': 215.53, 'unit': 'M', 'net_profit': 48.85}, {'period': '2022', 'revenue': 242.5, 'unit': 'M', 'net_profit': 74.25}, {'period': '2021', 'revenue': 210.3, 'unit': 'M', 'net_profit': 56.62}]","[{'period': ""Q4 '24"", 'revenue': 60.76, 'unit': 'M', 'net_profit': 9.24}, {'period': ""Q3 '24"", 'revenue': 55.55, 'unit': 'M', 'net_profit': 7.59}, {'period': ""Q2 '24"", 'revenue': 100.88, 'unit': 'M', 'net_profit': 7.53}, {'period': ""Q1 '24"", 'revenue': 98.01, 'unit': 'M', 'net_profit': 8.63}, {'period': ""Q4 '23"", 'revenue': 97.18, 'unit': 'M', 'net_profit': 8.6}, {'period': ""Q3 '23"", 'revenue': 55.87, 'unit': 'M', 'net_profit': 8.76}]",1.87,1.85,7011238000,822934000,793036000,6405389000,29898000,0,63431000,8492000,8267000,0,-0.32476358128300653,-0.3175182481751825,"[0.05, 0.12]","['2025-02-06', '1999-06-29']",__nan__,0.9135888697545284
169,PGEN,Precigen Inc. Common Stock,"Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.","Dr. Helen  Sabzevari MPH, Ph.D.",Biotechnology,1.39,USD,408719770,https://images.financialmodelingprep.com/symbol/PGEN.png,1781831,-2.96,0.22,2403125,-123496000,-126235000,"[{'period': '2024', 'revenue': 3.92, 'unit': 'M', 'net_profit': -126.23}, {'period': '2023', 'revenue': 6.22, 'unit': 'M', 'net_profit': -95.9}, {'period': '2022', 'revenue': 26.91, 'unit': 'M', 'net_profit': -79.78}, {'period': '2021', 'revenue': 103.87, 'unit': 'M', 'net_profit': -96.77}]","[{'period': ""Q4 '24"", 'revenue': 1.19, 'unit': 'M', 'net_profit': -19.73}, {'period': ""Q3 '24"", 'revenue': 0.9530000000000001, 'unit': 'M', 'net_profit': -23.98}, {'period': ""Q2 '24"", 'revenue': 0.717, 'unit': 'M', 'net_profit': -58.79}, {'period': ""Q1 '24"", 'revenue': 1.06, 'unit': 'M', 'net_profit': -23.74}, {'period': ""Q4 '23"", 'revenue': 1.23, 'unit': 'M', 'net_profit': -33.06}, {'period': ""Q3 '23"", 'revenue': 16.72, 'unit': 'M', 'net_profit': 87.38}]",-0.46,-0.46,145266000,102414000,97910000,106753000,1163000,0,21518000,29517000,-68173000,-0.38408087328805507,-0.3162641808475142,-0.1794871794871795,__nan__,__nan__,__nan__,0.7348794625032699
170,PGNY,Progyny Inc. Common Stock,"Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.",Mr. Peter  Anevski CPA,Medical - Healthcare Information Services,22.56,USD,1926924048,https://images.financialmodelingprep.com/symbol/PGNY.png,1867516,39.58,1.05,1788263,67455000,54336000,"[{'period': '2024', 'revenue': 1170.0, 'unit': 'M', 'net_profit': 54.34}, {'period': '2023', 'revenue': 1090.0, 'unit': 'M', 'net_profit': 62.04}, {'period': '2022', 'revenue': 786.91, 'unit': 'M', 'net_profit': 30.36}, {'period': '2021', 'revenue': 500.62, 'unit': 'M', 'net_profit': 65.77}]","[{'period': ""Q4 '24"", 'revenue': 298.43, 'unit': 'M', 'net_profit': 10.53}, {'period': ""Q3 '24"", 'revenue': 286.62, 'unit': 'M', 'net_profit': 10.42}, {'period': ""Q2 '24"", 'revenue': 304.09, 'unit': 'M', 'net_profit': 16.48}, {'period': ""Q1 '24"", 'revenue': 278.08, 'unit': 'M', 'net_profit': 16.9}, {'period': ""Q4 '23"", 'revenue': 269.94, 'unit': 'M', 'net_profit': 13.47}, {'period': ""Q3 '23"", 'revenue': 280.89, 'unit': 'M', 'net_profit': 15.9}]",0.59,0.57,607102000,472721000,227954000,185040000,235324000,0,168627000,162314000,173700000,0.04638175754285271,-0.12413559649886358,-0.09230769230769238,__nan__,__nan__,__nan__,0.30479227543312326
171,PGRW,Progress Acquisition Corp. Class A Common Stock,"Progress Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. George A. Barrios,Shell Companies,10.31,USD,54340814,https://images.financialmodelingprep.com/symbol/PGRW.png,2112,515.5,-0.04,4396,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
172,PGRWU,Progress Acquisition Corp. Units,"Progress Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. George A. Barrios,Shell Companies,10.35,USD,218157300,https://images.financialmodelingprep.com/symbol/PGRWU.png,2252,5175,-0.02,3197,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
173,PGRWW,Progress Acquisition Corp. Warrant,"Progress Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. Warren W. Schlichting,Shell Companies,0.0004,USD,0,https://images.financialmodelingprep.com/symbol/PGRWW.png,0,0,0,1580958,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
174,PHAR,Pharming Group N.V. ADS each representing 10 ordinary shares,"Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.","Dr. Sijmen  de Vries M.B.A., M.D.",Biotechnology,8.2,USD,557853380,https://images.financialmodelingprep.com/symbol/PHAR.png,6695,-45.56,0.36,4470,7190519,-10644363,"[{'period': '2024', 'revenue': 286.89, 'unit': 'M', 'net_profit': -10.64}, {'period': '2023', 'revenue': 245.32, 'unit': 'M', 'net_profit': -10.55}, {'period': '2022', 'revenue': 205.62, 'unit': 'M', 'net_profit': 13.67}, {'period': '2021', 'revenue': 189.85, 'unit': 'M', 'net_profit': 16.0}]","[{'period': ""Q4 '24"", 'revenue': 92.67, 'unit': 'M', 'net_profit': 2.86}, {'period': ""Q3 '24"", 'revenue': 75.06, 'unit': 'M', 'net_profit': -1.03}, {'period': ""Q2 '24"", 'revenue': 74.03, 'unit': 'M', 'net_profit': -1.2}, {'period': ""Q1 '24"", 'revenue': 55.46, 'unit': 'M', 'net_profit': -12.42}, {'period': ""Q4 '23"", 'revenue': 81.87, 'unit': 'M', 'net_profit': -2.72}, {'period': ""Q3 '23"", 'revenue': 66.66, 'unit': 'M', 'net_profit': 3.46}]",-0.0154,-0.0154,386879691,269025248,162067112,172716303,53167758,4233000,71242035,53037443,-2493369,-0.27199362154500356,-0.00913566552901024,-0.06206896551724136,__nan__,__nan__,__nan__,0.44643414223570604
175,PHAS,PhaseBio Pharmaceuticals Inc. Common Stock,"PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania. On October 23, 2022, PhaseBio Pharmaceuticals, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.",Mr. Jonathan Mow,Biotechnology,0.0701,USD,0,https://images.financialmodelingprep.com/symbol/PHAS.png,1785986,-0.029453781512605044,0,8603716,1662582,-131071,"[{'period': '2021', 'revenue': 10.83, 'unit': 'K', 'net_profit': -131.07}, {'period': '2020', 'revenue': 0.32, 'unit': 'M', 'net_profit': -98.56}, {'period': '2019', 'revenue': 2.36, 'unit': 'M', 'net_profit': -39.25}, {'period': '2018', 'revenue': 0.668, 'unit': 'M', 'net_profit': -23.85}]","[{'period': ""Q2 '22"", 'revenue': 0.20800000000000002, 'unit': 'M', 'net_profit': -16.78}, {'period': ""Q1 '22"", 'revenue': 0.117, 'unit': 'M', 'net_profit': -11.29}, {'period': ""Q4 '21"", 'revenue': 0.158, 'unit': 'M', 'net_profit': 87.83}, {'period': ""Q3 '21"", 'revenue': 0.335, 'unit': 'M', 'net_profit': -31.92}, {'period': ""Q2 '21"", 'revenue': 10.34, 'unit': 'M', 'net_profit': -28.68}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.36}]",-0.0045,-0.0045,60540000,48784000,41800000,153574000,0,0,27883000,41800000,-50095000,1.0172088560427277,0.9986702074772993,0.9986725663716813,__nan__,__nan__,__nan__,2.536736042286092
176,PHAT,Phathom Pharmaceuticals Inc. Common Stock,"Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.",Mr. Paul  Cocja,Biotechnology,4.43,USD,302911882,https://images.financialmodelingprep.com/symbol/PHAT.png,1208155,-0.84,0.18,1121349,-261522000,-334326000,"[{'period': '2024', 'revenue': 55.25, 'unit': 'M', 'net_profit': -334.33}, {'period': '2023', 'revenue': 0.682, 'unit': 'M', 'net_profit': -201.59}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -223.01}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -148.09}]","[{'period': ""Q4 '24"", 'revenue': 29.66, 'unit': 'M', 'net_profit': -74.45}, {'period': ""Q3 '24"", 'revenue': 16.35, 'unit': 'M', 'net_profit': -85.58}, {'period': ""Q2 '24"", 'revenue': 7.32, 'unit': 'M', 'net_profit': -91.45}, {'period': ""Q1 '24"", 'revenue': 1.91, 'unit': 'M', 'net_profit': -82.85}, {'period': ""Q4 '23"", 'revenue': 0.682, 'unit': 'M', 'net_profit': -79.57}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.24}]",-5.29,-5.29,378318000,360134000,297263000,631898000,38797000,0,85728000,297263000,-266770000,-0.6442857232676722,-0.6584289059089646,-0.34605597964376583,__nan__,__nan__,__nan__,1.6702826722492718
177,PHCF,Puhui Wealth Investment Management Co. Ltd. Ordinary Shares,"Puhui Wealth Investment Management Co., Ltd., through its subsidiaries, provides third-party wealth management services in the People's Republic of China. The company markets financial products, such as private equity funds, securities investment funds, and private placement bond products to high-net-worth individuals and small and medium enterprises, as well as offers trust plans and asset management plans. It also manages funds for individuals and corporate clients, as well as provides investment advisory services. The company was founded in 2013 and is headquartered in Beijing, China.",Mr. Zhe  Ji,Asset Management,1.75,USD,3939670,https://images.financialmodelingprep.com/symbol/PHCF.png,2377,-0.78125,0,4037,-1906203,-5118639,"[{'period': '2021', 'revenue': 2.03, 'unit': 'M', 'net_profit': -5.12}, {'period': '2020', 'revenue': 2.18, 'unit': 'M', 'net_profit': -4.69}, {'period': '2019', 'revenue': 3.18, 'unit': 'M', 'net_profit': -3.1}, {'period': '2018', 'revenue': 4140.0, 'unit': 'K', 'net_profit': 475.35}]","[{'period': ""Q4 '21"", 'revenue': 2.18, 'unit': 'B', 'net_profit': -4.68}, {'period': ""Q4 '20"", 'revenue': 800.92, 'unit': 'K', 'net_profit': -533.27}, {'period': ""Q4 '19"", 'revenue': 1.31, 'unit': 'M', 'net_profit': -1.99}, {'period': ""Q2 '19"", 'revenue': 1870.0, 'unit': 'K', 'net_profit': -463.49}, {'period': ""Q4 '18"", 'revenue': 3.39, 'unit': 'M', 'net_profit': 1.29}]",-2.67,-2.67,8429465,3252478,976056,5169849,1276211,0,3721272,581289,-1670646,0.44794751599941846,-0.09193741790959127,-0.0942622950819672,__nan__,__nan__,__nan__,0.6133068943284063
178,PHIC,Population Health Investment Co. Inc. Class A Ordinary Share,"Population Health Investment Co., Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/PHIC.png,16384,31.5,0.01,1048,5855362,13246292,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -248.71}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.12}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.56}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.05}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.24}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.05}]",0.61,0.61,173184243,647926,247444,12006711,0,0,842943,247444,-433799,24.543402826642005,54.261060292314184,54.04347826086956,__nan__,__nan__,__nan__,0.06932911904693316
179,PHICU,Population Health Investment Co. Inc. Unit,"Population Health Investment Co., Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.03,USD,0,https://images.financialmodelingprep.com/symbol/PHICU.png,476,36.34057971014493,-0.02,655,5855362,13246292,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -248.71}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.12}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.56}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.05}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.24}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.05}]",0.61,0.61,173184243,647926,247444,12006711,0,0,842943,247444,-433799,24.543402826642005,54.261060292314184,54.04347826086956,__nan__,__nan__,__nan__,0.06932911904693316
180,PHICW,Population Health Investment Co. Inc. Warrant,,,Shell Companies,0.0003,USD,0,https://images.financialmodelingprep.com/symbol/PHICW.png,13237,0,-0.0005,2903,5855362,13246292,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -248.71}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.12}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.56}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.05}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.24}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.05}]",0.61,0.61,173184243,647926,247444,12006711,0,0,842943,247444,-433799,24.543402826642005,54.261060292314184,54.04347826086956,__nan__,__nan__,__nan__,0.06932911904693316
181,PHIO,Phio Pharmaceuticals Corp. Common Stock,"Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.",Mr. Robert J. Bitterman,Biotechnology,1.54,USD,7358351,https://images.financialmodelingprep.com/symbol/PHIO.png,8662232,-0.17,0.53,150614702,0,-7150000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.15}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.83}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.3}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.21}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.85}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.15}, {'period': ""Q4 '23"", 'revenue': 0.03, 'unit': 'M', 'net_profit': -1.9}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.78}]",-0.91,-0.91,5738000,5736000,5382000,1015000,0,0,1015000,5382000,-7113000,1,0.339552928135969,0.9805845956902071,__nan__,__nan__,__nan__,0.17689090275357267
182,PHIOW,Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021,"Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. Phio Pharmaceuticals has collaboration with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.","Dr. Gerrit Dispersyn Ph.D., Dr. Med. Sc",Biotechnology,0.0232,USD,421414,https://images.financialmodelingprep.com/symbol/PHIOW.png,0,-0.020549158547387068,0.0062,214336,0,-7150000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.15}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.83}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.3}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.21}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.85}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.15}, {'period': ""Q4 '23"", 'revenue': 0.03, 'unit': 'M', 'net_profit': -1.9}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.78}]",-0.91,-0.91,5738000,5736000,5382000,1015000,0,0,1015000,5382000,-7113000,1,0.339552928135969,0.9805845956902071,__nan__,__nan__,__nan__,0.17689090275357267
183,PHUN,Phunware Inc. Common Stock,"Phunware, Inc., together with its subsidiaries, offers integrated software platform that equips companies with the products, solutions, and services to engage, manage, and monetize their mobile application portfolios in the United States and internationally. The company's products and services include cloud-based mobile software that licenses in software development kits (SDKs) form utilized inside mobile applications, such as analytics that provides data related to application use and engagement; content management that allows application administrators to create and manage app content in a cloud-based portal; alerts, notifications, and messaging; marketing automation that enables location-triggered messages and workflow; advertising; and location-based services that include mapping, navigation, wayfinding, workflow, asset management, and policy enforcement. It also engages the integration of its SDK licenses into existing applications maintained by its customers, as well as custom application development and support services; provision of cloud-based vertical solutions for healthcare, retail, sports, aviation, real estate, hospitality, education, and other applications; offering application transactions, including re-occurring and one-time transactional media purchases for application discovery, user acquisition and audience building, audience engagement, and audience monetization; and pre-packaged and custom high-end personal computer systems for gaming, streaming, and cryptocurrency mining enthusiasts. The company was founded in 2009 and is headquartered in Austin, Texas.",Mr. Stephen  Chen,Software - Application,2.7,USD,54460890,https://images.financialmodelingprep.com/symbol/PHUN.png,699786,-2.87,0.31,353164,-10140000,-10316000,"[{'period': '2024', 'revenue': 3.19, 'unit': 'M', 'net_profit': -10.32}, {'period': '2023', 'revenue': 4.83, 'unit': 'M', 'net_profit': -52.78}, {'period': '2022', 'revenue': 21.79, 'unit': 'M', 'net_profit': -50.89}, {'period': '2021', 'revenue': 10.64, 'unit': 'M', 'net_profit': -53.52}]","[{'period': ""Q4 '24"", 'revenue': 0.592, 'unit': 'M', 'net_profit': -2.63}, {'period': ""Q3 '24"", 'revenue': 0.665, 'unit': 'M', 'net_profit': -2.76}, {'period': ""Q2 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -2.63}, {'period': ""Q1 '24"", 'revenue': 0.921, 'unit': 'M', 'net_profit': -2.29}, {'period': ""Q4 '23"", 'revenue': -6.19, 'unit': 'M', 'net_profit': -23.01}, {'period': ""Q3 '23"", 'revenue': 2.79, 'unit': 'M', 'net_profit': -18.98}]",-0.94,-0.94,114781000,113759000,112974000,7598000,276000,0,6451000,112974000,-13125000,0.7471195570851414,0.8045656910107037,0.9576194770063119,__nan__,__nan__,__nan__,0.06619562471140694
184,PHUNW,Phunware Inc. Warrants,"Phunware, Inc., together with its subsidiaries, offers integrated software platform that equips companies with the products, solutions, and services to engage, manage, and monetize their mobile application portfolios in the United States and internationally. The company's products and services include cloud-based mobile software that licenses in software development kits (SDKs) form utilized inside mobile applications, such as analytics that provides data related to application use and engagement; content management that allows application administrators to create and manage app content in a cloud-based portal; alerts, notifications, and messaging; marketing automation that enables location-triggered messages and workflow; advertising; and location-based services that include mapping, navigation, wayfinding, workflow, asset management, and policy enforcement. It also engages the integration of its SDK licenses into existing applications maintained by its customers, as well as custom application development and support services; provision of cloud-based vertical solutions for healthcare, retail, sports, aviation, real estate, hospitality, education, and other applications; offering application transactions, including re-occurring and one-time transactional media purchases for application discovery, user acquisition and audience building, audience engagement, and audience monetization; and pre-packaged and custom high-end personal computer systems for gaming, streaming, and cryptocurrency mining enthusiasts. The company was founded in 2009 and is headquartered in Austin, Texas.",Mr. Michael  Snavely,Software - Application,0.0184,USD,2240419,https://images.financialmodelingprep.com/symbol/PHUNW.png,6663,0,0,6663,-10140000,-10316000,"[{'period': '2024', 'revenue': 3.19, 'unit': 'M', 'net_profit': -10.32}, {'period': '2023', 'revenue': 4.83, 'unit': 'M', 'net_profit': -52.78}, {'period': '2022', 'revenue': 21.79, 'unit': 'M', 'net_profit': -50.89}, {'period': '2021', 'revenue': 10.64, 'unit': 'M', 'net_profit': -53.52}]","[{'period': ""Q4 '24"", 'revenue': 0.592, 'unit': 'M', 'net_profit': -2.63}, {'period': ""Q3 '24"", 'revenue': 0.665, 'unit': 'M', 'net_profit': -2.76}, {'period': ""Q2 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -2.63}, {'period': ""Q1 '24"", 'revenue': 0.921, 'unit': 'M', 'net_profit': -2.29}, {'period': ""Q4 '23"", 'revenue': -6.19, 'unit': 'M', 'net_profit': -23.01}, {'period': ""Q3 '23"", 'revenue': 2.79, 'unit': 'M', 'net_profit': -18.98}]",-0.94,-0.94,114781000,113759000,112974000,7598000,276000,0,6451000,112974000,-13125000,0.7471195570851414,0.8045656910107037,0.9576194770063119,__nan__,__nan__,__nan__,0.06619562471140694
185,PHVS,Pharvaris N.V. Ordinary Shares,"Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.","Mr. Berndt Axel Edvard Modig CPA, M.B.A.",Biotechnology,12.3,USD,670265130,https://images.financialmodelingprep.com/symbol/PHVS.png,43018,-4.3,0.47,74287,-96853839,-100875000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -100.88}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -76.33}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.73}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.99}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.76}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.71}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.73}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.02}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.91}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.6}]",-2.63,-2.63,291374765,289419576,280728037,23614024,2944514,0,22974981,280728037,-120668277,-0.1186007371084556,-0.32151999048060187,-0.158590308370044,__nan__,__nan__,__nan__,0.08104347677466166
186,PI,Impinj Inc. Common Stock,"Impinj, Inc. operates a cloud connectivity platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Its platform, which comprises multiple product families, wirelessly connects individual items and delivers data about the connected items to business and consumer applications. The company's platform comprises endpoint ICs, a miniature radios-on-a-chip that attaches to a host item and includes a number to identify the item. Its platform also consists of systems products that comprise reader ICs, readers, and gateways to wirelessly provide power to and communicate bidirectionally with endpoint ICs on host items, as well as to read, write, authenticate, and engage the endpoint ICs on those items; and software and algorithms that enables its partners to deliver use cases, such as retail self-checkout and loss prevention, and warehouse pallet and carton tracking to end-users. The company primarily serves retail, supply chain and logistics, aviation, automotive, healthcare, industrial and manufacturing, sports, food, datacenter, travel, banking, and linen and uniform tracking sectors through distributors, system integrators, value-added resellers, and software solution partners. Impinj, Inc. was incorporated in 2000 and is headquartered in Seattle, Washington.",Dr. Chris  Diorio Ph.D.,Communication Equipment,77.24,USD,2204282844,https://images.financialmodelingprep.com/symbol/PI.png,750186,55.57,14.7,1854659,57817000,40838000,"[{'period': '2024', 'revenue': 366.09, 'unit': 'M', 'net_profit': 40.84}, {'period': '2023', 'revenue': 307.54, 'unit': 'M', 'net_profit': -43.37}, {'period': '2022', 'revenue': 257.8, 'unit': 'M', 'net_profit': -24.3}, {'period': '2021', 'revenue': 190.28, 'unit': 'M', 'net_profit': -51.26}]","[{'period': ""Q4 '24"", 'revenue': 91.57, 'unit': 'M', 'net_profit': -2.69}, {'period': ""Q3 '24"", 'revenue': 95200.0, 'unit': 'K', 'net_profit': 221.0}, {'period': ""Q2 '24"", 'revenue': 102.5, 'unit': 'M', 'net_profit': 9.96}, {'period': ""Q1 '24"", 'revenue': 76.83, 'unit': 'M', 'net_profit': 33.34}, {'period': ""Q4 '23"", 'revenue': 70.65, 'unit': 'M', 'net_profit': -15.18}, {'period': ""Q3 '23"", 'revenue': 65.0, 'unit': 'M', 'net_profit': -15.76}]",1.46,1.39,489080000,326398000,164714000,339216000,56802000,74871000,331177000,46053000,111198000,3.155018822915502,1.941705483558548,1.9012345679012346,__nan__,__nan__,__nan__,0.6935797824486791
187,PINC,Premier Inc. Class A Common Stock,"Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; STOCKD, an e-commerce platform; PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company also provides services to other businesses, including food service, schools, and universities. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina.",Mr. Michael J. Alkire,Medical - Healthcare Information Services,19.68,USD,1796929632,https://images.financialmodelingprep.com/symbol/PINC.png,1443829,49.2,0.74,2253380,256974000,119544000,"[{'period': '2024', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 119.54}, {'period': '2023', 'revenue': 1340.0, 'unit': 'M', 'net_profit': 175.03}, {'period': '2022', 'revenue': 1430.0, 'unit': 'M', 'net_profit': 265.87}, {'period': '2021', 'revenue': 1720.0, 'unit': 'M', 'net_profit': 287.52}]","[{'period': ""Q2 '25"", 'revenue': 240.27, 'unit': 'M', 'net_profit': -96.02}, {'period': ""Q1 '25"", 'revenue': 248.14, 'unit': 'M', 'net_profit': 70.78}, {'period': ""Q4 '24"", 'revenue': 350.27, 'unit': 'M', 'net_profit': 60.68}, {'period': ""Q3 '24"", 'revenue': 342.6, 'unit': 'M', 'net_profit': -40.2}, {'period': ""Q2 '24"", 'revenue': 334.75, 'unit': 'M', 'net_profit': 54.3}, {'period': ""Q1 '24"", 'revenue': 318.75, 'unit': 'M', 'net_profit': 44.76}]",1.05,1.04,3401449000,748016000,125146000,1439218000,462525000,228562000,746563000,125146000,215371000,-0.35475981831010317,-0.3169929039114189,-0.2857142857142857,"[0.21, 0.19]","['2025-02-28', '2020-08-31']",__nan__,0.42311908836498796
188,PIRS,Pieris Pharmaceuticals Inc. Common Stock,"Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; and immune-oncology program comprises Cinrebafusp alfa, a 4-1BB/ HER2 bispecific for the treatment of HER2-high and HER2-low expressing gastric cancers. The company also develops PRS-344/S095012, a bispecific anticalin-antibody fusion protein targeting 4- 1BB and PD-L1 for immuno-oncology diseases that is in phase 1 clinical trial; and PRS-352, a preclinical-stage program addressing undisclosed targets for immuno-oncology diseases. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich, Enumeral Biomedical Holdings, Inc., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. The company also has a clinical trial collaboration and supply agreement with Eli Lilly and Company. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.",Mr. Stephen S. Yoder J.D.,Biotechnology,13.6,USD,17955264,https://images.financialmodelingprep.com/symbol/PIRS.png,22126,-1.1230388109000826,-2.51,51728,-22762000,-24543000,"[{'period': '2023', 'revenue': 42.81, 'unit': 'M', 'net_profit': -24.54}, {'period': '2022', 'revenue': 25.9, 'unit': 'M', 'net_profit': -31.25}, {'period': '2021', 'revenue': 31.42, 'unit': 'M', 'net_profit': -43.37}, {'period': '2020', 'revenue': 29.32, 'unit': 'M', 'net_profit': -37.23}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.89}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.59}, {'period': ""Q1 '24"", 'revenue': 0.053, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q4 '23"", 'revenue': 1.3, 'unit': 'M', 'net_profit': -4.58}, {'period': ""Q3 '23"", 'revenue': 19.52, 'unit': 'M', 'net_profit': -10.75}, {'period': ""Q2 '23"", 'revenue': 20.05, 'unit': 'M', 'net_profit': 3.98}]",-21.8,-21.8,38680000,38680000,26366000,11922000,572000,0,11922000,17396000,-53990000,0.253631504738171,0.21469938885866957,0.35330762385048947,__nan__,__nan__,__nan__,0.3082213029989659
189,PIXY,ShiftPixy Inc. Common Stock,"ShiftPixy, Inc., together with its subsidiaries, provides staffing solutions in the United States. It offers employment administrative services, such as payroll processing, human resources consulting, and workers' compensation administration and coverage. The Company also operates human resources information systems platform to assist in customer acquisition for the onboarding of new clients into the company's closed proprietary operating and processing information system. It primarily serves restaurant and hospitality service industries. The company was incorporated in 2015 and is headquartered in Miami, Florida.",Mr. Douglas J. Beck CPA,Staffing & Employment Services,6.53,USD,3265294,https://images.financialmodelingprep.com/symbol/PIXY.png,0,0.01088877772219443,-1.09,247238,-29502000,-33626000,"[{'period': '2023', 'revenue': 17.13, 'unit': 'M', 'net_profit': -33.63}, {'period': '2022', 'revenue': 36.0, 'unit': 'M', 'net_profit': -43.99}, {'period': '2021', 'revenue': 23.42, 'unit': 'M', 'net_profit': -27.37}, {'period': '2020', 'revenue': 8.64, 'unit': 'M', 'net_profit': -77.25}]","[{'period': ""Q3 '24"", 'revenue': 4.13, 'unit': 'M', 'net_profit': -4.42}, {'period': ""Q2 '24"", 'revenue': 3.81, 'unit': 'M', 'net_profit': -4.7}, {'period': ""Q1 '24"", 'revenue': 3.77, 'unit': 'M', 'net_profit': -5.55}, {'period': ""Q4 '23"", 'revenue': 3.3, 'unit': 'M', 'net_profit': -14.98}, {'period': ""Q3 '23"", 'revenue': 3.99, 'unit': 'M', 'net_profit': -7.46}, {'period': ""Q2 '23"", 'revenue': 4.58, 'unit': 'M', 'net_profit': -5.77}]",-298.82,-298.82,6500000,3820000,75000,57625000,2374000,0,54835000,75000,-9589000,0.24128176113568564,0.23568587339470395,0.886068758316462,__nan__,__nan__,__nan__,8.865384615384615
190,PKBK,Parke Bancorp Inc. Common Stock,"Parke Bancorp, Inc. operates as the bank holding company for Parke Bank that provides personal and business financial services to individuals and small to mid-sized businesses. The company offers various deposit products, including checking, savings, time, money market, and individual retirement accounts, as well as certificates of deposit. Its loan portfolio comprises commercial and industrial, construction, commercial and residential real estate mortgage, and consumer loans. In addition, the company provides debit cards, internet banking, and online bill payment services. It operates through 7 branch offices in Galloway Township, Northfield, Washington Township, and Collingswood, New Jersey; and Philadelphia, Pennsylvania. Parke Bancorp, Inc. was founded in 1999 and is headquartered in Washington Township, New Jersey.",Mr. Vito S. Pantilione,Banks - Regional,18.42,USD,218140692,https://images.financialmodelingprep.com/symbol/PKBK.png,25113,8.11,0.72,23278,0,27512000,"[{'period': '2024', 'revenue': 63.01, 'unit': 'M', 'net_profit': 27.51}, {'period': '2023', 'revenue': 72.96, 'unit': 'M', 'net_profit': 28.46}, {'period': '2022', 'revenue': 81.71, 'unit': 'M', 'net_profit': 41.82}, {'period': '2021', 'revenue': 77.92, 'unit': 'M', 'net_profit': 40.76}]","[{'period': ""Q4 '24"", 'revenue': 16.76, 'unit': 'M', 'net_profit': 7.4}, {'period': ""Q3 '24"", 'revenue': 15.62, 'unit': 'M', 'net_profit': 7.51}, {'period': ""Q2 '24"", 'revenue': 31.15, 'unit': 'M', 'net_profit': 6.46}, {'period': ""Q1 '24"", 'revenue': 30.19, 'unit': 'M', 'net_profit': 6.15}, {'period': ""Q4 '23"", 'revenue': 31.55, 'unit': 'M', 'net_profit': 8.17}, {'period': ""Q3 '23"", 'revenue': 17.52, 'unit': 'M', 'net_profit': 1.03}]",2.3,2.27,2142236000,19834000,10175000,1842163000,9659000,0,7968000,4624000,35039000,0,-0.03337783711615487,-0.033613445378151294,"[0.18, 0.2]","['2025-04-04', '2006-12-08']",__nan__,0.8599253303557591
191,PKOH,Park-Ohio Holdings Corp. Common Stock,"Park-Ohio Holdings Corp. provides supply chain management outsourcing services, capital equipment, and manufactured components in the United States, Europe, Asia, Mexico, Canada, and internationally. It operates through three segments: Supply Technologies, Assembly Components, and Engineered Products. The Supply Technologies segment offers Total Supply Management solution, including engineering and design support, part usage and cost analysis, supplier selection, quality assurance, bar coding, product packaging and tracking, just-in-time and point-of-use delivery, electronic billing, and ongoing technical support services, as well as provides spare parts and aftermarket products; and production components, such as valves, fuel hose assemblies, electro-mechanical hardware, labels, fittings, steering components, and other products. It also engineers and manufactures precision cold-formed and cold-extruded fasteners and other products, including locknuts, SPAC nuts, SPAC bolts, and wheel hardware. The Assembly Components segment manufactures aluminum products, direct fuel injection fuel rails and pipes, fuel filler pipes, and flexible multi-layer plastic and rubber assemblies; turbo charging and coolant hoses; and fluid handling systems. It also offers machining services, as well as value-added services, such as design engineering, machining, and part assembly. The Engineered Products segment designs and manufactures engineered products, including induction heating and melting systems, pipe threading systems, and forged and machined products primarily for ferrous and non-ferrous metals, silicon, coatings, forging, foundry, automotive, and construction equipment industries; engineers and installs mechanical forging presses; sells spare parts; provides field services; and offers aerospace and defense structural components, and rail products, such as railcar center plates and draft lugs. Park-Ohio Holdings Corp. was founded in 1907 and is headquartered in Cleveland, Ohio.",Mr. Matthew V. Crawford,Industrial - Machinery,20.46,USD,291166260,https://images.financialmodelingprep.com/symbol/PKOH.png,23237,6.41,1.87,31265,125400000,31800000,"[{'period': '2024', 'revenue': 1660.0, 'unit': 'M', 'net_profit': 31.8}, {'period': '2023', 'revenue': 1660.0, 'unit': 'M', 'net_profit': 7.8}, {'period': '2022', 'revenue': 1490.0, 'unit': 'M', 'net_profit': 11.4}, {'period': '2021', 'revenue': 1440.0, 'unit': 'M', 'net_profit': -26.0}]","[{'period': ""Q4 '24"", 'revenue': 388.4, 'unit': 'M', 'net_profit': 4.0}, {'period': ""Q3 '24"", 'revenue': 417.6, 'unit': 'M', 'net_profit': 9.8}, {'period': ""Q2 '24"", 'revenue': 432.6, 'unit': 'M', 'net_profit': 11.9}, {'period': ""Q1 '24"", 'revenue': 417.6, 'unit': 'M', 'net_profit': 9.6}, {'period': ""Q4 '23"", 'revenue': 389.3, 'unit': 'M', 'net_profit': -14.5}, {'period': ""Q3 '23"", 'revenue': 418.8, 'unit': 'M', 'net_profit': 11.1}]",2.47,2.41,1365100000,836000000,53100000,1028000000,249500000,0,361100000,53100000,3600000,0.060016906170752324,3.076923076923077,2.920634920634921,"[0.125, 0.125]","['2025-02-07', '2014-05-21']",__nan__,0.7530583840011721
192,PLAB,Photronics Inc. Common Stock,"Photronics, Inc., together with its subsidiaries, engages in the manufacture and sale of photomask products and services in the United States, Taiwan, Korea, Europe, China, and internationally. The company offers photomasks that are used in the manufacture of integrated circuits and flat panel displays (FPDs); and to transfer circuit patterns onto semiconductor wafers, FDP substrates, and other types of electrical and optical components. It sells its products to semiconductor and FPD manufacturers, designers, and foundries, as well as to other high-performance electronics manufacturers through its sales personnel and customer service representatives. The company was formerly known as Photronic Labs, Inc. and changed its name to Photronics, Inc. in 1990. Photronics, Inc. was incorporated in 1969 and is based in Brookfield, Connecticut.",Dr. KangJyh  Lee Ph.D.,Semiconductors,19.38,USD,1231825746,https://images.financialmodelingprep.com/symbol/PLAB.png,616675,8.25,2.46,1361427,221518000,130688000,"[{'period': '2024', 'revenue': 866.95, 'unit': 'M', 'net_profit': 130.69}, {'period': '2023', 'revenue': 892.08, 'unit': 'M', 'net_profit': 125.48}, {'period': '2022', 'revenue': 824.55, 'unit': 'M', 'net_profit': 179.24}, {'period': '2021', 'revenue': 663.76, 'unit': 'M', 'net_profit': 78.82}]","[{'period': ""Q1 '25"", 'revenue': 212.14, 'unit': 'M', 'net_profit': 42.85}, {'period': ""Q4 '24"", 'revenue': 222.63, 'unit': 'M', 'net_profit': 33.87}, {'period': ""Q3 '24"", 'revenue': 210.98, 'unit': 'M', 'net_profit': 34.39}, {'period': ""Q2 '24"", 'revenue': 217.0, 'unit': 'M', 'net_profit': 36.25}, {'period': ""Q1 '24"", 'revenue': 216.33, 'unit': 'M', 'net_profit': 26.18}, {'period': ""Q4 '23"", 'revenue': 227.47, 'unit': 'M', 'net_profit': 44.61}]",2.12,2.09,1712059000,931062000,640669000,231300000,200830000,0,183811000,598485000,130502000,-0.36927912896410736,0.041463123082440136,0.034146341463414775,__nan__,__nan__,__nan__,0.13510048427069393
193,PLAY,Dave & Buster's Entertainment Inc. Common Stock,"Dave & Buster's Entertainment, Inc. owns and operates entertainment and dining venues for adults and families in North America. Its venues offer a menu of entrées and appetizers, as well as a selection of non-alcoholic and alcoholic beverages; and an assortment of entertainment attractions centered on playing games and watching live sports, and other televised events. The company operates its venues under the Dave & Buster's name. As of January 30, 2022, it owned and operated 144 stores located in 40 states, Puerto Rico, and one Canadian Province. The company was founded in 1982 and is headquartered in Coppell, Texas.",Mr. Kevin M. Sheehan CPA,Entertainment,17.53,USD,605053209,https://images.financialmodelingprep.com/symbol/PLAY.png,1556381,12.01,1.47,2441964,443400000,58300000,"[{'period': '2024', 'revenue': 2130.0, 'unit': 'M', 'net_profit': 58.3}, {'period': '2023', 'revenue': 2210.0, 'unit': 'M', 'net_profit': 126.9}, {'period': '2022', 'revenue': 1960.0, 'unit': 'M', 'net_profit': 137.1}, {'period': '2021', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 108.7}]","[{'period': ""Q4 '24"", 'revenue': 534.5, 'unit': 'M', 'net_profit': 9.3}, {'period': ""Q3 '24"", 'revenue': 453.0, 'unit': 'M', 'net_profit': -32.7}, {'period': ""Q2 '24"", 'revenue': 557.1, 'unit': 'M', 'net_profit': 40.3}, {'period': ""Q1 '24"", 'revenue': 588.1, 'unit': 'M', 'net_profit': 41.4}, {'period': ""Q4 '23"", 'revenue': 599.1, 'unit': 'M', 'net_profit': 36.1}, {'period': ""Q3 '23"", 'revenue': 466.9, 'unit': 'M', 'net_profit': -5.2}]",1.49,1.46,4015800000,94400000,6900000,3870000000,20100000,0,433900000,6900000,-217900000,-0.11971411554496725,-0.5405831363278172,-0.4931972789115646,"[0.16, 0.15]","['2020-01-09', '2018-09-24']",__nan__,0.9636934110264456
194,PLBC,Plumas Bancorp,"Plumas Bancorp operates as the bank holding company for the Plumas Bank that provides various banking products and services for small and middle market businesses, and individuals in Northeastern California and Northwestern Nevada. The company accepts various deposits, such as checking, money market checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. Its loan portfolio includes term real estate, commercial, and industrial term loans; government-guaranteed and agricultural loans, as well as credit lines; consumer, automobile, and home equity loans; land development and construction loans; and small business administration loans. The company also provides remote deposit, telephone and mobile banking, internet banking with bill-pay options, cashier's check, bank-by-mail, automated teller machine, night depository, safe deposit box, direct deposit, electronic funds transfer, and other customary banking services. As of February 28, 2022, it operated 14 full-service branches and 3 lending offices. Plumas Bancorp was incorporated in 1980 and is headquartered in Reno, Nevada.",Mr. Richard L. Belstock CPA,Banks - Regional,42.38,USD,250892990,https://images.financialmodelingprep.com/symbol/PLBC.png,11286,8.83,0.57,37912,0,28619000,"[{'period': '2024', 'revenue': 62.23, 'unit': 'M', 'net_profit': 28.62}, {'period': '2023', 'revenue': 80.09, 'unit': 'M', 'net_profit': 29.78}, {'period': '2022', 'revenue': 69.28, 'unit': 'M', 'net_profit': 26.44}, {'period': '2021', 'revenue': 55.65, 'unit': 'M', 'net_profit': 21.01}]","[{'period': ""Q4 '24"", 'revenue': 21.09, 'unit': 'M', 'net_profit': 7.75}, {'period': ""Q3 '24"", 'revenue': 24.1, 'unit': 'M', 'net_profit': 7.83}, {'period': ""Q2 '24"", 'revenue': 23.36, 'unit': 'M', 'net_profit': 6.79}, {'period': ""Q1 '24"", 'revenue': 22.03, 'unit': 'M', 'net_profit': 6.25}, {'period': ""Q4 '23"", 'revenue': 21.88, 'unit': 'M', 'net_profit': 7.52}, {'period': ""Q3 '23"", 'revenue': 19.96, 'unit': 'M', 'net_profit': 7.97}]",4.85,4.8,1537032000,463350000,463350000,1445426000,0,0,0,82018000,9510000000,0,-0.03885679742074154,-0.04527559055118119,"[0.3, 0.1556]","['2025-02-03', '1997-03-27']",__nan__,0.9404007203493486
195,PLBY,PLBY Group Inc. Common Stock,"PLBY Group, Inc. operates as a pleasure and leisure company worldwide. The company operates through three segments: Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It offers sexual wellness products, such as products that enhance sexual experience, lingerie, bedroom accessories, intimates, and adult content; style and apparel products for men and women; gaming and lifestyle products, including digital casino and social games, and other home and hospitality offerings; and beauty and grooming products for men and women, such as skincare, haircare, bath and body, grooming, cosmetics, and fragrance. The company offers its products under its flagship brand, Playboy. It also owns and operates digital commerce retail platforms, such as Playboy.com, HoneyBirdette.com, Yandy.com, and LoversStores.com; and Honey Birdette and Lovers retail stores. In addition, the company licenses content for programming on Playboy television; trademarks under multi-year arrangements with consumer products, online gaming, and location-based entertainment businesses; and programming content to cable television operators and direct-to-home satellite television operators. Further, its business covers the subscription sale of PlayboyPlus.com and Playboy.tv, which are online content platforms. The company was founded in 1953 and is headquartered in Los Angeles, California.",Mr. Ben  Kohn,Leisure,0.98,USD,91872162,https://images.financialmodelingprep.com/symbol/PLBY.png,752016,-0.94,0.0456,589386,-79397000,-79397000,"[{'period': '2024', 'revenue': 116.14, 'unit': 'M', 'net_profit': -79.4}, {'period': '2023', 'revenue': 142.95, 'unit': 'M', 'net_profit': -180.42}, {'period': '2022', 'revenue': 266.93, 'unit': 'M', 'net_profit': -277.7}, {'period': '2021', 'revenue': 246.57, 'unit': 'M', 'net_profit': -79.72}]","[{'period': ""Q4 '24"", 'revenue': 83.31, 'unit': 'M', 'net_profit': -12.54}, {'period': ""Q3 '24"", 'revenue': 12.86, 'unit': 'M', 'net_profit': -33.76}, {'period': ""Q2 '24"", 'revenue': 24.89, 'unit': 'M', 'net_profit': -16.65}, {'period': ""Q1 '24"", 'revenue': 28.32, 'unit': 'M', 'net_profit': -16.45}, {'period': ""Q4 '23"", 'revenue': 39.36, 'unit': 'M', 'net_profit': -9.64}, {'period': ""Q3 '23"", 'revenue': 33.28, 'unit': 'M', 'net_profit': -15.07}]",-1.04,-1.04,284704000,57504000,30904000,292643000,8842000,0,55844000,30904000,-21401000,0.5161197923015041,0.5599275016905186,0.5889328063241106,__nan__,__nan__,__nan__,1.0278851017196808
196,PLCE,Children's Place Inc. (The) Common Stock,"The Children's Place, Inc. operates as a children's specialty apparel retailer. The company operates in two segments, The Children's Place U.S. and The Children's Place International. It sells apparel, footwear, accessories, and other items for children; and designs, contracts to manufacture, and sells merchandise under the proprietary The Children's Place, Place, Baby Place, Gymboree, and Sugar & Jade brand names. As of January 29, 2022, the company had 672 stores in the United States, Canada, and Puerto Rico; online stores at childrensplace.com, gymboree.com, and sugarandjade.com; and seven international franchise partners operated 211 international points of distribution in 16 countries. The company was formerly known as The Children's Place Retail Stores, Inc. and changed its name to The Children's Place, Inc. in June 2014. The Children's Place, Inc. was founded in 1969 and is headquartered in Secaucus, New Jersey.",Mr. Muhammad  Umair,Apparel - Retail,6.99,USD,89367150,https://images.financialmodelingprep.com/symbol/PLCE.png,367267,-0.49,0.93,666935,-36525000,-154541000,"[{'period': '2023', 'revenue': 1600.0, 'unit': 'M', 'net_profit': -154.54}, {'period': '2022', 'revenue': 1710.0, 'unit': 'M', 'net_profit': -1.14}, {'period': '2021', 'revenue': 1920.0, 'unit': 'M', 'net_profit': 187.17}, {'period': '2020', 'revenue': 1520.0, 'unit': 'M', 'net_profit': -140.37}]","[{'period': ""Q3 '24"", 'revenue': 390.17, 'unit': 'M', 'net_profit': 20.08}, {'period': ""Q2 '24"", 'revenue': 319.65, 'unit': 'M', 'net_profit': -32.11}, {'period': ""Q1 '24"", 'revenue': 267.88, 'unit': 'M', 'net_profit': -37.8}, {'period': ""Q4 '23"", 'revenue': 455.03, 'unit': 'M', 'net_profit': -128.84}, {'period': ""Q3 '23"", 'revenue': 480.23, 'unit': 'M', 'net_profit': 38.48}, {'period': ""Q2 '23"", 'revenue': 345.6, 'unit': 'M', 'net_profit': -35.35}]",-12.36,-12.36,800308000,452126000,13639000,809327000,33219000,0,616404000,13639000,65241000,-1.2628416401606195,-134.80052724077328,-140.58075601374568,"[0.56, 0.1325]","['2019-12-13', '2014-03-25']",__nan__,1.0112694112766585
197,PLIN,China Xiangtai Food Co. Ltd. Ordinary Shares,"China Xiangtai Food Co., Ltd. engages in the wholesale and retail of feed raw material in China. It distributes feed raw materials consisting of soybean meal and soybean oil. The company sells its products to animal husbandry businesses, feed solution manufacturers, and trading companies. China Xiangtai Food Co., Ltd. was incorporated in 2018 and is headquartered in Chongqing, China.",Ms. Zeshu Dai,Packaged Foods,1.15,USD,115624450,https://images.financialmodelingprep.com/symbol/PLIN.png,457111,-0.8345428156748912,0.02999997,290617,-46311212,-45609519,"[{'period': '2021', 'revenue': 80.5, 'unit': 'M', 'net_profit': -45.61}, {'period': '2020', 'revenue': 110.55, 'unit': 'M', 'net_profit': -4.88}, {'period': '2019', 'revenue': 102.55, 'unit': 'M', 'net_profit': 4.36}, {'period': '2018', 'revenue': 101.1, 'unit': 'M', 'net_profit': 3.77}]","[{'period': ""Q2 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '19"", 'revenue': 25610.0, 'unit': 'K', 'net_profit': -308.53}, {'period': ""Q2 '19"", 'revenue': 102.55, 'unit': 'M', 'net_profit': 4.36}, {'period': ""Q4 '18"", 'revenue': 54.91, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q2 '18"", 'revenue': 101.1, 'unit': 'M', 'net_profit': 3.77}]",-1.92,-1.92,40875828,32521714,7603,42495816,11142558,0,38697292,7603,-10543830,-18.308357786055154,-8.352073286908066,-7.727272727272727,__nan__,__nan__,__nan__,1.039631931125652
198,PLL,Piedmont Lithium Inc. Common Stock,"Piedmont Lithium Inc., an exploration stage company, engages in the exploration and development of resource projects in the United States. The company primarily holds a 100% interest in the Carolina Lithium Project that include an area of approximately 3,116 acres located within the Carolina Tin-Spodumene Belt situated to the west of Charlotte, North Carolina in the United States. It also owns a 61-acre property in Kings Mountain, North Carolina. Piedmont Lithium Inc. is headquartered in Belmont, North Carolina.","Mr. Keith Douglas Phillips B.Com., H.B.Com, MBA",Industrial Materials,5.91,USD,129686085,https://images.financialmodelingprep.com/symbol/PLL.png,280509,-1.79,0.57,407746,-9558753,-12974674,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.97}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.99}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.82}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.9}]","[{'period': ""Q3 '23"", 'revenue': 47.13, 'unit': 'M', 'net_profit': 22.89}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.64}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.64}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.9}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.66}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.58}]",-0.74,-0.74,287921083,101858804,99730799,17632422,2128005,95647802,13411165,99246963,-52180434,0.517209996652859,0.35106668811326364,0.5,"[0.305, 0.15]","['2015-04-22', '2009-08-04']",__nan__,0.061240468451558304
199,PLMI,Plum Acquisition Corp. I Class A Ordinary Share,"Plum Acquisition Corp. I does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in San Francisco, California.",Mr. Kanishka B. Roy,Shell Companies,9,USD,100951200,https://images.financialmodelingprep.com/symbol/PLMI.png,1091,-50,-2.98,8522,3063558,-34727,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': -34.73}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.23}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.59}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.23}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.21}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.01}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.61}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.27}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -573.74}]",-0.0019,-0.0019,35701532,145556,94703,9379298,0,35555976,7736027,94703,-1062642,1.751897255988987,-1.0013763794858221,-1.0070370370370372,__nan__,__nan__,__nan__,0.2627141602774917
200,PLMIU,Plum Acquisition Corp. I Units,"Plum Acquisition Corp. I does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in San Francisco, California.",Mr. Kanishka B. Roy,Shell Companies,10.89,USD,100951193,https://images.financialmodelingprep.com/symbol/PLMIU.png,735,45.949367088607595,1.38,2499,3063558,-34727,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': -34.73}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.23}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.59}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.23}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.21}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.01}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.61}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.27}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -573.74}]",-0.0019,-0.0019,35701532,145556,94703,9379298,0,35555976,7736027,94703,-1062642,1.751897255988987,-1.0013763794858221,-1.0070370370370372,__nan__,__nan__,__nan__,0.2627141602774917
201,PLMIW,Plum Acquisition Corp. I Warrant,"Plum Acquisition Corp. I is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination. The company was founded on January 11, 2021 and is headquartered in San Francisco, CA.",Mr. Kanishka B. Roy,Shell Companies,0.184,USD,100951200,https://images.financialmodelingprep.com/symbol/PLMIW.png,0,0,0.0841,47258,3063558,-34727,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': -34.73}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.23}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.59}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.23}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.21}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.01}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.61}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.27}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -573.74}]",-0.0019,-0.0019,35701532,145556,94703,9379298,0,35555976,7736027,94703,-1062642,1.751897255988987,-1.0013763794858221,-1.0070370370370372,__nan__,__nan__,__nan__,0.2627141602774917
202,PLMR,Palomar Holdings Inc. Common stock,"Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance, commercial flood, real estate error and omission, and real estate investor products. It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.",Mr. D. McDonald Armstrong,Insurance - Property & Casualty,143.13,USD,3818364888,https://images.financialmodelingprep.com/symbol/PLMR.png,235490,31.95,12.07,477906,157440000,117573000,"[{'period': '2024', 'revenue': 553.86, 'unit': 'M', 'net_profit': 117.57}, {'period': '2023', 'revenue': 375.93, 'unit': 'M', 'net_profit': 79.2}, {'period': '2022', 'revenue': 327.09, 'unit': 'M', 'net_profit': 52.17}, {'period': '2021', 'revenue': 247.79, 'unit': 'M', 'net_profit': 45.85}]","[{'period': ""Q4 '24"", 'revenue': 155.64, 'unit': 'M', 'net_profit': 34.97}, {'period': ""Q3 '24"", 'revenue': 148.5, 'unit': 'M', 'net_profit': 30.5}, {'period': ""Q2 '24"", 'revenue': 131.4, 'unit': 'M', 'net_profit': 25.73}, {'period': ""Q1 '24"", 'revenue': 118.53, 'unit': 'M', 'net_profit': 26.38}, {'period': ""Q4 '23"", 'revenue': 105.39, 'unit': 'M', 'net_profit': 25.9}, {'period': ""Q3 '23"", 'revenue': 90.94, 'unit': 'M', 'net_profit': 18.43}]",4.61,4.48,829766000,149264000,149264000,1533190000,0,4459000,260247000,1797000,260914000,0.40671908506075766,0.4844888322117145,0.4451410658307211,__nan__,__nan__,__nan__,1.8477377959569323
203,PLPC,Preformed Line Products Company Common Stock,"Preformed Line Products Company, together with its subsidiaries, designs and manufactures products and systems that are used in the construction and maintenance of overhead, ground-mounted, and underground networks for the energy, telecommunication, cable operator, information, and other industries. The company offers formed wire products to support, protect, terminate, and secure power conductor and communication cables, as well as to control cable dynamics; and hardware products to support and protect transmission conductors, spacers, spacer-dampers, stockbridge dampers, corona suppression devices, and various compression fittings for dead-end applications. It also provides protective closures to protect fixed line communication networks, such as copper cable or fiber optic cable from moisture, environmental hazards, and other contaminants; and hardware assemblies, pole line hardware, resale products, underground connectors, solar hardware systems, guy markers, tree guards, fiber optic cable markers, pedestal markers, and urethane products that are used by energy, renewable energy, communications, cable, and special industries for various applications. The company serves public and private energy utilities and communication companies, cable operators, financial institutions, governmental agencies, contractors and subcontractors, distributors, and value-added resellers in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It markets its products through a direct sales force, as well as through manufacturing representatives. The company was incorporated in 1947 and is headquartered in Mayfield, Ohio.",Mr. Dennis F. McKenna,Electrical Equipment & Parts,142.41,USD,703646386,https://images.financialmodelingprep.com/symbol/PLPC.png,30549,18.99,11.67,37733,73821000,37094000,"[{'period': '2024', 'revenue': 593.71, 'unit': 'M', 'net_profit': 37.09}, {'period': '2023', 'revenue': 669.68, 'unit': 'M', 'net_profit': 63.33}, {'period': '2022', 'revenue': 637.02, 'unit': 'M', 'net_profit': 54.4}, {'period': '2021', 'revenue': 517.42, 'unit': 'M', 'net_profit': 35.73}]","[{'period': ""Q4 '24"", 'revenue': 167.12, 'unit': 'M', 'net_profit': 10.45}, {'period': ""Q3 '24"", 'revenue': 146.97, 'unit': 'M', 'net_profit': 7.68}, {'period': ""Q2 '24"", 'revenue': 138.72, 'unit': 'M', 'net_profit': 9.37}, {'period': ""Q1 '24"", 'revenue': 140.9, 'unit': 'M', 'net_profit': 9.6}, {'period': ""Q4 '23"", 'revenue': 145.6, 'unit': 'M', 'net_profit': 6.33}, {'period': ""Q3 '23"", 'revenue': 160.44, 'unit': 'M', 'net_profit': 15.13}]",7.56,7.5,573877000,315793000,57244000,151553000,111402000,0,108413000,57244000,52829000,-0.29803257799796506,-0.4142929324827891,-0.4125874125874126,"[0.2, 0.15]","['2025-04-01', '2000-12-29']",__nan__,0.26408620662615856
204,PLRX,Pliant Therapeutics Inc. Common Stock,"Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.","Dr. Bernard  Coulie M.B.A., M.D., Ph.D.",Biotechnology,1.31,USD,80219553,https://images.financialmodelingprep.com/symbol/PLRX.png,2745185,-0.38,0.085,1561025,-228365000,-210304000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -210.3}, {'period': '2023', 'revenue': 1.58, 'unit': 'M', 'net_profit': -161.34}, {'period': '2022', 'revenue': 9.69, 'unit': 'M', 'net_profit': -121.5}, {'period': '2021', 'revenue': 7.57, 'unit': 'M', 'net_profit': -17.91}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -49.73}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.76}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.85}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -46.95}, {'period': ""Q4 '23"", 'revenue': 4.84, 'unit': 'M', 'net_profit': -41.11}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.49}]",-3.47,-3.47,396949000,362264000,355724000,92868000,0,0,33218000,71188000,-159351000,-0.4432654144652021,-0.30351564436951456,-0.2618181818181819,__nan__,__nan__,__nan__,0.23395448785612258
205,PLSE,Pulse Biosciences Inc Common Stock (DE),"Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.",Mr. Paul Arthur LaViolette,Medical - Instruments & Supplies,15.57,USD,1047453066,https://images.financialmodelingprep.com/symbol/PLSE.png,184552,-16.92,1.09,183260,-56257000,-53585000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -53.59}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.21}, {'period': '2022', 'revenue': 0.7000000000000001, 'unit': 'M', 'net_profit': -58.95}, {'period': '2021', 'revenue': 1.42, 'unit': 'M', 'net_profit': -63.16}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.39}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.68}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.38}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.14}, {'period': ""Q4 '23"", 'revenue': 1.74, 'unit': 'M', 'net_profit': -11.93}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.57}]",-0.92,-0.92,132460000,119449000,118038000,17598000,0,0,10055000,118038000,-36468000,-0.327849505511365,-0.269485903814262,-0.0454545454545455,__nan__,__nan__,__nan__,0.13285520157028538
206,PLTK,Playtika Holding Corp. Common Stock,"Playtika Holding Corp. develops mobile games in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company owns a portfolio of casual and casino-themed games. It distributes its games to the end customer through various web and mobile platforms, such as Apple, Facebook, Google, and other web and mobile platforms and its own proprietary platforms. The company was founded in 2010 and is headquartered in Herzliya Pituarch, Israel. Playtika Holding Corp. is a subsidiary of Playtika Holding Uk Ii Limited.",Mr. Robert  Antokol,Electronic Gaming & Multimedia,4.94,USD,1854085740,https://images.financialmodelingprep.com/symbol/PLTK.png,1883314,11.23,0.4,1885069,601400000,162200000,"[{'period': '2024', 'revenue': 2550.0, 'unit': 'M', 'net_profit': 162.2}, {'period': '2023', 'revenue': 2570.0, 'unit': 'M', 'net_profit': 235.0}, {'period': '2022', 'revenue': 2620.0, 'unit': 'M', 'net_profit': 275.3}, {'period': '2021', 'revenue': 2580.0, 'unit': 'M', 'net_profit': 308.5}]","[{'period': ""Q4 '24"", 'revenue': 650.3, 'unit': 'M', 'net_profit': -16.7}, {'period': ""Q3 '24"", 'revenue': 620.8, 'unit': 'M', 'net_profit': 39.3}, {'period': ""Q2 '24"", 'revenue': 627.0, 'unit': 'M', 'net_profit': 86.6}, {'period': ""Q1 '24"", 'revenue': 651.2, 'unit': 'M', 'net_profit': 53.0}, {'period': ""Q4 '23"", 'revenue': 637.9, 'unit': 'M', 'net_profit': 37.3}, {'period': ""Q3 '23"", 'revenue': 630.1, 'unit': 'M', 'net_profit': 37.9}]",0.44,0.44,3639200000,872800000,565800000,3770300000,187600000,20600000,558900000,565800000,449200000,-0.14525298465036954,-0.3097872340425532,-0.3125,"[0.1, 0.1]","['2025-03-21', '2024-03-21']",__nan__,1.0360244009672455
207,PLUG,Plug Power Inc. Common Stock,"Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including green hydrogen production, storage and delivery, and energy generation through mobile or stationary applications. The company provides proton exchange membrane (PEM), fuel cell and fuel processing technologies, and fuel cell/battery hybrid technologies, as well as related hydrogen and green hydrogen generation, storage, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled PEM fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; and GenFuel Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. It has strategic agreements with Airbus; Lhyfe; Edison Motors; Phillips 66; Apex Clean Energy; BAE Systems; and Universal Hydrogen Co. The company was founded in 1997 and is headquartered in Latham, New York.",Mr. Andrew J. Marsh,Electrical Equipment & Parts,1.21,USD,1175730380,https://images.financialmodelingprep.com/symbol/PLUG.png,61625673,-0.45,0.09,43650531,-1976413000,-2104701000,"[{'period': '2024', 'revenue': 0.62881, 'unit': 'B', 'net_profit': -2.1}, {'period': '2023', 'revenue': 0.89134, 'unit': 'B', 'net_profit': -1.37}, {'period': '2022', 'revenue': 701.44, 'unit': 'M', 'net_profit': -724.01}, {'period': '2021', 'revenue': 502.34, 'unit': 'M', 'net_profit': -459.96}]","[{'period': ""Q4 '24"", 'revenue': 0.19147, 'unit': 'B', 'net_profit': -1.34}, {'period': ""Q3 '24"", 'revenue': 173.73, 'unit': 'M', 'net_profit': -211.17}, {'period': ""Q2 '24"", 'revenue': 143.35, 'unit': 'M', 'net_profit': -262.33}, {'period': ""Q1 '24"", 'revenue': 120.26, 'unit': 'M', 'net_profit': -295.78}, {'period': ""Q4 '23"", 'revenue': 222.16, 'unit': 'M', 'net_profit': -642.39}, {'period': ""Q3 '23"", 'revenue': 198.71, 'unit': 'M', 'net_profit': -283.48}]",-2.45,-2.45,3602846000,1477484000,205693000,1795090000,251296000,85494000,748489000,205693000,-1062891000,-0.5686900603454366,-0.5375878576860728,-0.06521739130434799,__nan__,__nan__,__nan__,0.49824222295374265
208,PLUS,ePlus inc. Common Stock,"ePlus inc., together with its subsidiaries, provides information technology (IT) solutions that enable organizations to optimize their IT environment and supply chain processes in the United States and internationally. It operates in two segments, Technology and Financing. The Technology segment offers hardware, perpetual and subscription software, maintenance, software assurance, and internally provided and outsourced services; and professional and managed services, including managed, professional, security solutions, cloud consulting and hosting, staff augmentation, server and desktop support, and project management services. The Financing segment engages in financing arrangements, such as sales-type and operating leases; loans and consumption-based financing arrangements; and underwriting, management, and disposal of IT equipment and assets. Its financing operations comprise sales, pricing, credit, contracts, accounting, risk management, and asset management. This segment primarily finances IT, communication-related, and medical equipment; and industrial machinery and equipment, office furniture and general office equipment, transportation equipment, and other general business equipment directly, as well as through vendors. ePlus inc. serves commercial entities, state and local governments, government contractors, and educational institutions. The company was formerly known as MLC Holdings, Inc. and changed its name to ePlus inc. in 1999. ePlus inc. was founded in 1990 and is headquartered in Herndon, Virginia.",Mr. Mark P. Marron,Software - Application,59.41,USD,1581280324,https://images.financialmodelingprep.com/symbol/PLUS.png,243988,15.19,4.64,344760,190798000,115776000,"[{'period': '2024', 'revenue': 2230.0, 'unit': 'M', 'net_profit': 115.78}, {'period': '2023', 'revenue': 2070.0, 'unit': 'M', 'net_profit': 119.36}, {'period': '2022', 'revenue': 1820.0, 'unit': 'M', 'net_profit': 105.6}, {'period': '2021', 'revenue': 1570.0, 'unit': 'M', 'net_profit': 74.4}]","[{'period': ""Q3 '25"", 'revenue': 510.96, 'unit': 'M', 'net_profit': 24.13}, {'period': ""Q2 '25"", 'revenue': 147.99, 'unit': 'M', 'net_profit': 31.31}, {'period': ""Q1 '25"", 'revenue': 543.24, 'unit': 'M', 'net_profit': 27.34}, {'period': ""Q4 '24"", 'revenue': 551.76, 'unit': 'M', 'net_profit': 21.98}, {'period': ""Q3 '24"", 'revenue': 509.06, 'unit': 'M', 'net_profit': 27.28}, {'period': ""Q2 '24"", 'revenue': 587.61, 'unit': 'M', 'net_profit': 32.66}]",4.35,4.33,1653469000,1273529000,253021000,751690000,794100000,0,656990000,253021000,239946000,0.027475012924349475,-0.029994302758135326,-0.031180400890868723,"[2.5, 2.5]","['2012-12-13', '2012-12-13']",__nan__,0.45461390567346593
209,PLXP,PLx Pharma Inc. Common Stock,"PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.",Ms. Natasha  Giordano,Drug Manufacturers - Specialty & Generic,0.087,USD,2534980,https://images.financialmodelingprep.com/symbol/PLXP.png,4856519,-0.2230769230769231,0,50382179,-35241000,-51460000,"[{'period': '2021', 'revenue': 8.21, 'unit': 'M', 'net_profit': -51.46}, {'period': '2020', 'revenue': 0.03043, 'unit': 'M', 'net_profit': -15.1}, {'period': '2019', 'revenue': 0.5654600000000001, 'unit': 'M', 'net_profit': -21.34}, {'period': '2018', 'revenue': 753.11, 'unit': 'K', 'net_profit': 896.48}]","[{'period': ""Q3 '22"", 'revenue': 0.386, 'unit': 'M', 'net_profit': -6.16}, {'period': ""Q2 '22"", 'revenue': 0.483, 'unit': 'M', 'net_profit': -9.18}, {'period': ""Q1 '22"", 'revenue': 2.08, 'unit': 'M', 'net_profit': -3.37}, {'period': ""Q4 '21"", 'revenue': 1.59, 'unit': 'M', 'net_profit': 3.56}, {'period': ""Q3 '21"", 'revenue': 6.62, 'unit': 'M', 'net_profit': -21.64}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.5}]",-2.18,-2.18,76642000,73476000,69392000,24962000,634000,0,11879000,69392000,-32118000,-1.6183748229452284,-2.407272334815821,-0.40645161290322585,__nan__,__nan__,__nan__,0.3256960935257431
210,PLXS,Plexus Corp. Common Stock,"Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors. Plexus Corp. was founded in 1979 and is headquartered in Neenah, Wisconsin.",Mr. Todd P. Kelsey,"Hardware, Equipment & Parts",124.45,USD,3365152890,https://images.financialmodelingprep.com/symbol/PLXS.png,203731,28.87,13.5,304867,167732000,111815000,"[{'period': '2024', 'revenue': 3960.0, 'unit': 'M', 'net_profit': 111.81}, {'period': '2023', 'revenue': 4210.0, 'unit': 'M', 'net_profit': 139.09}, {'period': '2022', 'revenue': 3810.0, 'unit': 'M', 'net_profit': 138.24}, {'period': '2021', 'revenue': 3370.0, 'unit': 'M', 'net_profit': 138.91}]","[{'period': ""Q1 '25"", 'revenue': 976.12, 'unit': 'M', 'net_profit': 37.27}, {'period': ""Q4 '24"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': 41.22}, {'period': ""Q3 '24"", 'revenue': 960.75, 'unit': 'M', 'net_profit': 25.14}, {'period': ""Q2 '24"", 'revenue': 966.9, 'unit': 'M', 'net_profit': 16.24}, {'period': ""Q1 '24"", 'revenue': 982.61, 'unit': 'M', 'net_profit': 29.21}, {'period': ""Q4 '23"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 40.26}]",4.08,4.01,3153821000,2477150000,345109000,1828996000,742926000,0,1643294000,345109000,341320000,-0.4186972569269958,-0.19611917120796007,-0.19047619047619047,__nan__,__nan__,__nan__,0.5799301862724613
211,PLYA,Playa Hotels & Resorts N.V. Ordinary Shares,"Playa Hotels & Resorts N.V., together with its subsidiaries, owns, develops, and operates resorts in prime beachfront locations in Mexico and the Caribbean. As of December 31, 2021, it owned a portfolio of 22 resorts with 8,366 rooms located in Mexico, Jamaica, and the Dominican Republic. The company was founded in 2006 and is headquartered in Fairfax, Virginia.",Mr. Bruce D. Wardinski,"Gambling, Resorts & Casinos",13.34,USD,1705225520,https://images.financialmodelingprep.com/symbol/PLYA.png,4864752,23.82,0.03,6437759,249710000,73813000,"[{'period': '2024', 'revenue': 938.57, 'unit': 'M', 'net_profit': 73.81}, {'period': '2023', 'revenue': 977.5, 'unit': 'M', 'net_profit': 53.85}, {'period': '2022', 'revenue': 856.26, 'unit': 'M', 'net_profit': 56.71}, {'period': '2021', 'revenue': 534.64, 'unit': 'M', 'net_profit': -89.68}]","[{'period': ""Q4 '24"", 'revenue': 218.94, 'unit': 'M', 'net_profit': 9.04}, {'period': ""Q3 '24"", 'revenue': 183.52, 'unit': 'M', 'net_profit': -12.7}, {'period': ""Q2 '24"", 'revenue': 236.23, 'unit': 'M', 'net_profit': 13.17}, {'period': ""Q1 '24"", 'revenue': 300.4, 'unit': 'M', 'net_profit': 54.34}, {'period': ""Q4 '23"", 'revenue': 242.52, 'unit': 'M', 'net_profit': 1.0}, {'period': ""Q3 '23"", 'revenue': 213.15, 'unit': 'M', 'net_profit': -10.5}]",0.57,0.56,1823088000,273461000,189278000,1341198000,66957000,0,176630000,189278000,16248000,-0.022955899787539567,0.3706640421897051,0.5833333333333333,__nan__,__nan__,__nan__,0.7356737579315974
212,PMBC,Pacific Mercantile Bancorp Common Stock,"Pacific Mercantile Bancorp is a holding company of Pacific Mercantile Bank, which engages in the provision of banking services. The company is headquartered in Costa Mesa, California and currently employs 160 full-time employees. The firm's business operations are conducted by the Bank. The company operates through commercial banking segment. The Bank offers its customers different loan products, including commercial loans and credit lines, accounts receivable and inventory financing, Small Business Administration (SBA) guaranteed business loans, and owner-occupied commercial real estate loans. Its investments primarily include securities available for sale, which consist of residential mortgage backed securities issued by the United States agencies; residential collateralized mortgage obligations issued by non agencies; asset backed security and mutual funds. Its sources of funds include deposits, and borrowings and contractual obligations. Its deposits consist of noninterest bearing demand deposits, interest-bearing checking accounts, money market and savings deposits, and time deposits.",Mr. Bradford Dinsmore,Banks - Regional,9.4,USD,0,https://images.financialmodelingprep.com/symbol/PMBC.png,47064,15.905245346869712,-0.110001,149544,21411000,8334000,"[{'period': '2020', 'revenue': 57.73, 'unit': 'M', 'net_profit': 8.33}, {'period': '2019', 'revenue': 54.51, 'unit': 'M', 'net_profit': 5.68}, {'period': '2018', 'revenue': 52.79, 'unit': 'M', 'net_profit': 27.34}, {'period': '2017', 'revenue': 47.66, 'unit': 'M', 'net_profit': 10.45}]","[{'period': ""Q2 '21"", 'revenue': 14.55, 'unit': 'M', 'net_profit': 3.89}, {'period': ""Q1 '21"", 'revenue': 14.32, 'unit': 'M', 'net_profit': 3.39}, {'period': ""Q4 '20"", 'revenue': 14.54, 'unit': 'M', 'net_profit': 3.7}, {'period': ""Q3 '20"", 'revenue': 16.41, 'unit': 'M', 'net_profit': 5.09}, {'period': ""Q2 '20"", 'revenue': 14.34, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q1 '20"", 'revenue': 12.44, 'unit': 'M', 'net_profit': -2.36}]",0.35,0.35,286658000,286269000,330049000,1428841000,5666000,42183000,10188000,287866000,9877000,-0.12087866967768425,0.46725352112676055,0.4583333333333333,"[0.1, 0.1]","['2008-02-27', '2008-02-27']",__nan__,4.984479763341683
213,PMD,Psychemedics Corporation,"Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.",Mr. Brian  Hullinger,Medical - Diagnostics & Research,2.67,USD,15738208,https://images.financialmodelingprep.com/symbol/PMD.png,42860,-5.235294117647059,0,112269,-251000,-4154000,"[{'period': '2023', 'revenue': 22.1, 'unit': 'M', 'net_profit': -4.15}, {'period': '2022', 'revenue': 25.24, 'unit': 'M', 'net_profit': -1.08}, {'period': '2021', 'revenue': 24910.0, 'unit': 'K', 'net_profit': -665.0}, {'period': '2020', 'revenue': 21.36, 'unit': 'M', 'net_profit': -3.86}]","[{'period': ""Q3 '24"", 'revenue': 5170.0, 'unit': 'K', 'net_profit': -535.0}, {'period': ""Q2 '24"", 'revenue': 4730.0, 'unit': 'K', 'net_profit': -827.0}, {'period': ""Q1 '24"", 'revenue': 5360.0, 'unit': 'K', 'net_profit': -688.0}, {'period': ""Q4 '23"", 'revenue': 5000.0, 'unit': 'K', 'net_profit': -945.0}, {'period': ""Q3 '23"", 'revenue': 5.7, 'unit': 'M', 'net_profit': -2.1}, {'period': ""Q2 '23"", 'revenue': 5540.0, 'unit': 'K', 'net_profit': -726.0}]",-0.72,-0.72,12326000,6805000,1964000,5654000,3705000,0,4709000,1964000,-1637000,-1.1124048365427677,-2.8321033210332103,-2.7894736842105265,"[0.07, 0.02]","['2023-05-24', '1997-01-13']",__nan__,0.4587051760506247
214,PME,Pingtan Marine Enterprise Ltd.,"Pingtan Marine Enterprise Ltd., together with its subsidiaries, engages in the ocean fishing business. The company catches a range of fish species, such as red fish, ribbon fish, sea catfish, seabream, shrimp, silver pomfret and seaperch, slender shad, sole fish, Spanish mackerel, and threadfin. As of December 31, 2021, it owned 51 squid jigging vessels, 26 trawlers, 25 seine vessels, 13 drifters, four longline fishing vessels, and 3 transport vessels, as well as had operating license rights to 20 drifters. The company serves various customers, including distributors, restaurant owners, and exporters in the People's Republic of China. Pingtan Marine Enterprise Ltd. is based in Fuzhou, the People's Republic of China.",Mr. Xinrong  Zhuo,Agricultural Farm Products,0.27,USD,23204070,https://images.financialmodelingprep.com/symbol/PME.png,265,13.5,-0.02,2350,35574250,-2385299,"[{'period': '2021', 'revenue': 164.08, 'unit': 'M', 'net_profit': -2.39}, {'period': '2020', 'revenue': 87.24, 'unit': 'M', 'net_profit': -86.12}, {'period': '2019', 'revenue': 89.62, 'unit': 'M', 'net_profit': 1.07}, {'period': '2018', 'revenue': 64.26, 'unit': 'M', 'net_profit': 13.4}]","[{'period': ""Q4 '21"", 'revenue': 62.81, 'unit': 'M', 'net_profit': 6.67}, {'period': ""Q3 '21"", 'revenue': 36.1, 'unit': 'M', 'net_profit': -1.16}, {'period': ""Q2 '21"", 'revenue': 36.87, 'unit': 'M', 'net_profit': -3.64}, {'period': ""Q1 '21"", 'revenue': 28.31, 'unit': 'M', 'net_profit': -15.23}, {'period': ""Q4 '20"", 'revenue': 31.02, 'unit': 'M', 'net_profit': -83.41}, {'period': ""Q3 '20"", 'revenue': 15450.0, 'unit': 'K', 'net_profit': 689.18}]",-0.0281,-0.0281,576235498,240438276,5789508,484145619,140627548,32968520,243384265,5789508,-1398708,1.0319902265921073,0.9723025100383268,0.9742201834862385,"[0.01, 0.01]","['2018-07-30', '2014-10-02']",__nan__,0.8401870774715792
215,PMGM,Priveterra Acquisition Corp. Class A Common Stock,"Priveterra Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the medical technology sector. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.",Mr. Oleg  Grodnensky,Shell Companies,11.05,USD,60639405,https://images.financialmodelingprep.com/symbol/PMGM.png,0,52.61904761904762,-0.01,24807,-27727000,42005000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': 42.01}, {'period': '2023', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.56}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.64}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.17}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 164.11}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -118.02}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.38}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.64}]",5597.28,5250.96,3142000,1590000,13000,31711000,0,0,14149000,13000,-20292000,0,0,0,__nan__,__nan__,__nan__,10.092616168045831
216,PMGMU,Priveterra Acquisition Corp. Units,"Priveterra Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the medical technology sector. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.",Mr. Oleg  Grodnensky,Shell Companies,10.96,USD,54379848,https://images.financialmodelingprep.com/symbol/PMGMU.png,62,81.18518518518519,0.05,2500,-27727000,42005000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': 42.01}, {'period': '2023', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.56}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.64}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.17}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 164.11}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -118.02}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.38}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.64}]",5597.28,5250.96,3142000,1590000,13000,31711000,0,0,14149000,13000,-20292000,0,0,0,__nan__,__nan__,__nan__,10.092616168045831
217,PMGMW,Priveterra Acquisition Corp. Warrant,"Priveterra Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with other businesses. The company was incorporated in 2020 and is based in Fort Lauderdale, Florida.",Mr. Oleg  Grodnensky,Shell Companies,0.02,USD,185870,https://images.financialmodelingprep.com/symbol/PMGMW.png,0,0,-0.0001,40700,-27727000,42005000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': 42.01}, {'period': '2023', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.56}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.64}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.17}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 164.11}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -118.02}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.38}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.64}]",5597.28,5250.96,3142000,1590000,13000,31711000,0,0,14149000,13000,-20292000,0,0,0,__nan__,__nan__,__nan__,10.092616168045831
218,PMVP,PMV Pharmaceuticals Inc. Common Stock,"PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.",Dr. David H. Mack Ph.D.,Biotechnology,0.9442,USD,49035705,https://images.financialmodelingprep.com/symbol/PMVP.png,132304,-0.83,0.0442,319602,-85448000,-58709000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.71}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -68.96}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -73.32}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.85}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.0}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.27}, {'period': ""Q4 '23"", 'revenue': 1.62, 'unit': 'M', 'net_profit': -15.76}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.64}]",-1.14,-1.14,191288000,175658000,169454000,15208000,0,0,14370000,40876000,-51937000,-0.08333438985736925,0.1486513921113689,0.20833333333333337,__nan__,__nan__,__nan__,0.07950315754255363
219,PNBK,Patriot National Bancorp Inc. Common Stock,"Patriot National Bancorp, Inc. operates as the holding company for Patriot Bank, N.A. that provides community banking services to individuals, small and medium-sized businesses, and professionals. The company accepts consumer and commercial deposit accounts, such as checking, interest-bearing negotiable order of withdrawal, money market, savings, prepaid deposit, on-line national money market, individual retirement accounts, and health savings accounts, as well as certificate of deposit account registry service. Its loan portfolio comprises commercial real estate, commercial business, small business administration, construction, purchased residential real estate, and various consumer loans. The company also offers automated clearing house transfers, lockbox, Internet banking, bill payment, remote deposit capture, debit card, money order, traveler's check, and automatic teller machine services. It operated through a network of eight branch offices located in Fairfield and New Haven Counties, Connecticut; and one branch offices located in Westchester County, New York. The company was founded in 1994 and is headquartered in Stamford, Connecticut.",Mr. David Christopher Lowery,Banks - Regional,1.4,USD,5588590,https://images.financialmodelingprep.com/symbol/PNBK.png,1368911,-0.19,0.03,50338,-4279999,-4179000,"[{'period': '2023', 'revenue': 27.08, 'unit': 'M', 'net_profit': -4.18}, {'period': '2022', 'revenue': 36.63, 'unit': 'M', 'net_profit': 6.16}, {'period': '2021', 'revenue': 29.55, 'unit': 'M', 'net_profit': 5.09}, {'period': '2020', 'revenue': 25.96, 'unit': 'M', 'net_profit': -3.82}]","[{'period': ""Q3 '24"", 'revenue': 7.06, 'unit': 'M', 'net_profit': -26.95}, {'period': ""Q2 '24"", 'revenue': 3.99, 'unit': 'M', 'net_profit': -3.08}, {'period': ""Q1 '24"", 'revenue': 16250.0, 'unit': 'K', 'net_profit': -299.0}, {'period': ""Q4 '23"", 'revenue': 18100.0, 'unit': 'K', 'net_profit': 905.0}, {'period': ""Q3 '23"", 'revenue': 15.07, 'unit': 'M', 'net_profit': -3.77}, {'period': ""Q2 '23"", 'revenue': 8440.0, 'unit': 'K', 'net_profit': -546.0}]",-1.05,-1.05,1093425000,52517000,52517000,1049042000,0,93637000,4523000,52517000,-11127000,-1.4638559661861927,-1.6782989774387276,-1.6730769230769231,"[0.01, 0.02]","['2019-12-06', '2001-06-29']",__nan__,0.9594091958753458
220,PNFP,Pinnacle Financial Partners Inc. Common Stock,"Pinnacle Financial Partners, Inc., together with its subsidiaries, operates as the bank holding company for Pinnacle Bank that provides various banking products and services in the United States. The company accepts various deposits, including savings, checking, noninterest-bearing and interest-bearing checking, money market, and certificate of deposit accounts. Its loan products include commercial loans, such as equipment and working capital loans; commercial real estate loans comprising investment properties and business loans secured by real estate; and loans to individuals consisting of secured and unsecured installment and term loans, lines of credit, residential first mortgage loans, and home equity loans and lines of credit, as well as provides credit cards for consumers and businesses. The company also offers various securities and other financial products; investment products; brokerage and investment advisory programs; and fiduciary and investment management services, such as personal trust, endowments, foundations, individual retirement accounts, pensions, and custody. In addition, it provides insurance agency services primarily in the property and casualty area; merger and acquisition advisory services; and private debt, equity and mezzanine, and other middle-market advisory services. Further, the company offers treasury management, telephone and online banking, mobile banking, debit cards, direct deposit and remote deposit capture, mobile deposit option, automated teller machine, and cash management services. It serves individuals, small to medium-sized businesses, and professional entities. As of December 31, 2020, the company operated 114 offices, including 48 in Tennessee, 36 in North Carolina, 20 in South Carolina, 9 in Virginia, and 1 in Georgia. Pinnacle Financial Partners, Inc. was incorporated in 2000 and is headquartered in Nashville, Tennessee.",Mr. Michael Terry Turner,Banks - Regional,96.34,USD,7453507878,https://images.financialmodelingprep.com/symbol/PNFP.png,549960,16.16,9.11,1062056,0,475056000,"[{'period': '2024', 'revenue': 2700.0, 'unit': 'M', 'net_profit': 475.06}, {'period': '2023', 'revenue': 1600.0, 'unit': 'M', 'net_profit': 562.15}, {'period': '2022', 'revenue': 1400.0, 'unit': 'M', 'net_profit': 560.74}, {'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': 527.32}]","[{'period': ""Q4 '24"", 'revenue': 684.36, 'unit': 'M', 'net_profit': 151.26}, {'period': ""Q3 '24"", 'revenue': 414.1, 'unit': 'M', 'net_profit': 146.69}, {'period': ""Q2 '24"", 'revenue': 683.66, 'unit': 'M', 'net_profit': 53.16}, {'period': ""Q1 '24"", 'revenue': 744.59, 'unit': 'M', 'net_profit': 123.94}, {'period': ""Q4 '23"", 'revenue': 709.23, 'unit': 'M', 'net_profit': 94.98}, {'period': ""Q3 '23"", 'revenue': 382.99, 'unit': 'M', 'net_profit': 132.6}]",6.01,5.96,52589449000,6116769000,5902689000,46157568000,214080000,0,55619000,320320000,904306000,0,-0.1549331853306579,-0.16527777777777783,"[0.24, 0.08]","['2025-02-07', '2013-11-22']",__nan__,0.8776963607281757
221,PNFPP,Pinnacle Financial Partners Inc. Depositary shares of Pinnacle Financial Partners Inc. each representing a 1/40th Interest in a share of its 6.75% Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series B,"Pinnacle Financial Partners, Inc., together with its subsidiaries, operates as the bank holding company for Pinnacle Bank that provides various banking products and services in the United States. The company accepts various deposits, including savings, checking, noninterest-bearing and interest-bearing checking, money market, and certificate of deposit accounts. Its loan products include commercial loans, such as equipment and working capital loans; commercial real estate loans comprising investment properties and business loans secured by real estate; and loans to individuals consisting of secured and unsecured installment and term loans, lines of credit, residential first mortgage loans, and home equity loans and lines of credit, as well as provides credit cards for consumers and businesses. The company also offers various securities and other financial products; investment products; brokerage and investment advisory programs; and fiduciary and investment management services, such as personal trust, endowments, foundations, individual retirement accounts, pensions, and custody. In addition, it provides insurance agency services primarily in the property and casualty area; merger and acquisition advisory services; and private debt, equity and mezzanine, and other middle-market advisory services. Further, the company offers treasury management, telephone and online banking, mobile banking, debit cards, direct deposit and remote deposit capture, mobile deposit option, automated teller machine, and cash management services. It serves individuals, small to medium-sized businesses, and professional entities. As of December 31, 2020, the company operated 114 offices, including 48 in Tennessee, 36 in North Carolina, 20 in South Carolina, 9 in Virginia, and 1 in Georgia. Pinnacle Financial Partners, Inc. was incorporated in 2000 and is headquartered in Nashville, Tennessee.",Mr. Michael Terry Turner,Banks - Regional,23.83,USD,1843648461,https://images.financialmodelingprep.com/symbol/PNFPP.png,13375,3.51,-0.1,19391,0,475056000,"[{'period': '2024', 'revenue': 2700.0, 'unit': 'M', 'net_profit': 475.06}, {'period': '2023', 'revenue': 1600.0, 'unit': 'M', 'net_profit': 562.15}, {'period': '2022', 'revenue': 1400.0, 'unit': 'M', 'net_profit': 560.74}, {'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': 527.32}]","[{'period': ""Q4 '24"", 'revenue': 684.36, 'unit': 'M', 'net_profit': 151.26}, {'period': ""Q3 '24"", 'revenue': 414.1, 'unit': 'M', 'net_profit': 146.69}, {'period': ""Q2 '24"", 'revenue': 683.66, 'unit': 'M', 'net_profit': 53.16}, {'period': ""Q1 '24"", 'revenue': 744.59, 'unit': 'M', 'net_profit': 123.94}, {'period': ""Q4 '23"", 'revenue': 709.23, 'unit': 'M', 'net_profit': 94.98}, {'period': ""Q3 '23"", 'revenue': 382.99, 'unit': 'M', 'net_profit': 132.6}]",6.01,5.96,52589449000,6116769000,5902689000,46157568000,214080000,0,55619000,320320000,904306000,0,-0.1549331853306579,-0.16527777777777783,"[0.422, 0.422]","['2025-02-14', '2020-08-14']",__nan__,0.8776963607281757
222,PNNT,PennantPark Investment Corporation Common Stock,"PennantPark Investment Corporation, a business development company is a private equity fund specializes in direct and mezzanine investments in middle market companies. It invests in the form of mezzanine debt, senior secured loans, and equity investments. The fund typically invests in buildings and real estate, hotels, gaming and leisure, technology, telecommunications, transportation, information technology services, electronics, healthcare & pharmaceuticals, education and childcare, financial services, printing and publishing, consumer products, business services, energy & Related Services and utilities, distribution, oil and gas, media, environmental services, aerospace and defense, building materials, capital equipment, chemicals, plastics, & rubber, food & beverage, wholesale, manufacturing and basic industries and retail. It invests in equity securities and debt transactions through preferred stock, common stock, warrants, options, senior secured debt, subordinated debt, subordinated loans, first lien debt, mezzanine loans, and distressed debt securities and private equity co-investments. It seeks to invest in companies based in the United States. The fund seeks to invest between $10 million and $100 million cross the capital structure (senior secured loans, subordinated debt, and other investments) in its portfolio companies with EBITDA between $10 to $50 million. Its mezzanine loans, senior secured loans, and other investments in its portfolio companies are between $15 million and $50 million. The fund may also make non-control equity and debt investments.",Mr. Arthur Howard Penn,Asset Management,6.41,USD,418547995,https://images.financialmodelingprep.com/symbol/PNNT.png,539372,7.63,0.5,1489029,0,48851000,"[{'period': '2024', 'revenue': 115.25, 'unit': 'M', 'net_profit': 48.85}, {'period': '2023', 'revenue': 145.37, 'unit': 'M', 'net_profit': -33.81}, {'period': '2022', 'revenue': 104.97, 'unit': 'M', 'net_profit': -24.74}, {'period': '2021', 'revenue': 171.31, 'unit': 'M', 'net_profit': 166.62}]","[{'period': ""Q1 '25"", 'revenue': 18.57, 'unit': 'M', 'net_profit': -1.28}, {'period': ""Q4 '24"", 'revenue': 20.45, 'unit': 'M', 'net_profit': 18.37}, {'period': ""Q3 '24"", 'revenue': 29.09, 'unit': 'M', 'net_profit': 3.75}, {'period': ""Q2 '24"", 'revenue': 28.17, 'unit': 'M', 'net_profit': 16.09}, {'period': ""Q1 '24"", 'revenue': 12.3, 'unit': 'M', 'net_profit': 10.65}, {'period': ""Q4 '23"", 'revenue': 16.38, 'unit': 'M', 'net_profit': 12.27}]",0.75,0.75,1389086000,55122000,49861000,895178000,5261000,1328050000,276994000,49861000,-172396000,0,2.4449965983376223,2.442307692307692,"[0.08, 0.14]","['2025-04-15', '2007-06-20']",__nan__,0.644436701543317
223,PNNTG,PennantPark Investment Corporation 5.50% Notes Due 2024,,None,,25.08,USD,0,https://images.financialmodelingprep.com/symbol/PNNTG.png,5589,0,-0.0100002,2643,74041654000,92200209000,"[{'period': '2020', 'revenue': 100.22, 'unit': 'B', 'net_profit': 92.2}]","[{'period': ""Q4 '20"", 'revenue': 7000000.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '20"", 'revenue': 0.07482, 'unit': 'B', 'net_profit': 23.9}, {'period': ""Q2 '20"", 'revenue': 78.95, 'unit': 'M', 'net_profit': 74.64}]",-0.24,-0.24,361780085000,7536719000,7536719000,311415394000,0,0,87500000000,7536719000,108812276000,0,0,0,"[0.344, 0.413]","['2021-10-04', '2020-01-02']",__nan__,0.8607864471036321
224,PNRG,PrimeEnergy Resources Corporation Common Stock,"PrimeEnergy Resources Corporation, an independent oil and natural gas company, through its subsidiaries, engages in acquiring, developing, and producing oil and natural gas properties in the United States. It also acquires producing oil and gas properties through joint ventures with industry partners; and provides contract services to third parties, including well-servicing support operations, site-preparation, and construction services for oil and gas drilling and reworking operations. The company operates approximately 710 active wells and owns non-operating interests in approximately 822 additional wells primarily in Oklahoma and Texas. The company was formerly known as PrimeEnergy Corporation and changed its name to PrimeEnergy Resources Corporation in December 2018. The company was incorporated in 1973 and is headquartered in Houston, Texas.",Mr. Charles E. Drimal Jr.,Oil & Gas Exploration & Production,206.58,USD,354801150,https://images.financialmodelingprep.com/symbol/PNRG.png,18452,8.9,23.84,22025,66417000,28103000,"[{'period': '2023', 'revenue': 123.12, 'unit': 'M', 'net_profit': 28.1}, {'period': '2022', 'revenue': 125.09, 'unit': 'M', 'net_profit': 48.66}, {'period': '2021', 'revenue': 79.61, 'unit': 'M', 'net_profit': 2.1}, {'period': '2020', 'revenue': 58.42, 'unit': 'M', 'net_profit': -2.36}]","[{'period': ""Q3 '24"", 'revenue': 69.45, 'unit': 'M', 'net_profit': 22.08}, {'period': ""Q2 '24"", 'revenue': 64.6, 'unit': 'M', 'net_profit': 19.73}, {'period': ""Q1 '24"", 'revenue': 42.42, 'unit': 'M', 'net_profit': 11.32}, {'period': ""Q4 '23"", 'revenue': 34.94, 'unit': 'M', 'net_profit': 5.88}, {'period': ""Q3 '23"", 'revenue': 35.36, 'unit': 'M', 'net_profit': 10.72}, {'period': ""Q2 '23"", 'revenue': 29.61, 'unit': 'M', 'net_profit': 10.09}]",15.19,10.77,288568000,31776000,11061000,127618000,20301000,0,64809000,11061000,-4764000,0.18219682810914722,-0.4225094525727437,-0.39020473705339226,__nan__,__nan__,__nan__,0.44224584846552634
225,PNTG,The Pennant Group Inc. Common Stock ,"The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.",Mr. Brent J. Guerisoli,Medical - Care Facilities,25.19,USD,874654737,https://images.financialmodelingprep.com/symbol/PNTG.png,215126,35.99,0.84,419632,44442000,22559000,"[{'period': '2024', 'revenue': 695.24, 'unit': 'M', 'net_profit': 22.56}, {'period': '2023', 'revenue': 544.89, 'unit': 'M', 'net_profit': 13.38}, {'period': '2022', 'revenue': 473.24, 'unit': 'M', 'net_profit': 6.64}, {'period': '2021', 'revenue': 439.69, 'unit': 'M', 'net_profit': 2.15}]","[{'period': ""Q4 '24"", 'revenue': 188.89, 'unit': 'M', 'net_profit': 5.76}, {'period': ""Q3 '24"", 'revenue': 180.69, 'unit': 'M', 'net_profit': 6.21}, {'period': ""Q2 '24"", 'revenue': 168.75, 'unit': 'M', 'net_profit': 5.69}, {'period': ""Q1 '24"", 'revenue': 156.91, 'unit': 'M', 'net_profit': 4.91}, {'period': ""Q4 '23"", 'revenue': 145.95, 'unit': 'M', 'net_profit': 4.35}, {'period': ""Q3 '23"", 'revenue': 140.19, 'unit': 'M', 'net_profit': 4.38}]",0.72,0.7,679521000,122856000,24246000,367556000,81302000,0,101700000,24246000,30306000,0.45055160258502513,0.6861499364675985,0.5999999999999999,__nan__,__nan__,__nan__,0.5409045489396207
226,POAI,Predictive Oncology Inc. Common Stock,"Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.","Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.",Medical - Instruments & Supplies,1,USD,8931620,https://images.financialmodelingprep.com/symbol/POAI.png,3740824,-0.5,0.02,354405,-10860205,-12664388,"[{'period': '2024', 'revenue': 1.62, 'unit': 'M', 'net_profit': -12.66}, {'period': '2023', 'revenue': 1.78, 'unit': 'M', 'net_profit': -13.98}, {'period': '2022', 'revenue': 1.51, 'unit': 'M', 'net_profit': -36.21}, {'period': '2021', 'revenue': 1.42, 'unit': 'M', 'net_profit': -19.66}]","[{'period': ""Q4 '24"", 'revenue': 0.6115900000000001, 'unit': 'M', 'net_profit': -2.17}, {'period': ""Q3 '24"", 'revenue': 0.34569, 'unit': 'M', 'net_profit': -3.09}, {'period': ""Q2 '24"", 'revenue': 0.27872, 'unit': 'M', 'net_profit': -3.18}, {'period': ""Q1 '24"", 'revenue': 0.41964999999999997, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q4 '23"", 'revenue': 0.33503, 'unit': 'M', 'net_profit': -3.48}, {'period': ""Q3 '23"", 'revenue': 0.7150599999999999, 'unit': 'M', 'net_profit': -3.16}]",-2.32,-2.32,4972517,2225918,734673,5175127,745566,0,3593401,734673,-10984078,0.17613449297421366,0.09436370952534427,0.33333333333333337,__nan__,__nan__,__nan__,1.040745964267191
227,PODD,Insulet Corporation Common Stock,"Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.",Dr. James R. Hollingshead Ph.D.,Medical - Devices,264.72,USD,18590253192,https://images.financialmodelingprep.com/symbol/PODD.png,793863,45.8,17.68,1515170,423700000,418300000,"[{'period': '2024', 'revenue': 2070.0, 'unit': 'M', 'net_profit': 418.3}, {'period': '2023', 'revenue': 1700.0, 'unit': 'M', 'net_profit': 206.3}, {'period': '2022', 'revenue': 1310.0, 'unit': 'M', 'net_profit': 4.6}, {'period': '2021', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 16.8}]","[{'period': ""Q4 '24"", 'revenue': 597.5, 'unit': 'M', 'net_profit': 100.7}, {'period': ""Q3 '24"", 'revenue': 372.6, 'unit': 'M', 'net_profit': 77.5}, {'period': ""Q2 '24"", 'revenue': 488.5, 'unit': 'M', 'net_profit': 188.6}, {'period': ""Q1 '24"", 'revenue': 441.7, 'unit': 'M', 'net_profit': 51.5}, {'period': ""Q4 '23"", 'revenue': 509.8, 'unit': 'M', 'net_profit': 103.3}, {'period': ""Q3 '23"", 'revenue': 432.7, 'unit': 'M', 'net_profit': 51.9}]",5.97,5.66,3087700000,1891300000,953400000,1876100000,365500000,0,528400000,953400000,305400000,0.30933250927070455,1.0276296655356276,1.0168918918918919,__nan__,__nan__,__nan__,0.6076043657091038
228,POLA,Polar Power Inc. Common Stock,"Polar Power, Inc. designs, manufactures, and sells direct current (DC) power generators, renewable energy, and cooling systems in the United States and internationally. The company offers DC base power systems, DC hybrid power systems, DC solar hybrid power systems, and mobile power systems. Its DC power systems are available in diesel, natural gas, LPG/propane, and renewable fuel formats. The company serves customers in the telecommunications, military, commercial, industrial, and marine markets. It sells its products through a direct sales force, and a network of independent service providers and dealers. The company was formerly known as Polar Products, Inc. and changed its name to Polar Power, Inc. in October 1991. Polar Power, Inc. was incorporated in 1979 and is based in Gardena, California.",Mr. Arthur D. Sams,Electrical Equipment & Parts,2.08,USD,5223982,https://images.financialmodelingprep.com/symbol/POLA.png,159890,-1.12,0.04,10339,-3861000,-4677000,"[{'period': '2024', 'revenue': 13.97, 'unit': 'M', 'net_profit': -4.68}, {'period': '2023', 'revenue': 15.29, 'unit': 'M', 'net_profit': -6.55}, {'period': '2022', 'revenue': 16.06, 'unit': 'M', 'net_profit': -5.58}, {'period': '2021', 'revenue': 16.9, 'unit': 'M', 'net_profit': -3.22}]","[{'period': ""Q4 '24"", 'revenue': 2.62, 'unit': 'M', 'net_profit': -3.05}, {'period': ""Q3 '24"", 'revenue': 4910.0, 'unit': 'K', 'net_profit': 13.0}, {'period': ""Q2 '24"", 'revenue': 4660.0, 'unit': 'K', 'net_profit': 501.0}, {'period': ""Q1 '24"", 'revenue': 1.77, 'unit': 'M', 'net_profit': -2.14}, {'period': ""Q4 '23"", 'revenue': 3.6, 'unit': 'M', 'net_profit': -3.15}, {'period': ""Q3 '23"", 'revenue': 1.91, 'unit': 'M', 'net_profit': -1.84}]",-1.86,-1.86,17546000,15597000,498000,9034000,2153000,0,8560000,498000,-536000,0.31078186362013566,0.28573610262675625,0.4608695652173913,__nan__,__nan__,__nan__,0.5148751852274023
229,POOL,Pool Corporation Common Stock,"Pool Corporation distributes swimming pool supplies, equipment, and related leisure products in the United States and internationally. The company offers maintenance products, including chemicals, supplies, and pool accessories; repair and replacement parts for pool equipment, such as cleaners, filters, heaters, pumps, and lights; fiberglass pools, and hot tubs and packaged pool kits comprising walls, liners, braces, and coping for in-ground and above-ground pools; pool equipment and components for new pool construction and the remodeling of existing pools; and irrigation and related products consisting of irrigation system components, and professional lawn care equipment and supplies. It also provides building materials, such as concrete, plumbing and electrical components, functional and decorative pool surfaces, decking materials, tiles, hardscapes, and natural stones for pool installations and remodeling; and commercial products, including heaters, safety equipment, and commercial pumps and filters. In addition, the company offers other pool construction and recreational products comprising discretionary recreational and related outdoor living products, such as grills and components for outdoor kitchens. It serves swimming pool remodelers and builders; specialty retailers that sell swimming pool supplies; swimming pool repair and service businesses; irrigation construction and landscape maintenance contractors; and commercial customers that serve hotels, universities, and community recreational facilities. As of March 03, 2022, the company operated 410 sales centers in North America, Europe, and Australia. Pool Corporation was incorporated in 1993 and is headquartered in Covington, Louisiana.",Mr. Peter D. Arvan,Industrial - Distribution,313.56,USD,11826918792,https://images.financialmodelingprep.com/symbol/POOL.png,427203,27.77,22.6,693499,662685000,434325000,"[{'period': '2024', 'revenue': 5310.0, 'unit': 'M', 'net_profit': 434.32}, {'period': '2023', 'revenue': 5540.0, 'unit': 'M', 'net_profit': 523.23}, {'period': '2022', 'revenue': 6180.0, 'unit': 'M', 'net_profit': 748.46}, {'period': '2021', 'revenue': 5300.0, 'unit': 'M', 'net_profit': 650.62}]","[{'period': ""Q4 '24"", 'revenue': 987.48, 'unit': 'M', 'net_profit': 37.3}, {'period': ""Q3 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 125.7}, {'period': ""Q2 '24"", 'revenue': 1770.0, 'unit': 'M', 'net_profit': 192.44}, {'period': ""Q1 '24"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 78.89}, {'period': ""Q4 '23"", 'revenue': 1000.0, 'unit': 'M', 'net_profit': 51.44}, {'period': ""Q3 '23"", 'revenue': 1470.0, 'unit': 'M', 'net_profit': 137.84}]",11.49,11.42,3368184000,1729114000,77862000,2094719000,314861000,1439000,844186000,77862000,599710000,-0.15764700199693152,-0.16991412937738543,-0.14572490706319696,"[1.2, 0.1]","['2025-03-12', '2004-05-20']",__nan__,0.6219134702854714
230,POSH,Poshmark Inc. Class A Common Stock,"Poshmark, Inc. operates as a social marketplace for new and secondhand style products in the United States, Canada, India, and Australia. The company offers apparel, footwear, home, beauty, and pet products, as well as accessories. As of December 31, 2021, it had 7.6 million active buyers. The company was formerly known as GoshPosh, Inc. and changed its name to Poshmark, Inc. in 2011. Poshmark, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.",Mr. Manish  Chandra,Specialty Retail,17.9,USD,0,https://images.financialmodelingprep.com/symbol/POSH.png,1137154,0,0,5195459,-94994000,-98329000,"[{'period': '2021', 'revenue': 326.01, 'unit': 'M', 'net_profit': -98.33}, {'period': '2020', 'revenue': 262.08, 'unit': 'M', 'net_profit': 16.84}, {'period': '2019', 'revenue': 205.22, 'unit': 'M', 'net_profit': -48.69}, {'period': '2018', 'revenue': 148.31, 'unit': 'M', 'net_profit': -14.47}]","[{'period': ""Q3 '22"", 'revenue': 88.43, 'unit': 'M', 'net_profit': -23.54}, {'period': ""Q2 '22"", 'revenue': 89.1, 'unit': 'M', 'net_profit': -22.88}, {'period': ""Q1 '22"", 'revenue': 90.9, 'unit': 'M', 'net_profit': -14.02}, {'period': ""Q4 '21"", 'revenue': 84.2, 'unit': 'M', 'net_profit': -14.78}, {'period': ""Q3 '21"", 'revenue': 79.65, 'unit': 'M', 'net_profit': -7.2}, {'period': ""Q2 '21"", 'revenue': 81.76, 'unit': 'M', 'net_profit': -3.0}]",-1.34,-1.34,608673000,591275000,581538000,191054000,0,0,187807000,581538000,26672000,-5.531075602194133,-6.837281092312259,-6.826086956521739,__nan__,__nan__,__nan__,0.31388610961879365
231,POW,Powered Brands Class A Ordinary Shares,"Powered Brands does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Powered Brands was incorporated in 2020 and is based in New York, New York.",Ms. Katherine  Power,Shell Companies,10.125,USD,0,https://images.financialmodelingprep.com/symbol/POW.png,42402,0,-0.005,667,2845235,6925981,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.93}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.02}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.92}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.07}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.39}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.76}]",0.2,0.2,949.7249999999985,923.482,628.62,18525,0,276026,272.137,628.62,-1347776,0,0,0,__nan__,__nan__,__nan__,19.505646371318043
232,POWI,Power Integrations Inc. Common Stock,"Power Integrations, Inc. designs, develops, manufactures, and markets analog and mixed-signal integrated circuits (ICs), and other electronic components and circuitry used in high-voltage power conversion worldwide. The company provides a range of alternating current to direct current power conversion products that address power supply ranging from less than one watt of output to approximately 500 watts of output for mobile-device chargers, consumer appliances, utility meters, LCD monitors, main and standby power supplies for desktop computers and TVs, LED lighting, and various other consumer and industrial applications, as well as power conversion in high-power applications comprising industrial motors, solar and wind-power systems, electric vehicles, and high-voltage DC transmission systems. It also offers high-voltage diodes; high-voltage gate-driver products used to operate high-voltage switches, such as insulated-gate bipolar transistors and silicon-carbide MOSFETs under the SCALE and SCALE-2 product-family names; and SCALE-iDriver for use in powertrain and charging applications for electric vehicles. In addition, the company provides motor-driver ICs for use in refrigerator compressors, ceiling fans, and air purifiers, as well as pumps, fans, and blowers used in consumer appliances, such as dishwashers and laundry machines. It serves communications, computer, consumer, and industrial markets. The company sells its products to original equipment manufacturers and merchant power supply manufacturers through direct sales force, as well as a network of independent sales representatives and distributors. Power Integrations, Inc. was incorporated in 1988 and is headquartered in San Jose, California.",Mr. Balu  Balakrishnan,Semiconductors,48.33,USD,2747420343,https://images.financialmodelingprep.com/symbol/POWI.png,586614,86.3,6.2,958461,17929000,32234000,"[{'period': '2024', 'revenue': 418.97, 'unit': 'M', 'net_profit': 32.23}, {'period': '2023', 'revenue': 444.54, 'unit': 'M', 'net_profit': 55.73}, {'period': '2022', 'revenue': 651.14, 'unit': 'M', 'net_profit': 170.85}, {'period': '2021', 'revenue': 703.28, 'unit': 'M', 'net_profit': 164.41}]","[{'period': ""Q4 '24"", 'revenue': 105.25, 'unit': 'M', 'net_profit': 9.14}, {'period': ""Q3 '24"", 'revenue': 115.84, 'unit': 'M', 'net_profit': 14.29}, {'period': ""Q2 '24"", 'revenue': 106.2, 'unit': 'M', 'net_profit': 4.85}, {'period': ""Q1 '24"", 'revenue': 91.69, 'unit': 'M', 'net_profit': 3.95}, {'period': ""Q4 '23"", 'revenue': 89.51, 'unit': 'M', 'net_profit': 14.27}, {'period': ""Q3 '23"", 'revenue': 125.51, 'unit': 'M', 'net_profit': 19.8}]",0.57,0.56,828826000,514039000,299995000,79054000,27172000,0,55317000,50972000,63895000,-0.7524815351694623,-0.42165605095541403,-0.4123711340206186,"[0.21, 0.025]","['2025-02-28', '2008-11-25']",__nan__,0.09538069510367676
233,POWL,Powell Industries Inc. Common Stock,"Powell Industries, Inc., together with its subsidiaries, designs, develops, manufactures, sells, and services custom-engineered equipment and systems for the distribution, control, and monitoring of electrical energy. The company's principal products include integrated power control room substations, custom-engineered modules, electrical houses, medium-voltage circuit breakers, monitoring and control communications systems, motor control centers, and bus duct systems, as well as traditional and arc-resistant distribution switchgears and control gears. Its products have application in voltages ranging from 480 volts to 38,000 volts; and are used in oil and gas refining, onshore and offshore oil and gas production, petrochemical, liquid natural gas terminals, pipeline, terminal, mining and metals, light rail traction power, electric utility, pulp and paper, and other heavy industrial markets. It also provides value-added services, such as spare parts, field service inspection, installation, commissioning, modification and repair, retrofit and retrofill components for existing systems, and replacement circuit breakers for switchgear. The company has operations in the United States, Canada, the Middle East, Africa, Europe, Mexico, and Central and South America. Powell Industries, Inc. was founded in 1947 and is headquartered in Houston, Texas.",Mr. Brett A. Cope,Electrical Equipment & Parts,183.17,USD,2209891099,https://images.financialmodelingprep.com/symbol/POWL.png,500552,13.91,19.4,706106,178773000,149848000,"[{'period': '2024', 'revenue': 1010.0, 'unit': 'M', 'net_profit': 149.85}, {'period': '2023', 'revenue': 699.31, 'unit': 'M', 'net_profit': 54.52}, {'period': '2022', 'revenue': 532.58, 'unit': 'M', 'net_profit': 13.74}, {'period': '2021', 'revenue': 470560.0, 'unit': 'K', 'net_profit': 631.0}]","[{'period': ""Q1 '25"", 'revenue': 241.43, 'unit': 'M', 'net_profit': 34.76}, {'period': ""Q4 '24"", 'revenue': 275.06, 'unit': 'M', 'net_profit': 46.05}, {'period': ""Q3 '24"", 'revenue': 288.17, 'unit': 'M', 'net_profit': 46.22}, {'period': ""Q2 '24"", 'revenue': 255.11, 'unit': 'M', 'net_profit': 33.49}, {'period': ""Q1 '24"", 'revenue': 194.02, 'unit': 'M', 'net_profit': 24.09}, {'period': ""Q4 '23"", 'revenue': 208.64, 'unit': 'M', 'net_profit': 26.43}]",12.51,12.29,928180000,776481000,358392000,445107000,317293000,0,428015000,315331000,96678000,1.5134690549166268,1.7482439248051354,1.7254901960784315,"[0.2675, 0.25]","['2025-02-19', '2013-11-18']",__nan__,0.47954814798853673
234,POWRU,Powered Brands Units,"Powered Brands does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Powered Brands was incorporated in 2020 and is based in New York, New York.",Ms. Katherine  Power,Shell Companies,10.16,USD,0,https://images.financialmodelingprep.com/symbol/POWRU.png,4711,0,0.04,10,2845235,6925981,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.93}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.02}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.92}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.07}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.39}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.76}]",0.2,0.2,949.7249999999985,923.482,628.62,18525,0,276026,272.137,628.62,-1347776,0,0,0,__nan__,__nan__,__nan__,19.505646371318043
235,POWRW,Powered Brands Warrants,"Powered Brands focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Ms. Katherine  Power,Shell Companies,0.0002,USD,0,https://images.financialmodelingprep.com/symbol/POWRW.png,0,0,0,277398,2845235,6925981,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.93}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.02}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.92}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.07}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.39}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.76}]",0.2,0.2,949.7249999999985,923.482,628.62,18525,0,276026,272.137,628.62,-1347776,0,0,0,__nan__,__nan__,__nan__,19.505646371318043
236,POWW,AMMO Inc. Common Stock,"AMMO, Inc. designs, produces, and markets ammunition and ammunition component products for sport and recreational shooters, hunters, individuals seeking home or personal protection, manufacturers, and law enforcement and military agencies. The company's products include STREAK Visual Ammunition that enables shooters to see the path of the bullets fired by them; and Stelth Subsonic ammunition primarily for suppressed firearms. It also owns and operates GunBroker.com, an auction site that supports the lawful sale of firearms, ammunition, and hunting/shooting accessories. In addition, the company offers Jesse James ammunition, a jacketed hollow point projectile for self-defense; and Jeff Rann's ammunition for game hunting. Further, its products include armor piercing and hard armor piercing incendiary tactical rounds; and ammunition casings for pistol ammunition through large rifle ammunition. The company is based in Scottsdale, Arizona.",Mr. Jared R. Smith,Aerospace & Defense,1.32,USD,156759240,https://images.financialmodelingprep.com/symbol/POWW.png,879126,-6.29,0.07,440631,380362,-15565200,"[{'period': '2024', 'revenue': 145.05, 'unit': 'M', 'net_profit': -15.57}, {'period': '2023', 'revenue': 191.44, 'unit': 'M', 'net_profit': -4.6}, {'period': '2022', 'revenue': 240.27, 'unit': 'M', 'net_profit': 33.25}, {'period': '2021', 'revenue': 62.48, 'unit': 'M', 'net_profit': -11.4}]","[{'period': ""Q1 '25"", 'revenue': 30.95, 'unit': 'M', 'net_profit': -7.06}, {'period': ""Q4 '24"", 'revenue': 40.42, 'unit': 'M', 'net_profit': -5.33}, {'period': ""Q3 '24"", 'revenue': 36.01, 'unit': 'M', 'net_profit': -1.64}, {'period': ""Q2 '24"", 'revenue': 34.37, 'unit': 'M', 'net_profit': -7.5}, {'period': ""Q1 '24"", 'revenue': 34.25, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q4 '23"", 'revenue': 43.68, 'unit': 'M', 'net_profit': -2.94}]",-0.16,-0.16,399902216,131525265,55586441,43345187,28221321,0,30940272,55586441,24606576,-0.9744986205486295,-2.386656072034217,-3.0816326530612246,__nan__,__nan__,__nan__,0.1083894643884644
237,POWWP,AMMO Inc. 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock,"AMMO, Inc. designs, produces, and markets ammunition and ammunition component products for sport and recreational shooters, hunters, individuals seeking home or personal protection, manufacturers, and law enforcement and military agencies. The company's products include STREAK Visual Ammunition that enables shooters to see the path of the bullets fired by them; and Stelth Subsonic ammunition primarily for suppressed firearms. It also owns and operates GunBroker.com, an auction site that supports the lawful sale of firearms, ammunition, and hunting/shooting accessories. In addition, the company offers Jesse James ammunition, a jacketed hollow point projectile for self-defense; and Jeff Rann's ammunition for game hunting. Further, its products include armor piercing and hard armor piercing incendiary tactical rounds; and ammunition casings for pistol ammunition through large rifle ammunition. The company is based in Scottsdale, Arizona.",Mr. Jared R. Smith,Aerospace & Defense,21.25,USD,2523586250,https://images.financialmodelingprep.com/symbol/POWWP.png,6229,73.78,-0.26,1212,380362,-15565200,"[{'period': '2024', 'revenue': 145.05, 'unit': 'M', 'net_profit': -15.57}, {'period': '2023', 'revenue': 191.44, 'unit': 'M', 'net_profit': -4.6}, {'period': '2022', 'revenue': 240.27, 'unit': 'M', 'net_profit': 33.25}, {'period': '2021', 'revenue': 62.48, 'unit': 'M', 'net_profit': -11.4}]","[{'period': ""Q1 '25"", 'revenue': 30.95, 'unit': 'M', 'net_profit': -7.06}, {'period': ""Q4 '24"", 'revenue': 40.42, 'unit': 'M', 'net_profit': -5.33}, {'period': ""Q3 '24"", 'revenue': 36.01, 'unit': 'M', 'net_profit': -1.64}, {'period': ""Q2 '24"", 'revenue': 34.37, 'unit': 'M', 'net_profit': -7.5}, {'period': ""Q1 '24"", 'revenue': 34.25, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q4 '23"", 'revenue': 43.68, 'unit': 'M', 'net_profit': -2.94}]",-0.16,-0.16,399902216,131525265,55586441,43345187,28221321,0,30940272,55586441,24606576,-0.9744986205486295,-2.386656072034217,-3.0816326530612246,"[0.54688, 0.241]","['2025-02-28', '2021-08-30']",__nan__,0.1083894643884644
238,PPBI,Pacific Premier Bancorp Inc,"Pacific Premier Bancorp, Inc. operates as the bank holding company for Pacific Premier Bank that provides banking services to businesses, professionals, real estate investors, and non-profit organizations. The company accepts deposit products, such as checking, money market, and savings accounts; and certificates of deposit. Its loan portfolio includes commercial real estate owner and non-owner-occupied, multifamily, construction and land, franchise real estate secured, small business administration (SBA), and SBA paycheck protection program loans; revolving lines or credit, term loans, seasonal loans, and loans secured by liquid collateral; one-to-four family and home equity lines of credit loans; and savings account secured loans and auto loans. The company also offers cash management, electronic banking, treasury management, and online bill payment services. It operates 61 full-service depository branches located in Arizona, California, Nevada, Oregon, and Washington. Pacific Premier Bancorp, Inc. was founded in 1983 and is headquartered in Irvine, California.",Mr. Steven R. Gardner,Banks - Regional,20.02,USD,1930684756,https://images.financialmodelingprep.com/symbol/PPBI.png,726970,12.13,1.02,1081409,0,158802000,"[{'period': '2024', 'revenue': 822.57, 'unit': 'M', 'net_profit': 158.8}, {'period': '2023', 'revenue': 440.2, 'unit': 'M', 'net_profit': 30.85}, {'period': '2022', 'revenue': 762.6, 'unit': 'M', 'net_profit': 283.74}, {'period': '2021', 'revenue': 750.1, 'unit': 'M', 'net_profit': 339.89}]","[{'period': ""Q4 '24"", 'revenue': 195.46, 'unit': 'M', 'net_profit': 33.89}, {'period': ""Q3 '24"", 'revenue': 136.56, 'unit': 'M', 'net_profit': 35.98}, {'period': ""Q2 '24"", 'revenue': 226.44, 'unit': 'M', 'net_profit': 41.91}, {'period': ""Q1 '24"", 'revenue': 239.01, 'unit': 'M', 'net_profit': 47.02}, {'period': ""Q4 '23"", 'revenue': 217.19, 'unit': 'M', 'net_profit': -135.38}, {'period': ""Q3 '23"", 'revenue': 224.06, 'unit': 'M', 'net_profit': 46.03}]",1.65,1.65,17903585000,1869123000,1801170000,14947842000,67953000,0,0,117955000,226459000,-1,4.147218980941268,4.32258064516129,"[0.33, 0.22]","['2025-02-03', '2019-02-14']",__nan__,0.8349077573011215
239,PPBT,Purple Biotech Ltd. American Depositary Shares,"Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.","Mr. Gil  Efron CPA, M.A.",Biotechnology,2.37,USD,31381,https://images.financialmodelingprep.com/symbol/PPBT.png,21136,-0.05,0.01,13439,-7052000,-7240000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.24}, {'period': '2023', 'revenue': 195.8, 'unit': 'K', 'net_profit': -19.88}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.67}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.38}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -410.0}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -663.0}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.76}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.83}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.04}]",-0.21,-0.21,37038000,8908000,8524000,4127000,275000,0,3987000,7401000,-14367000,0.6826996625421822,-363.1851106639839,-2099,__nan__,__nan__,__nan__,0.11142610292132404
240,PPC,Pilgrim's Pride Corporation Common Stock,"Pilgrim's Pride Corporation engages in the production, processing, marketing and distribution of fresh, frozen and value-added chicken, and pork products to retailers, distributors, and foodservice operators in the United States, the United Kingdom, Mexico, the Middle East, Asia, Continental Europe, and internationally. The company offers fresh products, including pre-marinated or non-marinated chicken, frozen whole chickens, breast fillets, mini breast fillets and prepackaged case-ready chicken, primary pork cuts, and pork and pork ribs; prepared products, which include portion-controlled breast fillets, tenderloins and strips, delicatessen products, salads, formed nuggets and patties, and bone-in chicken parts; processed sausages, bacon, slow cooked, smoked meat, gammon joints, as well as variety of meat products, pre-packed meats, sandwich and deli counter meats, pulled pork balls, meatballs, and coated foods. In addition, its exported products include whole chickens and chicken parts sold either refrigerated for distributors in the U.S. or frozen for distribution to export markets and primary pork cuts, hog heads and trotters frozen for distribution to export markets. The company offers its products under the Pilgrim's, Just BARE, Gold'n Pump, Gold Kist, County Pride, Pierce Chicken, Pilgrim's Mexico, County Post, Savoro, To-Ricos, Del Dia, Moy Park, O'Kane, Richmond, Fridge Raiders, and Denny brands. Pilgrim's Pride Corporation sells its products to the foodservice market principally consists of chain restaurants, food processors, broad-line distributors, and other institutions; and retail market, which comprise primarily grocery store chains, wholesale clubs, and other retail distributors. The company was founded in 1946 and is headquartered in Greeley, Colorado. Pilgrim's Pride Corporation operates as a subsidiary of JBS S.A.",Mr. Fabio  Sandri,Packaged Foods,50.37,USD,11943835140,https://images.financialmodelingprep.com/symbol/PPC.png,1437009,11.02,1.29,1587055,2007066000,1086438000,"[{'period': '2024', 'revenue': 17.88, 'unit': 'B', 'net_profit': 1.09}, {'period': '2023', 'revenue': 17360.0, 'unit': 'M', 'net_profit': 321.57}, {'period': '2022', 'revenue': 17470.0, 'unit': 'M', 'net_profit': 745.93}, {'period': '2021', 'revenue': 14780.0, 'unit': 'M', 'net_profit': 31.0}]","[{'period': ""Q4 '24"", 'revenue': 4370.0, 'unit': 'M', 'net_profit': 235.85}, {'period': ""Q3 '24"", 'revenue': 4580.0, 'unit': 'M', 'net_profit': 349.86}, {'period': ""Q2 '24"", 'revenue': 4560.0, 'unit': 'M', 'net_profit': 326.3}, {'period': ""Q1 '24"", 'revenue': 4360.0, 'unit': 'M', 'net_profit': 174.42}, {'period': ""Q4 '23"", 'revenue': 4530.0, 'unit': 'M', 'net_profit': 134.65}, {'period': ""Q3 '23"", 'revenue': 4360.0, 'unit': 'M', 'net_profit': 121.28}]",4.58,4.57,10650576000,5120163000,2053378000,6397180000,1004334000,0,2552133000,2043158000,1990127000,1.032690091290812,2.3785007494386985,2.367647058823529,"[6.3, 0.0067]","['2025-04-03', '1988-02-24']",__nan__,0.6006416929938813
241,PPD,PPD Inc. Common Stock,"PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.",Mr. David S. Simmons,Drug Manufacturers - Specialty & Generic,47.28,USD,0,https://images.financialmodelingprep.com/symbol/PPD.png,1438713,0,0,1868187,668544000,153691000,"[{'period': '2020', 'revenue': 4680.0, 'unit': 'M', 'net_profit': 153.69}, {'period': '2019', 'revenue': 4030.0000000000005, 'unit': 'M', 'net_profit': 47.82}, {'period': '2018', 'revenue': 3750.0, 'unit': 'M', 'net_profit': 104.19}, {'period': '2017', 'revenue': 3000.0, 'unit': 'M', 'net_profit': 296.03}]","[{'period': ""Q3 '21"", 'revenue': 1560.0, 'unit': 'M', 'net_profit': 167.07}, {'period': ""Q2 '21"", 'revenue': 1580.0, 'unit': 'M', 'net_profit': 51.01}, {'period': ""Q1 '21"", 'revenue': 1380.0, 'unit': 'M', 'net_profit': 45.88}, {'period': ""Q4 '20"", 'revenue': 1360.0, 'unit': 'M', 'net_profit': 100.1}, {'period': ""Q3 '20"", 'revenue': 1230.0, 'unit': 'M', 'net_profit': 7.51}, {'period': ""Q2 '20"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 61.92}]",0.44,0.44,6293843000,2546203000,767999000,7040363000,1632104000,309072000,2277561000,767999000,88003000,0.06566010788201838,2.2138809309717487,2.142857142857143,__nan__,__nan__,__nan__,1.118611156967214
242,PPGH,Poema Global Holdings Corp. Class A Ordinary Share,"Poema Global Holdings Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on companies in the technology sector. The company was founded in 2020 and is based in San Francisco, California.",Mr. Homer  Sun J.D.,Shell Companies,12.74,USD,0,https://images.financialmodelingprep.com/symbol/PPGH.png,249679,0,2.4399996,5986014,-9704377,-16002606,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.0}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.99}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-0.37,-0.37,345763,606.499,345289,55728,0,0,2252.642,138.47,-1627796,0,0,0,__nan__,__nan__,__nan__,0.16117398333540606
243,PPGHU,Poema Global Holdings Corp. Unit,"Poema Global Holdings Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on companies in the technology sector. The company was founded in 2020 and is based in San Francisco, California.",,Shell Companies,13.055,USD,0,https://images.financialmodelingprep.com/symbol/PPGHU.png,4241,0,2.227,12597,-9704377,-16002606,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.0}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.99}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-0.37,-0.37,345763,606.499,345289,55728,0,0,2252.642,138.47,-1627796,0,0,0,__nan__,__nan__,__nan__,0.16117398333540606
244,PPGHW,Poema Global Holdings Corp. Warrant,"Poema Global Holdings Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on companies in the technology sector. The company was founded in 2020 and is based in San Francisco, California.",Mr. Homer  Sun J.D.,Shell Companies,1.66,USD,0,https://images.financialmodelingprep.com/symbol/PPGHW.png,0,0,0.17999995,1303946,-9704377,-16002606,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.0}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.99}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-0.37,-0.37,345763,606.499,345289,55728,0,0,2252.642,138.47,-1627796,0,0,0,__nan__,__nan__,__nan__,0.16117398333540606
245,PPIH,Perma-Pipe International Holdings Inc. Common Stock,"Perma-Pipe International Holdings, Inc., together with its subsidiaries, engineers, designs, manufactures, and sells specialty piping and leak detection systems. It offers provides and jacketed district heating and cooling piping systems for energy distribution from central energy plants to various locations; and primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, as well as engages in the coating and insulation of oil and gas gathering and transmission pipelines. The company also offers liquid and powder based anti-corrosion coatings for external and internal surfaces of steel pipe, including shapes like bends, reducers, tees, and other spools/fittings that is used in pipelines for the transportation of oil and gas products and potable water. It has operations in the United States, Canada, the Middle East, Europe, India, and internationally. The company was formerly known as MFRI, Inc. and changed its name to Perma-Pipe International Holdings, Inc. in March 2017. Perma-Pipe International Holdings, Inc. was incorporated in 1993 and is headquartered in Niles, Illinois.",Mr. David J. Mansfield,Construction,11.32,USD,90362692,https://images.financialmodelingprep.com/symbol/PPIH.png,28388,5.75,2.09,222507,15987000,10471000,"[{'period': '2023', 'revenue': 150.67, 'unit': 'M', 'net_profit': 10.47}, {'period': '2022', 'revenue': 142.57, 'unit': 'M', 'net_profit': 5.95}, {'period': '2021', 'revenue': 138.55, 'unit': 'M', 'net_profit': 6.06}, {'period': '2020', 'revenue': 84.69, 'unit': 'M', 'net_profit': -7.64}]","[{'period': ""Q3 '24"", 'revenue': 41.56, 'unit': 'M', 'net_profit': 2.49}, {'period': ""Q2 '24"", 'revenue': 37.51, 'unit': 'M', 'net_profit': 3.29}, {'period': ""Q1 '24"", 'revenue': 34.32, 'unit': 'M', 'net_profit': 1.44}, {'period': ""Q4 '23"", 'revenue': 40.18, 'unit': 'M', 'net_profit': 8.64}, {'period': ""Q3 '23"", 'revenue': 45.69, 'unit': 'M', 'net_profit': 1.94}, {'period': ""Q2 '23"", 'revenue': 35.14, 'unit': 'M', 'net_profit': 1.02}]",1.31,1.3,155711000,98818000,5845000,83733000,66340000,0,57742000,5845000,3625000,0.08093306288032455,0.7613120269133726,0.7466666666666667,__nan__,__nan__,__nan__,0.537746209323683
246,PPSI,Pioneer Power Solutions Inc. Common Stock,"Pioneer Power Solutions, Inc., together with its subsidiaries, designs, manufactures, sells, and services electric power systems, distributed energy resources, used and new power generation equipment, and mobile EV charging solutions in the United States, Canada, and internationally. The company operates in two segments, Transmission & Distribution Solutions and Critical Power Solutions. The Transmission & Distribution Solutions segment provides electric power systems, including e-Bloc, and distributed energy resources that help customers effectively and efficiently protect, control, transfer, monitor, and manage their electric energy requirements. It also provides low voltage switchgears and transfer switches. The Critical Power Solutions segment provides new and used power generation equipment, and aftermarket field-services to ensure smooth and uninterrupted power to operations during times of emergency. The company serves utility, industrial, commercial, and backup power markets. The company was incorporated in 2008 and is headquartered in Fort Lee, New Jersey. Pioneer Power Solutions, Inc. is a subsidiary of Provident Pioneer Partners, L.P.",Mr. Nathan J. Mazurek,Electrical Equipment & Parts,2.49,USD,27421125,https://images.financialmodelingprep.com/symbol/PPSI.png,55822,-2.86,0.21,67111,-1243000,-1898000,"[{'period': '2023', 'revenue': 41.49, 'unit': 'M', 'net_profit': -1.9}, {'period': '2022', 'revenue': 27.0, 'unit': 'M', 'net_profit': -3.64}, {'period': '2021', 'revenue': 18.31, 'unit': 'M', 'net_profit': -2.17}, {'period': '2020', 'revenue': 19.49, 'unit': 'M', 'net_profit': -2.99}]","[{'period': ""Q3 '24"", 'revenue': 10.91, 'unit': 'M', 'net_profit': -1.12}, {'period': ""Q2 '24"", 'revenue': 6.34, 'unit': 'M', 'net_profit': -2.28}, {'period': ""Q1 '24"", 'revenue': 8.59, 'unit': 'M', 'net_profit': -1.03}, {'period': ""Q4 '23"", 'revenue': 8.41, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q3 '23"", 'revenue': 12.44, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q2 '23"", 'revenue': 12130.0, 'unit': 'K', 'net_profit': -319.0}]",-0.19,-0.19,33022000,27683000,3582000,18804000,9010000,0,18262000,3582000,-6391000,0.7344584490493484,0.4782847718526663,0.48648648648648646,"[1.5, 1.37]","['2024-12-17', '2019-10-08']",__nan__,0.5694385561141058
247,PPTA,Perpetua Resources Corp. Common Shares,"Perpetua Resources Corp. engages in the mineral exploration activities in the United States. The company primarily explores for gold, silver, and antimony. Its principal asset is the 100% owned Stibnite gold project located in Valley County, Idaho. The company was formerly known as Midas Gold Corp. and changed its name to Perpetua Resources Corp. in February 2021. Perpetua Resources Corp. was incorporated in 2011 and is headquartered in Boise, Idaho.",Ms. Jessica  Largent,Other Precious Metals,10.82,USD,771058562,https://images.financialmodelingprep.com/symbol/PPTA.png,955211,-49.18,1.29,1410977,0,14483001,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.48}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.77}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.71}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.95}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.3}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.67}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.94}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.87}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.63}]",0.22,0.22,117609997,46690134,44104825,8751267,2585309,0,6751267,44104825,-11890427,1,1.7715551712785238,734.3333333333334,__nan__,__nan__,__nan__,0.07440921029867895
248,PRAA,PRA Group Inc. Common Stock,"PRA Group, Inc., a financial and business services company, engages in the purchase, collection, and management of portfolios of nonperforming loans in the Americas, Australia, and Europe. It is involved in the purchase of accounts that are primarily the unpaid obligations of individuals owed to credit originators, which include banks and other types of consumer, retail, and auto finance companies. The company also acquires nonperforming loans, including Visa and MasterCard credit cards, private label and other credit cards, installment loans, lines of credit, deficiency balances of various types, legal judgments, and trade payables from banks, credit unions, consumer finance companies, retailers, utilities, automobile finance companies, and other credit originators. In addition, it provides fee-based services on class action claims recoveries and by servicing consumer bankruptcy accounts. The company was formerly known as Portfolio Recovery Associates, Inc. and changed its name to PRA Group, Inc. in October 2014. PRA Group, Inc. was incorporated in 1996 and is headquartered in Norfolk, Virginia.",Mr. Vikram A. Atal,Financial - Credit Services,18.05,USD,713148280,https://images.financialmodelingprep.com/symbol/PRAA.png,306670,10.08,1.8,495322,209128000,70601000,"[{'period': '2024', 'revenue': 1120.0, 'unit': 'M', 'net_profit': 70.6}, {'period': '2023', 'revenue': 815.5, 'unit': 'M', 'net_profit': -83.48}, {'period': '2022', 'revenue': 968.75, 'unit': 'M', 'net_profit': 117.15}, {'period': '2021', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 183.16}]","[{'period': ""Q3 '24"", 'revenue': 295.94, 'unit': 'M', 'net_profit': 18.46}, {'period': ""Q2 '24"", 'revenue': 283.58, 'unit': 'M', 'net_profit': 27.15}, {'period': ""Q1 '24"", 'revenue': 289.76, 'unit': 'M', 'net_profit': 21.52}, {'period': ""Q4 '23"", 'revenue': 255.59, 'unit': 'M', 'net_profit': 3.48}, {'period': ""Q3 '23"", 'revenue': 221.42, 'unit': 'M', 'net_profit': -8.78}, {'period': ""Q2 '23"", 'revenue': 218.77, 'unit': 'M', 'net_profit': -12.26}]",1.79,1.78,4931155000,4322001000,161700000,3737548000,4160301000,10542000,333201000,105938000,-98639000,0.5660561038805434,1.8457539202415036,1.8403755868544602,"[1, 1]","['2007-05-07', '2007-05-07']",__nan__,0.7579457551019995
249,PRAH,PRA Health Sciences Inc. Common Stock,,,,,,,,,,,,433769000,197043000,"[{'period': '2020', 'revenue': 3180.0, 'unit': 'M', 'net_profit': 197.04}, {'period': '2019', 'revenue': 3070.0, 'unit': 'M', 'net_profit': 243.02}, {'period': '2018', 'revenue': 2870.0, 'unit': 'M', 'net_profit': 153.91}, {'period': '2017', 'revenue': 2260.0, 'unit': 'M', 'net_profit': 86.93}]","[{'period': ""Q1 '21"", 'revenue': 933.77, 'unit': 'M', 'net_profit': 56.94}, {'period': ""Q4 '20"", 'revenue': 873.46, 'unit': 'M', 'net_profit': 51.26}, {'period': ""Q3 '20"", 'revenue': 796.31, 'unit': 'M', 'net_profit': 91.25}, {'period': ""Q2 '20"", 'revenue': 729.89, 'unit': 'M', 'net_profit': 13.87}, {'period': ""Q1 '20"", 'revenue': 783.71, 'unit': 'M', 'net_profit': 40.66}, {'period': ""Q4 '19"", 'revenue': 800.24, 'unit': 'M', 'net_profit': 74.8}]",3.02,3.02,4178501000,1460514000,506303000,2699316000,855205000,0,1266023000,506303000,360370000,-0.08238402582539511,-0.18919019010781005,-0.17934782608695654,__nan__,__nan__,__nan__,0.6460010420004686
250,PRAX,Praxis Precision Medicines Inc. Common Stock,"Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.",Mr. Marcio Silva De'Souza M.B.A.,Biotechnology,30.85,USD,622037805,https://images.financialmodelingprep.com/symbol/PRAX.png,527234,-3.02,2.25,870479,-200165000,-182819000,"[{'period': '2024', 'revenue': 8.55, 'unit': 'M', 'net_profit': -182.82}, {'period': '2023', 'revenue': 2.45, 'unit': 'M', 'net_profit': -123.28}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -213.07}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -166.88}]","[{'period': ""Q4 '24"", 'revenue': 7.46, 'unit': 'M', 'net_profit': -58.68}, {'period': ""Q3 '24"", 'revenue': 0.302, 'unit': 'M', 'net_profit': -51.91}, {'period': ""Q2 '24"", 'revenue': 0.357, 'unit': 'M', 'net_profit': -32.68}, {'period': ""Q1 '24"", 'revenue': 0.431, 'unit': 'M', 'net_profit': -39.55}, {'period': ""Q4 '23"", 'revenue': 0.515, 'unit': 'M', 'net_profit': -26.88}, {'period': ""Q3 '23"", 'revenue': 0.468, 'unit': 'M', 'net_profit': -24.63}]",-10.21,-10.21,483110000,404372000,392567000,37660000,0,0,37550000,215372000,-131757000,-0.5893553330527787,-0.4829935835557322,0.4537185660781166,__nan__,__nan__,__nan__,0.07795326116205419
251,PRCH,Porch Group Inc. Common Stock,"Porch Group, Inc. operates a software platform in the United States and Canada. The company operates through two segments, Vertical Software and Insurance. The Vertical Software segment provides software and services to home services companies and gives early access to homebuyers and homeowners. It offers services to home services companies, such as home inspectors, consumers, such as homebuyers and homeowners, service providers, such as moving, insurance, warranty, and security companies, and TV/Internet providers. This segment operates through Floify, HireAHelper, ISN, iRoofing, Palm-Tech, Porch.com, Rynoh, and V12 brands. The Insurance segment offers property related insurance policies through our own risk-bearing carrier and independent agency as well as risk-bearing home warranty company. This segment operates though American Home Protect, Elite Insurance Group, and Homeowners of America brands. In addition, the company provides property and casualty, home, auto, flood, and umbrella insurance products; and contractor services. The company was incorporated in 2011 and is headquartered in Seattle, Washington.",Mr. Matthew  Ehrlichman,Software - Application,5.93,USD,603389360,https://images.financialmodelingprep.com/symbol/PRCH.png,2452673,-17.97,0.7,3463143,37346000,-32829000,"[{'period': '2024', 'revenue': 437.85, 'unit': 'M', 'net_profit': -32.83}, {'period': '2023', 'revenue': 430.3, 'unit': 'M', 'net_profit': -133.93}, {'period': '2022', 'revenue': 275.95, 'unit': 'M', 'net_profit': -156.56}, {'period': '2021', 'revenue': 192.43, 'unit': 'M', 'net_profit': -109.08}]","[{'period': ""Q4 '24"", 'revenue': 100.36, 'unit': 'M', 'net_profit': 30.47}, {'period': ""Q3 '24"", 'revenue': 111.2, 'unit': 'M', 'net_profit': 14.38}, {'period': ""Q2 '24"", 'revenue': 110.84, 'unit': 'M', 'net_profit': -64.32}, {'period': ""Q1 '24"", 'revenue': 115.44, 'unit': 'M', 'net_profit': -13.36}, {'period': ""Q4 '23"", 'revenue': 114.61, 'unit': 'M', 'net_profit': -2.49}, {'period': ""Q3 '23"", 'revenue': 129.56, 'unit': 'M', 'net_profit': -5.74}]",-0.33,-0.33,813968000,365127000,191742000,857193000,111409000,158652000,414156000,167643000,-32205000,1.484585041781284,0.7548849051391368,0.7625899280575539,__nan__,__nan__,__nan__,1.0531040532305938
252,PRDO,Perdoceo Education Corporation Common Stock,"Perdoceo Education Corporation provides postsecondary education through online, campus-based, and blended learning programs in the United States. The company operates in two segments, Colorado Technical University and American InterContinental University. It offers academic programs in the career-oriented disciplines of business and management, nursing, healthcare management, computer science, engineering, information systems and technology, project management, cybersecurity, and criminal justice, as well as business studies, information technologies, education, and health sciences. The company also operates intellipath, a personalized learning platform; and a mobile application and two-way messaging platform. As of December 31, 2021, it had a total student enrollment of approximately 40,400 students. The company was formerly known as Career Education Corporation and changed its name to Perdoceo Education Corporation in January 2020. Perdoceo Education Corporation was incorporated in 1994 and is based in Schaumburg, Illinois.",Mr. Todd S. Nelson,Education & Training Services,26.2,USD,1726954660,https://images.financialmodelingprep.com/symbol/PRDO.png,564891,11.96,1.22,820261,215472000,147590000,"[{'period': '2024', 'revenue': 681.26, 'unit': 'M', 'net_profit': 147.59}, {'period': '2023', 'revenue': 710.0, 'unit': 'M', 'net_profit': 147.65}, {'period': '2022', 'revenue': 695.21, 'unit': 'M', 'net_profit': 95.87}, {'period': '2021', 'revenue': 693.03, 'unit': 'M', 'net_profit': 109.64}]","[{'period': ""Q4 '24"", 'revenue': 176.43, 'unit': 'M', 'net_profit': 31.46}, {'period': ""Q3 '24"", 'revenue': 169.83, 'unit': 'M', 'net_profit': 38.26}, {'period': ""Q2 '24"", 'revenue': 166.74, 'unit': 'M', 'net_profit': 38.43}, {'period': ""Q1 '24"", 'revenue': 168.26, 'unit': 'M', 'net_profit': 39.44}, {'period': ""Q4 '23"", 'revenue': 147.92, 'unit': 'M', 'net_profit': 17.19}, {'period': ""Q3 '23"", 'revenue': 179.92, 'unit': 'M', 'net_profit': 41.31}]",2.25,2.19,1237034000,640154000,568925000,277498000,28137000,0,132162000,700678000,156969000,0.02893816973239356,-0.00041990626608511905,0.013513513513513424,"[0.13, 0.11]","['2025-02-28', '2023-08-31']",__nan__,0.22432528127763668
253,PRFT,Perficient Inc. Common Stock,"Perficient, Inc. provides digital consultancy services and solutions in the United States. The company offers strategy and consulting solutions in the areas of digital and technology strategy, management consulting, and organizational change management; and data and intelligence solutions in the areas of analytics, artificial intelligence and machine learning, big data, business intelligence, and custom product portfolio. It also provides blockchain, cloud, commerce, corporate performance management, customer relationship management, content management systems, customer experience platforms, custom application development, DevOps, enterprise resource planning, integration and APIs, intelligent automation, Internet of Things, mobile, portals and collaboration, supply chain, product information management, and order management systems. In addition, the company offers analytics, content architecture, conversion rate optimization, creative design, email marketing, journey sciences, paid media and search, marketing automation research, SEO, and social media services; product development services, as well as a suite of proprietary products; and optimized global delivery solutions. It serves the healthcare, financial services, retail and consumer goods, manufacturing, automotive and transportation, telecommunications, energy and utilities, and life science markets. Perficient, Inc. was incorporated in 1997 and is headquartered in St. Louis, Missouri.",Mr. Thomas J. Hogan,Information Technology Services,75.96,USD,2670502932,https://images.financialmodelingprep.com/symbol/PRFT.png,354368,36.344497607655505,0.48,2993827,161508000,98933000,"[{'period': '2023', 'revenue': 906.54, 'unit': 'M', 'net_profit': 98.93}, {'period': '2022', 'revenue': 905.06, 'unit': 'M', 'net_profit': 104.39}, {'period': '2021', 'revenue': 761.03, 'unit': 'M', 'net_profit': 52.09}, {'period': '2020', 'revenue': 612.13, 'unit': 'M', 'net_profit': 30.18}]","[{'period': ""Q2 '24"", 'revenue': 222.82, 'unit': 'M', 'net_profit': 17.44}, {'period': ""Q1 '24"", 'revenue': 215.3, 'unit': 'M', 'net_profit': 11.55}, {'period': ""Q4 '23"", 'revenue': 220.79, 'unit': 'M', 'net_profit': 23.18}, {'period': ""Q3 '23"", 'revenue': 223.24, 'unit': 'M', 'net_profit': 22.6}, {'period': ""Q2 '23"", 'revenue': 231.1, 'unit': 'M', 'net_profit': 26.36}, {'period': ""Q1 '23"", 'revenue': 231.41, 'unit': 'M', 'net_profit': 26.8}]",2.91,2.76,1064604000,325953000,128886000,533981000,178998000,-21582000,78472000,128886000,137575000,-0.088303198965854,-0.05229327917848111,-0.05519480519480517,__nan__,__nan__,__nan__,0.5015771122407956
254,PRFX,PainReform Ltd. Ordinary Shares,"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.",Dr. Ehud  Geller Ph.D.,Drug Manufacturers - Specialty & Generic,1.82,USD,3430702,https://images.financialmodelingprep.com/symbol/PRFX.png,1106949,-0.01,0.1,36752,-9569000,-9344000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.34}, {'period': '2022', 'revenue': 0.08600000000000001, 'unit': 'M', 'net_profit': -8.79}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.05}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.31}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.51}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 36.0}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.18}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.2}]",-42.86,-42.83,9930000,9799000,8026000,2691000,45000,0,2410000,8026000,-6688000,-0.08075446126044726,-0.06278434940855324,-4.195151515151515,__nan__,__nan__,__nan__,0.2709969788519637
255,PRGS,Progress Software Corporation Common Stock (DE),"Progress Software Corporation develops, deploys, and manages business applications. The company offers OpenEdge, a development software, which builds multi-language applications for secure deployment across various platforms and devices, as well as cloud; developer tools that consists of components for user interface development for Web, mobile, desktop, chat, and AR/VR apps, as well as automated application testing and reporting tools; Sitefinity, a web content management and customer analytics platform; Corticon, a business rules management system that provides applications with decision automation and change process, and decision-related insight capabilities. It also offers DataDirect Connect, which provides data connectivity using industry-standard interfaces to connect applications running on various platforms; MOVEit that offers secure collaboration and automated file transfers of critical business information; Chef, an infrastructure automation platform to build, deploy, manage, and secure applications in multi-cloud and hybrid environments, and on-premises; and WhatsUp Gold, a network monitoring solution. In addition, the company provides Kemp LoadMaster, a load balancing solutions; and Kemp Flowmon network performance monitoring and diagnostic solutions that collect and analyze network telemetry from various sources. Further, it provides project management, implementation, custom development, programming, and other services, as well as web-enable applications; and training services. The company sells its products to end users, independent software vendors, original equipment manufacturers, and system integrators. It has operations in the United States, Canada, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1981 and is headquartered in Burlington, Massachusetts.",Mr. Yogesh K. Gupta,Software - Application,57.38,USD,2468831880,https://images.financialmodelingprep.com/symbol/PRGS.png,841454,45.18,2.7,1119205,124003000,68438000,"[{'period': '2024', 'revenue': 753.41, 'unit': 'M', 'net_profit': 68.44}, {'period': '2023', 'revenue': 694.44, 'unit': 'M', 'net_profit': 70.2}, {'period': '2022', 'revenue': 602.01, 'unit': 'M', 'net_profit': 95.07}, {'period': '2021', 'revenue': 531.31, 'unit': 'M', 'net_profit': 78.42}]","[{'period': ""Q1 '25"", 'revenue': 238.01, 'unit': 'M', 'net_profit': 10.95}, {'period': ""Q4 '24"", 'revenue': 214.96, 'unit': 'M', 'net_profit': 1.15}, {'period': ""Q3 '24"", 'revenue': 178.69, 'unit': 'M', 'net_profit': 28.46}, {'period': ""Q2 '24"", 'revenue': 175.08, 'unit': 'M', 'net_profit': 16.19}, {'period': ""Q1 '24"", 'revenue': 184.69, 'unit': 'M', 'net_profit': 22.64}, {'period': ""Q4 '23"", 'revenue': 176.97, 'unit': 'M', 'net_profit': 15.34}]",1.58,1.54,2526966000,368813000,118077000,2088178000,198247000,0,455145000,118077000,206288000,-0.4188657846762364,-0.025058050913856718,-0.024691358024691377,"[0.175, 0.125]","['2024-08-30', '2016-11-29']",__nan__,0.8263577745011211
256,PRIM,Primoris Services Corporation Common Stock,"Primoris Services Corporation, a specialty contractor company, provides a range of construction, fabrication, maintenance, replacement, and engineering services in the United States and Canada. It operates through three segments: Utilities, Energy/Renewables, and Pipeline Services. The Utilities segment offers installation and maintenance services for new and existing natural gas distribution systems, electric utility distribution and transmission systems, and communications systems. The Energy/Renewables segment provides a range of services, including engineering, procurement, and construction, as well as retrofits, highway and bridge construction, demolition, site work, soil stabilization, mass excavation, flood control, upgrades, repairs, outages, and maintenance services to renewable energy and energy storage, renewable fuels, petroleum, refining, and petrochemical industries, as well as state departments of transportation. The Pipeline Services segment offers a range of services comprising pipeline construction, maintenance, facility, and integrity services; installation of compressor and pump stations; and metering facilities for entities in the petroleum and petrochemical industries, as well as gas, water, and sewer utilities. The company was founded in 1960 and is headquartered in Dallas, Texas.",Mr. David L. King,Engineering & Construction,58.58,USD,3158352416,https://images.financialmodelingprep.com/symbol/PRIM.png,979516,17.7,4.82,1261406,317452000,180888000,"[{'period': '2024', 'revenue': 6370.0, 'unit': 'M', 'net_profit': 180.89}, {'period': '2023', 'revenue': 5720.0, 'unit': 'M', 'net_profit': 126.14}, {'period': '2022', 'revenue': 4420.0, 'unit': 'M', 'net_profit': 133.02}, {'period': '2021', 'revenue': 3500.0, 'unit': 'M', 'net_profit': 115.74}]","[{'period': ""Q4 '24"", 'revenue': 1740.0, 'unit': 'M', 'net_profit': 53.97}, {'period': ""Q3 '24"", 'revenue': 1650.0, 'unit': 'M', 'net_profit': 58.44}, {'period': ""Q2 '24"", 'revenue': 1560.0, 'unit': 'M', 'net_profit': 49.54}, {'period': ""Q1 '24"", 'revenue': 1410.0, 'unit': 'M', 'net_profit': 18.94}, {'period': ""Q4 '23"", 'revenue': 1520.0, 'unit': 'M', 'net_profit': 37.66}, {'period': ""Q3 '23"", 'revenue': 1530.0, 'unit': 'M', 'net_profit': 48.14}]",3.37,3.31,4195868000,2159472000,455825000,2786335000,834386000,0,1670686000,455825000,381758000,-0.12518980051311587,0.4339688453763526,0.42194092827004215,"[0.08, 0.025]","['2025-03-31', '2008-09-19']",__nan__,0.6640664100967905
257,PRLD,Prelude Therapeutics Incorporated Common Stock,"Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.","Dr. Krishna  Vaddi D.V.M., Ph.D.",Biotechnology,0.6647,USD,36661263,https://images.financialmodelingprep.com/symbol/PRLD.png,228975,-0.4,0.0542,162010,-139714000,-127173000,"[{'period': '2024', 'revenue': 7.0, 'unit': 'M', 'net_profit': -127.17}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -121.83}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -107.34}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -110.78}]","[{'period': ""Q4 '24"", 'revenue': 4.0, 'unit': 'M', 'net_profit': -28.73}, {'period': ""Q3 '24"", 'revenue': 3.0, 'unit': 'M', 'net_profit': -32.27}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.74}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.43}, {'period': ""Q4 '23"", 'revenue': 3.42, 'unit': 'M', 'net_profit': -33.08}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.61}]",-1.68,-1.68,175515000,135895000,133614000,44056000,0,0,25641000,12474000,-103652000,-0.06564054062299783,-0.04383905706218399,0.16831683168316836,__nan__,__nan__,__nan__,0.25100988519499756
258,PROF,Profound Medical Corp. Common Stock,"Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.","Dr. Arun Swarup Menawat MBA, Ph.D.",Medical - Devices,4.49,USD,134878702,https://images.financialmodelingprep.com/symbol/PROF.png,82572,-4.01,-0.04,345879,-33062000,-27816000,"[{'period': '2024', 'revenue': 10.68, 'unit': 'M', 'net_profit': -27.82}, {'period': '2023', 'revenue': 7.2, 'unit': 'M', 'net_profit': -28.57}, {'period': '2022', 'revenue': 6.68, 'unit': 'M', 'net_profit': -28.67}, {'period': '2021', 'revenue': 6.87, 'unit': 'M', 'net_profit': -30.7}]","[{'period': ""Q4 '24"", 'revenue': 2.96, 'unit': 'K', 'net_profit': 5.28}, {'period': ""Q3 '24"", 'revenue': 2.83, 'unit': 'M', 'net_profit': -9.36}, {'period': ""Q2 '24"", 'revenue': 2.23, 'unit': 'M', 'net_profit': -6.92}, {'period': ""Q1 '24"", 'revenue': 1.91, 'unit': 'M', 'net_profit': -6.2}, {'period': ""Q4 '23"", 'revenue': 2.01, 'unit': 'M', 'net_profit': -8.91}, {'period': ""Q3 '23"", 'revenue': 1.73, 'unit': 'M', 'net_profit': -5.56}]",-1.12,-1.12,70234000,69065000,54912000,9812000,7045000,0,6565000,54912000,-23453000,-0.2345319442888615,0.02635724036543106,0.17037037037037034,__nan__,__nan__,__nan__,0.13970441666429365
259,PROG,Progenity Inc. Common Stock,"Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. It also develops systemic oral delivery of biotherapeutics, which include PGN-OB, a combination product of a variant of adalimumab and the Oral Biotherapeutics Delivery System (OBDM) for the treatment of inflammatory conditions; and PGN-OB2, a combination product of a GLP-1 receptor agonist and the OBDS for the treatment of Type 2 diabetes. In addition, the company develops Recoverable Sampling System, an ingestible smart capsule designed to autonomously identify locations in the GI tract, collect, and preserve a sample for analysis; and PIL Dx, an ingestible smart capsule designed to sample, measure, and transmit results. It has partnership agreement with Ionis Pharmaceuticals to evaluate the OBDS for delivery of antisense oligonucleotides. The company was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.",Dr. Harry  Stylli,Biotechnology,0.8845,USD,8181227,https://images.financialmodelingprep.com/symbol/PROG.png,6366301,-0.2568234610917538,-0.03179997,2779613,-114054000,-124115000,"[{'period': '2023', 'revenue': 0.004, 'unit': 'M', 'net_profit': -124.11}, {'period': '2022', 'revenue': 0.305, 'unit': 'M', 'net_profit': -48.83}, {'period': '2021', 'revenue': 1.25, 'unit': 'M', 'net_profit': -178.52}, {'period': '2020', 'revenue': 74.31, 'unit': 'M', 'net_profit': -192.53}]","[{'period': ""Q3 '24"", 'revenue': 0.032, 'unit': 'M', 'net_profit': -18.4}, {'period': ""Q2 '24"", 'revenue': 0.318, 'unit': 'M', 'net_profit': 6.46}, {'period': ""Q1 '24"", 'revenue': 0.542, 'unit': 'M', 'net_profit': -4.19}, {'period': ""Q4 '23"", 'revenue': 0.872, 'unit': 'M', 'net_profit': -15.41}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -73.45}, {'period': ""Q2 '23"", 'revenue': 0.002, 'unit': 'M', 'net_profit': -17.81}]",-78.7,-78.7,31215000,19071000,15211000,132636000,830000,3000000,62972000,15211000,-48602000,-2.053409364709662,-1.5417775957403235,-11.296874999999998,__nan__,__nan__,__nan__,4.249111004324844
260,PROV,Provident Financial Holdings Inc. Common Stock,"Provident Financial Holdings, Inc. operates as the holding company for Provident Savings Bank, F.S.B. that provides community banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its deposit products include checking, savings, and money market accounts, as well as time deposits; and loan portfolio consists of single-family, multi-family, commercial real estate, construction, mortgage, commercial business, and consumer loans. The company also offers investment services comprising the sale of investment products, such as annuities and mutual funds; and trustee services for real estate transactions. It operates through 12 full-service banking offices in Riverside County and one full-service banking office in San Bernardino County. The company was founded in 1956 and is based in Riverside, California.",Mr. Donavon P. Ternes,Banks - Regional,14.22,USD,95141896,https://images.financialmodelingprep.com/symbol/PROV.png,6354,15.63,0.4,3628,13542000,7351000,"[{'period': '2024', 'revenue': 38.93, 'unit': 'M', 'net_profit': 7.35}, {'period': '2023', 'revenue': 41.06, 'unit': 'M', 'net_profit': 8.59}, {'period': '2022', 'revenue': 36.31, 'unit': 'M', 'net_profit': 9.09}, {'period': '2021', 'revenue': 35.21, 'unit': 'M', 'net_profit': 7.56}]","[{'period': ""Q2 '25"", 'revenue': 14020.0, 'unit': 'K', 'net_profit': 872.0}, {'period': ""Q1 '25"", 'revenue': 10.21, 'unit': 'M', 'net_profit': 1.9}, {'period': ""Q4 '24"", 'revenue': 15.38, 'unit': 'M', 'net_profit': 1.95}, {'period': ""Q3 '24"", 'revenue': 14.65, 'unit': 'M', 'net_profit': 1.5}, {'period': ""Q2 '24"", 'revenue': 9.65, 'unit': 'M', 'net_profit': 2.14}, {'period': ""Q1 '24"", 'revenue': 9.89, 'unit': 'M', 'net_profit': 1.76}]",1.06,1.06,1272200000,51376000,51376000,1142259000,4287000,131900000,0,51376000,4096000,-0.1321456036913612,-0.1444366852886406,-0.11666666666666659,"[0.14, 0.05]","['2025-02-13', '2002-08-05']",__nan__,0.8978611853482157
261,PRPH,ProPhase Labs Inc. Common Stock (DE),"ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.",Mr. Ted William Karkus,Drug Manufacturers - Specialty & Generic,0.2924,USD,12245420,https://images.financialmodelingprep.com/symbol/PRPH.png,10365145,-0.12,0.0424,1135735,-43338000,0,"[{'period': '2024', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2023', 'revenue': 44.38, 'unit': 'M', 'net_profit': -16.78}, {'period': '2022', 'revenue': 122.65, 'unit': 'M', 'net_profit': 18.46}, {'period': '2021', 'revenue': 79.04, 'unit': 'M', 'net_profit': 6.27}]","[{'period': ""Q4 '24"", 'revenue': -2.48, 'unit': 'M', 'net_profit': -34.36}, {'period': ""Q3 '24"", 'revenue': 3.15, 'unit': 'M', 'net_profit': -6.59}, {'period': ""Q2 '24"", 'revenue': 2.47, 'unit': 'M', 'net_profit': -6.15}, {'period': ""Q1 '24"", 'revenue': 3.63, 'unit': 'M', 'net_profit': -6.26}, {'period': ""Q4 '23"", 'revenue': 3.5, 'unit': 'M', 'net_profit': -8.75}, {'period': ""Q3 '23"", 'revenue': 8.37, 'unit': 'M', 'net_profit': -5.14}]",0,0,63200000,30637000,678000,55847000,20058000,0,32134000,678000,-18444000,-1.922910905779996,1,1,"[0.3, 1]","['2022-05-24', '2018-06-06']",__nan__,0.8836550632911392
262,PRPL,Purple Innovation Inc. Common Stock,"Purple Innovation, Inc. designs and manufactures mattresses, pillows, and cushions. The company also offers bases, foundations, sheets, mattress protectors, bed frames, seat cushions, weighted blankets, and duvets, as well as pet beds. It markets and sells its products through its e-commerce online channels retail brick-and-mortar wholesale partners, and third-party online retailers, as well as through Purple retail showrooms. The company was founded in 2010 and is headquartered in Lehi, Utah.",Mr. Robert T. DeMartini,"Furnishings, Fixtures & Appliances",0.6938,USD,74614721,https://images.financialmodelingprep.com/symbol/PRPL.png,790103,-0.76,0.0678,497351,-45170000,-97897000,"[{'period': '2024', 'revenue': 487.88, 'unit': 'M', 'net_profit': -97.9}, {'period': '2023', 'revenue': 510.54, 'unit': 'M', 'net_profit': -120.76}, {'period': '2022', 'revenue': 575.69, 'unit': 'M', 'net_profit': -89.93}, {'period': '2021', 'revenue': 726.23, 'unit': 'M', 'net_profit': 3.11}]","[{'period': ""Q4 '24"", 'revenue': 128.97, 'unit': 'M', 'net_profit': -8.48}, {'period': ""Q3 '24"", 'revenue': 118.6, 'unit': 'M', 'net_profit': -39.23}, {'period': ""Q2 '24"", 'revenue': 120270.0, 'unit': 'K', 'net_profit': 27.0}, {'period': ""Q1 '24"", 'revenue': 120.03, 'unit': 'M', 'net_profit': -50.22}, {'period': ""Q4 '23"", 'revenue': 145.94, 'unit': 'M', 'net_profit': -18.33}, {'period': ""Q3 '23"", 'revenue': 140.0, 'unit': 'M', 'net_profit': -36.0}]",-0.91,-0.91,307845000,126368000,29011000,287636000,33057000,0,101003000,29011000,-25094000,0.52015212356853,0.18930579593729557,0.22222222222222215,"[0.001, 0.001]","['2023-04-27', '2023-04-27']",__nan__,0.9343533271613962
263,PRPO,Precipio Inc.  Common Stock,"Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.",Mr. Ilan  Danieli,Medical - Diagnostics & Research,5.69,USD,8559524,https://images.financialmodelingprep.com/symbol/PRPO.png,9985,-1.94,0.71,36592,-4216000,-4290000,"[{'period': '2024', 'revenue': 15.96, 'unit': 'M', 'net_profit': -4.29}, {'period': '2023', 'revenue': 15.2, 'unit': 'M', 'net_profit': -5.85}, {'period': '2022', 'revenue': 9.41, 'unit': 'M', 'net_profit': -12.2}, {'period': '2021', 'revenue': 8.85, 'unit': 'M', 'net_profit': -8.55}]","[{'period': ""Q4 '24"", 'revenue': 5450.0, 'unit': 'K', 'net_profit': -365.0}, {'period': ""Q3 '24"", 'revenue': 4600.0, 'unit': 'K', 'net_profit': -626.0}, {'period': ""Q2 '24"", 'revenue': 4.44, 'unit': 'M', 'net_profit': -1.22}, {'period': ""Q1 '24"", 'revenue': 3.43, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q4 '23"", 'revenue': 4330.0, 'unit': 'K', 'net_profit': 925.0}, {'period': ""Q3 '23"", 'revenue': 3.74, 'unit': 'M', 'net_profit': -1.46}]",-2.93,-2.93,16996000,3451000,3451000,4902000,0,0,4271000,3451000,216000,0.023622047244094488,0.26704254228600716,0.3503325942350332,__nan__,__nan__,__nan__,0.2884208048952695
264,PRQR,ProQR Therapeutics N.V. Ordinary Shares,"ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.",Mr. Daniel Anton de Boer,Biotechnology,1.2,USD,126255600,https://images.financialmodelingprep.com/symbol/PRQR.png,487955,-3.43,0.07,795407,-24122000,-27763000,"[{'period': '2024', 'revenue': 18.91, 'unit': 'M', 'net_profit': -27.76}, {'period': '2023', 'revenue': 6.51, 'unit': 'M', 'net_profit': -28.12}, {'period': '2022', 'revenue': 4.04, 'unit': 'M', 'net_profit': -64.89}, {'period': '2021', 'revenue': 1.35, 'unit': 'M', 'net_profit': -61.68}]","[{'period': ""Q4 '24"", 'revenue': 4.31, 'unit': 'M', 'net_profit': -9.3}, {'period': ""Q3 '24"", 'revenue': 3.84, 'unit': 'M', 'net_profit': -8.11}, {'period': ""Q2 '24"", 'revenue': 6.34, 'unit': 'M', 'net_profit': -2.69}, {'period': ""Q1 '24"", 'revenue': 4.48, 'unit': 'M', 'net_profit': -7.7}, {'period': ""Q4 '23"", 'revenue': 3.2, 'unit': 'M', 'net_profit': -5.34}, {'period': ""Q3 '23"", 'revenue': 1.37, 'unit': 'M', 'net_profit': -5.71}]",-0.34,-0.34,167958000,153845000,149408000,79398000,2027000,0,38902000,149408000,-37811000,-0.0010374735444246173,0.012660478679896156,0.02857142857142844,__nan__,__nan__,__nan__,0.4727253241881899
265,PRSR,Prospector Capital Corp. Class A Ordinary Shares,"Prospector Capital Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in La Jolla, California.",Mr. Derek K. Aberle,Shell Companies,4.74,USD,48912325,https://images.financialmodelingprep.com/symbol/PRSR.png,162443,-18.96,0,162443,-1000636,8528246,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.53}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.38}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -20.0}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 372.81}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.38}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 865.21}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.23}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.51}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 661.6}]",0.21,0.21,329802135,18401,18401,945108,0,329783734,788108,18401,-766231,-1.6397760672514339,2.9452933948382327,2.909090909090909,__nan__,__nan__,__nan__,0.0028656818731631318
266,PRSRU,Prospector Capital Corp. Unit,"Prospector Capital Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in La Jolla, California.",Mr. Derek K. Aberle,Shell Companies,4.43,USD,38572010,https://images.financialmodelingprep.com/symbol/PRSRU.png,2061,-295.3333333333333,-0.02,6206,-1000636,8528246,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.53}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.38}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -20.0}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 372.81}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.38}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 865.21}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.23}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.51}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 661.6}]",0.21,0.21,329802135,18401,18401,945108,0,329783734,788108,18401,-766231,-1.6397760672514339,2.9452933948382327,2.909090909090909,__nan__,__nan__,__nan__,0.0028656818731631318
267,PRSRW,Prospector Capital Corp. Warrants,"Prospector Capital Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in La Jolla, California.",Mr. Derek K. Aberle,Shell Companies,0.075,USD,653025,https://images.financialmodelingprep.com/symbol/PRSRW.png,0,0,0.035,83939,-1000636,8528246,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.53}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.38}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -20.0}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 372.81}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.38}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 865.21}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.23}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.51}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 661.6}]",0.21,0.21,329802135,18401,18401,945108,0,329783734,788108,18401,-766231,-1.6397760672514339,2.9452933948382327,2.909090909090909,__nan__,__nan__,__nan__,0.0028656818731631318
268,PRTA,Prothena Corporation plc Ordinary Shares,"Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.",Dr. Gene G. Kinney Ph.D.,Biotechnology,10.26,USD,552265020,https://images.financialmodelingprep.com/symbol/PRTA.png,444365,-4.52,-0.22,1323565,-154561000,-122310000,"[{'period': '2024', 'revenue': 135.16, 'unit': 'M', 'net_profit': -122.31}, {'period': '2023', 'revenue': 91.37, 'unit': 'M', 'net_profit': -147.03}, {'period': '2022', 'revenue': 53.91, 'unit': 'M', 'net_profit': -116.95}, {'period': '2021', 'revenue': 200.58, 'unit': 'M', 'net_profit': 66.97}]","[{'period': ""Q4 '24"", 'revenue': 2.12, 'unit': 'M', 'net_profit': -57.96}, {'period': ""Q3 '24"", 'revenue': 0.97, 'unit': 'M', 'net_profit': -59.0}, {'period': ""Q2 '24"", 'revenue': 132.01, 'unit': 'M', 'net_profit': 66.89}, {'period': ""Q1 '24"", 'revenue': 0.05, 'unit': 'M', 'net_profit': -72.24}, {'period': ""Q4 '23"", 'revenue': 0.316, 'unit': 'M', 'net_profit': -67.48}, {'period': ""Q3 '23"", 'revenue': 84.87, 'unit': 'M', 'net_profit': 21.91}]",-2.27,-2.27,547108000,485412000,471388000,60182000,0,0,48501000,471388000,-150348000,0.18698318850337703,0.16811763745681094,0.1775362318840579,__nan__,__nan__,__nan__,0.11000021933512213
269,PRTC,PureTech Health plc American Depositary Shares,"PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome; and therapies to treat cognitive dysfunction associated with depression, multiple sclerosis, post COVID and ICU, and cancer related conditions. It also provides hematopoietic stem cell based therapies for patients with blood cancer; a voice-based technology platform to detect voice changes linked to health conditions; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100 to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210 to treat solid tumors; Glyph, a synthetic lymphatic targeting chemistry platform; Orasome technology to enable the oral administration of macromolecule therapeutic payloads; meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases; and Alivio technology platform for inflammation-targeted disease immunomodulation. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.","Dr. Bharatt M. Chowrira J.D., Ph.D.",Biotechnology,15.1708,USD,364385928,https://images.financialmodelingprep.com/symbol/PRTC.png,4522,-5.06,-0.0492,33989,-11627000,-65697000,"[{'period': '2023', 'revenue': 3.33, 'unit': 'M', 'net_profit': -65.7}, {'period': '2022', 'revenue': 2.09, 'unit': 'M', 'net_profit': -37.06}, {'period': '2021', 'revenue': 9.98, 'unit': 'M', 'net_profit': -62.71}, {'period': '2020', 'revenue': 8.34, 'unit': 'M', 'net_profit': 4.57}]","[{'period': ""Q2 '24"", 'revenue': 0.28800000000000003, 'unit': 'M', 'net_profit': -41.77}, {'period': ""Q4 '23"", 'revenue': 0.17857, 'unit': 'M', 'net_profit': -40.37}, {'period': ""Q2 '23"", 'revenue': 3.15, 'unit': 'M', 'net_profit': -25.0}, {'period': ""Q4 '22"", 'revenue': 9.01, 'unit': 'M', 'net_profit': -23.09}, {'period': ""Q2 '22"", 'revenue': 7.03, 'unit': 'M', 'net_profit': -28.34}, {'period': ""Q4 '21"", 'revenue': 11.66, 'unit': 'M', 'net_profit': 14.98}]",-2.38,-0.24,693973000,347201000,327143000,235742000,2376000,325626000,51370000,191081000,-106162000,0.7772093201502261,-0.7725285991797971,-12.222222222222221,__nan__,__nan__,__nan__,0.33969909492156036
270,PRTG,Portage Biotech Inc. Common Stock,"Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.",Mr. Alexander  Pickett,Biotechnology,5.02,USD,5627711,https://images.financialmodelingprep.com/symbol/PRTG.png,607027,-0.07,0.12,114267,-18199000,-75339000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -75.34}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -104.61}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -19.17}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.19}]","[{'period': ""Q2 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.36}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.66}, {'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.89}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.37}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.16}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.92}]",-3.7,-3.7,7779000,7695000,5028000,4450000,39000,0,2879000,5028000,-14297000,-0.15366085578446909,0.27981761000277217,0.42989214175654855,__nan__,__nan__,__nan__,0.5720529631057977
271,PRTH,Priority Technology Holdings Inc. Common Stock,"Priority Technology Holdings, Inc. operates as a payment technology company in the United States. It operates through three segments: Small and Medium-Sized Businesses (SMB) Payments, Business-To-Business Payments, and Enterprise Payments. The company offers MX product line, including MX Connect and MX Merchant products, such as MX Insights, MX Storefront, MX Retail, MX Invoice, MX B2B and ACH.com, and others, which provides flexible and customizable set of business applications that helps to manage critical business work functions and revenue performance to resellers and merchant clients using core payment processing as our leverage point. It also offers CPX, a platform that offers accounts payable automation solutions, including virtual card, purchase card, ACH +, dynamic discounting, or check. In addition, the company provides curated managed services and a suite of integrated accounts payable automation solutions to various financial institutions and card networks; and payment-adjacent technologies to facilitate the acceptance of electronic payments from customers. Further, it offers embedded payment and banking solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments; and managed services solutions that provide audience-specific programs for institutional partners and other third parties; and consulting and development solutions. The company serves SMB, and enterprises, as well as distribution partners, including retail and wholesale independent sales organizations, financial institutions, and independent software vendors. Priority Technology Holdings, Inc. was founded in 2005 and is headquartered in Alpharetta, Georgia.",Mr. Thomas Charles Priore,Software - Infrastructure,7.05,USD,560610360,https://images.financialmodelingprep.com/symbol/PRTH.png,711288,-22.74,0.65,563637,184270000,24015000,"[{'period': '2024', 'revenue': 879.7, 'unit': 'M', 'net_profit': 24.02}, {'period': '2023', 'revenue': 755.61, 'unit': 'M', 'net_profit': -1.31}, {'period': '2022', 'revenue': 663.64, 'unit': 'M', 'net_profit': -2.15}, {'period': '2021', 'revenue': 514.9, 'unit': 'M', 'net_profit': 1.39}]","[{'period': ""Q4 '24"", 'revenue': 227.07, 'unit': 'M', 'net_profit': 7.86}, {'period': ""Q3 '24"", 'revenue': 227.05, 'unit': 'M', 'net_profit': 10.61}, {'period': ""Q2 '24"", 'revenue': 219870.0, 'unit': 'K', 'net_profit': 936.0}, {'period': ""Q1 '24"", 'revenue': 205.72, 'unit': 'M', 'net_profit': 4.61}, {'period': ""Q4 '23"", 'revenue': 199280.0, 'unit': 'K', 'net_profit': -106.0}, {'period': ""Q3 '23"", 'revenue': 189010.0, 'unit': 'K', 'net_profit': -87.0}]",-0.31,-0.31,1826860000,1105085000,58600000,1991885000,71607000,0,1051671000,58600000,63916000,0.215060499159276,19.31807780320366,0.5079365079365079,__nan__,__nan__,__nan__,1.0903325925358265
272,PRTK,Paratek Pharmaceuticals Inc. Common Stock,"Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. In addition, it has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.","Dr. Evan  Loh FACC, FAHA, M.D.",Biotechnology,2.23,USD,127828952,https://images.financialmodelingprep.com/symbol/PRTK.png,599679,-2.009009009009009,0.04,4476125,-44900000,-63566000,"[{'period': '2022', 'revenue': 150.79, 'unit': 'M', 'net_profit': -63.57}, {'period': '2021', 'revenue': 120.95, 'unit': 'M', 'net_profit': -59.08}, {'period': '2020', 'revenue': 43.52, 'unit': 'M', 'net_profit': -116.26}, {'period': '2019', 'revenue': 16.54, 'unit': 'M', 'net_profit': -128.79}]","[{'period': ""Q2 '23"", 'revenue': 38.06, 'unit': 'M', 'net_profit': -14.55}, {'period': ""Q1 '23"", 'revenue': 29.21, 'unit': 'M', 'net_profit': -20.14}, {'period': ""Q4 '22"", 'revenue': 72.63, 'unit': 'M', 'net_profit': -7.16}, {'period': ""Q3 '22"", 'revenue': 27.84, 'unit': 'M', 'net_profit': -25.27}, {'period': ""Q2 '22"", 'revenue': 27.55, 'unit': 'M', 'net_profit': -22.07}, {'period': ""Q1 '22"", 'revenue': 22.76, 'unit': 'M', 'net_profit': -17.91}]",-1.17,-1.17,172538000,136842000,34248000,343580000,78038000,0,37388000,34248000,-66177000,-0.1036008356888288,-0.0758581003317311,0.04098360655737709,"[0.0556, 1.33]","['2014-10-31', '2014-05-21']",__nan__,1.9913294462669093
273,PRTS,CarParts.com Inc. Common Stock,"CarParts.com, Inc., together with its subsidiaries, operates as an online provider of aftermarket auto parts and accessories in the United States and the Philippines. It offers replacement parts, such as parts for the exterior of an automobile; mirror products; engine and chassis components, as well as other mechanical and electrical parts; and performance parts and accessories to individual consumers through its network of e-commerce websites and online marketplaces. The company also sells auto parts to collision repair shops; markets Kool-Vue products to auto parts wholesale distributors; and aftermarket catalytic converters under the Evan Fischer brand. Its flagship websites include www.carparts.com, www.jcwhitney.com, www.autopartswarehouse.com and www.usautoparts.com. The company was formerly known as U.S. Auto Parts Network, Inc. and changed its name to CarParts.com, Inc. in July 2020. CarParts.com, Inc. was incorporated in 1995 and is headquartered in Torrance, California.",Mr. David  Meniane CPA,Specialty Retail,0.87,USD,50716737,https://images.financialmodelingprep.com/symbol/PRTS.png,662029,-1.23,0.0525,661422,-40635000,-40601000,"[{'period': '2024', 'revenue': 588.85, 'unit': 'M', 'net_profit': -40.6}, {'period': '2023', 'revenue': 675.73, 'unit': 'M', 'net_profit': -8.22}, {'period': '2022', 'revenue': 661600.0, 'unit': 'K', 'net_profit': -951.0}, {'period': '2021', 'revenue': 582.44, 'unit': 'M', 'net_profit': -10.34}]","[{'period': ""Q4 '24"", 'revenue': 133.54, 'unit': 'M', 'net_profit': -15.42}, {'period': ""Q3 '24"", 'revenue': 144.75, 'unit': 'M', 'net_profit': -10.02}, {'period': ""Q2 '24"", 'revenue': 144.27, 'unit': 'M', 'net_profit': -8.69}, {'period': ""Q1 '24"", 'revenue': 166.29, 'unit': 'M', 'net_profit': -6.48}, {'period': ""Q4 '23"", 'revenue': 156.4, 'unit': 'M', 'net_profit': -6.09}, {'period': ""Q3 '23"", 'revenue': 166.86, 'unit': 'M', 'net_profit': -2.52}]",-0.71,-0.71,210574000,138868000,36397000,125399000,6098000,0,90423000,36397000,-10235000,-5.0465046803425615,-3.937492399367627,-3.733333333333333,__nan__,__nan__,__nan__,0.5955103669018967
274,PRVA,Privia Health Group Inc. Common Stock,"Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.",Mr. Parth  Mehrotra,Medical - Healthcare Information Services,23.05,USD,2777824650,https://images.financialmodelingprep.com/symbol/PRVA.png,816740,209.55,1.31,1387167,24250000,14385000,"[{'period': '2024', 'revenue': 1740.0, 'unit': 'M', 'net_profit': 14.38}, {'period': '2023', 'revenue': 1660.0, 'unit': 'M', 'net_profit': 23.08}, {'period': '2022', 'revenue': 1360.0, 'unit': 'M', 'net_profit': -12.06}, {'period': '2021', 'revenue': 966.22, 'unit': 'M', 'net_profit': -190.65}]","[{'period': ""Q4 '24"", 'revenue': 460.9, 'unit': 'M', 'net_profit': 4.4}, {'period': ""Q3 '24"", 'revenue': 437.92, 'unit': 'M', 'net_profit': 3.54}, {'period': ""Q2 '24"", 'revenue': 422.33, 'unit': 'M', 'net_profit': 3.47}, {'period': ""Q1 '24"", 'revenue': 415.24, 'unit': 'M', 'net_profit': 2.98}, {'period': ""Q4 '23"", 'revenue': 440.83, 'unit': 'M', 'net_profit': 2.84}, {'period': ""Q3 '23"", 'revenue': 417.28, 'unit': 'M', 'net_profit': 5.64}]",0.12,0.11,1135783000,834823000,491149000,452336000,316179000,0,449146000,491149000,109282000,-0.10786549922742991,-0.37670609645131936,-0.4000000000000001,__nan__,__nan__,__nan__,0.3982591745078065
275,PRVB,Provention Bio Inc. Common Stock,"Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.","Mr. Ashleigh W. Palmer B.Sc., M.B.A.",Biotechnology,24.98,USD,2375415796,https://images.financialmodelingprep.com/symbol/PRVB.png,2842990,-16.43421052631579,0,9124151,-124692000,-113565000,"[{'period': '2022', 'revenue': 12.89, 'unit': 'M', 'net_profit': -113.56}, {'period': '2021', 'revenue': 1.4, 'unit': 'M', 'net_profit': -114.43}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -98.58}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.2}]","[{'period': ""Q4 '22"", 'revenue': 10.81, 'unit': 'M', 'net_profit': -33.28}, {'period': ""Q3 '22"", 'revenue': 0.756, 'unit': 'M', 'net_profit': -28.19}, {'period': ""Q2 '22"", 'revenue': 0.746, 'unit': 'M', 'net_profit': -29.54}, {'period': ""Q1 '22"", 'revenue': 0.58, 'unit': 'M', 'net_profit': -21.97}, {'period': ""Q4 '21"", 'revenue': 0.717, 'unit': 'M', 'net_profit': -25.83}, {'period': ""Q3 '21"", 'revenue': 0.678, 'unit': 'M', 'net_profit': -27.02}]",-1.52,-1.52,236856000,174649000,165003000,115007000,1359000,0,90390000,44039000,-76203000,-0.07885583761615532,0.007576552013422819,0.16022099447513813,__nan__,__nan__,__nan__,0.48555662512243725
276,PSAC,Property Solutions Acquisition Corp. Common Stock,"Property Solutions Acquisition Corp. intends to enter a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more target businesses that service the real estate industry. The company was founded in 2020 and is based in New York, New York.",Mr. Jordan D. Vogel,Shell Companies,13.78,USD,9680159779,https://images.financialmodelingprep.com/symbol/PSAC.png,793944,0,-0.05000019,1401866,-2109383,-2109383,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.11}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.73}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.11}]",-0.0715,-0.0715,230562435,677956,230433874,225562428,0,0,0,549395,,0,0,0,__nan__,__nan__,__nan__,0.9783138697333761
277,PSACU,Property Solutions Acquisition Corp. Unit,"Property Solutions Acquisition Corp. intends to enter a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more target businesses that service the real estate industry. The company was founded in 2020 and is based in New York, New York.",Mr. Jordan D. Vogel,Shell Companies,17.08,USD,11998340278,https://images.financialmodelingprep.com/symbol/PSACU.png,2435,-108.78980891719745,0.05999947,1854,-2109383,-2109383,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.11}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.73}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.11}]",-0.0715,-0.0715,230562435,677956,230433874,225562428,0,0,0,549395,,0,0,0,__nan__,__nan__,__nan__,0.9783138697333761
278,PSACW,Property Solutions Acquisition Corp. Warrant,,,,,,,,,,,,,,[],"[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.73}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.82}]",,,230562435,677956,549395,2041838,0,0,2041838,549395,,,,,__nan__,__nan__,__nan__,0.008855900572007752
279,PSAG,Property Solutions Acquisition Corporation II Class A Common Stock,"Property Solutions Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.",Mr. Jordan D. Vogel,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/PSAG.png,94743,0,-0.02,15755,1522572,3883470,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.88}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.13}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.11}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.9}]",0.11,0.11,317801291,741191,531984,16009851,0,0,285139,531984,-838145,0,0,0,__nan__,__nan__,__nan__,0.050376922477637136
280,PSAGU,Property Solutions Acquisition Corporation II Units,"Property Solutions Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.",Mr. Jordan D. Vogel,Shell Companies,10.06,USD,0,https://images.financialmodelingprep.com/symbol/PSAGU.png,10394,121.20481927710843,-0.02,100,1522572,3883470,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.88}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.13}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.11}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.9}]",0.11,0.11,317801291,741191,531984,16009851,0,0,285139,531984,-838145,0,0,0,__nan__,__nan__,__nan__,0.050376922477637136
281,PSAGW,Property Solutions Acquisition Corporation II Warrant,,,Shell Companies,0.003,USD,0,https://images.financialmodelingprep.com/symbol/PSAGW.png,0,0,0,1207,1522572,3883470,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.88}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.13}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.11}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.9}]",0.11,0.11,317801291,741191,531984,16009851,0,0,285139,531984,-838145,0,0,0,__nan__,__nan__,__nan__,0.050376922477637136
282,PSEC,Prospect Capital Corporation Common Stock,"Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, leveraged buyouts, refinancing, acquisitions, recapitalizations, turnaround, growth capital, development, capital expenditures and subordinated debt tranches of collateralized loan obligations, cash flow term loans, market place lending and bridge transactions. It also makes real estate investments particularly in multi-family residential real estate asset class. The fund makes secured debt, senior debt, senior and secured term loans, unitranche debt, first-lien and second lien, private debt, private equity, mezzanine debt, and equity investments in private and microcap public businesses. It focuses on both primary origination and secondary loans/portfolios and invests in situations like debt financings for private equity sponsors, acquisitions, dividend recapitalizations, growth financings, bridge loans, cash flow term loans, real estate financings/investments. It also focuses on investing in small-sized and medium-sized private companies rather than large public companies. The fund typically invests across all industry sectors, with a particular expertise in the energy and industrial sectors. It invests in aerospace and defense, chemicals, conglomerate services, consumer services, ecological, electronics, financial services, machinery, manufacturing, media, pharmaceuticals, retail, software, specialty minerals, textiles and leather, transportation, oil and gas production, coal production, materials, industrials, consumer discretionary, information technology, utilities, pipeline, storage, power generation and distribution, renewable and clean energy, oilfield services, healthcare, food and beverage, education, business services, and other select sectors. It prefers to invest in the United States and Canada. The fund seeks to invest between $10 million to $500 million per transaction in companies with EBITDA between $5 million and $150 million, sales value between $25 million and $500 million, and enterprise value between $5 million and $1000 million. It fund also co-invests for larger deals. The fund seeks control acquisitions by providing multiple levels of the capital structure. The fund focuses on sole, agented, club, or syndicated deals.","Mr. John Francis Barry III, J.D.",Asset Management,3.72,USD,1652915040,https://images.financialmodelingprep.com/symbol/PSEC.png,2838277,-17.71,0.22,4062934,0,262834000,"[{'period': '2024', 'revenue': 770.31, 'unit': 'M', 'net_profit': 262.83}, {'period': '2023', 'revenue': 852.21, 'unit': 'M', 'net_profit': -101.64}, {'period': '2022', 'revenue': 0.6224700000000001, 'unit': 'B', 'net_profit': 1.32}, {'period': '2021', 'revenue': 1020.0, 'unit': 'M', 'net_profit': 963.81}]","[{'period': ""Q2 '25"", 'revenue': 148600.0, 'unit': 'K', 'net_profit': -66.0}, {'period': ""Q1 '25"", 'revenue': 151.47, 'unit': 'M', 'net_profit': -134.01}, {'period': ""Q4 '24"", 'revenue': 71.95, 'unit': 'M', 'net_profit': 29.56}, {'period': ""Q3 '24"", 'revenue': 132.45, 'unit': 'M', 'net_profit': 144.36}, {'period': ""Q2 '24"", 'revenue': 211.06, 'unit': 'M', 'net_profit': -27.74}, {'period': ""Q1 '24"", 'revenue': 28.76, 'unit': 'M', 'net_profit': 116.66}]",0.5,0.34,7857092000,115874000,85872000,2559171000,28840000,7718243000,155519000,85872000,279983000,1,3.5859052941234344,2.923076923076923,"[0.045, 0.1]","['2025-04-28', '2004-12-08']",__nan__,0.3257147809902188
283,PSHG,Performance Shipping Inc. Common Shares,"Performance Shipping Inc., through its subsidiaries, provides shipping transportation services through its ownership of tanker vessels worldwide. It owned and operated five Aframax tanker vessels with a combined carrying capacity of 546,094 dwt. The company was incorporated in 2010 and is based in Athens, Greece.",Mr. Andreas Nikolaos Michalopoulos,Marine Shipping,1.41,USD,17529402,https://images.financialmodelingprep.com/symbol/PSHG.png,55203,1.27,0.05,79480,56037000,43730000,"[{'period': '2024', 'revenue': 87.44, 'unit': 'M', 'net_profit': 43.73}, {'period': '2023', 'revenue': 108.94, 'unit': 'M', 'net_profit': 69.41}, {'period': '2022', 'revenue': 75.17, 'unit': 'M', 'net_profit': 36.3}, {'period': '2021', 'revenue': 36.49, 'unit': 'M', 'net_profit': -11.3}]","[{'period': ""Q4 '24"", 'revenue': 21.68, 'unit': 'M', 'net_profit': 9.7}, {'period': ""Q3 '24"", 'revenue': 22.89, 'unit': 'M', 'net_profit': 12.41}, {'period': ""Q2 '24"", 'revenue': 20.51, 'unit': 'M', 'net_profit': 10.19}, {'period': ""Q1 '24"", 'revenue': 22.37, 'unit': 'M', 'net_profit': 11.43}, {'period': ""Q4 '23"", 'revenue': 23.84, 'unit': 'M', 'net_profit': 24.96}, {'period': ""Q3 '23"", 'revenue': 24.11, 'unit': 'M', 'net_profit': 10.37}]",1.06,1.07,330393000,71314000,71314000,55150000,0,0,0,71314000,0,-0.4026160931303569,-0.370002737239422,-0.8047882136279926,"[0.01, 0.21]","['2020-10-29', '2011-08-11']",__nan__,0.16692242269055338
284,PSMT,PriceSmart Inc. Common Stock,"PriceSmart, Inc. owns and operates U.S. style membership shopping warehouse clubs in the United States, Central America, the Caribbean, and Colombia. Its warehouse clubs sell brand name and private label consumer products, essential goods, fresh produce, prepared foods, and fresh-baked goods, as well as provides services, such as optical, tire center, and other ancillary services. The company also operates Click & Go, an e-commerce platform for online ordering, curbside pickup, and delivery services. As of March 29, 2022, it operated 49 warehouse clubs in 12 countries and one U.S. territory. PriceSmart, Inc. was incorporated in 1994 and is headquartered in San Diego, California.",Mr. Robert E. Price,Discount Stores,85.79,USD,2630518717,https://images.financialmodelingprep.com/symbol/PSMT.png,253821,18.29,3.67,365539,296997000,138875000,"[{'period': '2024', 'revenue': 4910.0, 'unit': 'M', 'net_profit': 138.88}, {'period': '2023', 'revenue': 4410.0, 'unit': 'M', 'net_profit': 109.2}, {'period': '2022', 'revenue': 4070.0000000000005, 'unit': 'M', 'net_profit': 104.53}, {'period': '2021', 'revenue': 3620.0, 'unit': 'M', 'net_profit': 97.96}]","[{'period': ""Q2 '25"", 'revenue': 1360.0, 'unit': 'M', 'net_profit': 43.76}, {'period': ""Q1 '25"", 'revenue': 1260.0, 'unit': 'M', 'net_profit': 37.43}, {'period': ""Q4 '24"", 'revenue': 1230.0, 'unit': 'M', 'net_profit': 29.07}, {'period': ""Q3 '24"", 'revenue': 1230.0, 'unit': 'M', 'net_profit': 32.49}, {'period': ""Q2 '24"", 'revenue': 1290.0, 'unit': 'M', 'net_profit': 39.27}, {'period': ""Q1 '24"", 'revenue': 1170.0, 'unit': 'M', 'net_profit': 38.05}]",4.57,4.57,2022694000,832347000,225529000,899729000,18847000,6882000,680148000,125364000,39044000,0.06735548327972543,0.271690856645758,0.30199430199430216,"[0.63, 0.63]","['2025-08-15', '2025-02-18']",__nan__,0.4448171596890088
285,PSNL,Personalis Inc. Common Stock,"Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.",Mr. Christopher M. Hall,Medical - Diagnostics & Research,3.38,USD,298481716,https://images.financialmodelingprep.com/symbol/PSNL.png,1066883,-2.47,0.38,1071746,-70301000,-81284000,"[{'period': '2024', 'revenue': 84.61, 'unit': 'M', 'net_profit': -81.28}, {'period': '2023', 'revenue': 73.48, 'unit': 'M', 'net_profit': -108.3}, {'period': '2022', 'revenue': 65.05, 'unit': 'M', 'net_profit': -113.31}, {'period': '2021', 'revenue': 85.49, 'unit': 'M', 'net_profit': -65.23}]","[{'period': ""Q4 '24"", 'revenue': 16.8, 'unit': 'M', 'net_profit': -16.43}, {'period': ""Q3 '24"", 'revenue': 25.71, 'unit': 'M', 'net_profit': -39.09}, {'period': ""Q2 '24"", 'revenue': 22.58, 'unit': 'M', 'net_profit': -12.8}, {'period': ""Q1 '24"", 'revenue': 19.52, 'unit': 'M', 'net_profit': -12.97}, {'period': ""Q4 '23"", 'revenue': 19.68, 'unit': 'M', 'net_profit': -26.58}, {'period': ""Q3 '23"", 'revenue': 18.25, 'unit': 'M', 'net_profit': -29.1}]",-1.37,-1.37,270268000,203015000,185009000,67311000,8140000,0,31126000,91415000,-46753000,0.27380251428099206,0.24942749501366626,0.3911111111111111,__nan__,__nan__,__nan__,0.24905279204345315
286,PSTI,Pluristem Therapeutics Inc. Common Stock,"Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.",Mr. Yaky Yanay,Biotechnology,1,USD,40848400,https://images.financialmodelingprep.com/symbol/PSTI.png,0,-0.6839945280437757,-0.029999971,170627,-48417000,-49865000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -49.87}, {'period': '2020', 'revenue': 0.023, 'unit': 'M', 'net_profit': -29.15}, {'period': '2019', 'revenue': 0.054, 'unit': 'M', 'net_profit': -35.31}, {'period': '2018', 'revenue': 0.05, 'unit': 'M', 'net_profit': -26.13}]","[{'period': ""Q3 '22"", 'revenue': 0.234, 'unit': 'M', 'net_profit': -10.04}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.94}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.43}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.57}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.25}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.55}]",-1.77,-1.77,93538000,67371000,64950000,36387000,1490000,0,11517000,31241000,-31283000,-0.7679471262688965,-0.7105172886937431,-0.10624999999999996,__nan__,__nan__,__nan__,0.38900767602471725
287,PSTV,PLUS THERAPEUTICS Inc. Common Stock ,"Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.","Dr. Marc H. Hedrick M.B.A., M.D.",Biotechnology,0.8398,USD,14276264,https://images.financialmodelingprep.com/symbol/PSTV.png,16140368,-0.36,0.0397,948878,0,-12978000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.98}, {'period': '2023', 'revenue': 4.91, 'unit': 'M', 'net_profit': -13.32}, {'period': '2022', 'revenue': 0.224, 'unit': 'M', 'net_profit': -20.27}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.4}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.9}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q2 '24"", 'revenue': 1.28, 'unit': 'M', 'net_profit': -2.94}, {'period': ""Q1 '24"", 'revenue': 1.68, 'unit': 'M', 'net_profit': -3.26}, {'period': ""Q4 '23"", 'revenue': 1.31, 'unit': 'M', 'net_profit': -3.81}, {'period': ""Q3 '23"", 'revenue': 1.24, 'unit': 'M', 'net_profit': -3.22}]",-0.2,-1.69,6633000,5259000,76000,15582000,0,0,15551000,76000,-10700000,1,0.025382997897266446,0.9528301886792453,__nan__,__nan__,__nan__,2.349163274536409
288,PSTX,Poseida Therapeutics Inc. Common Stock,"Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.",Mr. Mark J. Gergen J.D.,Biotechnology,9.5,USD,925933688,https://images.financialmodelingprep.com/symbol/PSTX.png,1798028,-15.079365079365079,0,21344052,-109038000,-123430000,"[{'period': '2023', 'revenue': 64.7, 'unit': 'M', 'net_profit': -123.43}, {'period': '2022', 'revenue': 130.36, 'unit': 'M', 'net_profit': -64.0}, {'period': '2021', 'revenue': 0.03124, 'unit': 'M', 'net_profit': 4.4}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.45}]","[{'period': ""Q3 '24"", 'revenue': 71.75, 'unit': 'M', 'net_profit': 20.23}, {'period': ""Q2 '24"", 'revenue': 25.97, 'unit': 'M', 'net_profit': -31.37}, {'period': ""Q1 '24"", 'revenue': 28.14, 'unit': 'M', 'net_profit': -24.27}, {'period': ""Q4 '23"", 'revenue': 25.0, 'unit': 'M', 'net_profit': -23.99}, {'period': ""Q3 '23"", 'revenue': 9.35, 'unit': 'M', 'net_profit': -31.78}, {'period': ""Q2 '23"", 'revenue': 20.01, 'unit': 'M', 'net_profit': -27.46}]",-1.37,-1.37,273885000,226475000,212202000,170184000,9010000,0,71318000,44472000,-95233000,-0.9906890130353817,-0.9285334833286459,-0.5393258426966293,__nan__,__nan__,__nan__,0.6213702831480366
289,PT,Pintec Technology Holdings Limited American Depositary Shares,"Pintec Technology Holdings Limited, together with its subsidiaries, operates an online technology platform that enables financial services in the People's Republic of China. The company connects business partners and financial partners on its platform and enables them to provide financial services to end users. Its technology platform's financial services include assistance for borrowers to obtain loans from third party investors and various financial partners; a lending solution for borrowers who want to finance online purchases or who have personal or business installment loan requests; and a wealth management and insurance product distribution solution for asset management and insurance companies to facilitate the sales of products. Pintec Technology Holdings Limited was founded in 2012 and is headquartered in Beijing, the People's Republic of China.",Mr. Zexiong  Huang,Financial - Credit Services,1,USD,411222,https://images.financialmodelingprep.com/symbol/PT.png,23381,-2.63,0.038,10286,-88793000,-78762000,"[{'period': '2023', 'revenue': 52.72, 'unit': 'M', 'net_profit': -78.76}, {'period': '2022', 'revenue': 74.57, 'unit': 'M', 'net_profit': -196.56}, {'period': '2021', 'revenue': 173.24, 'unit': 'M', 'net_profit': -108.82}, {'period': '2020', 'revenue': 378.26, 'unit': 'M', 'net_profit': -296.14}]","[{'period': ""Q2 '24"", 'revenue': 7.46, 'unit': 'M', 'net_profit': -4.21}, {'period': ""Q1 '24"", 'revenue': 7.46, 'unit': 'M', 'net_profit': -4.21}, {'period': ""Q4 '23"", 'revenue': 17.25, 'unit': 'M', 'net_profit': -39.75}, {'period': ""Q3 '23"", 'revenue': 8.81, 'unit': 'M', 'net_profit': -39.75}, {'period': ""Q2 '23"", 'revenue': 36.67, 'unit': 'M', 'net_profit': 89.76}, {'period': ""Q1 '23"", 'revenue': 17540.0, 'unit': 'K', 'net_profit': 369.5}]",-5.57,-5.57,113197000,108197000,40551000,493076000,1569000,0,488295000,40508000,7882000,0.4596763887959205,0.5992918084830354,0.7569808027923212,"[0.018, 0.128]","['2014-05-27', '2007-05-15']",__nan__,4.355910492327535
290,PTC,PTC Inc. Common Stock,"PTC Inc. operates as software and services company in the Americas, Europe, and the Asia Pacific. The company operates in two segments, Software Products and Professional Services. It offers ThingWorx platform, which offers a set of capabilities that enable enterprises to digitally transform every aspect of their business with innovative solutions that are simple to create, easy to implement, scalable to meet future needs, and designed to enable customers to accelerate time to value; and Vuforia, which enables the visualization of digital information in a physical context and the creation of AR. The company also provides Onshape, a software-as-a-service product development platform unites computer-aided design with data management, collaboration tools, and real-time analytics; Arena, a PLM solution enables product teams to collaborate virtually anytime and anywhere; Creo, a 3D CAD technology enables the digital design, testing, and modification of product models; and Windchill, a product lifecycle management software. In addition, it offers Integrity, an application lifecycle management solution; Servigistics, service parts management solution; and consulting, implementation, training, cloud, and license and support services. The company was formerly known as Parametric Technology Corporation and changed its name to PTC Inc. in January 2013. PTC Inc. was incorporated in 1985 and is headquartered in Boston, Massachusetts.",Mr. Neil  Barua,Software - Application,149.24,USD,17957153760,https://images.financialmodelingprep.com/symbol/PTC.png,1149731,45.92,12.5,1387459,730022000,376333000,"[{'period': '2024', 'revenue': 2300.0, 'unit': 'M', 'net_profit': 376.33}, {'period': '2023', 'revenue': 2100.0, 'unit': 'M', 'net_profit': 245.54}, {'period': '2022', 'revenue': 1930.0, 'unit': 'M', 'net_profit': 313.08}, {'period': '2021', 'revenue': 1810.0, 'unit': 'M', 'net_profit': 476.92}]","[{'period': ""Q1 '25"", 'revenue': 565.13, 'unit': 'M', 'net_profit': 82.23}, {'period': ""Q4 '24"", 'revenue': 626.55, 'unit': 'M', 'net_profit': 126.52}, {'period': ""Q3 '24"", 'revenue': 518.64, 'unit': 'M', 'net_profit': 68.98}, {'period': ""Q2 '24"", 'revenue': 603.07, 'unit': 'M', 'net_profit': 114.44}, {'period': ""Q1 '24"", 'revenue': 550.21, 'unit': 'M', 'net_profit': 66.39}, {'period': ""Q4 '23"", 'revenue': 546.62, 'unit': 'M', 'net_profit': 45.6}]",3.14,3.12,6383542000,1298705000,265808000,3169144000,861953000,170944000,1667193000,265808000,735606000,0.21843960977726593,0.5326749205832043,0.5169082125603867,__nan__,__nan__,__nan__,0.4964554161310445
291,PTCT,PTC Therapeutics Inc. Common Stock,"PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.","Dr. Matthew B. Klein F.A.C.S., M.D., M.S.",Biotechnology,42.75,USD,3371666850,https://images.financialmodelingprep.com/symbol/PTCT.png,892709,-9.04,2.98,1586868,-120463000,-363295000,"[{'period': '2024', 'revenue': 806.78, 'unit': 'M', 'net_profit': -363.3}, {'period': '2023', 'revenue': 937.82, 'unit': 'M', 'net_profit': -626.6}, {'period': '2022', 'revenue': 698.8, 'unit': 'M', 'net_profit': -559.02}, {'period': '2021', 'revenue': 538.59, 'unit': 'M', 'net_profit': -523.9}]","[{'period': ""Q4 '24"", 'revenue': 213.17, 'unit': 'M', 'net_profit': -65.89}, {'period': ""Q3 '24"", 'revenue': 196.79, 'unit': 'M', 'net_profit': -106.65}, {'period': ""Q2 '24"", 'revenue': 186.7, 'unit': 'M', 'net_profit': -99.18}, {'period': ""Q1 '24"", 'revenue': 210.12, 'unit': 'M', 'net_profit': -91.58}, {'period': ""Q4 '23"", 'revenue': 307.06, 'unit': 'M', 'net_profit': -155.79}, {'period': ""Q3 '23"", 'revenue': 196.58, 'unit': 'M', 'net_profit': -132.97}]",-4.73,-4.73,1705024000,1365531000,1139696000,2803095000,158554000,0,580981000,779709000,-114190000,0.6353363201549919,0.42021595776598936,0.43488649940262836,__nan__,__nan__,__nan__,1.644020846627379
292,PTE,PolarityTE Inc. Common Stock,"PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.",Mr. Richard  Hague,Biotechnology,0.241,USD,1777671,https://images.financialmodelingprep.com/symbol/PTE.png,267677,-0.41551724137931034,-0.002,8317499,-24287000,10211000,"[{'period': '2022', 'revenue': 0.8140000000000001, 'unit': 'M', 'net_profit': 10.21}, {'period': '2021', 'revenue': 9.4, 'unit': 'M', 'net_profit': -28.21}, {'period': '2020', 'revenue': 10.13, 'unit': 'M', 'net_profit': -43.92}, {'period': '2019', 'revenue': 5.65, 'unit': 'M', 'net_profit': -92.34}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.24}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 15.45}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.4}, {'period': ""Q2 '22"", 'revenue': 0.073, 'unit': 'M', 'net_profit': 6.59}, {'period': ""Q1 '22"", 'revenue': 0.741, 'unit': 'M', 'net_profit': 1.28}, {'period': ""Q4 '21"", 'revenue': 1.04, 'unit': 'M', 'net_profit': -8.55}]",1.49,1.33,22847000,13255000,11446000,6229000,0,0,2067000,11446000,-22634000,0.23234717744484482,1.3619381823337586,1.1691259931895572,"[0.336, 0.3355]","['2016-01-19', '2016-01-12']",__nan__,0.2726397338819101
293,PTEN,Patterson-UTI Energy Inc. Common Stock,"Patterson-UTI Energy, Inc., through its subsidiaries, provides onshore contract drilling services to oil and natural gas operators in the United States and internationally. It operates through three segments: Contract Drilling Services, Pressure Pumping Services, and Directional Drilling Services. The Contract Drilling Services segment markets its contract drilling services primarily in west Texas, Appalachia, Rockies, Oklahoma, South Texas, East Texas, and Colombia. As of December 31, 2021, this segment had a drilling fleet of 192 marketable land-based drilling rigs. The Pressure Pumping Services segment offers pressure pumping services that consist of well stimulation for the completion of new wells and remedial work on existing wells, as well as hydraulic fracturing, cementing, and acid pumping services in Texas and the Appalachian region. The Directional Drilling Services segment provides a suite of directional drilling services, including directional drilling and measurement-while-drilling services; supply and rental of downhole performance motors; and software and services that enhances the accuracy of directional and horizontal wellbores, wellbore quality, and on-bottom rate of penetration. It also services equipment to drilling contractors, as well as provides electrical controls and automation to the energy, marine, and mining industries in North America and other markets; and owns and invests in oil and natural gas assets as a non-operating working interest owner located principally in Texas and New Mexico. Patterson-UTI Energy, Inc. was founded in 1978 and is headquartered in Houston, Texas.",Mr. William Andrew Hendricks Jr.,Oil & Gas Drilling,6.56,USD,2534718400,https://images.financialmodelingprep.com/symbol/PTEN.png,11270344,-2.69,1.1,17688315,286890000,-968031000,"[{'period': '2024', 'revenue': 5380.0, 'unit': 'M', 'net_profit': -968.03}, {'period': '2023', 'revenue': 4150.0, 'unit': 'M', 'net_profit': 246.29}, {'period': '2022', 'revenue': 2650.0, 'unit': 'M', 'net_profit': 154.66}, {'period': '2021', 'revenue': 1360.0, 'unit': 'M', 'net_profit': -657.08}]","[{'period': ""Q4 '24"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': -51.58}, {'period': ""Q3 '24"", 'revenue': 1360.0, 'unit': 'M', 'net_profit': -978.76}, {'period': ""Q2 '24"", 'revenue': 1350.0, 'unit': 'M', 'net_profit': 11.08}, {'period': ""Q1 '24"", 'revenue': 1510.0, 'unit': 'M', 'net_profit': 51.23}, {'period': ""Q4 '23"", 'revenue': 1580.0, 'unit': 'M', 'net_profit': 61.95}, {'period': ""Q3 '23"", 'revenue': 1010000.0, 'unit': 'K', 'net_profit': 50.0}]",-2.44,-2.44,5833466000,1295315000,241293000,2357622000,763806000,0,841993000,239182000,497150000,-0.7371333803681543,-4.930419989281016,-3.7727272727272725,"[0.08, 0.04]","['2025-03-03', '2004-05-13']",__nan__,0.40415457979869945
294,PTGX,Protagonist Therapeutics Inc. Common Stock,"Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.",Dr. Dinesh V. Patel Ph.D.,Biotechnology,42.57,USD,2613129651,https://images.financialmodelingprep.com/symbol/PTGX.png,1083501,10.06,0.9,1862366,252843000,275188000,"[{'period': '2024', 'revenue': 434.43, 'unit': 'M', 'net_profit': 275.19}, {'period': '2023', 'revenue': 60.0, 'unit': 'M', 'net_profit': -78.95}, {'period': '2022', 'revenue': 26.58, 'unit': 'M', 'net_profit': -123.41}, {'period': '2021', 'revenue': 27.36, 'unit': 'M', 'net_profit': -122.63}]","[{'period': ""Q4 '24"", 'revenue': 170.64, 'unit': 'M', 'net_profit': 131.67}, {'period': ""Q3 '24"", 'revenue': 4.67, 'unit': 'M', 'net_profit': -33.21}, {'period': ""Q2 '24"", 'revenue': 4.17, 'unit': 'M', 'net_profit': -30.62}, {'period': ""Q1 '24"", 'revenue': 254.95, 'unit': 'M', 'net_profit': 207.34}, {'period': ""Q4 '23"", 'revenue': 60.0, 'unit': 'M', 'net_profit': 27.34}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.1}]",4.47,4.23,744725000,591641000,418913000,69430000,0,0,47398000,97249000,182797000,3.798793446978083,4.485377746817807,4.215827338129496,__nan__,__nan__,__nan__,0.09322904427808923
295,PTIC,PropTech Investment Corporation II Class A Common Stock,"PropTech Investment Corporation II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the PropTech or real estate industries. The company was incorporated in 2020 and is based in Wilson, Wyoming.",Mr. Thomas D. Hennessy,Shell Companies,10.73,USD,517799756,https://images.financialmodelingprep.com/symbol/PTIC.png,330867,268.25,0.79,28414,11028290,23250007,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -129.88}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -830.15}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.23}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 7.98}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.95}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.72}]",0.81,0.81,231100105,1096159,947498,15736633,0,230003947,263303,947498,-919412,0,180.01420563913828,181,__nan__,__nan__,__nan__,0.06809444331494353
296,PTICU,PropTech Investment Corporation II Unit,"PropTech Investment Corporation II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the PropTech or real estate industries. The company was incorporated in 2020 and is based in Wilson, Wyoming.",Mr. Thomas D. Hennessy,Shell Companies,10.54,USD,0,https://images.financialmodelingprep.com/symbol/PTICU.png,5574,51.16504854368932,1.26,2157,11028290,23250007,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -129.88}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -830.15}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.23}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 7.98}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.95}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.72}]",0.81,0.81,231100105,1096159,947498,15736633,0,230003947,263303,947498,-919412,0,180.01420563913828,181,__nan__,__nan__,__nan__,0.06809444331494353
297,PTICW,PropTech Investment Corporation II Warrant,"Proptech Investment Corporation II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilson, Wyoming.",Mr. Thomas D. Hennessy,Shell Companies,0.15,USD,0,https://images.financialmodelingprep.com/symbol/PTICW.png,18822,0,-0.03,34542,11028290,23250007,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -129.88}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -830.15}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.23}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 7.98}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.95}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.72}]",0.81,0.81,231100105,1096159,947498,15736633,0,230003947,263303,947498,-919412,0,180.01420563913828,181,__nan__,__nan__,__nan__,0.06809444331494353
298,PTIX,Protagenic Therapeutics Inc. Common Stock,"Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.",Dr. Garo H. Armen Ph.D.,Biotechnology,0.267,USD,2009357,https://images.financialmodelingprep.com/symbol/PTIX.png,5445329,-0.24,-0.0073,630769,-5700950,-5525344,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.53}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.0}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.6}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.99}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.55}, {'period': ""Q3 '24"", 'revenue': 25.14, 'unit': 'K', 'net_profit': -640.78}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.61}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q4 '23"", 'revenue': 0.0032, 'unit': 'M', 'net_profit': -1.68}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.4}]",-1.13,-1.13,1955913,1882867,1838469,942759,0,0,942759,1838469,-4216517,-0.2672280959447456,-0.10495896707867237,0.017391304347826105,__nan__,__nan__,__nan__,0.4820045676878266
299,PTIXW,Protagenic Therapeutics Inc. Warrant,"Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.",Dr. Garo H. Armen Ph.D.,Biotechnology,0.0016,USD,12041,https://images.financialmodelingprep.com/symbol/PTIXW.png,16589.97647,,0,11129,-5700950,-5525344,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.53}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.0}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.6}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.99}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.55}, {'period': ""Q3 '24"", 'revenue': 25.14, 'unit': 'K', 'net_profit': -640.78}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.61}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q4 '23"", 'revenue': 0.0032, 'unit': 'M', 'net_profit': -1.68}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.4}]",-1.13,-1.13,1955913,1882867,1838469,942759,0,0,942759,1838469,-4216517,-0.2672280959447456,-0.10495896707867237,0.017391304347826105,__nan__,__nan__,__nan__,0.4820045676878266
300,PTMN,Portman Ridge Finance Corporation Common Stock,"Portman Ridge Finance Corporation is a business development company specializing in investments in unitranche loans (including last out), first lien loans, second lien loans, subordinated debt, equity co-investment, buyout in middle market companies. It also makes acquisitions in businesses complementary to the firm's business. It primarily invests in healthcare, cargo transport, manufacturing, industrial & environmental services, logistics & distribution, media & telecommunications, real estate, education, automotive, agriculture, aerospace/defense, packaging, electronics, finance, non-durable consumer, consumer products, business services, utilities, insurance, and food and beverage sectors. The fund typically invests $1 million to $20 million in its portfolio companies. It provides senior secured term loans from $2 million to $20 million maturing in five to seven years; second lien term loans from $5 million to $15 million maturing in six to eight years; senior unsecured loans $5 million to $23 million maturing in six to eight years; mezzanine loans from $5 million to $15 million maturing in seven to ten years; and equity investments from $1 to $5 million. The fund targets the companies with EBITDA between $5 million and $25 million. While investing in debt securities, it invests in those middle market firms with EBITDA between $10 million and $50 million and/or total debt between $25 million and $150 million. It invests in minority, and majority or control equity positions alongside its private equity sponsor partners.",Mr. Edward Joseph Goldthorpe,Asset Management,12.7,USD,116816886,https://images.financialmodelingprep.com/symbol/PTMN.png,47247,-19.84,0.68,147024,0,-5935000,"[{'period': '2024', 'revenue': 46.9, 'unit': 'M', 'net_profit': -5.93}, {'period': '2023', 'revenue': 58.4, 'unit': 'M', 'net_profit': 11.38}, {'period': '2022', 'revenue': 54.24, 'unit': 'M', 'net_profit': -21.0}, {'period': '2021', 'revenue': 38.75, 'unit': 'M', 'net_profit': 26.03}]","[{'period': ""Q4 '24"", 'revenue': -1.29, 'unit': 'M', 'net_profit': -2.54}, {'period': ""Q3 '24"", 'revenue': 0.308, 'unit': 'M', 'net_profit': -1.51}, {'period': ""Q2 '24"", 'revenue': -4.97, 'unit': 'M', 'net_profit': -6.37}, {'period': ""Q1 '24"", 'revenue': 14.47, 'unit': 'M', 'net_profit': 4.49}, {'period': ""Q4 '23"", 'revenue': 3.55, 'unit': 'M', 'net_profit': 7.0}, {'period': ""Q3 '23"", 'revenue': 13.91, 'unit': 'M', 'net_profit': 7.45}]",-0.64,-0.64,453634000,23620000,17532000,275141000,6088000,405021000,10001000,17532000,56634000,-1,-1.5214831737105703,-1.5333333333333332,"[0.54, 0.29]","['2025-03-24', '2007-04-03']",__nan__,0.6065264067508167
301,PTNR,Partner Communications Company Ltd. American Depositary Shares,"Partner Communications Company Ltd. provides various telecommunication services in Israel. It operates in two segments, Cellular and Fixed-Line. The company offers cellular telephony services, including basic cellular telephony, text messaging, internet browsing and data transfer, content, handset repair, roaming, and services provided to other operators that are permitted to use its cellular network, as well as Machine to Machine and Internet of Things services. It also provides cellular content and value-added services, such as multimedia messaging, cyber protection, cloud backup, ringtone, music streaming, and various business services; and international roaming services, as well as sells and leases cellular handsets, and related cellular devices and accessories. In addition, the company offers Internet service provider (ISP) services comprising email accounts, Wi-Fi networking, anti-virus and anti-spam filtering, and infrastructure and ISP access; network and data infrastructure services, information security and integration solutions, designated services, business information storage services, and data center and cloud services; international long distance services; fixed-line transmission and data capacity services; and voice over broadband telephony and primary rate interface services. Further, it provides television, high speed broadband fiber optic based network, and value added services; and sells and rents modems, domestic routers, servers, and related equipment, as well as tablets, laptops, datacards, audio accessories and other devices, and integration projects. Additionally, the company offers office communication private branch exchange services to business customers. It offers its services and products through sales and service centers, and direct sales force, as well as through dealers and online. The company was incorporated in 1997 and is headquartered in Rosh HaAyin, Israel.",Mr. Tamir  Amar,Telecommunications Services,6.61,USD,0,https://images.financialmodelingprep.com/symbol/PTNR.png,15993,0,0,35591,880000000,115000000,"[{'period': '2021', 'revenue': 3360.0, 'unit': 'M', 'net_profit': 115.0}, {'period': '2020', 'revenue': 3190.0, 'unit': 'M', 'net_profit': 17.0}, {'period': '2019', 'revenue': 3230.0, 'unit': 'M', 'net_profit': 19.0}, {'period': '2018', 'revenue': 3260.0, 'unit': 'M', 'net_profit': 57.0}]","[{'period': ""Q3 '22"", 'revenue': 891.0, 'unit': 'M', 'net_profit': 51.0}, {'period': ""Q2 '22"", 'revenue': 859.0, 'unit': 'M', 'net_profit': 47.0}, {'period': ""Q1 '22"", 'revenue': 854.0, 'unit': 'M', 'net_profit': 39.0}, {'period': ""Q4 '21"", 'revenue': 853.0, 'unit': 'M', 'net_profit': 77.0}, {'period': ""Q3 '21"", 'revenue': 837.0, 'unit': 'M', 'net_profit': 24.0}, {'period': ""Q2 '21"", 'revenue': 840.0, 'unit': 'M', 'net_profit': 9.0}]",0.62,0.62,5393000000,1489000000,652000000,3534000000,620000000,280000000,1422000000,308000000,102000000,0.08374384236453201,5.764705882352941,5.681034482758621,"[0.256, 0.0949]","['2012-08-27', '2005-09-22']",__nan__,0.655293899499351
302,PTOC,Pine Technology Acquisition Corp. Class A Common Stock,"Pine Technology Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the insurance-related technology sector. The company was incorporated in 2020 and is based in Aurora, Ohio.",Mr. Christopher M. Longo,Shell Companies,10.17,USD,438581240,https://images.financialmodelingprep.com/symbol/PTOC.png,158373,72.64285714285714,0.03,209912,-4081009,-1586098,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.59}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 40.79}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.29}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.41}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.42}]",-0.0442,-0.0442,345734458,604055,313382,35958009,0,0,1448688,313382,-1486542,0,0,0,__nan__,__nan__,__nan__,0.10400470120337267
303,PTOCU,Pine Technology Acquisition Corp. Unit,"Pine Technology Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the insurance-related technology sector. The company was incorporated in 2020 and is based in Aurora, Ohio.",Mr. Christopher M. Longo,Shell Companies,10.11,USD,442497584,https://images.financialmodelingprep.com/symbol/PTOCU.png,524,22.17105263157895,0,64,-4081009,-1586098,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.59}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 40.79}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.29}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.41}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.42}]",-0.0442,-0.0442,345734458,604055,313382,35958009,0,0,1448688,313382,-1486542,0,0,0,__nan__,__nan__,__nan__,0.10400470120337267
304,PTOCW,Pine Technology Acquisition Corp. Warrant,"Pine Technology Acquisition Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify the business in the areas of InsurTech or insurance. The company was incorporated in 2020 and is based in Aurora, Ohio.",Mr. Christopher M. Longo,Shell Companies,0.002,USD,438581240,https://images.financialmodelingprep.com/symbol/PTOCW.png,0,0,0.0001,6438,-4081009,-1586098,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.59}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 40.79}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.29}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.41}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.42}]",-0.0442,-0.0442,345734458,604055,313382,35958009,0,0,1448688,313382,-1486542,0,0,0,__nan__,__nan__,__nan__,0.10400470120337267
305,PTON,Peloton Interactive Inc. Class A Common Stock,"Peloton Interactive, Inc. provides interactive fitness products in North America and internationally. It offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, and Peloton Tread+ names. The company also provides connected fitness subscriptions for various household users, and access to various live and on-demand classes, as well as Peloton Digital app for connected fitness subscribers to provide access to its classes. As of June 30, 2021, it had approximately 5.9 million members. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.",Mr. Peter C. Stern,Leisure,5.87,USD,2194787130,https://images.financialmodelingprep.com/symbol/PTON.png,15409609,-7.62,0.87,18922985,-330800000,-551900000,"[{'period': '2024', 'revenue': 2700.0, 'unit': 'M', 'net_profit': -551.9}, {'period': '2023', 'revenue': 2.8, 'unit': 'B', 'net_profit': -1.26}, {'period': '2022', 'revenue': 3.58, 'unit': 'B', 'net_profit': -2.82}, {'period': '2021', 'revenue': 4019.9999999999995, 'unit': 'M', 'net_profit': -189.0}]","[{'period': ""Q2 '25"", 'revenue': 673.9, 'unit': 'M', 'net_profit': -92.0}, {'period': ""Q1 '25"", 'revenue': 586000.0, 'unit': 'K', 'net_profit': -900.0}, {'period': ""Q4 '24"", 'revenue': 643.6, 'unit': 'M', 'net_profit': -30.5}, {'period': ""Q3 '24"", 'revenue': 717.7, 'unit': 'M', 'net_profit': -167.3}, {'period': ""Q2 '24"", 'revenue': 743.6, 'unit': 'M', 'net_profit': -194.9}, {'period': ""Q1 '24"", 'revenue': 595.6, 'unit': 'M', 'net_profit': -159.3}]",-1.51,-1.51,2185200000,1266000000,697600000,2704300000,103600000,0,685200000,697600000,-85800000,0.6808797993440092,0.5625743045097884,0.5851648351648351,__nan__,__nan__,__nan__,1.2375526267618524
306,PTPI,Petros Pharmaceuticals Inc. Common Stock,"Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.",Mr. Fady  Boctor M.B.A.,Drug Manufacturers - Specialty & Generic,0.0518,USD,2772284,https://images.financialmodelingprep.com/symbol/PTPI.png,36032173,-0.02,-0.0031,4868288,-12048480000,-14318790,"[{'period': '2024', 'revenue': 5110.0, 'unit': 'M', 'net_profit': -14.32}, {'period': '2023', 'revenue': 5.82, 'unit': 'M', 'net_profit': -8.16}, {'period': '2022', 'revenue': 5.99, 'unit': 'M', 'net_profit': -27.04}, {'period': '2021', 'revenue': 7.81, 'unit': 'M', 'net_profit': -9.36}]","[{'period': ""Q4 '24"", 'revenue': 0.7254, 'unit': 'M', 'net_profit': -9.27}, {'period': ""Q3 '24"", 'revenue': 1.58, 'unit': 'M', 'net_profit': -2.22}, {'period': ""Q2 '24"", 'revenue': 1420.0, 'unit': 'K', 'net_profit': -662.03}, {'period': ""Q1 '24"", 'revenue': 1.39, 'unit': 'M', 'net_profit': -8.03}, {'period': ""Q4 '23"", 'revenue': -364.25, 'unit': 'K', 'net_profit': 318.15}, {'period': ""Q3 '23"", 'revenue': 1.67, 'unit': 'M', 'net_profit': -4.55}]",-0.0229,-0.0229,10635310000,7294278000,3709971000,18102888000,416076000,0,18027665000,3709971,-2603051000,-2859.6004314946967,-0.7540683860276157,0.9963937007874016,__nan__,__nan__,__nan__,1.7021495377191638
307,PTRS,Partners Bancorp Common Stock,"Partners Bancorp operates as the holding company for the Bank of Delmarva that provides financial services to individual and corporate customers in the United States. It offers checking, money market, NOW, IRA, savings, cash management, and time deposit accounts, as well as remote deposit capture and mobile deposit services. The company also provides commercial real estate, small business administration, term, purchase and refinance mortgage, bridge, equipment, home equity, agriculture, car, unsecured consumer, construction/permanent mortgage, and lot loans, as well as mobile home, boat, RV, and motorcycle loans; lines of credit; and business credit cards. In addition, it offers online bill payment, automated teller machine/debit card, merchant, transfer, cash advance and management, sweep, cash concentration, payroll direct deposit, and ACH origination services, as well as phone, mobile, and internet banking services. The company operates through 15 branches. The company was formerly known as Delmar Bancorp and changed its name to Partners Bancorp in August 2020. Partners Bancorp was founded in 1896 and is based in Salisbury, Maryland.",Mr. John W. Breda,Banks - Regional,7.15,USD,128597040,https://images.financialmodelingprep.com/symbol/PTRS.png,10627,8.03370786516854,0.07,157109,25311586,13614994,"[{'period': '2022', 'revenue': 61.2, 'unit': 'M', 'net_profit': 13.61}, {'period': '2021', 'revenue': 54.82, 'unit': 'M', 'net_profit': 7.41}, {'period': '2020', 'revenue': 52.37, 'unit': 'M', 'net_profit': 5.67}, {'period': '2019', 'revenue': 34.08, 'unit': 'M', 'net_profit': 5.88}]","[{'period': ""Q3 '23"", 'revenue': 16.39, 'unit': 'M', 'net_profit': 4.54}, {'period': ""Q2 '23"", 'revenue': 15.91, 'unit': 'M', 'net_profit': 3.76}, {'period': ""Q1 '23"", 'revenue': 16.42, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q4 '22"", 'revenue': 17.54, 'unit': 'M', 'net_profit': 4.22}, {'period': ""Q3 '22"", 'revenue': 1.1e-05, 'unit': 'M', 'net_profit': 4.11}, {'period': ""Q2 '22"", 'revenue': 14.34, 'unit': 'M', 'net_profit': 3.18}]",0.76,0.76,1574612496,152901000,252256148,1435283521,4566487,138544760,71686000,118599506,20225000,1.467161419639129,0.8368018075810638,0.8095238095238096,"[0.046, 0.07]","['2023-11-17', '2000-12-20']",__nan__,0.9115153884819672
308,PTSI,P.A.M. Transportation Services Inc. Common Stock,"P.A.M. Transportation Services, Inc., through its subsidiaries, operates as a truckload transportation and logistics company in the United States, Mexico, and Canada. The company operates a truckload dry van carrier that transports general commodities. Its freight primarily consists of automotive parts; expedited goods; consumer goods, such as general retail store merchandise; and manufactured goods, including heating and air conditioning units. The company also provides brokerage and logistics services. As of December 31, 2021, it operated a fleet of 1,970 trucks, which included 378 independent contractor trucks; and trailer fleet consisted of 6,859 trailers. The company was founded in 1980 and is headquartered in Tontitown, Arkansas.",Mr. Joseph A. Vitiritto,Trucking,19.72,USD,429550900,https://images.financialmodelingprep.com/symbol/PTSI.png,0,-164.33333333333334,,0,107261000,18416000,"[{'period': '2023', 'revenue': 810.81, 'unit': 'M', 'net_profit': 18.42}, {'period': '2022', 'revenue': 946.86, 'unit': 'M', 'net_profit': 90.67}, {'period': '2021', 'revenue': 707.12, 'unit': 'M', 'net_profit': 76.52}, {'period': '2020', 'revenue': 486.82, 'unit': 'M', 'net_profit': 17.83}]","[{'period': ""Q3 '24"", 'revenue': 182.58, 'unit': 'M', 'net_profit': 2.41}, {'period': ""Q2 '24"", 'revenue': 182.95, 'unit': 'M', 'net_profit': -2.91}, {'period': ""Q1 '24"", 'revenue': 182590.0, 'unit': 'K', 'net_profit': 281.0}, {'period': ""Q4 '23"", 'revenue': 180.17, 'unit': 'M', 'net_profit': -2.23}, {'period': ""Q3 '23"", 'revenue': 201.5, 'unit': 'M', 'net_profit': 6.1}, {'period': ""Q2 '23"", 'revenue': 207.41, 'unit': 'M', 'net_profit': 9.32}]",0.83,0.83,760457000,251041000,143817000,446241000,91690000,0,137096000,100614000,80517000,-0.4548139187362129,-0.7968943003352744,-0.7965686274509803,"[1, 1]","['2012-12-13', '2012-03-28']",__nan__,0.5868063545999314
309,PTVCA,Protective Insurance Corporation Class A Common Stock,,,,,,,,,,,,44507000,4463000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.46}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.35}, {'period': '2018', 'revenue': 439.17, 'unit': 'M', 'net_profit': -34.08}, {'period': '2017', 'revenue': 371.23, 'unit': 'M', 'net_profit': 18.32}]","[{'period': ""Q1 '21"", 'revenue': 140.53, 'unit': 'M', 'net_profit': 12.94}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.46}, {'period': ""Q3 '20"", 'revenue': 124.95, 'unit': 'M', 'net_profit': 3.28}, {'period': ""Q2 '20"", 'revenue': 116.61, 'unit': 'M', 'net_profit': 11.37}, {'period': ""Q1 '20"", 'revenue': 90.8, 'unit': 'M', 'net_profit': -22.16}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.35}]",0.32,0.32,455511000,19976000,12917000,0,7059000,0,0,12917000,0,2.3343572070722205,-0.39254117326800053,-0.9996770808105271,__nan__,__nan__,__nan__,0.0
310,PTVCB,Protective Insurance Corporation Class B Common Stock,,,,,,,,,,,,12232000,4463000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.46}, {'period': '2019', 'revenue': 456.46, 'unit': 'M', 'net_profit': 7.35}, {'period': '2018', 'revenue': 442.81, 'unit': 'M', 'net_profit': -34.08}, {'period': '2017', 'revenue': 333.45, 'unit': 'M', 'net_profit': 18.32}]","[{'period': ""Q1 '21"", 'revenue': 140.53, 'unit': 'M', 'net_profit': 12.94}, {'period': ""Q4 '20"", 'revenue': 136.38, 'unit': 'M', 'net_profit': 11.97}, {'period': ""Q3 '20"", 'revenue': 34.15, 'unit': 'M', 'net_profit': 25.44}, {'period': ""Q2 '20"", 'revenue': 99.62, 'unit': 'M', 'net_profit': 11.37}, {'period': ""Q1 '20"", 'revenue': 111.32, 'unit': 'M', 'net_profit': -22.16}, {'period': ""Q4 '19"", 'revenue': 113.77, 'unit': 'M', 'net_profit': 3.77}]",0.32,0.32,1722827000,19976000,978993000,1359745000,556485000,75985000,205469000,58301000,73392000,-0.1693039049235993,-0.39254117326800053,-0.36,__nan__,__nan__,__nan__,0.7892522000177615
311,PTVE,Pactiv Evergreen Inc. Common stock,"Pactiv Evergreen Inc. manufactures and distributes fresh foodservice and food merchandising products, and fresh beverage cartons in North America. It operates through three segments: Foodservice, Food Merchandising, and Beverage Merchandising. The Foodservice segment offers food containers, hot and cold cups, lids, dinnerware, tableware, service ware, and other products. The Food Merchandising segment provides clear rigid-display containers, containers for prepared and ready-to-eat food, trays for meat and poultry, and molded fiber cartons. The Beverage Merchandising segment offers cartons for fresh refrigerated beverage products. This segment also provides integrated fresh carton systems, which include printed cartons with high-impact graphics, spouts, and filling machines, as well as fiber-based liquid packaging board and range of paper-based products. The company serves full-service restaurants, quick service restaurants, foodservice distributors, supermarkets, grocery and healthy eating retailers, other food stores, food and beverage producers, and food packers and food processors. The company was formerly known as Reynolds Group Holdings Limited. Pactiv Evergreen Inc. was founded in 1880 and is headquartered in Lake Forest, Illinois. Pactiv Evergreen Inc. is a subsidiary of Packaging Finance Limited.",Mr. Michael Jack King,Packaging & Containers,18.01,USD,3253164310,https://images.financialmodelingprep.com/symbol/PTVE.png,751730,-23.39,0,5762075,440000000,-133000000,"[{'period': '2024', 'revenue': 4810.0, 'unit': 'M', 'net_profit': -133.0}, {'period': '2023', 'revenue': 5510.0, 'unit': 'M', 'net_profit': -223.0}, {'period': '2022', 'revenue': 6220.0, 'unit': 'M', 'net_profit': 318.0}, {'period': '2021', 'revenue': 5440.0, 'unit': 'M', 'net_profit': 33.0}]","[{'period': ""Q4 '24"", 'revenue': 1230.0, 'unit': 'M', 'net_profit': 49.0}, {'period': ""Q3 '24"", 'revenue': 1330.0, 'unit': 'M', 'net_profit': -213.0}, {'period': ""Q2 '24"", 'revenue': 1340.0, 'unit': 'M', 'net_profit': 19.0}, {'period': ""Q1 '24"", 'revenue': 1170.0, 'unit': 'M', 'net_profit': 20.0}, {'period': ""Q4 '23"", 'revenue': 1270.0, 'unit': 'M', 'net_profit': 21.0}, {'period': ""Q3 '23"", 'revenue': 1380.0, 'unit': 'M', 'net_profit': 72.0}]",-0.74,-0.74,5877000000,1475000000,146000000,4769000000,441000000,0,960000000,0,395000000,-0.31357254290171604,0.40358744394618834,0.40800000000000003,"[0.1, 0.1]","['2024-12-02', '2021-02-11']",__nan__,0.811468436277012
312,PUBM,PubMatic Inc. Class A Common Stock,"PubMatic, Inc. provides a cloud infrastructure platform that enables real-time programmatic advertising transactions for Internet content creators and advertisers worldwide. The company's solutions include Openwrap, a header bidding solution that provides enterprise-grade management and analytics tools; Openwrap OTT, a header bidding management solution for OTT; Openwrap SDK, a header bidding solution for in-app developers; private marketplace solutions; and media buyer consoles. In addition, it offers Real-Time Bidding (RTB) programmatic technologies, which provides various selling options across screens and ad formats; digital advertising inventory quality solutions to detect and filter out invalid traffic and other nefarious activity; Ad quality solutions targeting the reduction of security issues, quality issues, and performance issues; Identity Hub, an identity solution that allows for the use of any advertiser preferred user identifier in a scaled and privacy-compliant fashion; Audience Encore, an audience data platform; and cross-platform video, a sell side platform, which connects trusted video buyers to premium publishers. The company's platform supports an array of ad formats and digital device types, including mobile app, mobile web, desktop, display, video, over-the-top (OTT), connected television, and media. PubMatic, Inc. was incorporated in 2006 and is based in Redwood City, California.",Mr. Rajeev K. Goel,Software - Application,8.98,USD,435775091,https://images.financialmodelingprep.com/symbol/PUBM.png,525144,39.04,1.21,768241,3927000,12504000,"[{'period': '2024', 'revenue': 291.26, 'unit': 'M', 'net_profit': 12.5}, {'period': '2023', 'revenue': 267.01, 'unit': 'M', 'net_profit': 8.88}, {'period': '2022', 'revenue': 256.38, 'unit': 'M', 'net_profit': 28.7}, {'period': '2021', 'revenue': 226.91, 'unit': 'M', 'net_profit': 56.6}]","[{'period': ""Q4 '24"", 'revenue': 85.5, 'unit': 'M', 'net_profit': 13.9}, {'period': ""Q3 '24"", 'revenue': 71790.0, 'unit': 'K', 'net_profit': -912.0}, {'period': ""Q2 '24"", 'revenue': 67.27, 'unit': 'M', 'net_profit': 1.97}, {'period': ""Q1 '24"", 'revenue': 66.7, 'unit': 'M', 'net_profit': -2.45}, {'period': ""Q4 '23"", 'revenue': 84.6, 'unit': 'M', 'net_profit': 18.7}, {'period': ""Q3 '23"", 'revenue': 63.68, 'unit': 'M', 'net_profit': 1.77}]",0.25,0.23,739519000,575546000,140587000,462256000,424814000,0,418810000,100452000,55833000,-0.9161004999359057,0.4079495552302669,0.47058823529411753,__nan__,__nan__,__nan__,0.6250765700407968
313,PUCK,Goal Acquisitions Corp. Common Stock,"Goal Acquisitions Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Bee Cave, Texas.",Brig.Gen. Harvey W. Schiller,Shell Companies,13,USD,96970510,https://images.financialmodelingprep.com/symbol/PUCK.png,44,-43.33,0,200,-915680,-1137038,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.14}, {'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -296.85}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.76}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -593.61}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -733.88}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -593.06}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -573.17}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 17.58}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -191.15}]",-0.16,-0.16,3332338,470131,303746,12551270,0,0,12548608,303746,-1577008,0.7707984832370359,-2.830306582719393,-2.9312039312039313,__nan__,__nan__,__nan__,3.7665056785956286
314,PUCKU,Goal Acquisitions Corp. Unit,"Goal Acquisitions Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Bee Cave, Texas.",Brig.Gen. Harvey W. Schiller,Shell Companies,12.99,USD,96970506,https://images.financialmodelingprep.com/symbol/PUCKU.png,27,-259.8,0,56,-915680,-1137038,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.14}, {'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -296.85}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.76}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -593.61}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -733.88}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -593.06}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -573.17}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 17.58}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -191.15}]",-0.16,-0.16,3332338,470131,303746,12551270,0,0,12548608,303746,-1577008,0.7707984832370359,-2.830306582719393,-2.9312039312039313,__nan__,__nan__,__nan__,3.7665056785956286
315,PUCKW,Goal Acquisitions Corp. Warrant,"Goal Acquisitions Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in Austin, Texas.",Brig.Gen. Harvey W. Schiller,Shell Companies,0.0086,USD,83394639,https://images.financialmodelingprep.com/symbol/PUCKW.png,38715.82653,,-0.0014,52634,-915680,-1137038,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.14}, {'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': -296.85}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.76}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -593.61}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -733.88}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -593.06}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -573.17}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 17.58}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -191.15}]",-0.16,-0.16,3332338,470131,303746,12551270,0,0,12548608,303746,-1577008,0.7707984832370359,-2.830306582719393,-2.9312039312039313,__nan__,__nan__,__nan__,3.7665056785956286
316,PULM,Pulmatrix Inc. Common Stock,"Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.","Mr. Peter  Ludlum CMA, MBA",Biotechnology,5.66,USD,20671961,https://images.financialmodelingprep.com/symbol/PULM.png,29031,-2.16,0.13,32008,-6710000,-9559000,"[{'period': '2024', 'revenue': 7.81, 'unit': 'M', 'net_profit': -9.56}, {'period': '2023', 'revenue': 7.3, 'unit': 'M', 'net_profit': -14.12}, {'period': '2022', 'revenue': 6.07, 'unit': 'M', 'net_profit': -18.73}, {'period': '2021', 'revenue': 5.17, 'unit': 'M', 'net_profit': -22.5}]","[{'period': ""Q4 '24"", 'revenue': 0.003, 'unit': 'M', 'net_profit': -1.99}, {'period': ""Q3 '24"", 'revenue': 0.366, 'unit': 'M', 'net_profit': -2.59}, {'period': ""Q2 '24"", 'revenue': 1.55, 'unit': 'M', 'net_profit': -5.81}, {'period': ""Q1 '24"", 'revenue': 5880.0, 'unit': 'K', 'net_profit': 825.0}, {'period': ""Q4 '23"", 'revenue': 2.2, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q3 '23"", 'revenue': 1.75, 'unit': 'M', 'net_profit': -3.77}]",-2.62,-2.62,9943000,9920000,9521000,996000,0,0,929000,9521000,-11114000,0.4941575574820957,0.32306493874371506,0.32299741602067183,__nan__,__nan__,__nan__,0.1001709745549633
317,PUYI,Puyi Inc. American Depository Shares,"Puyi Inc. provides third-party wealth management services in China. The company distributes publicly raised fund and privately raised securities investment fund products through online and offline. It also provides asset management services that include managing fund of funds and non-performing loan funds; and corporate financing services. Puyi Inc. was incorporated in 2018 and is headquartered in Guangzhou, China.",Mr. Yinan  Hu,Asset Management,8.96,USD,2213424640,https://images.financialmodelingprep.com/symbol/PUYI.png,6061,-89.6,2.27,13581,-57559000,-43577000,"[{'period': '2023', 'revenue': 114.44, 'unit': 'M', 'net_profit': -43.58}, {'period': '2022', 'revenue': 188.74, 'unit': 'M', 'net_profit': -60.67}, {'period': '2021', 'revenue': 191.2, 'unit': 'M', 'net_profit': -46.37}, {'period': '2020', 'revenue': 129.48, 'unit': 'M', 'net_profit': -32.9}]","[{'period': ""Q4 '23"", 'revenue': 48.08, 'unit': 'M', 'net_profit': -12.67}, {'period': ""Q2 '23"", 'revenue': 67.15, 'unit': 'M', 'net_profit': -30.86}, {'period': ""Q4 '22"", 'revenue': 90.21, 'unit': 'M', 'net_profit': -22.15}, {'period': ""Q4 '21"", 'revenue': 95.6, 'unit': 'M', 'net_profit': -23.18}, {'period': ""Q2 '21"", 'revenue': 95.6, 'unit': 'M', 'net_profit': -23.18}, {'period': ""Q4 '20"", 'revenue': 64.74, 'unit': 'M', 'net_profit': -16.45}]",-0.72,-0.72,271533000,237995000,164470000,54499000,57601000,0,31066000,164470000,-137779000,-0.17479334625982243,0.28170174889148963,0.28712871287128716,__nan__,__nan__,__nan__,0.2007085694924742
318,PVAC,Penn Virginia Corporation Common Stock,"Penn Virginia Corporation, an independent oil and gas company, engages in the onshore exploration, development, and production of crude oil, natural gas liquids, and natural gas in the United States. It primarily operates wells in the Eagle Ford Shale field in South Texas. As of December 31, 2019, it had total proved reserves of approximately 133 million barrels of oil equivalent; and 510 gross productive wells, as well as owned approximately 100,200 gross acres of leasehold and royalty interests. Penn Virginia Corporation was founded in 1882 and is headquartered in Houston, Texas.",Mr. John Brooks,Oil & Gas Exploration & Production,30.66,USD,581279874,https://images.financialmodelingprep.com/symbol/PVAC.png,403759,0,-0.960001,624716,-144269000,-310557000,"[{'period': '2019', 'revenue': 273.27, 'unit': 'M', 'net_profit': -310.56}, {'period': '2018', 'revenue': 471.21, 'unit': 'M', 'net_profit': 70.59}, {'period': '2017', 'revenue': 441.01, 'unit': 'M', 'net_profit': 224.78}, {'period': '2016', 'revenue': 160.09, 'unit': 'M', 'net_profit': 32.66}]","[{'period': ""Q3 '21"", 'revenue': 305.09, 'unit': 'M', 'net_profit': 227.59}, {'period': ""Q3 '20"", 'revenue': 140.13, 'unit': 'M', 'net_profit': 43.06}, {'period': ""Q2 '20"", 'revenue': 123.79, 'unit': 'M', 'net_profit': 7.6}, {'period': ""Q1 '20"", 'revenue': 88.31, 'unit': 'M', 'net_profit': -20.02}, {'period': ""Q4 '19"", 'revenue': 67.0, 'unit': 'M', 'net_profit': -135.52}, {'period': ""Q3 '19"", 'revenue': 69.41, 'unit': 'M', 'net_profit': -243.41}]",-20.46,-20.46,907326000,153420000,13020000,694488000,42562000,0,148195000,13020000,53213000,-2.3619791174971208,-5.399509838643414,-5.381156316916488,__nan__,__nan__,__nan__,0.7654227918080161
319,PVBC,Provident Bancorp Inc. (MD) Common Stock,"Provident Bancorp, Inc. operates as the bank holding company for The Provident Bank that provides various financial services to individuals and small businesses in the United States. It offers checking, term certificate, negotiable order of withdrawal, money market, and savings accounts, as well as certificates of deposit. The company also provides commercial real estate, multi-family residential real estate, commercial business, construction and land development, mortgage warehouse, one- to four-family residential, and consumer loans, as well as home equity loans and lines of credit; and invests in securities, and state and municipal bonds. As of December 31, 2021, it operated through its main office and six branch offices located in Amesbury and Newburyport, Massachusetts; and Bedford, Exeter, Portsmouth, and Seabrook, New Hampshire, as well as two loan production offices located in Boston, Massachusetts, and Ponte Vedra, Florida. The company was founded in 1828 and is headquartered in Amesbury, Massachusetts.",Mr. Joseph B. Reilly,Banks - Regional,11.23,USD,199764855,https://images.financialmodelingprep.com/symbol/PVBC.png,25149,26.12,0.25,37633,0,7271000,"[{'period': '2024', 'revenue': 55.27, 'unit': 'M', 'net_profit': 7.27}, {'period': '2023', 'revenue': 65.91, 'unit': 'M', 'net_profit': 10.95}, {'period': '2022', 'revenue': 81.18, 'unit': 'M', 'net_profit': -21.47}, {'period': '2021', 'revenue': 66.6, 'unit': 'M', 'net_profit': 16.14}]","[{'period': ""Q4 '24"", 'revenue': 16.54, 'unit': 'M', 'net_profit': 4.88}, {'period': ""Q3 '24"", 'revenue': 13710.0, 'unit': 'K', 'net_profit': 716.0}, {'period': ""Q2 '24"", 'revenue': 23.39, 'unit': 'M', 'net_profit': -3.31}, {'period': ""Q1 '24"", 'revenue': 23.39, 'unit': 'M', 'net_profit': 4.98}, {'period': ""Q4 '23"", 'revenue': 25.21, 'unit': 'M', 'net_profit': 2.92}, {'period': ""Q3 '23"", 'revenue': 15.38, 'unit': 'M', 'net_profit': 2.47}]",0.43,0.43,1593170000,169142000,169142000,1362083000,0,0,0,169142000,11526000,0,-0.33622421033412453,-0.3484848484848485,"[0.04, 0.03]","['2022-08-11', '2020-04-29']",__nan__,0.8549514489979099
320,PWFL,PowerFleet Inc. Common Stock,"PowerFleet, Inc. provides wireless Internet-of-Things asset management solutions in the United States, Israel, and internationally. The company offers real-time intelligence for organizations to capture IoT data from various types of assets with devices and sensors to increase efficiencies, and improve safety and security, as well as increase their profitability in easy-to-understand reports, dashboards, and real-time alerts; and application programming interfaces for additional integrations and development to boost other enterprise management systems and third-party applications. It also provides hosting, maintenance, and support and consulting services; and Software as a Service, including system monitoring, help desk technical support, escalation procedure development, routine diagnostic data analysis, and software updates services. The company offers its products under the PowerFleet, Pointer, and Cellocator brands. It sells its products to commercial and government sectors in manufacturing, automotive manufacturing, wholesale and retail, food and grocery distribution, pharmaceutical and medical distribution, construction, mining, utilities, heavy industry, aerospace and defense, homeland security, and vehicle rental, logistics, shipping, and freight transportation markets, as well as through indirect sales channels, such as original equipment manufacturers, vehicle importers, distributors, and industrial equipment dealers. The company was formerly known as I.D. Systems, Inc. PowerFleet, Inc. was incorporated in 1993 and is headquartered in Woodcliff Lake, New Jersey.",Mr. Steve  Towe,Communication Equipment,4.57,USD,490589500,https://images.financialmodelingprep.com/symbol/PWFL.png,971930,-9.326530612244898,0.01,13698637,-75000,-5675000,"[{'period': '2023', 'revenue': 133.74, 'unit': 'M', 'net_profit': -5.67}, {'period': '2022', 'revenue': 135.16, 'unit': 'M', 'net_profit': -7.0}, {'period': '2021', 'revenue': 126.21, 'unit': 'M', 'net_profit': -13.29}, {'period': '2020', 'revenue': 113.59, 'unit': 'M', 'net_profit': -9.01}]","[{'period': ""Q2 '24"", 'revenue': 75.43, 'unit': 'M', 'net_profit': -22.34}, {'period': ""Q1 '24"", 'revenue': 33.74, 'unit': 'M', 'net_profit': -19.64}, {'period': ""Q4 '23"", 'revenue': 34.55, 'unit': 'M', 'net_profit': -3.5}, {'period': ""Q3 '23"", 'revenue': 34.2, 'unit': 'M', 'net_profit': -4.97}, {'period': ""Q2 '23"", 'revenue': 32.05, 'unit': 'M', 'net_profit': -2.98}, {'period': ""Q1 '23"", 'revenue': 32.84, 'unit': 'M', 'net_profit': 4.77}]",-0.053328,-0.053328,217746000,81942000,19332000,79825000,34708000,20257000,58556000,19332000,-2696000,-1.133214920071048,0.18940151406941866,0.20000000000000004,__nan__,__nan__,__nan__,0.36659686056230656
321,PWOD,Penns Woods Bancorp Inc. Common Stock,"Penns Woods Bancorp, Inc. operates as the bank holding company for Jersey Shore State Bank and Luzerne Bank, which provides commercial and retail banking services to individuals, partnerships, non-profit organizations, and corporations. It accepts time, demand, and savings deposits, including super NOW accounts, statement savings accounts, money market accounts, and certificates of deposit, as well as checking and individual retirement accounts. The company also offers loan products comprising residential, commercial, and construction real estate loans; agricultural loans for the purchase or improvement of real estate; commercial loans for the acquisition and improvement of real estate, purchase of equipment, and working capital purposes; letters of credit; consumer loans, such as construction and residential mortgages, home equity loans and lines, automobile financing, personal loans and lines of credit, and overdraft and check lines; and revolving credit loans with overdraft protection. In addition, it provides securities brokerage and financial planning services, which include the sale of life insurance products, annuities, and estate planning services; property and casualty, and auto insurance products; safe deposit services; ATM services; and Internet and telephone banking services. Further, the company engages in real estate transactions and investment activities. It operates through a network of twenty-seven offices located in Clinton, Lycoming, Centre, Montour, Union, Blair, and Luzerne Counties, Pennsylvania. The company was founded in 1907 and is headquartered in Williamsport, Pennsylvania.",Mr. Richard Allen Grafmyre CFP,Banks - Regional,27.12,USD,206461306,https://images.financialmodelingprep.com/symbol/PWOD.png,17540,11.54,1.2,65327,0,17739000,"[{'period': '2024', 'revenue': 109.7, 'unit': 'M', 'net_profit': 17.74}, {'period': '2023', 'revenue': 64.44, 'unit': 'M', 'net_profit': 16.61}, {'period': '2022', 'revenue': 66.49, 'unit': 'M', 'net_profit': 17.42}, {'period': '2021', 'revenue': 61.39, 'unit': 'M', 'net_profit': 16.03}]","[{'period': ""Q4 '24"", 'revenue': 18.27, 'unit': 'M', 'net_profit': 3.74}, {'period': ""Q3 '24"", 'revenue': 17.48, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q2 '24"", 'revenue': 16.54, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q1 '24"", 'revenue': 16.21, 'unit': 'M', 'net_profit': 3.81}, {'period': ""Q4 '23"", 'revenue': 16.17, 'unit': 'M', 'net_profit': 5.55}, {'period': ""Q3 '23"", 'revenue': 15.21, 'unit': 'M', 'net_profit': 2.22}]",2.35,2.35,2232338000,215645000,204531000,2027107000,11114000,0,44930000,19989000,19365000,0,0.06809971098265896,0.004273504273504373,"[0.32, 1.8295]","['2025-03-11', '1994-06-09']",__nan__,0.9080645493648364
322,PXLW,Pixelworks Inc.  Common Stock,"Pixelworks, Inc., together with its subsidiaries, develops and markets semiconductor and software solutions for mobile, home entertainment, content, and business and education markets. The company provides video display processor products, including image processor integrated circuits, such as embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing within high-end display systems; video co-processor integrated circuits that work with an image processor to post-process video signals to enhance the performance or feature set of the overall video solution; and transcoder integrated circuits, which comprise embedded microprocessors, digital signal processing technology, and software that control the operations and signal processing for converting bitrates, resolutions, and codecs. As of March 31, 2022, it had an intellectual property portfolio of 334 patents related to the visual display of digital image data. The company sells its through a direct sales force, distributors, and manufacturers' representatives in Japan, China, Taiwan, the United States, Europe, and Korea. Pixelworks, Inc. was incorporated in 1997 and is based in Portland, Oregon.",Mr. Todd A. DeBonis,Semiconductors,0.5556,USD,34971409,https://images.financialmodelingprep.com/symbol/PXLW.png,299506,-1.13,0.0635,118471,-25211000,-28719000,"[{'period': '2024', 'revenue': 43.21, 'unit': 'M', 'net_profit': -28.72}, {'period': '2023', 'revenue': 59.68, 'unit': 'M', 'net_profit': -26.18}, {'period': '2022', 'revenue': 70.15, 'unit': 'M', 'net_profit': -15.23}, {'period': '2021', 'revenue': 55.1, 'unit': 'M', 'net_profit': -19.41}]","[{'period': ""Q4 '24"", 'revenue': 9.09, 'unit': 'M', 'net_profit': -5.36}, {'period': ""Q3 '24"", 'revenue': 9.53, 'unit': 'M', 'net_profit': -8.14}, {'period': ""Q2 '24"", 'revenue': 8.54, 'unit': 'M', 'net_profit': -10.15}, {'period': ""Q1 '24"", 'revenue': 16.05, 'unit': 'M', 'net_profit': -5.07}, {'period': ""Q4 '23"", 'revenue': 20.07, 'unit': 'M', 'net_profit': -3.74}, {'period': ""Q3 '23"", 'revenue': 16.03, 'unit': 'M', 'net_profit': -7.0}]",-0.49,-0.49,64072000,34852000,23647000,24194000,5804000,0,8346000,23647000,-23567000,-0.13190858887442194,-0.09715006112469438,-0.04255319148936174,__nan__,__nan__,__nan__,0.3776064427519041
323,PXS,Pyxis Tankers Inc. Common Stock,"Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker sector in the United States. Its fleet transports refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, and fuel oil, as well as other liquid bulk items, including vegetable oils and organic chemicals. As of March 31, 2022, the company operated a fleet of five tankers. Pyxis Tankers Inc. was incorporated in 2015 and is based in Maroussi, Greece.",Mr. Valentios  Valentis,Marine Shipping,2.82,USD,29570238,https://images.financialmodelingprep.com/symbol/PXS.png,19006,3.1,0.12,19592,23628000,12868000,"[{'period': '2024', 'revenue': 51.54, 'unit': 'M', 'net_profit': 12.87}, {'period': '2023', 'revenue': 45.47, 'unit': 'M', 'net_profit': 37.04}, {'period': '2022', 'revenue': 58.34, 'unit': 'M', 'net_profit': 13.39}, {'period': '2021', 'revenue': 25.34, 'unit': 'M', 'net_profit': -15.62}]","[{'period': ""Q4 '24"", 'revenue': 12040.0, 'unit': 'K', 'net_profit': 314.0}, {'period': ""Q3 '24"", 'revenue': 13.79, 'unit': 'M', 'net_profit': 3.71}, {'period': ""Q2 '24"", 'revenue': 13.91, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q1 '24"", 'revenue': 11.8, 'unit': 'M', 'net_profit': 3.65}, {'period': ""Q4 '23"", 'revenue': 13.25, 'unit': 'M', 'net_profit': 21.83}, {'period': ""Q3 '23"", 'revenue': 11.1, 'unit': 'M', 'net_profit': 3.34}]",0.68,0.91,188881000,46123000,38243000,89217000,5040000,0,12254000,21243000,-26317000,-0.5134467278942383,-0.6525636525636526,-0.799410029498525,__nan__,__nan__,__nan__,0.4723450214685437
324,PXSAP,Pyxis Tankers Inc. 7.75% Series A Cumulative Convertible Preferred Shares,"Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker sector in the United States. Its fleet transports refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, and fuel oil, as well as other liquid bulk items, including vegetable oils and organic chemicals. As of March 31, 2022, the company operated a fleet of five tankers. Pyxis Tankers Inc. was incorporated in 2015 and is based in Maroussi, Greece.",Mr. Valentios  Valentis,Marine Shipping,24.9701,USD,46870800,https://images.financialmodelingprep.com/symbol/PXSAP.png,2379,-16.95186693822132,-0.0299,761,23628000,12868000,"[{'period': '2024', 'revenue': 51.54, 'unit': 'M', 'net_profit': 12.87}, {'period': '2023', 'revenue': 45.47, 'unit': 'M', 'net_profit': 37.04}, {'period': '2022', 'revenue': 58.34, 'unit': 'M', 'net_profit': 13.39}, {'period': '2021', 'revenue': 25.34, 'unit': 'M', 'net_profit': -15.62}]","[{'period': ""Q4 '24"", 'revenue': 12040.0, 'unit': 'K', 'net_profit': 314.0}, {'period': ""Q3 '24"", 'revenue': 13.79, 'unit': 'M', 'net_profit': 3.71}, {'period': ""Q2 '24"", 'revenue': 13.91, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q1 '24"", 'revenue': 11.8, 'unit': 'M', 'net_profit': 3.65}, {'period': ""Q4 '23"", 'revenue': 13.25, 'unit': 'M', 'net_profit': 21.83}, {'period': ""Q3 '23"", 'revenue': 11.1, 'unit': 'M', 'net_profit': 3.34}]",0.68,0.91,188881000,46123000,38243000,89217000,5040000,0,12254000,21243000,-26317000,-0.5134467278942383,-0.6525636525636526,-0.799410029498525,"[0.1615, 0.199]","['2024-10-11', '2020-11-12']",__nan__,0.4723450214685437
325,PXSAW,Pyxis Tankers Inc. Warrant,"Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker sector in the United States. Its fleet transports refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, and fuel oil, as well as other liquid bulk items, including vegetable oils and organic chemicals. As of March 31, 2023, the company operated a fleet of four tankers. Pyxis Tankers Inc. was incorporated in 2015 and is based in Maroussi, Greece. Pyxis Tankers Inc. is a subsidiary of Maritime Investors Corp.",Mr. Valentios  Valentis,Marine Shipping,0.0145,USD,154273,https://images.financialmodelingprep.com/symbol/PXSAW.png,9712.97516,,-0.0049,10006,23628000,12868000,"[{'period': '2024', 'revenue': 51.54, 'unit': 'M', 'net_profit': 12.87}, {'period': '2023', 'revenue': 45.47, 'unit': 'M', 'net_profit': 37.04}, {'period': '2022', 'revenue': 58.34, 'unit': 'M', 'net_profit': 13.39}, {'period': '2021', 'revenue': 25.34, 'unit': 'M', 'net_profit': -15.62}]","[{'period': ""Q4 '24"", 'revenue': 12040.0, 'unit': 'K', 'net_profit': 314.0}, {'period': ""Q3 '24"", 'revenue': 13.79, 'unit': 'M', 'net_profit': 3.71}, {'period': ""Q2 '24"", 'revenue': 13.91, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q1 '24"", 'revenue': 11.8, 'unit': 'M', 'net_profit': 3.65}, {'period': ""Q4 '23"", 'revenue': 13.25, 'unit': 'M', 'net_profit': 21.83}, {'period': ""Q3 '23"", 'revenue': 11.1, 'unit': 'M', 'net_profit': 3.34}]",0.68,0.91,188881000,46123000,38243000,89217000,5040000,0,12254000,21243000,-26317000,-0.5134467278942383,-0.6525636525636526,-0.799410029498525,__nan__,__nan__,__nan__,0.4723450214685437
326,PYPD,PolyPid Ltd. Ordinary Shares,"PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.",Ms. Dikla  Czaczkes Akselbrad,Biotechnology,2.5121,USD,25600560,https://images.financialmodelingprep.com/symbol/PYPD.png,17385,-0.51,0.0421,3897,-20263000,-23865000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.86}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.52}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.71}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.32}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.52}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.76}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.45}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.36}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.6}]",-16.99,-16.99,25220000,16573000,15641000,17536000,0,0,12681000,15641000,-22039000,0.4428343598768148,0.39620493358633774,0.8608289646133683,__nan__,__nan__,__nan__,0.6953211736716891
327,PYPL,PayPal Holdings Inc. Common Stock,"PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. It provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, Zettle, Hyperwallet, Honey, and Paidy names. The company's payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 100 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. PayPal Holdings, Inc. was founded in 1998 and is headquartered in San Jose, California.",Mr. James Alexander Chriss,Financial - Credit Services,63.95,USD,63262025900,https://images.financialmodelingprep.com/symbol/PYPL.png,12726709,16.03,6.54,22189781,6743000000,4147000000,"[{'period': '2024', 'revenue': 31.8, 'unit': 'B', 'net_profit': 4.15}, {'period': '2023', 'revenue': 29.77, 'unit': 'B', 'net_profit': 4.25}, {'period': '2022', 'revenue': 27.52, 'unit': 'B', 'net_profit': 2.42}, {'period': '2021', 'revenue': 25.37, 'unit': 'B', 'net_profit': 4.17}]","[{'period': ""Q4 '24"", 'revenue': 8.37, 'unit': 'B', 'net_profit': 1.12}, {'period': ""Q3 '24"", 'revenue': 7.85, 'unit': 'B', 'net_profit': 1.01}, {'period': ""Q2 '24"", 'revenue': 7.86, 'unit': 'B', 'net_profit': 1.13}, {'period': ""Q1 '24"", 'revenue': 7700.0, 'unit': 'M', 'net_profit': 888.0}, {'period': ""Q4 '23"", 'revenue': 8.03, 'unit': 'B', 'net_profit': 1.4}, {'period': ""Q3 '23"", 'revenue': 7.42, 'unit': 'B', 'net_profit': 1.02}]",4.03,3.99,81611000000,61092000000,10823000000,61194000000,45618000000,4583000000,48376000000,6561000000,6767000000,-0.012737920937042459,-0.023316062176165803,0.0467532467532468,__nan__,__nan__,__nan__,0.7498253911850118
328,PYR,PyroGenesis Canada Inc. Common Shares,"PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and systems in Canada and internationally. It offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products, targeting primarily the aluminum and zinc industries; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP Nano Silicon Reactor, which is designed to transform silicon into spherical silicon powders and silicon nanowires for use in lithium-ion batteries. The company also provides plasma torches, including APT high-powered plasma torch for replacing fossil fuel burners. In addition, it offers plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. Further, the company provides engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Additionally, it offers installation, commissioning, and start-up services. The company is headquartered in Montréal, Canada.",Mr. Photis Peter Pascali Jr.,Industrial - Machinery,0.3799,USD,67956662,https://images.financialmodelingprep.com/symbol/PYR.png,24183,-3.1658333333333335,0,24183,-20963478,-32167027,"[{'period': '2022', 'revenue': 19.01, 'unit': 'M', 'net_profit': -32.17}, {'period': '2021', 'revenue': 31.07, 'unit': 'M', 'net_profit': -38.43}, {'period': '2020', 'revenue': 17.78, 'unit': 'M', 'net_profit': 41.77}, {'period': '2019', 'revenue': 4.81, 'unit': 'M', 'net_profit': -9.86}]","[{'period': ""Q3 '23"", 'revenue': 3.69, 'unit': 'M', 'net_profit': -6.23}, {'period': ""Q2 '23"", 'revenue': 3.04, 'unit': 'M', 'net_profit': -6.35}, {'period': ""Q1 '23"", 'revenue': 2.59, 'unit': 'M', 'net_profit': -5.84}, {'period': ""Q4 '22"", 'revenue': 3.3, 'unit': 'M', 'net_profit': -10.94}, {'period': ""Q3 '22"", 'revenue': 5.66, 'unit': 'M', 'net_profit': -6.06}, {'period': ""Q2 '22"", 'revenue': 5.85, 'unit': 'M', 'net_profit': -13.05}]",-0.19,-0.19,47666750,27448182,3445649,30797823,19555168,6242634,25797473,3445649,-11815309,-0.32545388157301985,0.16301316464932983,0.1739130434782609,__nan__,__nan__,__nan__,0.6461070452674034
329,PZZA,Papa John's International Inc. Common Stock,"Papa John's International, Inc. operates and franchises pizza delivery and carryout restaurants under the Papa John's trademark in the United States and internationally. It operates through four segments: Domestic Company-Owned Restaurants, North America Commissaries, North America Franchising, and International Operations. The company also operates dine-in and delivery restaurants under the Papa John's trademark internationally. As of December 26, 2021, it operated 5,650 Papa John's restaurants, which included 600 company-owned and 5,050 franchised restaurants in 50 countries and territories. The company was founded in 1984 and is based in Louisville, Kentucky.",Mr. Todd Allan Penegor,Restaurants,33.86,USD,1107536898,https://images.financialmodelingprep.com/symbol/PZZA.png,1632867,13.33,1.72,2223915,226111000,83320000,"[{'period': '2024', 'revenue': 2060.0, 'unit': 'M', 'net_profit': 83.32}, {'period': '2023', 'revenue': 2140.0, 'unit': 'M', 'net_profit': 82.1}, {'period': '2022', 'revenue': 2100.0, 'unit': 'M', 'net_profit': 67.77}, {'period': '2021', 'revenue': 2070.0, 'unit': 'M', 'net_profit': 120.02}]","[{'period': ""Q4 '24"", 'revenue': 530.77, 'unit': 'M', 'net_profit': 14.63}, {'period': ""Q3 '24"", 'revenue': 506.81, 'unit': 'M', 'net_profit': 41.81}, {'period': ""Q2 '24"", 'revenue': 507.89, 'unit': 'M', 'net_profit': 12.24}, {'period': ""Q1 '24"", 'revenue': 513.92, 'unit': 'M', 'net_profit': 14.64}, {'period': ""Q4 '23"", 'revenue': 571.32, 'unit': 'M', 'net_profit': 26.09}, {'period': ""Q3 '23"", 'revenue': 522.81, 'unit': 'M', 'net_profit': 15.86}]",2.55,2.54,888952000,230605000,37955000,1302265000,108819000,0,277963000,37955000,34148000,0.06402672878285216,0.014884650052376429,0.024096385542168516,"[0.46, 0.25]","['2025-02-10', '2013-09-04']",__nan__,1.4649441139679082
330,QADA,QAD Inc. Class A Common Stock,"QAD Inc. provides cloud-based enterprise software solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers various software solutions, such as customer and service management solutions for manufacturers to acquire new customers; manufacturing solutions, which supports manufacturing business processes; enterprise asset management to manage, maintain, and install capital equipment; supply chain execution solutions that provides tools to support inventory and warehouse management; and financials solutions to manage and control finance and accounting processes. The company also provides demand and supply chain planning solutions to manage various procurement, manufacturing, inventory, distribution, and sales activities; global trade and transportation solutions to manage and optimize network of carriers for shipments; embedded analytics and business intelligence that offers data to measure performance; and internationalization, which supports companies that manufacture and distribute their products worldwide. In addition, it offers customer support and product update services, as well as professional services, including consulting, deployment, training, technical, development, and integration. The company markets its products through direct and indirect sales channels; and distributors and sales agents. It serves automotive, life sciences, consumer products, food and beverage, high technology, and industrial products manufacturing companies. QAD Inc. was founded in 1979 and is headquartered in Santa Barbara, California.",Mr. Anton Chilton,Software - Application,87.65,USD,0,https://images.financialmodelingprep.com/symbol/QADA.png,236198,0,0.02000427,0,24122000,11065000,"[{'period': '2020', 'revenue': 307.87, 'unit': 'M', 'net_profit': 11.06}, {'period': '2019', 'revenue': 310.77, 'unit': 'M', 'net_profit': -15.95}, {'period': '2018', 'revenue': 333.02, 'unit': 'M', 'net_profit': 10.43}, {'period': '2017', 'revenue': 305.02, 'unit': 'M', 'net_profit': -9.06}]","[{'period': ""Q2 '21"", 'revenue': 84.84, 'unit': 'M', 'net_profit': -6.32}, {'period': ""Q1 '21"", 'revenue': 82.97, 'unit': 'M', 'net_profit': 1.83}, {'period': ""Q4 '20"", 'revenue': 82.98, 'unit': 'M', 'net_profit': 8.2}, {'period': ""Q3 '20"", 'revenue': 76.66, 'unit': 'M', 'net_profit': 3.21}, {'period': ""Q2 '20"", 'revenue': 74080.0, 'unit': 'K', 'net_profit': 60.0}, {'period': ""Q1 '20"", 'revenue': 74150.0, 'unit': 'K', 'net_profit': -410.0}]",0.52,0.52,350787000,248033000,142501000,221321000,86409000,0,179484000,142501000,29671000,1.5656243352478196,1.6937739043200202,1.65,"[0.072, 0.06]","['2021-07-02', '2011-03-11']",__nan__,0.6309270297930083
331,QADB,QAD Inc. Class B Common Stock,,Mr. Anton Chilton,Software - Application,87.54,USD,0,https://images.financialmodelingprep.com/symbol/QADB.png,5659,143.2733224222586,0,0,24122000,11065000,"[{'period': '2020', 'revenue': 307.87, 'unit': 'M', 'net_profit': 11.06}, {'period': '2019', 'revenue': 310.77, 'unit': 'M', 'net_profit': -15.95}, {'period': '2018', 'revenue': 333.02, 'unit': 'M', 'net_profit': 10.43}, {'period': '2017', 'revenue': 305.02, 'unit': 'M', 'net_profit': -9.06}]","[{'period': ""Q2 '21"", 'revenue': 84.84, 'unit': 'M', 'net_profit': -6.32}, {'period': ""Q1 '21"", 'revenue': 82.97, 'unit': 'M', 'net_profit': 1.83}, {'period': ""Q4 '20"", 'revenue': 82.98, 'unit': 'M', 'net_profit': 8.2}, {'period': ""Q3 '20"", 'revenue': 76.66, 'unit': 'M', 'net_profit': 3.21}, {'period': ""Q2 '20"", 'revenue': 74080.0, 'unit': 'K', 'net_profit': 60.0}, {'period': ""Q1 '20"", 'revenue': 74150.0, 'unit': 'K', 'net_profit': -410.0}]",0.52,0.52,350787000,248033000,142501000,221321000,86409000,0,179484000,142501000,29671000,1.5656243352478196,1.6937739043200202,1.65,"[0.06, 0.1]","['2021-07-02', '2004-07-15']",__nan__,0.6309270297930083
332,QCOM,QUALCOMM Incorporated Common Stock,"QUALCOMM Incorporated engages in the development and commercialization of foundational technologies for the wireless industry worldwide. The company operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on 3G/4G/5G and other technologies for use in wireless voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of wireless products comprising products implementing CDMA2000, WCDMA,LTE and/or OFDMA-based 5G standards and their derivatives. The QSI segment invests in early-stage companies in various industries, including 5G, artificial intelligence, automotive, consumer, enterprise, cloud, and IoT, and investment for supporting the design and introduction of new products and services for voice and data communications, new industries, and applications. It also provides development, and other services and related products to the United States government agencies and their contractors. QUALCOMM Incorporated was incorpotared in 1985 and is headquartered in San Diego, California.",Mr. Cristiano Renno Amon,Semiconductors,143.59,USD,158810540000,https://images.financialmodelingprep.com/symbol/QCOM.png,8596980,15.47,18.93,21177196,12739000000,10142000000,"[{'period': '2024', 'revenue': 38.96, 'unit': 'B', 'net_profit': 10.14}, {'period': '2023', 'revenue': 35.82, 'unit': 'B', 'net_profit': 7.23}, {'period': '2022', 'revenue': 44.2, 'unit': 'B', 'net_profit': 12.94}, {'period': '2021', 'revenue': 33.57, 'unit': 'B', 'net_profit': 9.04}]","[{'period': ""Q1 '25"", 'revenue': 11.67, 'unit': 'B', 'net_profit': 3.18}, {'period': ""Q4 '24"", 'revenue': 10.24, 'unit': 'B', 'net_profit': 2.92}, {'period': ""Q3 '24"", 'revenue': 9.39, 'unit': 'B', 'net_profit': 2.13}, {'period': ""Q2 '24"", 'revenue': 9.39, 'unit': 'B', 'net_profit': 2.33}, {'period': ""Q1 '24"", 'revenue': 9.94, 'unit': 'B', 'net_profit': 2.77}, {'period': ""Q4 '23"", 'revenue': 8.63, 'unit': 'B', 'net_profit': 1.49}]",9.09,8.98,55154000000,25231000000,13300000000,28880000000,3929000000,0,10504000000,7849000000,11161000000,0.2179940720910221,0.4023783185840708,0.40494590417310666,"[0.85, 1.125]","['2025-03-06', '1998-09-24']",__nan__,0.5236247597635711
333,QCRH,QCR Holdings Inc. Common Stock,"QCR Holdings, Inc., a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services. Its deposit products include noninterest-bearing demand, interest-bearing demand, time, and brokered deposits. The company also provides various commercial and retail lending/leasing, and investment services to corporations, partnerships, individuals, and government agencies. Its loan portfolio comprises loans to small and mid-sized businesses; business loans, including lines of credit for working capital and operational purposes; term loans for the acquisition of facilities, equipment, and other purposes; commercial and residential real estate loans; and installment and other consumer loans, such as home improvement, home equity, motor vehicle, and signature loans, as well as small personal credit lines. In addition, the company engages in leasing of machinery and equipment to commercial and industrial businesses under direct financing lease contracts; and issuance of trust preferred securities. It serves the Quad Cities, Cedar Rapids, Cedar Valley, Des Moines/Ankeny, and Springfield communities. The company was founded in 1993 and is headquartered in Moline, Illinois.",Mr. Larry J. Helling,Banks - Regional,67.37,USD,1138633844,https://images.financialmodelingprep.com/symbol/QCRH.png,88826,10.04,2.735,129113,0,113850000,"[{'period': '2024', 'revenue': 0.05978, 'unit': 'M', 'net_profit': 113.85}, {'period': '2023', 'revenue': 343.21, 'unit': 'M', 'net_profit': 113.56}, {'period': '2022', 'revenue': 304.16, 'unit': 'M', 'net_profit': 99.07}, {'period': '2021', 'revenue': 271.84, 'unit': 'M', 'net_profit': 98.91}]","[{'period': ""Q4 '24"", 'revenue': 89.01, 'unit': 'M', 'net_profit': 30.23}, {'period': ""Q3 '24"", 'revenue': 84.18, 'unit': 'M', 'net_profit': 27.79}, {'period': ""Q2 '24"", 'revenue': 150.56, 'unit': 'M', 'net_profit': 29.11}, {'period': ""Q1 '24"", 'revenue': 142.1, 'unit': 'M', 'net_profit': 26.73}, {'period': ""Q4 '23"", 'revenue': 160.52, 'unit': 'M', 'net_profit': 32.85}, {'period': ""Q3 '23"", 'revenue': 79.02, 'unit': 'M', 'net_profit': 25.12}]",6.77,6.71,9026030000,7067404000,372841000,8028643000,6694563000,0,1800000,91732000,444538000,-1,0.002571373218971803,-0.0029455081001473434,"[0.06, 0.671]","['2025-03-19', '2001-11-01']",__nan__,0.8894988162015859
334,QDEL,Quidel Corporation Common Stock,"QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.",Mr. Brian J. Blaser,Medical - Instruments & Supplies,28.85,USD,1946065210,https://images.financialmodelingprep.com/symbol/QDEL.png,977565,-0.94,2.65,2207379,-1960900000,-2027000000,"[{'period': '2024', 'revenue': 2.78, 'unit': 'B', 'net_profit': -2.03}, {'period': '2023', 'revenue': 3000.0, 'unit': 'M', 'net_profit': -10.1}, {'period': '2022', 'revenue': 3270.0, 'unit': 'M', 'net_profit': 548.7}, {'period': '2021', 'revenue': 1700.0, 'unit': 'M', 'net_profit': 704.2}]","[{'period': ""Q4 '24"", 'revenue': 707.8, 'unit': 'M', 'net_profit': -153.4}, {'period': ""Q3 '24"", 'revenue': 727.1, 'unit': 'M', 'net_profit': -19.9}, {'period': ""Q2 '24"", 'revenue': 636.3, 'unit': 'M', 'net_profit': -147.7}, {'period': ""Q1 '24"", 'revenue': 0.7097000000000001, 'unit': 'B', 'net_profit': -1.71}, {'period': ""Q4 '23"", 'revenue': 742.6, 'unit': 'M', 'net_profit': 7.0}, {'period': ""Q3 '23"", 'revenue': 744.0, 'unit': 'M', 'net_profit': -12.7}]",-30.16,-30.16,6423600000,1218900000,98300000,3439100000,282400000,0,998800000,98300000,83000000,-4.230477759472818,-199.69306930693068,-200.0666666666667,__nan__,__nan__,__nan__,0.5353851422878136
335,QELL,Qell Acquisition Corp. Class A Ordinary Shares,"Qell Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in in 2020 and is based in San Francisco, California.",Mr. Barry L. Engle II,Shell Companies,9.41,USD,0,https://images.financialmodelingprep.com/symbol/QELL.png,522987,0,0.02999973,737006,-293715000,-293715000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -293.71}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -401.74}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -293.71}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-6.19,-6.19,382118393000,2538901000,381603315000,13496028000,0,0,213528000,2023823000,-671514000,0,0,0,__nan__,__nan__,__nan__,0.03531896984608118
336,QELLU,Qell Acquisition Corp. Unit,"Qell Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in in 2020 and is based in San Francisco, California.",Mr. Barry L. Engle II,Shell Companies,10.03,USD,0,https://images.financialmodelingprep.com/symbol/QELLU.png,9563,0,0.0199995,11920,-293715000,-293715000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -293.71}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -401.74}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -293.71}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-6.19,-6.19,382118393000,2538901000,381603315000,13496028000,0,0,213528000,2023823000,-671514000,0,0,0,__nan__,__nan__,__nan__,0.03531896984608118
337,QELLW,Qell Acquisition Corp. Warrant,,,,,,,,,,,,-293715000,-293715000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -293.71}]","[{'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.59}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -293.71}]",-0.04,-0.04,379582030901,2538901,381603315,13496028,0,0,213528,2023823,,0,0,0,__nan__,__nan__,__nan__,3.555497073442853e-05
338,QFIN,360 DigiTech Inc. American Depositary Shares,"Qifu Technology, Inc., together with its subsidiaries, operates credit-tech platform under the 360 Jietiao brand in the People's Republic of China. The company provides credit-driven services that matches borrowers with financial institutions to conduct customer acquisition, initial and credit screening, advanced risk assessment, credit assessment, fund matching, and other post-facilitation services; and platform services, including loan facilitation and post-facilitation services to financial institution partners under intelligence credit engine, referral services, and risk management software-as-a-service. It offers e-commerce loans, enterprise loans, and invoice loans to SME owners. It serves financial institutions, consumers, and small- and micro-enterprises. The company was formerly known as 360 DigiTech, Inc. and changed its name to Qifu Technology, Inc. in March 2023. Qifu Technology, Inc. was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.",Mr. Haisheng  Wu,Financial - Credit Services,36.79,USD,2687454057,https://images.financialmodelingprep.com/symbol/QFIN.png,1788157,6.49,0.93,3801861,8080736000,6264314000,"[{'period': '2024', 'revenue': 17.17, 'unit': 'B', 'net_profit': 6.26}, {'period': '2023', 'revenue': 16.29, 'unit': 'B', 'net_profit': 4.29}, {'period': '2022', 'revenue': 16.55, 'unit': 'B', 'net_profit': 4.02}, {'period': '2021', 'revenue': 16.64, 'unit': 'B', 'net_profit': 5.78}]","[{'period': ""Q4 '24"", 'revenue': 4.48, 'unit': 'B', 'net_profit': 1.92}, {'period': ""Q3 '24"", 'revenue': 3.58, 'unit': 'B', 'net_profit': 1.8}, {'period': ""Q2 '24"", 'revenue': 4.16, 'unit': 'B', 'net_profit': 1.38}, {'period': ""Q1 '24"", 'revenue': 3.32, 'unit': 'B', 'net_profit': 1.16}, {'period': ""Q4 '23"", 'revenue': 3.89, 'unit': 'B', 'net_profit': 1.11}, {'period': ""Q3 '23"", 'revenue': 3.48, 'unit': 'B', 'net_profit': 1.14}]",42.04,41.29,48132618000,42780568000,7846489000,23886399000,2223040000,0,17472209000,4452416000,9343311000,0,0.4618022950825793,0.6119631901840491,"[0.69, 0.27]","['2025-04-23', '2021-12-14']",__nan__,0.4962622020684601
339,QH,Quhuo Limited American Depository Shares,"Quhuo Limited, through its subsidiaries, operates a workforce operational solution platform in the People's Republic of China. The company provides tech-enabled and end-to-end operational solutions to blue-chip on-demand consumer service businesses in industries with e-commerce exposure, including delivery, ride-hailing, housekeeping, and bike-sharing. It also offers on-demand delivery solutions for industry customers with focus on items, such as grocery, and prepared and fresh food; ride hailing solutions for ride-hailing companies; housekeeping solutions and other services for short-term rental properties and hotel cleaning services; and shared-bike maintenance solutions to address the demand for maintenance and distribution services from bike-sharing companies. In addition, the company develops computer software and applications. Quhuo Limited was founded in 2012 and is based in Beijing, the People's Republic of China.",Mr. Leslie  Yu,Software - Application,1.29,USD,1248529,https://images.financialmodelingprep.com/symbol/QH.png,12624,-2.35,-0.03,11908,-4359000,3334000,"[{'period': '2023', 'revenue': 3700.0, 'unit': 'M', 'net_profit': 3.33}, {'period': '2022', 'revenue': 3820.0, 'unit': 'M', 'net_profit': -13.13}, {'period': '2021', 'revenue': 4030.0000000000005, 'unit': 'M', 'net_profit': -191.23}, {'period': '2020', 'revenue': 2580.0, 'unit': 'M', 'net_profit': -5.6}]","[{'period': ""Q2 '24"", 'revenue': 809.97, 'unit': 'M', 'net_profit': -26.27}, {'period': ""Q1 '24"", 'revenue': 809.97, 'unit': 'M', 'net_profit': -26.27}, {'period': ""Q4 '23"", 'revenue': 983.03, 'unit': 'M', 'net_profit': 6.49}, {'period': ""Q3 '23"", 'revenue': 983.03, 'unit': 'M', 'net_profit': 6.49}, {'period': ""Q2 '23"", 'revenue': 868.16, 'unit': 'M', 'net_profit': -4.82}, {'period': ""Q1 '23"", 'revenue': 868.16, 'unit': 'M', 'net_profit': -4.82}]",0.006,0.006,1031936000,699433000,113563000,526658000,555064000,1415000,458790000,45185000,-130108000,-1.079020357848558,1.253922315308454,1.2564102564102564,__nan__,__nan__,__nan__,0.510359169560903
340,QIWI,QIWI plc American Depositary Shares,"Qiwi plc, together with its subsidiaries, operates electronic online payment systems primarily in the Russia, Kazakhstan, Moldova, Belarus, the United Arab Emirates, and internationally. The company operates through Payment Services, Consumer Financial Services, and Rocketbank segments. It offers payment services across online, mobile, and physical channels through a network of approximately 75,000 kiosks and 18,000 terminals. The company also provides Qiwi Wallet, which is an online and mobile payment processing, and money transfer system that allows customers to pay for the products and services of merchants, as well as perform peer-to-peer money transfers through a virtual wallet; and Visa prepaid cards. In addition, it offers payment-by installments card systems under the SOVEST brand name. Further, it provides digital banking services to retail customers under the Rocketbank name; and to small and medium businesses under the Tochka name. The company was incorporated in 2007 and is based in Nicosia, Cyprus.",Mr. Alexey  Mashchenkov,Software - Infrastructure,5.67,USD,355582716,https://images.financialmodelingprep.com/symbol/QIWI.png,0,1.1477732793522266,0,0,2423000000,2768000000,"[{'period': '2023', 'revenue': 7.21, 'unit': 'B', 'net_profit': 2.77}, {'period': '2022', 'revenue': 51.5, 'unit': 'B', 'net_profit': 13.12}, {'period': '2021', 'revenue': 41.13, 'unit': 'B', 'net_profit': 17.4}, {'period': '2020', 'revenue': 40.62, 'unit': 'B', 'net_profit': 8.84}]","[{'period': ""Q4 '23"", 'revenue': -45.91, 'unit': 'B', 'net_profit': -9.09}, {'period': ""Q3 '23"", 'revenue': 17.21, 'unit': 'B', 'net_profit': 2.86}, {'period': ""Q2 '23"", 'revenue': 18.04, 'unit': 'B', 'net_profit': 4.65}, {'period': ""Q1 '23"", 'revenue': 17.87, 'unit': 'B', 'net_profit': 4.34}, {'period': ""Q4 '22"", 'revenue': 14.81, 'unit': 'B', 'net_profit': 3.86}, {'period': ""Q3 '22"", 'revenue': 12.96, 'unit': 'B', 'net_profit': 4.46}]",88.28,88.28,122237000000,117367000000,12293000000,62381000000,662000000,479000000,61923000000,7300000000,8778000000,3.288062217161562,-0.7890083085601036,-0.9977892077242375,"[0.29, 0.29]","['2021-12-03', '2013-06-13']",__nan__,0.5103282966695845
341,QK,Q&K International Group Limited American Depositary Shares,"FLJ Group Limited operates a long-term apartment rental platform in the People's Republic of China. The company leases apartments from landlords, transforms them into standardized furnished rooms, and leases to people. It also provides internet connection and utility services as part of the lease agreement. The company was formerly known as Q&K International Group Limited and changed its name to FLJ Group Limited in September 2022. FLJ Group Limited was founded in 2012 and is based in Shanghai, the People's Republic of China.",Mr. Guangjie Jin,Real Estate - Services,2.74,USD,636759579,https://images.financialmodelingprep.com/symbol/QK.png,0,-0.31422018348623854,-0.1,5729,-586252000,-226821000,"[{'period': '2024', 'revenue': 288.37, 'unit': 'M', 'net_profit': -226.82}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -71.31}, {'period': '2022', 'revenue': 652.33, 'unit': 'M', 'net_profit': 820.02}, {'period': '2021', 'revenue': 1040.0, 'unit': 'M', 'net_profit': -569.17}]","[{'period': ""Q2 '24"", 'revenue': 38.37, 'unit': 'M', 'net_profit': 193.71}, {'period': ""Q1 '24"", 'revenue': 38.37, 'unit': 'M', 'net_profit': 193.71}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.66}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.66}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 531.62}, {'period': ""Q3 '22"", 'revenue': 144.06, 'unit': 'M', 'net_profit': 531.62}]",0,0,782836000,67643000,10117000,1339409000,36276000,0,1338822000,8085000,-9770000,-21.782993937509715,-2.180640275966514,1,__nan__,__nan__,__nan__,1.7109701137913944
342,QLGN,Qualigen Therapeutics Inc. Common Stock,"Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.",Mr. Kevin A. Richardson II,Biotechnology,3.1686,USD,2333455,https://images.financialmodelingprep.com/symbol/QLGN.png,79477,,0.0686,27645,-11300362,-13417212,"[{'period': '2023', 'revenue': 5.2, 'unit': 'M', 'net_profit': -13.42}, {'period': '2022', 'revenue': 4.98, 'unit': 'M', 'net_profit': -21.03}, {'period': '2021', 'revenue': 5.65, 'unit': 'M', 'net_profit': -17.9}, {'period': '2020', 'revenue': 4.31, 'unit': 'M', 'net_profit': -20.42}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.79}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.58}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.47}, {'period': ""Q3 '23"", 'revenue': 7.94, 'unit': 'M', 'net_profit': -3.66}, {'period': ""Q2 '23"", 'revenue': 1.63, 'unit': 'M', 'net_profit': -3.46}]",-2.46,-2.46,2033248,1166767,401803,4136805,0,0,4136805,401803,-10304263,0.1835796098531415,0.3621374035204686,0.551094890510949,__nan__,__nan__,__nan__,2.0345796479327656
343,QLI,Qilian International Holding Group Ltd. Ordinary Shares,"Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.",Mr. Chen  Xin,Drug Manufacturers - Specialty & Generic,5.41,USD,38681500,https://images.financialmodelingprep.com/symbol/QLI.png,22517,-4.918181818181818,-0.2,330,-1274660,-7780620,"[{'period': '2023', 'revenue': 46.47, 'unit': 'M', 'net_profit': -7.78}, {'period': '2022', 'revenue': 64.86, 'unit': 'M', 'net_profit': 1.08}, {'period': '2021', 'revenue': 57.1, 'unit': 'M', 'net_profit': 3.15}, {'period': '2020', 'revenue': 50.03, 'unit': 'M', 'net_profit': 5.06}]","[{'period': ""Q4 '23"", 'revenue': 17.31, 'unit': 'M', 'net_profit': -8.28}, {'period': ""Q2 '23"", 'revenue': 29160.0, 'unit': 'K', 'net_profit': 495.52}, {'period': ""Q4 '22"", 'revenue': 32770.0, 'unit': 'K', 'net_profit': 988.83}, {'period': ""Q2 '22"", 'revenue': 32090.000000000004, 'unit': 'K', 'net_profit': 87.86}, {'period': ""Q4 '21"", 'revenue': 27160.0, 'unit': 'K', 'net_profit': 802.28}, {'period': ""Q2 '21"", 'revenue': 29.94, 'unit': 'M', 'net_profit': 2.35}]",-0.22,-0.22,51257994,34512621,22419266,6684714,6354589,606005,6660139,7476247,-3401880,-1.3407824634423344,-8.226405298446261,-8.308970099667775,"[0.05, 0.05]","['2023-02-27', '2023-02-27']",__nan__,0.1304131020031724
344,QLYS,Qualys Inc. Common Stock,"Qualys, Inc. provides cloud-based information technology (IT), security, and compliance solutions in the United States and internationally. The company offers Qualys Cloud Apps, which includes Vulnerability Management; Vulnerability Management, Detection and Response; Threat Protection; Continuous Monitoring; Patch Management; Multi-Vector Endpoint Detection and Response; Certificate Assessment; SaaS Detection and Response; Secure Enterprise Mobility; Policy Compliance; Security Configuration Assessment; PCI Compliance; File Integrity Monitoring; Security Assessment Questionnaire; Out of-Band Configuration Assessment; Web Application Scanning; Web Application Firewall; Global Asset Inventory; Cybersecurity Asset Management; Certificate Inventory; Cloud Inventory; Cloud Security Assessment; and Container Security. Its integrated suite of IT, security, and compliance solutions delivered on its Qualys Cloud Platform enables customers to identify and manage IT assets, collect and analyze IT security data, discover and prioritize vulnerabilities, recommend and implement remediation actions, and verify the implementation of such actions. The company also provides asset tagging and management, reporting and dashboards, questionnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications, which enable integrated workflows, management and real-time analysis, and reporting across IT, security, and compliance solutions. The company offers its solutions through its sales teams, as well as through its network of channel partners, such as security consulting organizations, managed service providers, resellers, and consulting firms. It serves enterprises, government entities, and small and medium-sized businesses in various industries, including education, financial services, government, healthcare, insurance, manufacturing, media, retail, technology, and utilities. The company was incorporated in 1999 and is headquartered in Foster City, California.",Mr. Sumedh S. Thakar,Software - Infrastructure,125.73,USD,4586341221,https://images.financialmodelingprep.com/symbol/QLYS.png,342290,27.04,10.52,571199,187196000,173680000,"[{'period': '2024', 'revenue': 607.57, 'unit': 'M', 'net_profit': 173.68}, {'period': '2023', 'revenue': 554.46, 'unit': 'M', 'net_profit': 151.59}, {'period': '2022', 'revenue': 489.72, 'unit': 'M', 'net_profit': 107.99}, {'period': '2021', 'revenue': 411.17, 'unit': 'M', 'net_profit': 70.96}]","[{'period': ""Q4 '24"", 'revenue': 159.19, 'unit': 'M', 'net_profit': 43.97}, {'period': ""Q3 '24"", 'revenue': 153.87, 'unit': 'M', 'net_profit': 46.21}, {'period': ""Q2 '24"", 'revenue': 149.08, 'unit': 'M', 'net_profit': 43.77}, {'period': ""Q1 '24"", 'revenue': 145.81, 'unit': 'M', 'net_profit': 39.73}, {'period': ""Q4 '23"", 'revenue': 144.57, 'unit': 'M', 'net_profit': 40.59}, {'period': ""Q3 '23"", 'revenue': 142.0, 'unit': 'M', 'net_profit': 46.52}]",4.72,4.65,973537000,585691000,381423000,496421000,164551000,0,428390000,232182000,231760000,-0.015068925602441335,0.14568422441373396,0.14841849148418476,__nan__,__nan__,__nan__,0.5099148774006534
345,QMCO,Quantum Corporation Common Stock,"Quantum Corporation provides products for storing and managing digital video and unstructured data in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CatDV, an asset management and workflow orchestration platform that provides asset management, automation, and collaboration tools for organization that manages large volumes of digital media; StorNext software systems that enable high-speed ingest, editing, processing, and management of digital video and image datasets; and Scalar tape systems that provide long-term data storage facility to archive and preserve digital content for decades. It also provides DXi backup appliances for backup storage and multi-site disaster recovery; portfolio of products designed for the capture and analysis of video surveillance and security, including video recording servers, as well as hyperconverged storage systems for video surveillance management and recording; and appliances designed for video surveillance analytics and to run various types of access control systems. In addition, the company offers managed services, customer support agreements, software subscriptions, installation, and consulting and training services; and object storage systems for online content repositories, such as media archives, genome sequencing data repositories, and big data lakes. Further, it sells linear tape-open (LTO) tape cartridges, as well as standalone LTO tape drives for small business and desktop use. The company sells its products through a network of distributors, value-added resellers, direct marketing resellers, original equipment manufacturers, and other suppliers, as well as directly to corporate entities and government agencies. Quantum Corporation was founded in 1980 and is headquartered in San Jose, California.",Mr. James J. Lerner,Computer Hardware,12.08,USD,70477136,https://images.financialmodelingprep.com/symbol/QMCO.png,1527603,-0.47,1.6,742853,-16173000,-41286000,"[{'period': '2024', 'revenue': 311.6, 'unit': 'M', 'net_profit': -41.29}, {'period': '2023', 'revenue': 412.75, 'unit': 'M', 'net_profit': -37.94}, {'period': '2022', 'revenue': 372.83, 'unit': 'M', 'net_profit': -32.28}, {'period': '2021', 'revenue': 349.58, 'unit': 'M', 'net_profit': -35.46}]","[{'period': ""Q3 '25"", 'revenue': 72.55, 'unit': 'M', 'net_profit': -71.43}, {'period': ""Q2 '25"", 'revenue': 70.47, 'unit': 'M', 'net_profit': -13.53}, {'period': ""Q1 '25"", 'revenue': 71.34, 'unit': 'M', 'net_profit': -20.82}, {'period': ""Q4 '24"", 'revenue': 71.5, 'unit': 'M', 'net_profit': -18.94}, {'period': ""Q3 '24"", 'revenue': 71.93, 'unit': 'M', 'net_profit': -9.87}, {'period': ""Q2 '24"", 'revenue': 75.68, 'unit': 'M', 'net_profit': -3.33}]",-8.68,-8.68,187615000,131783999,25692000,309113000,67788000,0,249944000,25692000,-16025000,-4.805411764705882,-0.0881058429749888,-19.666666666666668,__nan__,__nan__,__nan__,1.647592143485329
346,QNST,QuinStreet Inc. Common Stock,"QuinStreet, Inc., an online performance marketing company, provides customer acquisition services for its clients in the United States and internationally. The company offers online marketing services, such as qualified clicks, leads, calls, applications, and customers through its websites or third-party publishers. It serves financial and home services industries. The company was incorporated in 1999 and is headquartered in Foster City, California.",Mr. Douglas  Valenti,Advertising Agencies,15.97,USD,901803542,https://images.financialmodelingprep.com/symbol/QNST.png,583014,-76.05,1.26,1281007,-5759000,-31331000,"[{'period': '2024', 'revenue': 613.51, 'unit': 'M', 'net_profit': -31.33}, {'period': '2023', 'revenue': 580.62, 'unit': 'M', 'net_profit': -68.87}, {'period': '2022', 'revenue': 582.1, 'unit': 'M', 'net_profit': -5.25}, {'period': '2021', 'revenue': 578.49, 'unit': 'M', 'net_profit': 23.55}]","[{'period': ""Q2 '25"", 'revenue': 282.6, 'unit': 'M', 'net_profit': -1.55}, {'period': ""Q1 '25"", 'revenue': 279.22, 'unit': 'M', 'net_profit': -1.37}, {'period': ""Q4 '24"", 'revenue': 198.32, 'unit': 'M', 'net_profit': -2.16}, {'period': ""Q3 '24"", 'revenue': 168.59, 'unit': 'M', 'net_profit': -7.05}, {'period': ""Q2 '24"", 'revenue': 122.68, 'unit': 'M', 'net_profit': -11.55}, {'period': ""Q1 '24"", 'revenue': 123.92, 'unit': 'M', 'net_profit': -10.56}]",-0.57,-0.57,368546000,169087000,50488000,151721000,111849000,0,126398000,50488000,-4686000,-1.3054443554843875,0.5450439984898208,0.5546875,__nan__,__nan__,__nan__,0.4116745263820527
347,QQQX,Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest,"Nuveen Nasdaq 100 Dynamic Overwrite Fund is a closed-ended equity indexed mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Asset Management, LLC and Nuveen Fund Advisors LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in the stocks of large-cap companies. The fund also invests through index call options. It seeks to replicate the performance of its portfolio against the NASDAQ 100 Index. The fund was previously known as NASDAQ Premium Income & Growth Fund Inc. Nuveen Nasdaq 100 Dynamic Overwrite Fund was formed on January 30, 2007 and is domiciled in the United States.",Mr. John G. Wenker,Asset Management,23.47,USD,1145964996,https://images.financialmodelingprep.com/symbol/QQQX.png,179485,3.58,2.16,497195,0,320055677,"[{'period': '2024', 'revenue': 320.99, 'unit': 'M', 'net_profit': 320.06}, {'period': '2023', 'revenue': 53.78, 'unit': 'M', 'net_profit': 327.5}, {'period': '2022', 'revenue': -375.04, 'unit': 'M', 'net_profit': -376.01}, {'period': '2021', 'revenue': 220.53, 'unit': 'M', 'net_profit': 219.63}]","[{'period': ""Q2 '24"", 'revenue': 21.69, 'unit': 'M', 'net_profit': 179.41}, {'period': ""Q4 '23"", 'revenue': 88.5, 'unit': 'M', 'net_profit': 60.57}, {'period': ""Q2 '23"", 'revenue': -34.71, 'unit': 'M', 'net_profit': 266.93}, {'period': ""Q4 '22"", 'revenue': 6.75, 'unit': 'M', 'net_profit': -71.37}, {'period': ""Q2 '22"", 'revenue': 108.18, 'unit': 'M', 'net_profit': 47.02}, {'period': ""Q4 '21"", 'revenue': 70.99, 'unit': 'M', 'net_profit': 45.05}]",6.55,6.55,1443582771,0,0,7533896,173692,1443243092,0,0,0,-1,-0.022740279193188075,-0.028189910979228544,"[0.56, 0.304]","['2025-03-14', '2007-03-20']",__nan__,0.005218887445422414
348,QRHC,Quest Resource Holding Corporation Common Stock,"Quest Resource Holding Corporation, together with its subsidiaries, provides solutions for the reuse, recycling, and disposal of various waste streams and recyclables in the United States. It offers disposal and recycling services for motor oil and automotive lubricants, oil filters, scrap tires, oily water, goods destruction, food waste, meat renderings, cooking oil and grease trap waste, plastics, cardboard, metal, glass, mixed paper, construction debris, as well as a large variety of regulated and non-regulated solid, liquid, and gas wastes. The company provides santifreeze and windshield washer fluid, dumpster and compacting equipment, and other minor ancillary services. In addition, it offers landfill diversion services. The company's services focus on the waste streams and recyclables from big box, grocers, and other retailers; automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and internal fleet operators; manufacturing plants; multi-family and commercial properties; restaurant chains and food operations; and construction and demolition projects. It markets its services to automotive, manufacturing, hospitality and retail, construction and demolition, and commercial and multi-family property management industries through direct sales force and strategic partnerships. The company was formerly known as Infinity Resources Holdings Corp. and changed its name to Quest Resource Holding Corporation in October 2013. Quest Resource Holding Corporation was incorporated in 2002 and is based in The Colony, Texas.",Mr. Perry W. Moss,Waste Management,2.69,USD,55431216,https://images.financialmodelingprep.com/symbol/QRHC.png,86480,-3.68,0.28,105838,5812000,-15063000,"[{'period': '2024', 'revenue': 288.53, 'unit': 'M', 'net_profit': -15.06}, {'period': '2023', 'revenue': 288.38, 'unit': 'M', 'net_profit': -7.29}, {'period': '2022', 'revenue': 284.04, 'unit': 'M', 'net_profit': -6.05}, {'period': '2021', 'revenue': 155.72, 'unit': 'M', 'net_profit': 1.69}]","[{'period': ""Q4 '24"", 'revenue': 69.97, 'unit': 'M', 'net_profit': -9.51}, {'period': ""Q3 '24"", 'revenue': 72.77, 'unit': 'M', 'net_profit': -3.39}, {'period': ""Q2 '24"", 'revenue': 73.15, 'unit': 'M', 'net_profit': -1.51}, {'period': ""Q1 '24"", 'revenue': 72650.0, 'unit': 'K', 'net_profit': -655.33}, {'period': ""Q4 '23"", 'revenue': 69.34, 'unit': 'M', 'net_profit': -2.33}, {'period': ""Q3 '23"", 'revenue': 70.43, 'unit': 'M', 'net_profit': -2.05}]",-0.73,-0.73,175645000,75139000,396000,121489000,62252000,0,44391000,396000,-10768000,-0.5565555013669565,-1.0658909917799126,-1.027777777777778,__nan__,__nan__,__nan__,0.6916735460730451
349,QRTEA,Qurate Retail Inc. Series A Common Stock ,"Qurate Retail, Inc., together with its subsidiaries, engages in the video and online commerce industries in North America, Europe, and Asia. The company markets and sells various consumer products primarily through merchandise-focused televised shopping programs, Internet, and mobile applications. It also operates as an online retailer offering women's, children's, and men's apparel; and other products, such as home, accessories, and beauty products through its app, mobile, and desktop applications. The company serves approximately 200 million homes worldwide. The company was formerly known as Liberty Interactive Corporation and changed its name to Qurate Retail, Inc. in April 2018. Qurate Retail, Inc. was founded in 1991 and is headquartered in Englewood, Colorado.",Mr. David L. Rawlinson II,Specialty Retail,0.3588,USD,213508592,https://images.financialmodelingprep.com/symbol/QRTEA.png,2999643,-0.5053521126760563,-0.0012,1646589,-1121000000,-1290000000,"[{'period': '2024', 'revenue': 9.0, 'unit': 'B', 'net_profit': -1.29}, {'period': '2023', 'revenue': 10910.0, 'unit': 'M', 'net_profit': -145.0}, {'period': '2022', 'revenue': 12.11, 'unit': 'B', 'net_profit': -2.53}, {'period': '2021', 'revenue': 14040.0, 'unit': 'M', 'net_profit': 340.0}]","[{'period': ""Q4 '24"", 'revenue': 2940.0, 'unit': 'M', 'net_profit': -17.0}, {'period': ""Q3 '24"", 'revenue': 2340.0, 'unit': 'M', 'net_profit': -23.0}, {'period': ""Q2 '24"", 'revenue': 2410.0, 'unit': 'M', 'net_profit': 20.0}, {'period': ""Q1 '24"", 'revenue': 2340.0, 'unit': 'M', 'net_profit': -1.0}, {'period': ""Q4 '23"", 'revenue': 3140.0, 'unit': 'M', 'net_profit': -273.0}, {'period': ""Q3 '23"", 'revenue': 2480.0, 'unit': 'M', 'net_profit': 1.0}]",0,0,9243000000,3299000000,905000000,10128000000,1143000000,0,2724000000,0,525000000,-2.213203463203463,-7.896551724137931,1,"[1.25, 1.5]","['2021-11-12', '2020-08-28']",__nan__,1.0957481337228172
350,QRTEB,Qurate Retail Inc. Series B Common Stock ,"Qurate Retail, Inc., together with its subsidiaries, engages in the video and online commerce industries in North America, Europe, and Asia. The company markets and sells various consumer products primarily through merchandise-focused televised shopping programs, Internet, and mobile applications. It also operates as an online retailer offering women's, children's, and men's apparel; and other products, such as home, accessories, and beauty products through its app, mobile, and desktop applications. The company serves approximately 200 million homes worldwide. The company was formerly known as Liberty Interactive Corporation and changed its name to Qurate Retail, Inc. in April 2018. Qurate Retail, Inc. was founded in 1991 and is headquartered in Englewood, Colorado.",Mr. David L. Rawlinson II,Specialty Retail,2,USD,51319600,https://images.financialmodelingprep.com/symbol/QRTEB.png,182009,-2.816901408450704,-0.02,5451,-440000000,-1290000000,"[{'period': '2024', 'revenue': 10.04, 'unit': 'B', 'net_profit': -1.29}, {'period': '2023', 'revenue': 10910.0, 'unit': 'M', 'net_profit': -145.0}, {'period': '2022', 'revenue': 12.11, 'unit': 'B', 'net_profit': -2.59}, {'period': '2021', 'revenue': 14040.0, 'unit': 'M', 'net_profit': 340.0}]","[{'period': ""Q4 '24"", 'revenue': 2.94, 'unit': 'B', 'net_profit': -1.29}, {'period': ""Q3 '24"", 'revenue': 2340.0, 'unit': 'M', 'net_profit': -23.0}, {'period': ""Q2 '24"", 'revenue': 2410.0, 'unit': 'M', 'net_profit': 20.0}, {'period': ""Q1 '24"", 'revenue': 2340.0, 'unit': 'M', 'net_profit': -1.0}, {'period': ""Q4 '23"", 'revenue': 3140.0, 'unit': 'M', 'net_profit': -273.0}, {'period': ""Q3 '23"", 'revenue': 2480.0, 'unit': 'M', 'net_profit': 1.0}]",-3.26,-3.25,9243000000,3299000000,905000000,10128000000,1143000000,0,2724000000,905000000,289000000,-1.4761904761904763,-7.896551724137931,-7.81081081081081,"[1.25, 1.5]","['2021-11-12', '2020-08-28']",__nan__,1.0957481337228172
351,QRTEP,Qurate Retail Inc. 8.0% Fixed Rate Cumulative Redeemable Preferred Stock,"Qurate Retail, Inc., together with its subsidiaries, engages in the video and online commerce industries in North America, Europe, and Asia. The company markets and sells various consumer products primarily through merchandise-focused televised shopping programs, Internet, and mobile applications. It also operates as an online retailer offering women's, children's, and men's apparel; and other products, such as home, accessories, and beauty products through its app, mobile, and desktop applications. The company serves approximately 200 million homes worldwide. The company was formerly known as Liberty Interactive Corporation and changed its name to Qurate Retail, Inc. in April 2018. Qurate Retail, Inc. was founded in 1991 and is headquartered in Englewood, Colorado.",Mr. David L. Rawlinson II,Specialty Retail,39.91,USD,130027858,https://images.financialmodelingprep.com/symbol/QRTEP.png,46165,120.21084337349397,0.41,21526,-440000000,-1290000000,"[{'period': '2024', 'revenue': 10.04, 'unit': 'B', 'net_profit': -1.29}, {'period': '2023', 'revenue': 10910.0, 'unit': 'M', 'net_profit': -145.0}, {'period': '2022', 'revenue': 12.11, 'unit': 'B', 'net_profit': -2.59}, {'period': '2021', 'revenue': 14040.0, 'unit': 'M', 'net_profit': 340.0}]","[{'period': ""Q4 '24"", 'revenue': 2.94, 'unit': 'B', 'net_profit': -1.29}, {'period': ""Q3 '24"", 'revenue': 2340.0, 'unit': 'M', 'net_profit': -23.0}, {'period': ""Q2 '24"", 'revenue': 2410.0, 'unit': 'M', 'net_profit': 20.0}, {'period': ""Q1 '24"", 'revenue': 2340.0, 'unit': 'M', 'net_profit': -1.0}, {'period': ""Q4 '23"", 'revenue': 3140.0, 'unit': 'M', 'net_profit': -273.0}, {'period': ""Q3 '23"", 'revenue': 2480.0, 'unit': 'M', 'net_profit': 1.0}]",-3.26,-3.25,9243000000,3299000000,905000000,10128000000,1143000000,0,2724000000,905000000,289000000,-1.4761904761904763,-7.896551724137931,-7.81081081081081,"[2, 2.016]","['2025-02-28', '2020-11-27']",__nan__,1.0957481337228172
352,QRVO,Qorvo Inc. Common Stock,"Qorvo, Inc. develops and commercializes technologies and products for wireless, wired, and power markets worldwide. The company operates through two segments, Mobile Products, and Infrastructure and Defense Products. It offers mobile devices, such as smartphones, wearables, laptops, tablets and other devices; radio frequency power management integrated circuits, ultra-wideband (UWB) system-on-a-chip (SoC) and system-in-package (SiP) solutions, MEMS-based sensors, antenna tuners, and antennaplexers, as well as discrete multiplexers, duplexers, filters, and switches; and cellular base stations include switch-low noise amplifier (LNA) modules, variable gain amplifiers, integrated power amplifier (PA) Doherty modules, discrete LNAs, and high power GaN amplifiers. The company's also provides SiC products, such as Schottky diodes and transistors for automotive, industrial, IT infrastructure and renewable energy markets; SoC hardware, firmware, and application software for smart home applications; power management solutions include programmable power management integrated circuits (ICs) and power application controllers; RF products and compound semiconductor foundry services to defense primes and other global defense and aerospace customers; RF connectivity and UWB SoC solutions for automotive connectivity; and Wi-Fi products, such as PAs, switches, LNAs and bulk acoustic wave filters, as well as integrated solutions including front end modules (FEMs) and integrated FEMs. It sells its products directly to original equipment manufacturers and original design manufacturers, as well as through a network of sales representative firms and distributors. The company was founded in 1957 and is headquartered in Greensboro, North Carolina.",Mr. Robert A. Bruggeworth,Semiconductors,62.11,USD,5800875248,https://images.financialmodelingprep.com/symbol/QRVO.png,2939781,221.82,11.3,5892107,463738000,-70322000,"[{'period': '2024', 'revenue': 3770.0, 'unit': 'M', 'net_profit': -70.32}, {'period': '2023', 'revenue': 3570.0, 'unit': 'M', 'net_profit': 103.15}, {'period': '2022', 'revenue': 4.65, 'unit': 'B', 'net_profit': 1.03}, {'period': '2021', 'revenue': 4019.9999999999995, 'unit': 'M', 'net_profit': 733.61}]","[{'period': ""Q3 '25"", 'revenue': 916.32, 'unit': 'M', 'net_profit': 41.27}, {'period': ""Q2 '25"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': -17.43}, {'period': ""Q1 '25"", 'revenue': 886670.0, 'unit': 'K', 'net_profit': 414.0}, {'period': ""Q4 '24"", 'revenue': 940.99, 'unit': 'M', 'net_profit': 2.73}, {'period': ""Q3 '24"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': -126.94}, {'period': ""Q2 '24"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 97.46}]",-0.72,-0.72,6554635000,2446034000,1029258000,2998263000,427387000,23252000,1230087000,1029258000,705959000,-0.12821370831296763,-1.6817318132464711,-1.7128712871287128,__nan__,__nan__,__nan__,0.4574263860611613
353,QTNT,Quotient Limited Ordinary Shares,"Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.",Mr. Franz Walt,Medical - Devices,0.38,USD,0,https://images.financialmodelingprep.com/symbol/QTNT.png,1673127,0,0,5811488,-84798000,-125130000,"[{'period': '2022', 'revenue': 38.51, 'unit': 'M', 'net_profit': -125.13}, {'period': '2021', 'revenue': 43.38, 'unit': 'M', 'net_profit': -108.47}, {'period': '2020', 'revenue': 32.66, 'unit': 'M', 'net_profit': -102.77}, {'period': '2019', 'revenue': 29.13, 'unit': 'M', 'net_profit': -105.39}]","[{'period': ""Q3 '23"", 'revenue': 9.95, 'unit': 'M', 'net_profit': -13.32}, {'period': ""Q2 '23"", 'revenue': 8.86, 'unit': 'M', 'net_profit': -45.93}, {'period': ""Q1 '23"", 'revenue': 8.81, 'unit': 'M', 'net_profit': -38.87}, {'period': ""Q4 '22"", 'revenue': 9.79, 'unit': 'M', 'net_profit': -25.91}, {'period': ""Q3 '22"", 'revenue': 10.17, 'unit': 'M', 'net_profit': -44.82}, {'period': ""Q2 '22"", 'revenue': 9.47, 'unit': 'M', 'net_profit': -27.11}]",-49.11,-49.11,193989000,101754000,67685000,338087000,6272000,15467000,32828000,65059000,-121895000,-0.1776518623448046,-0.15359085461417904,-0.03717001055966205,__nan__,__nan__,__nan__,1.7428153142703968
